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Ablation-catheter
A Randomized Study of Prophylactic Catheter Ablation 
in High-Risk Children With Asymptomatic 
Wolff-Parkinson-White Syndrome 1090-222·124A
Ablation of Postinfarction Ventricular Tachycardias 
Targeting Delayed Local Potentials Guided by 
Electroanatomical Mapping  890-6·154A
Ablation of Superior Pulmonary Veins Compared to 
Ablation of All Four Pulmonary Veins: A Randomized 
Clinical Trial 1071-223·118A
Accurate Identification of Pulmonary Vein Ostia With 
Real-Time Impedance Measurements 
1052-221·114A
Acute Resumption of Conduction in the Cavotricuspid 
Isthmus After Catheter Ablation of Common Atrial 
Flutter: Impact of Isthmus Anatomy 1090-216·123A
An Analysis of Patients With Hypertrophic Obstructive 
Cardiomyopathy and Persisting New York Heart 
Association Class III Symptoms During Long-Term 
Follow-Up After Septal Ablation 1032-132·167A
Atrial Tachycardia Originating From the Pulmonary 
Veins: Is Single Vein Isolation Adequate? 
1090-220·124A
Catheter-Based Cryoablation of Ventricular 
Tachycardia: First Clinical Experience  890-3·154A
Chronic Cure Rate After Pulmonary Vein Isolation in 
Patients With Nonparoxysmal Atrial Fibrillation: 
Impact of a Second Ablation  828-3·133A
Circumferential and Combined Technique in 
Cryoisolation of Pulmonary Veins: The "Arctic Circler" 
Experience 1071-208·117A
Computed Tomography Guided Evaluation of 
Pulmonary Vein Anatomy Following Percutaneous 
Cryoablation: 12-Month Results 1166-213·145A
Contribution of Epicardial Mapping and Ablation to 
Treatment of Patients With Previously Failed 
Accessory Pathway Ablations 1090-214·123A
Coronary Sinus Os and Fossa Ovalis Ablation: Effect 
on Interatrial Conduction and Inducibility of Atrial 
Fibrillation 1014-210·105A
Cryoablation of Atrial Flutter: Results of a Multicenter 
Clinical Study 1090-219·124A
Definition of the Pulmonary Vein Ostia During Isolation 
Procedures: Comparison Between the CARTO 
Approach and Intracardiac Echo Guided Isolation  
828-5·133A
Determinants of Natural Regression of Pulmonary Vein 
Stenosis Secondary to Radiofrequency Catheter 
Ablation for Atrial Fibrillation 1001-18·5A
Do Single Cryothermia Applications of Less Than Five 
Minutes Produce Permanent Cavotricuspid Isthmus 
Block in Humans? 1090-217·123A
Does Catheter Ablation of Atrial Fibrillation Alter 
Intrinsic Left Atrial Mechanical Function? 
1052-223·115A
Early Changes in Pulmonary Vein Activation Predict 
Effectiveness During Pulmonary Vein Isolation Using 
a Novel Curvilinear Cryoablation Catheter 
1052-219·114A
Effects of Alcohol Septal Ablation Versus Surgical 
Myectomy on the Cardiac Conduction System 
1032-126·166A
Efficacy of Cryoablation for Treatment of Paroxysmal 
Atrial Fibrillation 1166-216·145A
Electroanatomical Mapping to Assess Phrenic Nerve 
Proximity to Superior Vena Cava and Pulmonary Vein 
Ostia  860-3·149A
Expedited Geometric Rendering of Left Atrium and 
Pulmonary Veins Using Multipoint Electroanatomical 
Mapping 1071-207·117A
Factors Predictive of a Late Recurrence of Atrial 
Fibrillation After Segmental Pulmonary Vein Isolation  
828-2·133A
Identification and Characterization During Sinus 
Rhythm of a Mitral Isthmus in Patients With Inferior 
Myocardial Infarction and Monomorphic Ventricular 
Tachycardia  890-4·154A
Impairment of Left Atrial Appendage Mechanical 
Function Following Electrical Isolation With Epicardial 
Radiofrequency Bipolar Ablation 1086-137·432A
Incremental Value of Isolating the Right Inferior 
Pulmonary Vein During Pulmonary Vein Isolation 
Procedures in Patients With Paroxysmal Atrial 
Fibrillation  828-4·133A
Initial Results From the Substrate Mapping and Ablation 
in Sinus Rhythm to Halt Ventricular Tachycardia Trial 
(SMASH VT)  890-2·153A
Initial Results of Anatomical Pulmonary Vein Isolation 
for Atrial Fibrillation 1071-220·118A
Left Atrial Flutter Following Circumferential Pulmonary 
Vein Ablation for the Treatment of Atrial Fibrillation 
1052-208·114A
Left Atrial Flutter Post Pulmonary Vein Isolation: Draw a 
Line or Reisolation of the Recovered Pulmonary Vein 
Ostium? 1052-207·114A
Modes of Failure in Pulmonary Vein Isolation With 
Circumferential Laser Energy Ablation 
1071-225·119A
Modification of Electrophysiologic Properties of 
Pulmonary Veins and Adjacent Left Atrial Tissue by 
Radiofrequency Circumferential Ablation of the 
Pulmonary Vein Ostia: Correlation With 
Nonrecurrence of Atrial Fibrillation 1166-218·146A
Morphological Features of Marshall Ligament Tissue 
and Interatrial Septum in Patients With Repeated 
Pulmonary Vein Isolation: An Intracardiac 
Echocardiographic Imaging Study 1052-225·115A
Morphology of Intraoperative Radiofrequency Ablation 
to Treat Atrial Fibrillation  860-2·148A
Mortality of Heart Failure Patients From the General 
Population: Effects of the Therapeutic Regimen 
1069-112·180A
New Simplified Technique for 3-D Mapping and Ablation 
of Right Ventricular Outflow Tachycardia 
1130-225·138A
Optimal Catheter Ablation Strategy for Atrial Fibrillation: 
Trigger Isolation Alone or Supplementary Left Atrial 
Substrate Modification? 1001-19·5A
Percutaneous Cryothermic Pulmonary Vein Isolation for 
the Treatment of Atrial Fibrillation: Impact of Specific 
Catheter Design 1071-224·118A
Pre-Existent Left Atrial Scarring in Patients Undergoing 
Pulmonary Vein Isolation: An Independent Predictor 
of Procedural Failure 1052-224·115A
Prevalence of Asymptomatic Recurrences of Atrial 
Fibrillation After Successful Radiofrequency Catheter 
Ablation 1071-221·118A
Pulmonary Vein Isolation in Patients With Prior Cardiac 
Surgery 1166-212·144A
Pulmonary Vein Isolation to Prevent Atrial Fibrillation: 
Long-Term Safety, Efficacy, and Predictors of 
Outcome  828-1·132A
Radiation Skin Exposure, Effective Organ Doses, and 
Estimated Cancer Risk for Pulmonary Vein and 
Cavotricuspid Isthmus Ablation Using a Low Frame 
Pulsed Fluoroscopy System 1090-221·124A
Randomized Comparison of Anatomical Versus 
Voltage-Guided Ablation of the Cavotricuspid Isthmus 
for Atrial Flutter 1090-218·124A
Recovery of Left Atrial Function After Successful 
Radiofrequency Catheter Ablation in Patients With 
Paroxysmal Atrial Fibrillation 1038-153·319A
Registration of Cardiac Computed Tomography Images 
With Three-Dimensional Electroanatomical Mapping 
to Guide Catheter Manipulation in the Left Atrium: 
Implications for Pulmonary Venous Isolation 
1052-226·115A
Registration of Cardiac Magnetic Resonance Images 
With Three-Dimensional Electroanatomical Mapping 
to Guide Catheter Ablation in the Left Ventricle 
1110-221·130A
Remodeling of the Left Atrium and Pulmonary Veins 
Following Catheter Ablation of Atrial Fibrillation 
1071-219·117A
Remote Catheter Ablation Using the New Magnetic 
Navigation System Niobe  860-4·149A
Safety and Efficacy of Catheter Ablation of Atrial 
Fibrillation Using an Irrigated-Tip Ablation Catheter 
1052-220·114A
Safety and Efficacy of Freezor MAX, A New 9FR, 8mm 
Tip Cryoablation Catheter for the Treatment of Atrial 
Flutter 1090-215·123A
Structural Heart Disease Does Not Affect Outcomes of 
Pulmonary Vein Isolation for Treatment of Atrial 
Fibrillation  828-6·133A
Subclinical Pulmonary Vein Narrowing Is Common 
Following Atrial Fibrillation Ablation 1071-226·119A
Surface Electrocardiogram Clues to Localization of 
Ventricular Tachycardia to the Aortic Cusps 
1130-226·138A
The Sinus Nodal Tissue Arrangement Into the 
Musculature of the Terminal Crest: Implications in 
Ablation of Inappropriate Sinus Node Tachycardia? 
1090-213·123A
Thromboembolic Events in Patients Undergoing Atrial 
Fibrillation Ablation-Incidence, Timing, and Predictors 
1052-222·115A
Utility of Intracardiac Echocardiography to Guide 
Radiofrequency Catheter Ablation of Ventricular 
Tachycardia of Different Etiologies 1150-152·359A
Younger Age at Time of Symptom Onset Is Associated 
With Nonpulmonary Vein Triggers of Atrial Fibrillation 
1014-207·105A
Accessory pathways
A Randomized Study of Prophylactic Catheter Ablation 
in High-Risk Children With Asymptomatic 
Wolff-Parkinson-White Syndrome 1090-222·124A
Cardiac Conduction System-L acZ Expression in the 
Atrioventricular Ring and Moderator Band of 
Transgenic Murine Embryos: A Developmental 
Substrate for Wolff-Parkinson-White Syndrome and 
Mahaim Tachycardia? 1001-17·4A
Device Closure of Atrial Septal Defect After the Fifth 
Decade of Life: Beneficial Effect on Symptoms and 
Ventricular Function 1019-201·376A
Nicotine Administration Significantly Alters Peripheral, 
Bone Marrow and Splenic Stem Cell Populations in 
C57/Bl6 Mice. 1104-191·490A
Usefulness of a Ventricular Extrastimulus From the 
Summit of the Ventricular Septum in Diagnosis of 
Septal Accessory Pathway 1166-214·145A
Accessory pathways, ablation
A Randomized Study of Prophylactic Catheter Ablation 
in High-Risk Children With Asymptomatic 
Wolff-Parkinson-White Syndrome 1090-222·124A
Contribution of Epicardial Mapping and Ablation to 
Treatment of Patients With Previously Failed 
Accessory Pathway Ablations 1090-214·123A
Cryoablation for Septal Tachycardia Substrates in 
Pediatric Patients 1171-202·393A
ACE inhibitor
Added Ramipril to Simvastatin Shows Additive Effects 
on Flow-Mediated Dilation and Inflammation Markers 
in Diabetic and Hypercholesterolemic Patients: A 
Randomized, Double-Blind, Placebo-Controlled, 
Crossover Study 1065-166·467A
Angiotensin-Converting Enzyme Inhibitors Are 
Comparable to Angiotensin II Receptor Blockers in 
the Primary Prevention of Myocardial Infarction in 
Hypertensive Patients  888-4·531A
Contemporary Dosing of Angiotensin Converting 
Enzyme Inhibitors and Beta Blockers in Chronic 
Heart Failure: Report From the STAMINA:HFP (Study 
of Anemia in a Heart Failure Population) Registry 
1012-126·158A
Dose-Response Study of the Efficacy and Safety of 
Fosinopril in Children With Hypertension: A 
Randomized, Double-Blind, Placebo-Controlled, 
Multicenter Clinical Trial 1085-167·482A
Effect of Fosinopril and Pravastatin on Albuminuria in a 
Nonhypertensive, Nonhypercholesterolemic 
Population 1007-171·443A
Effect of Fosinopril and Pravastatin on Carotid 
Intima-Media-Thickness in Microalbuminuric Subjects 
Without Hypertension or Hypercholesterolemia  
825-4·495A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Intima-Media-Thickness in 
Microalbuminuric Patients Without Hypertension 
1007-172·443A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Urinary Albumin Excretion  
825-3·495A
Effects of Intracoronary Low-Dose Enalaprilat on QT 
Dynamicity in Patients Undergoing Direct 
Percutaneous Coronary Intervention for Acute 
Myocardial Infarction 1118-80·290A
Effects of Ramipril on Left Ventricular Size, Mitral 
Regurgitation Severity, Exercise Time, and Quality of 
Life in Asymptomatic Patients With Mitral 
Regurgitation  868-5·441A
Effects of Zofenopril on Ischemia Following Myocardial 
Infarction: The SMILE Study 1061-87·263A
Enalapril Can Prevent Perpetuation of Atrial Fibrillation 
Through Suppression of Interstitial Fibrosis and 
Connexin43 Expression Associated With Shortening 
of Excitable Gap in a Canine Rapid Atrial Pacing 
Model With Tachycardia-Mediated Cardiomyopathy 
1034-208·110A
Enhancing Quality of Heart Failure Care in Managed 
Medicare and Medicaid in North Carolina: Results of 
the North Carolina Achieving Cardiac Excellence (NC 
ACE) Project 1077-73·406A
High Angiotensin II Responsiveness Relates to 
Decreased Endothelium Dependent Relaxation in 
Human Arteries 1027-186·450A
Hydrochlorothiazide Further Improves Survival During 
Angiotensin-Converting Enzyme Inhibitor Therapy 
After Experimental Myocardial Infarction 
1041-100·257A
Impact of Combination Evidence-Based Medical 
Therapy on Mortality in Patients With Acute Coronary 
Syndromes 1137-98·298A
Improvement Initiatives Should Specifically Target 
Patients Admitted With Acute Myocardial Infarction 
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Who Undergo Coronary Artery Bypass Surgery 
Before Hospital Discharge: Lessons From the 
Guidelines Applied in Practice Projects  846-5·419A
Improvement of Endothelial Function in Patients With 
Myocardial Inflammation by Angiotensin-Converting 
Enzyme Inhibition With Quinapril: A Randomized 
Double-Blind, Placebo Controlled Study 
1013-114·161A
Neutral Endopeptidase Inhibition Augments the 
Vascular Actions of Bradykinin in Patients With Heart 
Failure on Chronic Angiotensin-Converting Enzyme 
Inhibitor Therapy 1012-127·158A
Predictors of Mortality in 1,346 Patients With Heart 
Failure Scheduled for Guideline-Based Treatment 
1069-110·179A
Racial Differences in Blood Pressure Response in 
Children With Hypertension Treated With Fosinopril 
1114-205·387A
Should Beta-Blockers Be Used Before Angiotensin 
Converting Enzyme Inhibitors in Patients With 
Chronic Heart Failure? Meta-Analysis of the 
Prognostic Benefit Conferred by Beta-Blockers in 
Patients Not Receiving ACE Inhibitors  821-1·195A
Simvastatin Combined With Ramipril Improved 
Endothelium-Dependent Vasodilation and 
Fibrinolysis Potential and Reduced Oxidant Stress 
and Inflammation Markers in Hypercholesterolemic 
Patients 1159-193·519A
Synergistic Effects of the Addition of Candesartan to 
Enalapril on Myocardial Fibrosis and Left Ventricular 
Diastolic Function in Dogs With Heart Failure 
1087-105·188A
The Angiotensin II Type Receptor A1166C 
Polymorphism and Heart Failure Outcomes 
1031-104·163A
The G1675A Gene Polymorphism of the Angiotensin II 
Type 2-Receptor Gene Influences Cardiac Structural 
Response to Antihypertensive Therapy 
1142-178·511A
The Influence of Duration of Atrial Fibrillation on 
Maintenance of Sinus Rhythm by Angiotensin II 
Modulators After Electrical Cardioversion 
1014-214·106A
The Long-Term Impact of Initiating Treatment With the 
Angiotensin-Converting Enzyme Inhibitor Trandolapril 
After a Myocardial Infarction in Patients With Left 
Ventricular Dysfunction: A 10- to 12-Year Follow-Up 
Study 1012-128·159A
Treatment With Inhibitors of Angiontensin-Converting 
Enzyme Improves the Prognosis of Congestive Heart 
Failure With Preserved Systolic Function  887-6·242A
Trends in the Use of Effective Cardiac Medications in 
Patients With Acute Myocardial Infarction: The 
GRACE Experience 1061-85·262A
Use of Angiotensin-Converting Enzyme Inhibitors After 
Acute Myocardial Infarction Is Associated With a 
Striking Reduction in 30-Day and One-Year Mortality: 
Insights From GUSTO V  833-1·286A
Acetylcholine
Clinical Impact of Selective Spasm Provocation Tests: 
Comparisons Between Acetylcholine and Ergonovine 
in 1,508 Consecutive Examinations 1119-100·293A
Coronary Vascular Dysfunction Is Only Partially 
Predicted by Traditional Cardiovascular Risk Factors 
in Women Undergoing Evaluation for Suspected 
Ischemia: Results From the National Heart, Lung, 
and Blood Institue WISE Study  819-3·484A
Influence of Genetic and Nongenetic Factors on 
Endothelium-Dependent Microvascular Reactivity in 
the National Heart, Lung, and Blood 
Institute-Sponsored Women’s Ischemia Syndrome 
Evaluation (WISE) 1027-193·452A
Spironolactone Improves Coronary Endothelial 
Function in Patients With Chronic Heart Failure 
1159-195·519A
Tetrahydrobiopterin Corrects Escherichia Coli 
Endotoxin-Induced Endothelial Dysfunction 
1027-196·452A
Venous Endothelium Dysfunction Is Also Presented in 
Hypertensive Patients 1059-11·13A
Acquired immunodeficiency syndrome
Effect of Pravastatin on Endothelial Function in Human 
Immunodeficiency Virus-Infected Persons on 
Protease Inhibitor-Containing Antiretroviral 
Combination Therapy 1008-187·446A
Effects of Pravastatin on Lipoproteins and Endothelial 
Function in Patients Receiving Human 
Immunodeficiency Virus Protease Inhibitors  
882-3·529A
Endothelial Dysfunction in Children With Human 
Immunodeficiency Virus: Impact of Disease and 
Protease Inhibitor Therapy  819-1·484A
HIV Cardiomyopathy Is Rare in the Era of Highly Active 
Antiretroviral Therapy 1013-117·161A
Adenosine
Abnormal Hemodynamic Response to Adenosine and 
Poststress Left Ventricular Ejection Fraction Provide 
Incremental Prognostic Information in Patients 
Undergoing Gated Myocardial Perfusion SPECT 
1170-144·368A
Are High Doses of Intracoronary Adenosine an 
Alternative to Standard Intravenous Adenosine for the 
Assessment of Fractional Flow Reserve? 
1157-44·93A
Caffeine Acutely Decreases Coronary Flow Reserve in 
Patients With Coronary Artery Disease 
1170-145·368A
Coronary Vascular Dysfunction Is Only Partially 
Predicted by Traditional Cardiovascular Risk Factors 
in Women Undergoing Evaluation for Suspected 
Ischemia: Results From the National Heart, Lung, 
and Blood Institue WISE Study  819-3·484A
Diagnostic Value of Adenosine Stress Magnetic 
Resonance (MR) Perfusion Imaging and Delayed MR 
Hyperenhancement Compared to Tl-201 SPECT and 
Coronary Angiography for Detection of Coronary 
Artery Disease and Myocardial Scar Tissue  
836-4·354A
Differential Vasodilatory Effects of CVT-3146, an A2A 
Adenosine Receptor Agonist in Various Vascular 
Beds in Anesthetized Dogs 1170-142·367A
Diltiazem Attenuates the Coronary Vasodilatory 
Response to Adenosine and Reduces the Regional 
Myocardial Blood Flow Disparity and Sestamibi 
Defect Magnitude in Dogs With Critical Coronary 
Stenoses 1170-143·368A
Effect of Acute Administration of L-Propionylcarnitine 
on Coronary Flow Velocity Reserve in Patients With 
Systemic Sclerosis 1164-132·231A
Effect of Caffeine on Fractional Flow Reserve 
1170-146·368A
Effect of Tadalafil, a Phosphodiesterase 5 Inhibitor, on 
Myocardial Blood Flow in Patients With Coronary 
Artery Disease 1170-147·369A
Hemodynamic Impairment of Intermediate Stenoses in 
Saphenous Vein Coronary Artery Bypass Grafts and 
Recipient Vessels: Evaluation by Doppler Flow 
Velocity 1157-46·93A
Initial Results Regarding the Safety, Tolerability, and 
Hemodynamic Effects of CVT-3146, a Selective 
Adenosine A2A Agonist, in Patients Undergoing 
Pharmacologic Stress SPECT Myocardial Perfusion 
Imaging 1170-141·367A
Intravenous Glucose Loading Attenuates Coronary 
Flow Velocity Reserve Due to Increased Baseline 
Coronary Flow Velocity in Healthy Volunteers 
1073-149·327A
Lesion Severity Index, a New Nonhyperemic 
Physiologic Parameter for the Assessment of 
Coronary Artery Stenosis: A Comparison to 
Fractional Flow Reserve 1157-41·92A
Steady State Free Precession Perfusion Allows Visual 
Assessment for the Clinical Diagnosis of Ischemia 
1169-154·366A
Utility of Adenosine in Differentiation of Patients With 
Right Ventricular Outflow Tract Tachycardia and 
Arrhythmogenic Right Ventricular Dysplasia 
1130-223·137A
Aging
Age-Related Changes in Adaptation of the Heart to 
Ischemia-Reperfusion: A Possible Role for NADPH 
Oxidase-Induced Superoxide Production 
1002-81·243A
Age-Related Complications and Outcomes After 
Primary Percutaneous Coronary Interventions 
1070-104·182A
Age-Related Left Ventricular Function Alterations in 
Mice: A Tissue Doppler Imaging Study  866-6·373A
Calcification of the Fibrous Skeleton of the Base of the 
Heart, Aortic Valve Sclerosis and Prevalent 
Cardiovascular Disease in the Elderly: The 
Cardiovascular Health Study 1128-125·212A
Carotid Artery Intima-Media Thickness Progression 
Rates in Young Adults: The Bogalusa Heart Study 
1082-188·478A
Clinical Outcomes of Elective Contemporary 
Percutaneous Coronary Interventions in 
Octogenarians: Insight From the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium 
1059-29·17A
Correlation Between the Extent of Diseased Vessels 
and the Incidence of In-Hospital Cardiac Mortality in 
Acute Myocardial Infarction  885-3·240A
Do Elderly Patients With Acute Myocardial Infarction 
Show the "Smoker´s Paradox"? Results From the 
PPRIMM75 Registry 1128-131·214A
Does Use of Harmonic Imaging Increase the Yield of 
Echocardiographic Left Ventricular Mass 
Measurements on a Population Basis? The Strong 
Heart Study 1112-149·342A
Effect of Aromatase Inhibition on Lipids and 
Inflammatory Markers of Cardiovascular Disease in 
Elderly Hypogonadal Men: A Double-Blind 
Placebo-Controlled Randomized Trial 1070-103·182A
Elderly Acute Coronary Syndrome Patients Were 
Undertreated With Worse One-Year Outcome: 
Findings From a Contemporary Registry 
1070-129·183A
Eplerenone Improves Coronary Hemodynamics and 
Reduces Cardiac Fibrosis in Aging Spontaneously 
Hypertensive Rats 1085-194·482A
Eplerenone Normalizes Diastolic Relaxation and 
Extracellular Matrix Accumulation in Aged Rats With 
Myocardial Infarction 1002-84·244A
Gender- and Age-Related Differences in the Prognostic 
Value of C-Reactive Protein in Patients With 
Angiographic Coronary Artery Disease 
1098-83·279A
Increased Capillary Fluid Filtration Rate in Elderly 
Subjects With Symptomatic Hypotension During 
Head-Up Tilt Table Testing 1070-133·184A
Increased Vascular Stiffness and Impaired Ejection 
Fraction in Older Patients Following First Transmural 
Myocardial Infarction 1128-126·212A
Influence of Age on Atrial Fibrillation Induction 
1128-132·214A
Intensive Aerobic Physical Training Decreases 
Age-Related Decline of Left Ventricular Diastolic 
Function 1059-28·17A
National Mortality Trends in Elderly Patients 
Hospitalized With Heart Failure Between 1992 and 
1999  885-1·239A
Prediction of Mortality Risk in the Very Old: Incremental 
Value of Inflammatory Mediators and Surrogate 
Markers of Atherosclerosis 1128-122·212A
Prognostic Implications of Admission Hyperglycemia in 
Elderly Patients With Acute Myocardial Infarction  
885-6·241A
Protective Effect of Diazoxide Is Maintained in Aged 
Heart 1070-131·183A
Rapidly Detective Value of Heart Fatty Acid-Binding 
Protein at Risk for Myocardial Damage in Pediatric 
Cardiac Operation 1039-204·379A
Sex Difference in Age Dependence of Global and 
Regional Repolarisation Heterogeneity 
1070-130·183A
Socioeconomic Status and Outcomes of Elderly 
Patients Hospitalized With Heart Failure 
1135-73·414A
The Blood Pressure Response to the Valsalva 
Maneuver: An Independent Predictor of Mortality in 
Elderly Cardiac Patients 1128-130·214A
The Burden of Vascular Disease in Long-Term 
Follow-Up of Elderly Myocardial Infarction Survivors  
885-2·240A
Valve Surgery in Octogenarians: In-Hospital and 
Long-Term Outcomes 1162-137·440A
Younger Age at Time of Symptom Onset Is Associated 
With Nonpulmonary Vein Triggers of Atrial Fibrillation 
1014-207·105A
Alcohol
Alcohol Consumption and Cardiac Structure and 
Function in American Indians: The Strong Heart 
Study 1163-118·228A
Effects of Wine, Beer, and Whisky on Vascular 
Endothelium and Thrombosis Fibrinolysis System 
1158-56·95A
Enhanced Cardiac Beta3-Adrenergic Functional 
Response in Alcoholic Monkeys 1029-181·456A
Epsilon Protein Kinase C (PKC) Activation by Delta 
PKC in Ethanol-Induced Cardiac Protection From 
Ischemia 1136-81·294A
Moderate Alcohol Use Is Associated With Reduced 
Cardiovascular Risk in Patients Following 
Complicated Acute Myocardial Infarction 
1153-73·417A
Aldosterone
Chronic Therapy With Eplerenone Reduces 
Tubulin-Alpha and -Beta mRNA Expression and 
Increases Titin mRNA Expression in Dogs With Heart 
Failure 1116-13·22A
Cost-Effectiveness of Eplerenone in Patients With 
Heart Failure Postmyocardial Infarction 
1108-122·200A
Eplerenone Normalizes Diastolic Relaxation and 
Extracellular Matrix Accumulation in Aged Rats With 
Myocardial Infarction 1002-84·244A
Suppressive Effects of Eplerenone on Accumulation of 
Extra Cellular Matrix in Neointima After Coronary 
Stent Implantation Using Swine 1158-53·95A
Survival Benefit With Spironolactone Therapy Is Not 
Related to Reduced hsCRP Levels in Severe 
Congestive Heart Failure: Results From a RALES 
Substudy 1108-121·199A
The Effect of Eplerenone on Markers of Cardiac 
Fibrosis: Insights From EPHESUS 1108-123·200A
The Mineralocorticoid Paradox: Profibrotic In Vivo in 
Experimental Asymptomatic Left Ventricular 
Dysfunction but Antifibrotic In Vitro 1116-11·22A
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Torasemide Inhibits Transcardiac Extraction of 
Aldosterone in Patients With Congestive Heart 
Failure 1145-118·221A
Ambulatory blood pressure
Accumulated Physical Activity Improves Arterial 
Compliance and Pressure Load Indices in 
Hypertensive African-American Women 
1009-170·449A
Ambulatory Blood Pressure Predicts Left Ventricular 
Hypertrophy in Prehypertensive Women 
1072-214·120A
Myocardial Sympathetic Denervation Precedes the 
Neurological Involvement in Patients With Familial 
Amyloidotic Polyneuropathy 1056-160·324A
The Effect of Losartan Versus Atenolol on Circulating 
Adhesion Molecules in Essential Hypertension: A 
LIFE Substudy 1007-180·445A
The Effects of Aspirin on Blood Pressure in Untreated 
Hypertensive Patients Are Dependent on the Time of 
Drug Administration 1085-196·483A
Ambulatory ECG
Depressive Symptoms Are Associated With Reduced 
Heart Rate Variability in Individuals Without Coronary 
Artery Disease 1072-215·120A
Effects of Intracoronary Low-Dose Enalaprilat on QT 
Dynamicity in Patients Undergoing Direct 
Percutaneous Coronary Intervention for Acute 
Myocardial Infarction 1118-80·290A
Holter-Based Risk Stratifiers May Increase 
Cost-Effectiveness of Defibrillator Therapy in MADIT 
II-Like Patients 1015-217·107A
PR Interval Prolongation but Not QRS Widening Is an 
Independent Factor of Functional Intolerance in Heart 
Failure Patients With Dilated Cardiomyopathy 
1072-209·119A
Prediction of Cardiac Risk by Phase-Rectified Signal 
Analysis 1148-221·141A
Robust Long-Term Cardiac Monitoring Using Dry, 
Nonadhesive Capacitive Electrodes 1148-223·141A
Suppression of Paroxysmal Atrial Tachyarrhythmias: 
Results of the SOPAT Trial  875-3·151A
Amiodarone
Amiodarone in Survivors of Life-Threatening Ventricular 
Arrhythmias: Does It Improve Outcome? Results of 
the Leiden Out of Hospital Cardiac Arrest Trial 
(LOHCAT) 1053-209·116A
Amiodarone Reduces Major Cardiovascular Morbidity 
After Cardiac Surgery: Results of a Meta-Analysis  
846-6·419A
Both Beta-Blockers and Amiodarone Increase Speed of 
QT / Heart Rate Adaptation 1106-187·494A
Early Recurrence of Arrhythmia Is Common in Patients 
Taking Amiodarone or Type IC Agents for Treatment 
of Atrial Fibrillation or Atrial Flutter  875-6·151A
Electrocardiogram Morphology Predictors of 
Pharmacologic Termination of Ventricular 
Tachycardia 1154-97·301A
Ibutilide Improves Cardioversion Success Rates in 
Patients on Chronic Amiodarone Therapy With 
Persistent Atrial Fibrillation 1129-218·136A
Randomized Trial of Two Antiarrhythmic Agents 
(Amiodarone and Sotalol) in Patients With Atrial 
Fibrillation for Whom Direct Current Cardioversion Is 
Planned  875-5·151A
Short Burst Oral Amiodarone Improves Cardioversion 
Success Rates for Patients in Persistent Atrial 
Fibrillation 1141-193·510A
Aneurysms
Clinical Outcomes From Patients Treated With 
Endovascular Stent Graft for Thoracic Aortic 
Aneurysms 1066-194·471A
Coronary Artery Aneurysms Are an Independent 
Predictor of High Five-Year Mortality 1099-92·282A
Endovascular Stent-Graft Placement for Nonsurgical 
Repair of Descending Aortic Perforations: Acute and 
Follow-Up Results 1066-193·470A
Reduced Shear Stress and Large Shear Stress 
Gradient Cause Coronary Aneurysm and Thrombus 
Formation in Children With Kawasaki Disease 
1157-48·94A
Surgical Treatment of Ascending Aortic Aneurysms in 
Patients With Giant Cell Aortitis 1046-170·460A
Sustained Upregulation of Inflammatory Cytokine and 
Its Receptor Genes Associated With Proteinase 
Activation in Abdominal Aortic Aneurysm: Results 
From Combined Study With cDNA Array and 
Real-Time Reverse Transcriptase Polymerase Chain 
Reaction Methods 1059-12·13A
Usefulness of Plasma Fibrin D-Dimers for 
Differentiation of Acute Versus Chronic Aortic 
Dissection 1046-172·461A
Angina pectoris
A Randomized Double-Blind Placebo-Controlled Phase 
2 Study on the Efficacy and Safety of Fasudil in 
Patients With Stable Angina 1023-96·254A
Blood Pressure Control, Angina Episodes, and 
Cardiovascular Outcomes in Patients With Ischemia: 
The International Verapamil/Trandolapril Study 
1085-197·483A
Can Intravascular Ultrasound Guided Cutting Balloon 
Angioplasty Before Stenting Be a Substitute for Drug 
Eluting Stent? Final Results of the Prospective 
Randomized Multicenter Trial Comparing Cutting 
Balloon With Balloon Angioplasty Before Stenting 
(Reduce III) 1138-66·82A
Clinical Outcomes of Elective Contemporary 
Percutaneous Coronary Interventions in 
Octogenarians: Insight From the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium 
1059-29·17A
Clopidogrel in Unstable Angina Patients Who Would 
Have Been Excluded From Randomized Pivotal Trials 
1137-99·298A
Comprehensive Stress Magnetic Resonance Imaging 
Compared to Stress Echo in the Evaluation of 
Patients Presenting to the Emergency Department 
With Chest Pain  836-5·354A
Contribution of Genetic Characteristics of Vascular 
Adrenergic Receptor to Variant Angina 1136-91·296A
Elevated High-Sensitivity C-Reactive Protein Was 
Associated With Coronary Artery Remodeling in 
Patients With Unstable Angina 1026-59·40A
Eliminating Angina Enhances Patients' Return to Work 
After Percutaneous Coronary Interventon 
1138-45·81A
Enhanced External Counterpulsation Decreases Wave 
Reflection Amplitude and Reduces Left Ventricular 
Afterload and Systolic Stress in Patients With 
Refractory Angina  891-1·307A
Enhanced External Counterpulsation Improves 
Functional Capacity and Quality of Life in Women 
With Chronic Angina  891-3·308A
Factors Impacting Five-Year Survival After 
Percutaneous Coronary Intervention for Chronic Total 
Occlusion 1080-65·57A
Frequency and Results of Repeat Enhanced External 
Counterpulsation for Refractory Angina  891-5·308A
Health Related Quality of Life Is Not Improved in 
Parallel to Chest Pain Symptoms in a Nonselected 
Population of Patients With Coronary Artery Disease 
1099-90·281A
High-Dose Dobutamine Stress Tl-201/I123-BMIPP Dual 
SPECT Reliably Identifies Myocardial Contractile 
Dysfunction Caused by Inducible Demand Ischemia 
1094-157·338A
High-Normal Creatinine: An Underappreciated 
Predictor of Poor Outcomes in Chest Pain Patients 
1098-80·278A
In Women With Symptoms of Ischemic Heart Disease, 
Global and Regional Myocardial Perfusion Status by 
Magnetic Resonance Imaging Better Assigns Risk: 
Results From the National Heart, Lung, and Blood 
Institute-Sponsored Women's Ischemia Syndrome 
Evaluation (WISE)  801-1 ·266A
Increased Thermal Heterogeneity of the Culprit Lesion 
Is Prolonged in Patients With Recent Myocardial 
Infarction: The Role of Inflammation  831-5·497A
Interleukin-6 Is a Better Predictor of Mortality Than 
C-Reactive Protein Very Early After Symptom Onset 
in Patients With Non-ST Elevation Acute Coronary 
Syndrome 1001-1·1A
Irbesartan Significantly Reduces C-Reactive Protein 
After One Month of Therapy in Unstable Angina 
1160-170·521A
Long-Term Improvement in Microvascular Angina 
Patients Treated With Enhanced External 
Counterpulsation  891-6·308A
Marked Underutilization and Geographic Variation in 
Secondary Prevention Pharmacologic Therapy in 
Patients With Chronic Angina Undergoing Treatment 
With Enhanced External Counterpulsation 
1077-74·407A
Medullar Neurostimulation Is a Safe Alternative for 
Refractory Angina  861-4·303A
N Terminal Pro Brain Natriuretic Peptide Is the Most 
Powerful Predictor of Long-Term Mortality in Diabetic 
Patients With Acute Coronary Syndromes  
827-4·284A
N-Terminal-Pro Braintype Natriuretic Peptide Predicts 
Extent of Coronary Artery Disease and Myocardial 
Ischemia in Patients With Stable Angina Pectoris 
1119-95·292A
Prognostic Value of Circulating B-Type Natriuretic 
Peptide in Patients With Stable Coronary Artery 
Disease 1119-97·293A
Protective Role of Low C-Reactive Protein Levels 
Against Classical Risk Factors for Coronary 
Atherosclerotic Disease 1119-98·293A
Relation Between Angina Pectoris and Coronary Flow 
Reserve in Patients With Aortic Stenosis: An 
Adenosine Transthoracic Doppler Echocardiographic 
Study 1073-148·327A
Relationship of Polymorphisms in the Oxidative 
Stress-Related Genes - Paraoxonase and p22phox - 
to Variant Angina and Coronary Artery Stenosis 
1027-188·451A
Symptoms Persist in Patients With Chronic Angina 
Despite Frequent Anti-Anginal Use and Prior 
Revascularization 1099-87·281A
The Effects of Enhanced External Counterpulsation on 
Myocardial Perfusion in Patients With Stable Angina: 
A Single-Blind Multicenter Pilot Study  891-4·308A
Treatment and Outcome of Diabetic Patients With 
Stable Angina and First Angiographic Diagnosis of 
Coronary Artery Disease in Germany: Results of the 
STAR Registry 1099-91·282A
Treatment Hours and Angina Improvement With 
Enhanced External Counterpulsation 1059-4·11A
Angiocardiography
Automation Comparable to Human Variability for 
Detecting Left Ventricular Borders From DICOM 
Angiograms 1020-70·399A
Does Cardiac Multislice Computed Tomography 
Change the Indication for Invasive Angiography in 
Symptomatic Patients With Suspected Coronary 
Artery Disease? 1116-18·24A
In Vivo Temperature Measurements of Human 
Atherosclerotic Plaques With a New 
Balloon-Thermography Catheter: The “Cooling 
Effect” of Blood Flow 1155-101·90A
Transthoracic Doppler Echocardiography as a 
Noninvasive Tool to Assess Coronary Artery 
Stenoses: A Comparison With Quantitative Coronary 
Angiography 1073-142·326A
Angiogenesis
A Phase I Study of Intramuscular Administration of 
Plasmid, Developmentally Regulated Endothelial Cell 
Locus-1 Gene, in Humans With Peripheral Arterial 
Disease 1066-191·470A
Acute and Early Changes in Plasma Vascular Growth 
Factors and Circulating Endothelial Progenitor Cells 
in Patients With Acute ST Elevation Myocardial 
Infarction 1025-63·38A
Acute Myocardial Infarction Is a Stimulus for Stem Cell 
Mobilisation and Elevated Erythropoietin Serum 
Levels 1078-94·270A
Adrenomedullin Enhances Therapeutic Potency of 
Bone Marrow Transplantation for Acute Myocardial 
Infarction in Rats 1061-96·265A
Angiogenic Profiling of the Ischemic Human Heart In 
Vivo 1104-190·489A
Antiangiogenic Therapy of Early Atherosclerosis With 
Paramagnetic _vβ3-Integrin-Targeted Fumagillin 
Nanoparticles 1055-155·322A
Asymmetric Dimethylarginine Impairs Angiogenesis 
and Limb Perfusion in a Murine Model of Hindlimb 
Ischemia  805-5·473A
Biodegradable Scaffolds Incorporating Vascular 
Endothelial Growth Factor as a Novel Sustained 
Delivery Platform to Induce Angiogenesis  
805-4·473A
Catheter-Based Transplantation of Autologous Bone 
Marrow Mononuclear Cells Safely Improves 
Collateral and Capillary Network in Adult Swine With 
Myocardial Ischemia 1100-57·64A
Comparison Between Intracoronary Infusion and Direct 
Transendocardial Injection of Mesenchymal Stem 
Cells in a Dog Acute Ischemia Model 1100-56·63A
Delivery of Human Myoblasts Transduced With a Novel 
Bicistronic Vector Carrying Human Vascular 
Endothelial Growth Factor 165 and Angiopoietin-I 
Forms Mature Blood Vessel in the Heart 1116-2·20A
Dimerization of Mitogen-Activated Protein Kinase and 
Auto-Phosphorylation of Akt Occur in the Newly 
Differentiated Endothelial-Like Cells From Adult Bone 
Marrow Stem Cells In Vitro 1122-165·498A
Documentation of Exercise-Induced Coronary 
Collateral Growth in Humans 1045-190·457A
Efficacy of Granulocyte-Colony Stimulating Factor After 
Coronary Ligation in Rats: Evaluation by 
Echocardiographic Acoustic Quantification and 
Myocardial Contrast 1061-97·265A
Enhanced Angiogenesis With Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused 
Myocardial Infarction Model 1078-93·270A
Enhancing Arteriogenesis Increases Atherosclerosis 
and Reducing Atherosclerosis Reduces 
Arteriogenesis: Demonstration of the Concept in Mice 
1140-166·507A
Evidence for Hypoxia and Hypoxia-Inducible 
Factor-1-Alpha Mediated Vascular Endothelial 
Growth Factor Expression in Lipid-Rich Plaque 
Macrophages as Link Between Inflammation and 
Angiogenesis 1045-197·459A
Exercise Training Increases the Number of Endothelial 
Progenitor Cells in Patients With Coronary Heart 
Disease and Cardiovascular Risk Factors 
1007-179·445A
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Fiber Type-Specific Angiogenic Dysregulation in a 
Genetic Mouse Model of Heart Failure 
1045-196·458A
First Human Heart Myoblast Allograft 1025-65·39A
Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients 
With Coronary Artery Disease 1045-193·458A
Heterologous Transplantation of CD34+ Cells From 
Patients With Coronary Ischemia Leads to Myocardial 
Salvage and Enhanced Functional Recovery in 
Murine Model of Myocardial Infarction 
1104-192·490A
High-Density Lipoprotein-Induced Tube Formation 
Requires the Activation of Ras/Raf/Mitogen-Activated 
Protein Kinase in Human Coronary Artery Endothelial 
Cells 1045-191·458A
Impaired Arteriogenic Response to Acute Hindlimb 
Ischemia in CD8 Knockout Mice 1045-194·458A
Indirect Imaging of Vasculat Endothelial Growth Factor 
Gene Expression Using a Positron Emission 
Tomography Reporter Gene  805-1·472A
Intramyocardial Injection of Autologous Bone Marrow 
Cells Improves Myocardial Perfusion in Severe 
Ischemic Heart Disease: A 30-Day Assessment 
1079-82·272A
Left Ventricular Assist Device Implantation Induces 
Neo-Neurogenesis Accompanied by 
Neo-Angiogenesis in the Nonscarred Myocardium in 
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Long-Term Clinical Outcome of Catheter-Based 
Intramyocardial Autologous Bone Marrow Cells 
Implantation in Patients With End-Stage Coronary 
Artery Disease 1025-64·39A
Monocyte Chemoattractant Protein-1 Activates 
Vascular Endothelial Growth Factor- and Tumor 
Necrosis Factor-Alpha-Mediated Angiogenesis in 
Ischemic Hindlimbs of Mice 1045-195·458A
Monocyte Chemoattractant Protein-1 Induced 
Monocyte Infiltration and Angiogenesis Does Not 
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Function in Chronically Infarcted Myocardium 
1078-99·271A
Monocytes, but Not Neutrophils or Lymphocytes Are 
Essential Mediators of Arteriogenesis 
1045-192·458A
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C57/Bl6 Mice. 1104-191·490A
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Technetium-99m Labeled Peptide Targeted at _vβ3 
Integrin Following Hindlimb Ischemia 1116-23·25A
One-Year Follow-Up of Transendocardial Injection of 
Autologous Bone Marrow Mononuclear Cells for 
Ischemic Cardiomyopathy  864-2·99A
Outpatient Clinic Base Therapeutic Program of 
Exercise After Heparin Administration for Patients 
With Arteriosclerosis Obliterans 1165-106·232A
Plaque Targeting in Atherosclerotic Mice Using a Small 
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Fibronectin Isoform 1045-189·457A
Platelet-Derived Vascular Endothelial Growth Factor in 
Patients With Hypertension: Relationship to Platelet 
Activation and Plasma Indices of Angiogenesis 
1161-175·522A
Quantification of Absolute Myocardial Perfusion by 
Contrast Echocardiography: Algorithm, In Vitro and In 
Vivo Validation 1036-157·315A
Repeated Non-invasive Measurement of pO2 by a 
Novel Electron Paramagnetic Resonance Method in a 
Rabbit Model of Hindlimb Ischemia  805-2·472A
SU11218, a Platelet-Derived Growth Factor Receptor 
and Vascular Endothelial Growth Factor Receptor 2 
Inhibitor Blocks Adventitial Angiogenesis and 
Prevents Intimal Hyperplasia After Coronary Stenting 
in a Porcine Model 1121-51·77A
The Critical Role of Thrombospondin (TSP)-1 in 
Limiting Expansion of Fibrosis in Healing Myocardial 
Infarcts: Studies in Dogs and TSP-1 -/- Mice 
1002-78·243A
The Modulating Role of CD44 During Arteriogenesis: 
An Experimental and a Clinical Approach  
805-3·472A
Three-Dimensional Computed Tomographic 
Angiography for Assessment of Arteriogenesis in the 
Rat Hindlimb Ischemia Model 1038-150·319A
Transendocardial Autologous Bone Marrow Cell 
Transplantation in Patients With Advanced Ischemic 
Heart Disease: Final Results From a Multi-center 
Feasibility Study  864-3·99A
Transendocardial Injection of Autologous Bone Marrow 
Mononuclear Cells May Enhance Myocardial Viability 
Around Cell Injection Site  814-1·186A
Transplantation of Autologous Bone Marrow 
Mononuclear Cells Does Not Alter Arrhythmia 
Threshold in Adult Swine With Chronic Myocardial 
Ischemia 1078-98·271A
Uncoupling Proteins Shift During Cardiac Hypertrophy 
and Renin-Angiotensin System Suppression  
849-1·225A
Utilizing of the Fibrin Meshwork to Induce 
Neovascularization in Patients With Chronic Limb 
Ischemia: Long-Term Follow-Up  848-2·516A
Vascular Endothelial Growth Factor (VEGF) Plays a 
Central Role in the Development of Diabetic 
Cardiomyopathy and Gene Transfer of VEGF 
Improves Heart Failure in Long-Standing 
Streptozotocin-Induced Diabetic Rat  404-5·533A
Angiography
16-Slice Computed Tomography for Coronary 
Angiography: Can We Do It at Higher Heart Rates? 
1075-160·329A
A Randomized Comparison of Transradial and 
Transfemoral Approaches for Coronary Angiography 
and Percutaneous Transluminal Coronary 
Angioplasty in Octogenarians: Final Results of the 
OCTO-PLUS Study 1004-47·30A
Any Measurable Coronary Artery Disease Identified in 
Women Presenting With Ischemic Chest Pain Is 
Associated With an Adverse Outcome: Findings From 
the National Institutes of Health-National Heart, Lung, 
and Blood Institute-Sponsored Womens Ischemia 
Syndrome Evaluation (WISE) Study Angiographic 
Core Laboratory 1119-93·292A
Assessment of Renal Artery Stenosis by 3-D 
Contrast-Enhanced and 3-D Phase-Contrast 
Magnetic Resonance Angiography: A Comparison 
With Conventional X-Ray Angiography 
1055-156·323A
Assessment of the Feasibility, Safety, and Success of 
Transradial Access for Percutaneous Coronary 
Intervention: A Report From the American College of 
Cardiology-National Cardiovascular Data Registry 
1004-51·30A
Beneficial Effect of Oral Acetylcysteine for Prevention of 
Contrast-Induced Nephropathy in Patients With Renal 
Insufficiency: A Meta-Analysis 1141-191·509A
Cardiac Catheterization Simulator 1001-40·10A
Catheter Sequence Rather Than Catheter Shape 
Determines the Frequency of Cerebral Microemboli 
During Cardiac Catheterization 1066-197·471A
Characteristics of Takotsubo Cardiomyopathy: First US 
Population-Based Report 1127-108·210A
Clinical, Angiographic, and Intravascular Ultrasound 
Comparisons Between Patients With Early Versus 
Late Saphenous Vein Graft Failure 1155-77·88A
Comparison of 16-Slice Submillimeter Multidetector 
Spiral Computed Tomography With Conventional 
Angiography for Diagnosis of Coronary Artery 
Disease 1018-143·312A
Coronary Blood Flow Velocity and Myocardial Perfusion 
With Balloon Occlusion and Filter-Based Distal 
Protection Devices in Saphenous Vein Graft Stenting: 
Early Experience of Two Centers 1063-65·52A
Coronary Lesion Temperature Measurement During 
Transient Blood Flow Occlusion Using a Novel 
Thermal Sensing System 1006-61·34A
Correlation Between the Extent of Diseased Vessels 
and the Incidence of In-Hospital Cardiac Mortality in 
Acute Myocardial Infarction  885-3·240A
Delineation of the Pericardiophrenic Vein for Optimal 
Left Ventricular Lead Placement  817-6·128A
Differences in the Rate of Invasively Confirmed 
Coronary Artery Disease Between Women and Men 
Presenting With an Acute Coronary Syndrome 
Without ST Elevation 1097-95·276A
Distinct Modes of Cardiovascular Death Associated 
With Impaired Epicardial and Myocardial Perfusion 
Following Fibrinolysis for ST Elevation Myocardial 
Infarction 1118-82·290A
Early Saphenous Vein Graft Failure: A Predictor of Poor 
Outcomes After Percutaneous Coronary Intervention 
1120-66·76A
Echocardiographic and Angiographic Correlations in 
Cardiogenic Shock 1050-120·173A
Enoxaparin Versus Unfractionated Heparin in Patients 
Treated With Tirofiban, Aspirin, and an Early 
Conservation Initial Management Strategy: Results 
From the A Phase of the A to Z Trial  861-2·302A
Evaluation of Myocardial Ischemia by Magnetic 
Resonance Myocardial Stress Perfusion in Renal 
Transplant Candidates: Comparison With SPECT and 
Coronary Angiography 1133-158·353A
Gender Differences in the Incidence of Coronary Artery 
Disease in Patients With Stable Angina and Positive 
or Negative Stress Test in Daily Clinical Practice in 
the Year 2002: Results of the ALKK Quality Control 
Registry 1119-96·293A
Healthcare Costs for Cardiovascular Disease in Women 
With and Without Obstructive Coronary Disease: 
Results From the National Institutes of 
Health-National Heart, Lung, and Blood 
Institutes-Sponsored Women's Ischemia Syndrome 
Evaluation (WISE) 1172-76·422A
High Left Ventricular Mass Does Not Limit the Utility of 
Fractional Flow Reserve for the Physiologic 
Assessment of Lesion Severity 1120-64·76A
Impact of Troponin Status and Coronary Artery Disease 
by Angiography on Outcome in Acute Coronary 
Syndrome: A TACTICS TIMI-18 Substudy  
884-5·307A
Late Four-Year Follow-Up From the First-in-Man 
Experience After Implantation of Sirolimus-Eluting 
Stents  862-5·98A
Myocardial Bridging Is Associated With Impairment in 
Endothelium-Dependent Vasorelaxation 
1065-170·468A
Noninvasive Assessment of Right Gastroepiploic Artery 
Graft Patency Using Transcutaneous Doppler 
Echocardiography 1073-145·326A
Optimal Reconstruction Protocol for Noninvasive 
Coronary Angiography With 16-Slice 
Multidetector-Row Computed Tomography 
1075-158·329A
Optimization of Pharmacokinetic Vectors With a 
Programmable Paclitaxel Eluting Stent 1139-51·83A
Patent Foramen Ovale Closure Using a Blind 
Transeptal Technique Is Safe 1005-64·33A
Population Rates of Invasive Cardiac Procedures in 
British Columbia, 1995-2001 1040-75·403A
Potential Impact of Frame Bias Upon Quantitative 
Coronary Angiographic Outcomes in Coronary Stent 
Trials 1081-62·61A
Predictors of 10-Year Patency of Saphenous Vein and 
Left Internal Mammary Artery Grafts After Coronary 
Artery Bypass Surgery: Results From a Department 
of Veterans Affairs Cooperative Study 1079-87·273A
Prevention of Contrast-Agent-Induced Nephropathy in 
Patients Undergoing a Coronary Procedure by 
Ascorbic Acid 1062-45·48A
Quantitative Evaluation of Coronary Reperfusion by 
Transthoracic Doppler Echocardiography in Patients 
With Anterior Acute Myocardial Infarction 
1026-61·41A
Radiation Exposure to Patients During Diagnostic 
Cardiac Catheterization 1155-81·89A
Reduction in Late Loss and Restenosis in Patients With 
Small Vessels Treated With the Slow Rate-Release, 
Polymer-Based Paclitaxel-Eluting Stent: Results 
From TAXUS-IV  843-4·87A
Results of Four Multicenter, Phase III, Magnetic 
Resonance Angiography (MRA) Trials With MS-325, 
a Blood Pool Contrast Agent, for the Detection of 
Vascular Disease in the Aortoiliac, Renal, and Pedal 
Regions 1133-156·352A
Sensitivity Encoding Contrast-Enhanced Magnetic 
Resonance Cineangiography With Subsecond 
Temporal Resolution in Congenital Cardiovascular 
Disease 1134-205·389A
Significant Increase in the Thrombolysis in Myocardial 
Infarction Frame Count When the Coronary Artery 
Stenosis Is More Than 75 Percent Reflects 
Significant Flow Abnormalities at This Degree of 
Stenosis in Chronically Diseased Coronary Arteries 
1157-45·93A
The Safety of Carotid and Cerebral Angiography 
Performed by Cardiologists in the Cardiac 
Catheterization Laboratory 1156-61·91A
The Use of Medical Simulators as Part of a 
Comprehensive Interventional Cardiology Teaching 
Course  853-1·422A
Three-Dimensional Computed Tomographic 
Angiography for Assessment of Arteriogenesis in the 
Rat Hindlimb Ischemia Model 1038-150·319A
Treatment Bias Against Women With Acute Coronary 
Syndrome: Fact or Fantasy? 1097-96·276A
White Blood Cell Count Predicts Angiographic Findings 
in Patients With Acute Coronary Syndromes 
1042-87·259A
Angioplasty
13-Year Follow-Up of the German Angioplasty Surgery 
Investigation 1138-42·80A
A Double-Blind Randomized Dose Finding Study of 
Gamma Radiation for In-Stent Restenosis 
1121-58·79A
A Pharmaco-Epidemiological Study of the Interaction 
Between Atorvastatin and Clopidogrel Following 
Percutaneous Coronary Interventions 1063-55·50A
A Prospective Study to Evaluate Adequacy of 
Anticoagulation for Percutaneous Coronary 
Interventions in Patients With Acute Coronary 
Syndromes Presenting for Early Angiography on 
Subcutaneous Enoxaparin 1004-54·31A
A Prospective, Randomized Trial of Mild Hypothermia 
During Primary Percutaneous Intervention for Acute 
Myocardial Infarction (COOL-MI): One-Year Clinical 
Outcome 1022-82·251A
A Randomized Comparison of Transradial and 
Transfemoral Approaches for Coronary Angiography 
and Percutaneous Transluminal Coronary 
Angioplasty in Octogenarians: Final Results of the 
OCTO-PLUS Study 1004-47·30A
A Randomized Study Comparing a 
Titanium-Nitride-Oxide Coated With an Uncoated 
Stent for Coronary Revascularization 1139-58·85A
592A SUBJECT INDEX JACC March 3, 2004
KEY: Abstract Title, Session-abstract number•page number
A Rational Approach to Coronary Stenting Prior to 
Noncardiac Surgery 1063-53·49A
A Systemic Inflammatory Response Reflected by 
Increased Soluble CD40 Ligand Is Evident Within 10 
Minutes of Coronary Stenting  878-1·101A
Abciximab Administration for the Prevention of 
Angiographic Restenosis in Small Coronary Arteries: 
Results From the Randomized ISAR-SMART-2 Trial 
1025-42·37A
Adjunctive Pharmacotherapy During Higher Risk 
Percutaneous Coronary Intervention: 
Eptifibatide-Based Antiplatelet Therapy Accompanied 
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1004-53·31A
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1062-42·47A
Adverse Outcomes in Women Undergoing 
Percutaneous Coronary Intervention 1043-64·44A
Age-Related Complications and Outcomes After 
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Cardiology-National Cardiovascular Data Registry 
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Insufficiency: A Meta-Analysis 1141-191·509A
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Biolimus A9: A New Generation Rapamycin Analogue 
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1139-52·84A
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1025-43·37A
Bone Marrow Mononuclear Cell Therapy Reduces 
Post-Angioplasty Neointimal Formation in Rabbits 
1064-188·467A
Can Intravascular Ultrasound Guided Cutting Balloon 
Angioplasty Before Stenting Be a Substitute for Drug 
Eluting Stent? Final Results of the Prospective 
Randomized Multicenter Trial Comparing Cutting 
Balloon With Balloon Angioplasty Before Stenting 
(Reduce III) 1138-66·82A
Clinical Outcomes in Coronary Angioplasty Centers 
With Off-Site Versus On-Site Cardiac Surgery 
Capabilities: A Preliminary Report From the 
American College of Cardiology - National 
Cardiovascular Data Registry  852-1·96A
Clinical Outcomes of Elective Contemporary 
Percutaneous Coronary Interventions in 
Octogenarians: Insight From the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium 
1059-29·17A
Combination Evidence-Based Therapy Improves 
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1172-72·421A
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With Balloon Occlusion and Filter-Based Distal 
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1077-68·405A
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1120-43·75A
Does Statin Therapy Reduce Contrast-Induced 
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Interventions 1172-68·420A
Drug-Eluting Balloon: A New Technique to Deliver 
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Drug-Eluting Stent Utilization and Outcomes From the 
Strategic Evaluation of New Transvascular Therapies 
(STENT) Group: A Large Prospective Multicenter 
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Intervention 1044-58·46A
Drug-Eluting Stent With Multidimensional 
Programmable Pharmacokinetics 1139-47·83A
Drug-Eluting Stents for Coronary Bifurcations: 
Bench-Top Insights Into the "Crush" Technique 
1024-53·36A
Duplex Outcomes of the CryoVascular Peripheral 
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Patients Undergoing Percutaneous Intervention 
1120-42·75A
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Patients With Acute Coronary Syndromes  
841-6·506A
Invasive Therapy Along With Glycoprotein IIb/IIIa 
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Balloon Occlusion of the Coronary Artery With 
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Angioplasty in Patients With Acute Coronary 
Syndrome Improves the Microcirculatory Function: 
Results of a Prospective Randomized Study 
1001-7·2A
The Use of Medical Simulators as Part of a 
Comprehensive Interventional Cardiology Teaching 
Course  853-1·422A
Thrombus Aspiration for the Treatment of No-Reflow 
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Acute Myocardial Infarction 1003-95·248A
Treatment and Outcome of Diabetic Patients With 
Stable Angina and First Angiographic Diagnosis of 
Coronary Artery Disease in Germany: Results of the 
STAR Registry 1099-91·282A
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A Phase I Open-Label Dose Escalation Trial of a 
Monoclonal Antibody Against Tissue Factor (Sunol 
cH36) in Stable Coronary Artery Disease: Results of 
the PROXIMATE-TIMI 27 Trial  861-3·303A
A Prospective Study to Evaluate Adequacy of 
Anticoagulation for Percutaneous Coronary 
Interventions in Patients With Acute Coronary 
Syndromes Presenting for Early Angiography on 
Subcutaneous Enoxaparin 1004-54·31A
Angiomax Versus Heparin as an Antithrombotic Agent 
in Patients Undergoing Percutaneous Coronary 
Intervention in Saphenous Vein Bypass Grafts 
1063-61·51A
Current Enoxaparin Dosing Strategies Yield 
Supratherapeutic Anti-Xa Activity in Many Elderly 
Patients 1141-190·509A
Endothelial, Coagulation, and Platelet Function in Atrial 
Fibrillation: Effect of Direct Current Cardioversion 
1129-212·134A
Enoxaparin Versus Unfractionated Heparin in Patients 
Treated With Tirofiban, Aspirin, and an Early 
Conservation Initial Management Strategy: Results 
From the A Phase of the A to Z Trial  861-2·302A
Establishing a New Therapeutic Activated Partial 
Thromboplastin Time Range for Unfractionated 
Heparin for Acute Coronary Syndromes 
1117-90·289A
Gender Bias Against Women: Men Receive Prophylaxis 
More Often to Prevent Deep Venous Thrombosis 
1001-13·3A
How Does Age Influence the Prescribing of 
Antithrombotic Therapy for Ambulatory Patients With 
Permanent Atrial Fibrillation? 1129-216·135A
Incidence and Evaluation of Heparin-Induced 
Thrombocytopenia (HIT) Among Patients Treated 
With Prolonged Heparin and Among 
Thrombocytopenic Patients in the Cardiac Care Unit: 
Preliminary Results of the CATCH Registry 
1123-180·501A
International Normalized Ratio Increase Prior to 
Warfarin-Associated Hemorrhage: Brief and Subtle 
1123-186·502A
Intravenous Wafarin Sodium for Anticoagulation After 
Valve Replacement Surgery 1162-135·439A
Long-Term Results of ISAR-REACT: A Randomized 
Trial Evaluating Abciximab in Patients With Elective 
Percutaneous Coronary Intervention After 
Pretreatment With a High Loading Dose of 
Clopidogrel 1001-8·2A
Obesity Does Not Attenuate the Effectiveness of 
Low-Dose Dalteparin in Preventing Venous 
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and Fibrinolysis in Hypertensive Patients With Left 
Ventricular Hypertrophy: A LIFE Substudy 
1085-193·482A
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Resonance Assessment of the Effect of Telmisartan 
Compared With Carvedilol on Left Ventricular Mass: 
A Multicenter, Randomized, Controlled Study 
1142-187·514A
Antioxidants
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Long-Term Safety, Efficacy, and Predictors of 
Outcome  828-1·132A
Randomized Comparison of Anatomical Versus 
Voltage-Guided Ablation of the Cavotricuspid Isthmus 
for Atrial Flutter 1090-218·124A
Safety and Efficacy of Freezor MAX, A New 9FR, 8mm 
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Enhanced External Counterpulsation Decreases Wave 
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High Angiotensin II Responsiveness Relates to 
Decreased Endothelium Dependent Relaxation in 
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Arteriosclerosis
16-Slice Multidetector-Row Computed Tomography and 
Magnetic Resonance Imaging for the In Vivo and 
Noninvasive Assessment of Vessel Areas and 
Diameters 1018-150·314A
Accelerated Coronary Stenosis Progression Is 
Associated With the ApolipoproteinC-III Content of 
ApoB Particles Among Those With Diabetes Mellitus 
1103-167·488A
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Long-Term Use of Pioglitazone Slows Arteriosclerotic 
Progression in Type 2 Diabetics 1159-187·518A
Lower Doses of Hormone Replacement Therapy Did 
Not Increase hsC-Reactive Protein or F1+2 Levels 
but Improved Flow-Mediated Dilation in 
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Double-Blind, Crossover Study 1001-11·3A
Metabolic Syndrome: An Underecognized Risk Factor 
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Refractory Angina  891-1·307A
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Remodeling: Comparison of Histochemical 
Characteristics and Intravascular Ultrasound Finding 
of Atherosclerotic Lesions 1082-177·476A
Increased Expression of Myeloid Related Protein in 
Infiltrated Neutrophils in Coronary Atherosclerotic 
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Added Ramipril to Simvastatin Shows Additive Effects 
on Flow-Mediated Dilation and Inflammation Markers 
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Nanoparticles 1055-155·322A
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841-5·506A
Breast Arterial Calcification Predicts Lower 
Cardiovascular Event Rate in a Higher Risk 
Population of Postmenopausal Women 
1128-127·213A
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Three-Dimensional Intravascular Ultrasound Study 
1059-8·12A
CX3CR1 Gene Disruption Is Not Associated With 
Decreased Neointima Formation After Carotid Wire 
Injury in Apolipoprotein-E Deficient Mice 
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Neurocognitive Outcomes in Atherosclerotic Patients 
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Coronary Stent Implantation 1081-54·59A
Effect of Fosinopril and Pravastatin on Carotid 
Intima-Media-Thickness in Microalbuminuric Subjects 
Without Hypertension or Hypercholesterolemia  
825-4·495A
Effects of Avasimibe on Coronary Atherosclerosis 
Assessed by Intravascular Ultrasound  882-2·529A
Effects of Ezetimibe, Simvastatin, and 
Ezetimibe-Simvastatin on Noncholesterol Sterol 
1008-183·445A
Effects of Pioglitazone on Endothelial Function and 
Aortic Stiffness in Patients With Type 2 Diabetes 
Mellitus 1065-173·469A
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Life-Years: A Description of the Patient-Journey in 
COMET  835-4·206A
Contemporary Dosing of Angiotensin Converting 
Enzyme Inhibitors and Beta Blockers in Chronic 
Heart Failure: Report From the STAMINA:HFP (Study 
of Anemia in a Heart Failure Population) Registry 
1012-126·158A
Cost-Effectiveness of Carvedilol Versus Metoprolol 
Tartrate for Patients With Heart Failure  889-4·425A
Effect of Beta-Blocker Therapy on Ventilatory 
Responses in Patients With Heart Failure 
1165-103·231A
Effect of the Beta1Ser49Gly Polymorphism on 
Outcomes in Recent Onset Cardiomyopathy: Results 
From the IMAC Trial 1031-105·163A
Effects of Beta-Adrenergic Blockade in Pediatric Marfan 
Syndrome 1114-202·387A
Effects of Carvedilol Compared to Atenolol on Ejection 
Fraction and Clinical Endpoints After Myocardial 
Infarction 1118-77·289A
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Enhancing Quality of Heart Failure Care in Managed 
Medicare and Medicaid in North Carolina: Results of 
the North Carolina Achieving Cardiac Excellence (NC 
ACE) Project 1077-73·406A
Evaluation of Beta-Blocker Dose in Community-Based 
Treatment of Heart Failure  821-3·196A
Exchange of Beta-Blocking Therapy in Heart Failure 
Patients. Experiences From the Post Study Phase of 
COMET (the Carvedilol or Metoprolol European Trial) 
1001-26·7A
Impact of Combination Evidence-Based Medical 
Therapy on Mortality in Patients With Acute Coronary 
Syndromes 1137-98·298A
Impact of Intravenous Beta-Blockade During Primary 
Percutaneous Intervention on Convalescent Left 
Ventricular Function  869-2·303A
Lack of Heart Rate Effects on the Mortality Benefits of 
Carvedilol Compared to Metoprolol in the Patients 
With Heart Failure: Results From the Carvedilol or 
Metoprolol European Trial (COMET) 1012-121·157A
Measurement Versus Calculation of Training Heart Rate 
in Patients With Coronary Artery Disease Treated by 
Beta-Blockers 1165-107·232A
Monotherapy With Extended Release Metoprolol 
Succinate Normalizes Exppression of Type-1 Protein 
Phosphatase in Left Ventricular Myocardium of Dogs 
With Chronic Heart Failure 1012-125·158A
National Evaluation of Long-Term Adherence to 
Beta-Blocker Therapy After Acute Myocardial 
Infarction in Patients With Commercial Health 
Insurance  838-4·415A
Practical Predictors of Clinical Outcomes in Patients 
Initiating Beta-Blockers for Heart Failure: Findings of 
a Community-Based Registry 1172-71·421A
Predictors of Mortality in 1,346 Patients With Heart 
Failure Scheduled for Guideline-Based Treatment 
1069-110·179A
Recovery of Left Ventricular Function by Carvedilol Is 
Associated With Concomitant Increase of Myocardial 
Perfusion in Patients With Acute Myocardial Infarction 
1061-94·264A
Reverse Left Ventricular Remodeling by Carvedilol 
Reduces the Spatial Dispersion of QRS Duration in 
Patients With Chronic Heart Failure: A Prospective 
Placebo-Controlled Study 1148-226·142A
Risks of Death and Hospitalization in Heart Failure 
Patients Receiving Carvedilol Versus Metoprolol 
Tartrate: A Retrospective Claims-Based Study  
821-5·196A
Safety and Tolerability of Fast Up-Titration of Carvedilol 
in Patients With Heart Failure 1012-123·158A
Safety of Beta-Blockers in Patients With Heart Failure 
and Renal Insufficiency: Data From IMPACT-HF 
1012-104·157A
Should Beta-Blockers Be Used Before Angiotensin 
Converting Enzyme Inhibitors in Patients With 
Chronic Heart Failure? Meta-Analysis of the 
Prognostic Benefit Conferred by Beta-Blockers in 
Patients Not Receiving ACE Inhibitors  821-1·195A
Suppression of Physiological Myocardial 
Fluorodeoxyglucose Uptake 1094-152·337A
Tolerability, Safety, and Efficacy of Beta-Blockade in 
Black Patients With Heart Failure in the Community 
Setting: Insights From a Large Prospective 
Beta-Blocker Registry 1172-70·420A
Trends in the Use of Effective Cardiac Medications in 
Patients With Acute Myocardial Infarction: The 
GRACE Experience 1061-85·262A
Blood cells
Granulocyte-Colony Stimulating Factor Induced 
Mobilization and Intra-Coronary Infusion of Mobilized 
Whole Leukocyte Is a Feasible, Safe Method of Stem 
Cell Transplantation in Patients With Myocardial 
Infarction 1061-93·264A
Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients 
With Coronary Artery Disease 1045-193·458A
Granulocyte-Colony Stimulating Factor Mobilizes Bone 
Marrow Stem Cells and Favorably Alters Cytokine 
Profile in Patients With Advanced Heart Failure 
1108-130·201A
Serum Inflammatory Markers Correlate With 
Hemoglobin Levels in Women Undergoing Evaluation 
for Suspected Ischemia: Results From the National 
Heart, Lung, and Blood Institute WISE Study  
847-6·515A
Which White Blood Cell Compartments Predict 
Increased Cardiovascular Risk? 1098-81·278A
Blood coagulation
Investigating Platelet Activation With Abciximab and 
High-Dose Tirofiban in Patients With Acute 
Myocardial Infarction Undergoing Primary 
Percutaneous Coronary Intervention  864-4·99A
Is the ICHOR Platelet Works Test as Valid as Flow 
Cytometry to Assess the Efficacy of Platelet 
Glycoprotein IIb/IIIa-Receptor Inhibitors in Patients 
Undergoing Percutaneous Coronary Intervention? 
1025-44·38A
Lack of Efficacy of Clopidogrel Pretreatment in the 
Prevention of Myocardial Damage After Elective Stent 
Implantation 1063-52·49A
Reduction of Plasma Cholesterol and Fibrinogen by 
H.E.L.P. Apheresis Increases Myocardial Perfusion in 
Heart Transplant Patients  813-3·186A
Blood flow
Assessment of Myocardial Perfusion and Metabolism in 
Normal and Diabetic Rats by MicroPET Imaging 
1116-24·25A
Atrial Fibrillation Reduces Endothelium-Independent 
Myocardial Perfusion Reserve: A Quantitative Study 
Using Positron Emission Tomography 1094-155·337A
Chest Compression Device Improves Blood Flow in 
Cerebrum and Myocardium Achieving Neurologically 
Intact Survival in a Porcine Model of Prolonged 
Cardiac Arrest 1154-95·301A
Drag Reduction by Polymer Infusion: A New 
Mechanism to Enhance Microcirculatory Perfusion for 
the Treatment of Ischemia 1118-79·290A
Effect of Glucose Lowering on Coronary Circulatory 
Dysfunction in Type 2 Diabetes Mellitus  816-4·339A
Effects of Nitroglycerin on Erythrocyte Rheology and 
Oxygen Unloading: Microvascular Mechanisms in 
Relieving Myocardial Ischemia 1023-90·253A
Effects of Surgical Myectomy on Myocardial Energetics 
and Blood Flow in Patients With Hypertrophic 
Cardiomyopathy and Symptomatic Left Ventricular 
Outflow Obstruction 1094-153·337A
Hemodynamic Impairment of Intermediate Stenoses in 
Saphenous Vein Coronary Artery Bypass Grafts and 
Recipient Vessels: Evaluation by Doppler Flow 
Velocity 1157-46·93A
Hyperglycaemia Reduces Myocardial Reperfusion 
During Primary Percutaneous Coronary Intervention 
for ST-Elevation Myocardial Infarction 1154-86·299A
Impaired Hyperaemic Myocardial Blood Flow Is Related 
to Systolic Function in Idiopathic Dilated 
Cardiomyopathy  834-3·204A
Left Ventricular Ejecting Force of the Intra-Aortic 
Balloon Pump Assisted and Nonassisted Beats 
1050-124·174A
Measurement of Compartment Blood Volume in the 
Myocardium: Myocardial Contrast Echocardiographic 
Study 1017-162·311A
Measurement of Endothelial Dysfunction With an 
Observer-Independent Magnetic Resonance 
Approach 1065-169·468A
Measurement of Myocardial Blood Volume and Flow 
Velocity in Capillaries and Arterioles in the 
Myocardium by Myocardial Contrast 
Echocardiography: Dependency on Its Measurement 
Unit of Backscatter 1017-161·311A
Measurements of Contrast Intensity in Systole Are 
More Accurate Predictors of Myocardial Blood Flow: 
Validated by Microspheres 1017-157·310A
Noninvasive Assessment of Right Gastroepiploic Artery 
Graft Patency Using Transcutaneous Doppler 
Echocardiography 1073-145·326A
Pharmacologic and Carbon Dioxide Reactivity of 
Coronary Circulation as Determined by Computed 
Tomography Perfusion 1038-154·320A
Quantification of Absolute Myocardial Perfusion by 
Contrast Echocardiography: Algorithm, In Vitro and In 
Vivo Validation 1036-157·315A
Repeated Non-invasive Measurement of pO2 by a 
Novel Electron Paramagnetic Resonance Method in a 
Rabbit Model of Hindlimb Ischemia  805-2·472A
The Assessment of Arterial Compliance Using 
Noninvasive Techniques: A Comparison of Radial 
and Ocular Measures of Arterial Pressure and Flow 
1027-192·452A
The Lonflit Study: Evaluation of Venous Thrombosis in 
5,000 Long-Haul Passengers 1123-178·500A
Upright Seated Pulmonary and Caval Blood Flow 
Characteristics During Rest and Cycling Exercise 
Using Magnetic Resonance Imaging  871-1·395A
Volume Overload Modulates Ejection Fraction 
Improvement in Cardiac Resynchronization Therapy 
1167-221·147A
Blood pressure
Aliskiren, a Novel, Orally Effective Nonpeptide Renin 
Inhibitor, Lowers Blood Pressure After Once-Daily 
Dosing in Marmosets, Rats and Humans 
1085-165·481A
Association of Prehypertension by Joint National 
Committee 7 Criteria With Left Ventricular Structure 
and Function: The Strong Heart Study 
1142-183·513A
Blood Pressure Changes Do Not Influence the 
Beneficial Effects of Carvedilol Compared to 
Metoprolol in the Patients With Heart Failure: Results 
From COMET (Carvedilol or Metoprolol European 
Trial) 1012-103·157A
Blood Pressure Response to Strength Training Is 
Influenced by AGT (-20) Genotype in the Elderly 
1161-171·521A
Body Fat Distribution Influences Cardiac Output in 
Normotensive and Hypertensive Overweight 
Individuals: The HyperGEN Study 1142-179·512A
Cardiovascular Variability in Hypertensive Subjects 
With and Without Obstructive Sleep Apnea 
1009-169·448A
Coarctation Long-Term Assessment (COALA-Study) 
Incidence of Restenosis and Hypertension After 
Surgical Repair  840-6·391A
Effect of Cardiovascular Disease Risk Factors on 
Ambulatory Blood Pressure Profile in Obesity  
888-5·531A
Enhanced External Counterpulsation Decreases Wave 
Reflection Amplitude and Reduces Left Ventricular 
Afterload and Systolic Stress in Patients With 
Refractory Angina  891-1·307A
Evaluation of B-Type Natriuretic Peptide Levels in 
Normal and Pre-Eclamptic Women During Pregnancy 
1049-109·171A
How Low Is Optimal Blood Pressure With Respect to 
Hypertension Risk? 1009-167·448A
Hypotension Associated With Nesiritide Infusion in 
Patients With Decompensated Heart Failure Is 
Related to Large Volume Diuresis: Implications for 
Monitoring and Dose Adjustments 1088-127·192A
Impact of Wide Pulse Pressure With and Without High 
Systolic Blood Pressure on Clinical Outcomes in 
Chronic Severe Aortic Regurgitation 1030-135·428A
Modulatory Effect of Inflammation on Blood Pressure 
Reduction Following Therapeutic Lifestyle Change 
via Cardiac Rehabilitation and Exercise Training 
1161-177·522A
Myocardial Contrast Echocardiography Can Detect 
Changes in Myocardial Blood Volume During Acute 
Changes in Blood Pressure 1017-159·310A
Post-Carotid Artery Stent Hypotension and Optimal 
Pressor Use 1156-65·91A
Predictors of Diastolic Hypertension: The Framingham 
Heart Study 1009-193·449A
Pulse Wave Velocity Measured by Complior Method in 
a Brazilian Young Population Followed-Up for a 13 
Year-Period: The Rio de Janeiro Study 
1142-188·514A
Regular Exercise Improves Risk Profile and Motor 
Development in Early Childhood 1161-181·523A
Stromelysin-1 (MMP-3) Gene 5A/6A Promoter 
Polymorphism Is Associated With Blood Pressure in 
a Community Population 1161-173·522A
Systolic Blood Pressure Measured Serially From 
Childhood to Adulthood Predicts Arterial Stiffness in 
Young Adults: The Bogalusa Heart Study  
847-5·515A
The Assessment of Arterial Compliance Using 
Noninvasive Techniques: A Comparison of Radial 
and Ocular Measures of Arterial Pressure and Flow 
1027-192·452A
The Blood Pressure Response to the Valsalva 
Maneuver: An Independent Predictor of Mortality in 
Elderly Cardiac Patients 1128-130·214A
The Effect of Chart Review, Feedback, and a 
Hand-Held Management Program on Blood Pressure 
Control in Hypertensive Patients: The PROMPT 
Study 1085-198·484A
The Renin Inhibitor Aliskiren Is a Potent and 
Long-Acting Antihypertensive in Double Transgenic 
Rats Expressing Human Renin and Angiotensinogen 
Genes 1085-195·483A
Blood pressure determination
Comparison of Intra-Arterial and Noninvasive 
Oscillometric Blood Pressure in Lean, Overweight, 
and Obese Subjects 1009-194·449A
Systolic Blood Pressure During Recovery Is Related to 
the Risk of Acute Myocardial Infarction in 
Middle-Aged Men 1146-112·224A
Systolic Reflective Index: A New Parameter to Study 
Arterial Elasticity  873-5·528A
Body surface mapping
Abnormalities in Magnetocardiographic Atrial Signals in 
Patients With Focally Triggered Lone Atrial Fibrillation 
1148-224·142A
Bradycardia
Chronotropic Incompetence in Children With Late 
Postoperative Atrial Flutter: A Case-Control Study 
1001-28·7A
Sinus Bradycardia Is a Poor-Prognostic Indicator in 
Cocaine-Induced Acute Coronary Syndromes 
1115-73·411A
Bradykinin
Chronic Infusion of Bradykinin Preserves Vascular 
Nitric Oxide-Mediated Endothelial Function and 
Limits the Alteration in Left Ventricular Function 
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During Pacing-Induced Heart Failure in Conscious 
Dogs 1144-103·218A
Neutral Endopeptidase Inhibition Augments the 
Vascular Actions of Bradykinin in Patients With Heart 
Failure on Chronic Angiotensin-Converting Enzyme 
Inhibitor Therapy 1012-127·158A
Brain
Neurodevelopmental Outcome After Repair of Total 
Anomalous Pulmonary Venous Connection  
857-1·394A
Utility of B-Type Natriuretic Peptide and ProBNP in 
Evaluation of Patients Receiving Natrecor Therapy 
(UBET Study) 1049-112·171A
Calcium
Abnormal Calcium Handling and Focal Source 
Ventricular Fibrillation During Subacute Myocardial 
Infarction in Rabbits 1001-15·4A
Calcification of the Culprit Lesion Is Associated With 
Adverse Clinical Outcomes in ST Elevation 
Myocardial Infarction Patients Treated With 
Fibrinolytic Therapy 1060-83·261A
Calcium-Phosphorus Product Is Associated With 
Severity of Aortic Stenosis in Patients With Normal 
Renal Function 1107-139·434A
Detection and Propagation of Calcified Nanostructures 
From Human Aneurysms 1059-13·13A
Dynamic Intracardiac Calcium Transition in Very 
Early-Stage Ebryonic Mouse Heart Tube Regulated 
by G Protein Coupled Signal Pathway 
1110-216·129A
Fasting Blood Glucose: An Underestimated Risk Factor 
for Subclinical Coronary Atherosclerosis 
1028-171·454A
Heavy Coronary Plaque Calcification Is Associated 
With Only Minor Degrees of Plaque Macrophage and 
Neovessel Density Than Plaques With Less 
Calcification: Solving the Calcium Paradox? 
1140-169·507A
Influence of Vessel Wall Calcium on Neointimal Growth 
Following Bare Metal and Sirolimus-Eluting Stent 
Implantation: A 3-D Intravascular Ultrasound 
Substudy of the SIRIUS Trial 1044-54·45A
Intracellular Calcium Regulates Tumor Necrosis 
Factor-Alpha-Induced Embryonic Stem Cell Migration 
1078-95·270A
Ischemia/Reperfusion Induced Intracellular Calcium 
Oscillations in the Intact Heart: Relation to 
Arrhythmogenesis 1110-214·128A
Patterns of Lesion Calcification in Infarct-Related 
Arteries: An Intravascular Ultrasound Analysis of 250 
Patients With Acute Myocardial Infarction 
1026-56·40A
Periadventitial Fat Inflammation Correlates With Plaque 
Inflammation in Patients With Coronary Plaque 
Ruptures: New Marker of Plaque Vulnerability?  
841-2·505A
Prevalence and Spectrum of Mutations in the Cardiac 
Ryanodine Receptor in Patients Referred for Long QT 
Syndrome Genetic Testing 1130-207·136A
Progression of Aortic Valve Calcification Measured by 
Electron Beam Computed Tomography: A 
Population-Based Study 1107-136·433A
Relationship Between Patterns of Calcification and 
Arterial Remodeling of Culprit Lesions: Comparing 
Patients With Acute Coronary Syndromes With 
Those With Stable Angina  832-4·74A
The Severity of Mitral Annular Calcification Is 
Associated With Prevalent Cardiovascular Disease in 
the Elderly: The Cardiovascular Health Study  
885-4·240A
Valve Renovation in Calcific Aortic Stenosis: Safety and 
Feasibility of a Novel Endoaortic System for Native 
Valve Preservation 1125-135·435A
Calcium channel blocking drugs
Improved Calcium Homeostasis and Antiarrhythmic 
Effects of a Novel Chimeric Molecule That Inhibits 
Both Type III Phosphodiesterase and L-Type Calcium 
Channel in Failing Hearts 1087-134·189A
Role of Amlodipine in Preventing and Reversing 
Monocrotaline-Induced Pulmonary Arterial 
Hypertension in Rats 1123-188·503A
Cardiac anatomy
Anatomical Observations of the Left Atrium and 
Pulmonary Veins by Multislice Computed 
Tomography in Patients With Atrial Fibrillation  
845-6·364A
Dynamic Changes of the Tricuspid Annulus and 
Papillary Muscles During the Cardiac Cycle 
1067-138·431A
Investigation of Coronary Venous Anatomy by Multislice 
Computed Tomography 1001-20·5A
Cardiac arrest
Compliance and Effectiveness of the Wearable 
Cardioverter Defibrillator Vest 1154-92·300A
Effects of Incomplete Chest Wall Decompression 
During Cardiopulmonary Resuscitation on Coronary 
and Cerebral Perfusion Pressures in a Porcine Model 
of Cardiac Arrest 1154-94·301A
Excessive Ventilation During Cardiopulmonary 
Resuscitation Decreases Survival Rates in a Porcine 
Model of Cardiac Arrest 1059-1·10A
Low Frequency Audible Doppler Reveals That a 
Substantial Fraction of Patients With Suspected 
Pulseless Electrical Activity Have Occult Blood Flow 
1154-93·300A
Multicenter Study of Safety and Efficacy of a Biphasic 
Impedance-Compensating Waveform for 
Transthoracic Defibrillation 1154-89·299A
Prospective Evaluation of Integrating the Existing 
Emergency Medical System With Automated External 
Defibrillators Operated by Volunteers and Lay 
Persons for Out-of-Hospital Cardiac Arrest: The 
Brescia Early Defibrillation Study (BEDS) 1059-3·11A
Cardiac mapping
Activation Mapping of Pulmonary Veins During Initiation 
of Atrial Fibrillation Using a Multielectrode Basket 
Catheter 1014-211·105A
Left Atrial Flutter Following Circumferential Pulmonary 
Vein Ablation for the Treatment of Atrial Fibrillation 
1052-208·114A
Local Velocity Estimation Analysis During Bipolar 
Single Site and Linear Triple Site Rapid Pacing in 
Canine Models: Implications for Antitachycardia 
Pacing 1035-222·113A
New Simplified Technique for 3-D Mapping and Ablation 
of Right Ventricular Outflow Tachycardia 
1130-225·138A
Polar Map Visualization of Left Ventricular 
Electromechanical Asynchrony 1059-38·19A
Registration of Cardiac Computed Tomography Images 
With Three-Dimensional Electroanatomical Mapping 
to Guide Catheter Manipulation in the Left Atrium: 
Implications for Pulmonary Venous Isolation 
1052-226·115A
Registration of Cardiac Magnetic Resonance Images 
With Three-Dimensional Electroanatomical Mapping 
to Guide Catheter Ablation in the Left Ventricle 
1110-221·130A
Surface Electrocardiogram Clues to Localization of 
Ventricular Tachycardia to the Aortic Cusps 
1130-226·138A
Cardiac output
Accuracy of Hemodynamic Measures by Impedance 
Cardiography in Heart Transplant Patients 
1089-113·194A
Alcohol Consumption and Cardiac Structure and 
Function in American Indians: The Strong Heart 
Study 1163-118·228A
Body Fat Distribution Influences Cardiac Output in 
Normotensive and Hypertensive Overweight 
Individuals: The HyperGEN Study 1142-179·512A
Mode of Death After Congenital Heart Surgery 
1116-27·26A
Sildenafil Citrate (Viagra) Induces Powerful 
Cardioprotective Effects Following 
Ischemia-Reperfusion Injury in Infant Rabbits 
1041-95·256A
Visualization of the Effect of Atrial-Ventricular and 
Right-Left Delay on Cardiac Output During 
Biventricular Pacing 1058-71·404A
Whole-Body Electrical Bioimpendance Is Accurate in 
Noninvasive Determination of Cardiac Output: A 
Thermodilution Controlled, Prospective, Double-Blind 
Evaluation 1126-117·209A
Cardiac pacing artificial
Atrial Pacing May Negate the Benefits of 
Resynchronization  872-1·236A
Changes in Left Ventricular Activation Sequence in a 
Finite Element Model of Single Site Right Ventricular 
and Dual Site Biventricular Pacing 1058-70·404A
Investigation of Coronary Venous Anatomy by Multislice 
Computed Tomography 1001-20·5A
Local Velocity Estimation Analysis During Bipolar 
Single Site and Linear Triple Site Rapid Pacing in 
Canine Models: Implications for Antitachycardia 
Pacing 1035-222·113A
Long-Term Reliability of Epicardial and Transvenous 
Leads Used for Cardiac Resynchronization Therapy 
1167-219·146A
The Monolithic Fetal Pacemaker III: Device Dimensions 
by Fetal Ultrasonography 1035-218·112A
Wide WRS Increases Risk From Right Ventricular 
Pacing 1147-214·139A
Cardiac resynchronization
3D Echocardiographic Quantification of Left Ventricular 
Asynchrony in Patients Selected for Cardiac 
Resynchronization Therapy 1016-154·309A
Acute Changes in Aortic Time-Velocity-Integral With 
Cardiac Resynchronization Therapy Predict Clinical 
Outcome  879-1·152A
Benefit of Biventricular Pacing in Subsets of Patients 
With Heart Failure  872-5·237A
Biventricular Pacing Resynchronizes Septal Perfusion/
Wall Motion Match by a Primary Increase of 
Myocardial Blood Flow 1167-222·147A
Cardiac Resynchronization Therapy Improves Sleep 
Related Breathing Disorders in Patients With Chronic 
Heart Failure  879-4·152A
Cardiac Resynchronization Therapy Results in a Lower 
Arrhythmia Burden 1091-209·125A
Changes in Left Ventricular Activation Sequence in a 
Finite Element Model of Single Site Right Ventricular 
and Dual Site Biventricular Pacing 1058-70·404A
Chronic Effect of Cardiac Resynchronization Therapy 
on Functional Mitral Regurgitation in the Advanced 
Systolic Heart Failure 1112-143·341A
Different Criteria of Cardiac Resynchronization Therapy 
Have Different Prognostic Value for Worsening Heart 
Failure or Major Arrhythmic Events in Idiopathic 
Dilated Cardiomyopathy 1127-107·210A
Does Wider QRS Reflect Heart Failure Severity? 
1163-122·229A
Echocardiographic Tissue Synchronization Imaging 
Predicts Acute Response to Biventricular Pacing 
Therapy 1092-164·333A
Effect of Cardiac Resynchronization Therapy in Patients 
With Right Bundle Branch Block 1059-19·14A
Heart Rate Variability and Heart Rate Changes Induced 
by Biventricular Pacing in Advanced Heart Failure  
817-3·127A
Heart Rate Variability Footprint: New Diagnostic Tool to 
Monitor the Clinical Benefit of Cardiac 
Resynchronization Therapy in Patients With 
End-Stage Heart Failure 1091-212·126A
Impact of Myocardial Viability Assessment on the 
Beneficial Effect of Cardiac Resynchronization 
Therapy in Patients With Ischemic Cardiomyopathy 
1068-121·176A
Implant Defibrillator Threshold Characteristics in an 
Implantable Cardioverter Defibrillator Population 
Receiving Cardiac Resynchronization Therapy  
817-5·128A
Improvement of Brain Natriuretic Peptide Levels 48 
Hours Following Cardiac Resynchronization Therapy 
1111-224·132A
In the Rapid Pacing Canine Model of Heart Failure, Left 
Ventricular Stimulation Resynchronizes Better the 
Left Ventricle Compared to Biventricular or Right 
Ventricular Stimulation: An 
Echocardiographic-Hemodynamic Correlation of 
Systolic and Diastolic Function 1111-225·132A
Lead Position and Long-Term Survival With 
Biventricular Pacing 1167-225·148A
Left Ventricular Asynchrony Predicts Heart Failure 
Progression After Cardiac Resynchronization 
Therapy 1111-212·131A
Left Ventricular Pre-Excitation Is Superior to Right 
Ventricular Pre-Excitation in Sequential Biventricular 
Pacing for Heart Failure  879-6·153A
Long-Term Reliability of Epicardial and Transvenous 
Leads Used for Cardiac Resynchronization Therapy 
1167-219·146A
Mechanical Activation Mapping With Strain Imaging: A 
New Approach to Localize Ventricular Lead 
Placement After Cardiac Resynchronization Therapy  
879-5·153A
Multisite Pacing Improves Synchronization of Regional 
Ventricular Contraction as Assessed by 
Three-Dimensional Echocardiography in Patients 
With Single Ventricle Congenital Heart Disease  
811-2·383A
Myocardial Strain and Displacement Following Cardiac 
Resynchronization Therapy 1092-162·333A
Narrowing of the Widest QRS Predicts Improvement in 
Functional Class and Echocardiographic Parameters 
in Patients With Cardiac Resynchronization Therapy 
Devices 1111-211·131A
Outcome of Resynchronization Therapy in Patients 
With Atrial Fibrillation 1167-226·148A
Polar Map Visualization of Left Ventricular 
Electromechanical Asynchrony 1059-38·19A
Preoperative QRS Widening and Ventricular 
Dysrhythmia Predict Adverse Outcomes Following 
Left Ventricular Reconstruction for Ischemic 
Cardiomyopathy 1079-78·271A
Prevalence of Echocardiographic Left Ventricular 
Contractile Dyssynchrony in Patients With Left 
Bundle Branch Block: Impact on Selection for Pacing 
1111-208·130A
QRS Intrinsicoid in Lead I: A Novel Surface 
Electrocardiogram Marker for Left Sided Conduction 
System Disease in Patients With a Right Bundle 
Branch Block Pattern 1072-217·121A
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Relationship Between QRS Duration and Left 
Ventricular Dyssynchrony in Patients With End Stage 
Heart Failure 1167-208·146A
Right Ventricular Resynchronization Fails to Improve 
Hemodynamics Early After Tetralogy of Fallot Repair  
811-3·383A
Should Patients With Complete Heart Block and Severe 
Heart Failure be Upgraded to a Resynchronization 
System? 1167-223·147A
Subendocardial Radial Strain Activation Imaging: A 
New Method to Quantify Regional Dyssynchrony in a 
Model of Left Bundle Branch Block and Biventricular 
Pacing  844-2·362A
The Predictive Value of QRS Duration as a Marker of 
Ventricular Dyssynchrony 1111-210·131A
Use of Real-Time Three-Dimensional 
Echocardiography to Measure Ventricular 
Dyssynchrony and Assess Cardiac 
Resynchronization in Heart Failure Patients 
1016-153·309A
Use of Resynchronization Therapy in Pediatric Patients 
With Congenital Heart Disease and Complete Heart 
Block  811-4·384A
Utility of Atrioventricular Delay Optimization in Patients 
Undergoing Cardiac Resynchronization Therapy  
879-3·152A
Volume Overload Modulates Ejection Fraction 
Improvement in Cardiac Resynchronization Therapy 
1167-221·147A
Cardiac surgery
13-Year Follow-Up of the German Angioplasty Surgery 
Investigation 1138-42·80A
Adjunctive Treatment With a Stent-Based Ventricle to 
Coronary Artery Bypass (VSTENT™) in Patients 
With Multivessel Disease Undergoing Coronary 
Artery Bypass Surgery (ADVANTAGE) 1079-85·273A
Aggressive Treatment of Atrial Fibrillation Reduces 
Stoke Following Cardiac Surgery 1115-72·411A
B-type Natriuretic Peptide Levels Predict Postoperative 
Atrial Fibrillation in Patients Undergoing Cardiac 
Surgery  408-4·535A
Changing Outlook After Aortic Valve Surgery for 
Chronic Aortic Regurgitation With Severe Left 
Ventricular Dysfunction  851-4·439A
Clinical Application of a Wear-Resistant Axial Flow 
Pump With an Intelligent Control Algorithm as a Left 
Ventricular Cardiac Assist Device 1050-125·174A
Clinical Outcome in Patients With Preoperative 
Congestive Heart Failure Undergoing Coronary 
Artery Bypass Graft Surgery 1108-119·199A
Clinical Outcomes in Coronary Angioplasty Centers 
With Off-Site Versus On-Site Cardiac Surgery 
Capabilities: A Preliminary Report From the 
American College of Cardiology - National 
Cardiovascular Data Registry  852-1·96A
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Sex Disparities in the Treatment of Non–ST-Segment 
Elevation Acute Coronary Syndromes  869-4·304A
Utility of an Online Clinical Database for Tracking 
Innovative Technology: The Academic Drug-Eluting 
Stent Experience 1020-68·399A
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Dilated Cardiomyopathy 1127-107·210A
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Atherosclerosis in Mice 1064-182·465A
High- but Not Low-Dose Folic Acid Improves 
Endothelial Function in Coronary Artery Disease 
1159-186·517A
Improved One-Year Survival of Hospitalized Heart 
Failure Patients Between 1995 and 2000 
1069-120·182A
Increased Vascular Stiffness and Impaired Ejection 
Fraction in Older Patients Following First Transmural 
Myocardial Infarction 1128-126·212A
Internist Use of a Hand Carried Ultrasound Device for 
the Screening of Cardiovascular Disease in the 
Medically Underserved 1096-73·409A
Left Atrial Enlargement as a Marker for Cardiac 
Disease: Teaching One Simple Measure for 
Point-of-Care Ultrasound Screening 1059-33·18A
Mice Deficient in Leptin or the Leptin Receptor Exhibit 
Reduced Neointima Formation Following Vascular 
Injury 1064-179·465A
Noninvasive Evaluation of Coronary Artery Plaque With 
ECG-Gated Multislice Computed Tomography  
845-3·363A
Paradoxical Utilization of Invasive Cardiac Procedures 
for Patients With Non-ST-Segment Elevation 
Myocardial Infarction: An American-Canadian 
Comparison From the CRUSADE Initiative and 
Canadian Registries 1097-93·276A
Peroxisome Proliferator Activated Receptor Gamma 
Agonist Protects Against Arterial Thrombosis in a 
Mouse Model of Insulin Resistance 1007-176·444A
Plasma Sphingomyelin Levels in Coronary Artery 
Disease: A Relationship With Serum Triglyceride and 
Apolipoprotein B and Other Risk Factors 
1124-198·505A
Preoperative Hemodynamic Status as a Predictor of 
Surgical Mortality in Acute Type A Aortic Dissection 
Patients: Insights From the International Registry of 
Acute Aortic Dissection (IRAD) 1046-176·461A
Prevalence of Aortic Intramural Hematoma: A 
Transesophageal Echocardiographic Hospital-Based 
Cohort Study of 2,147 Subjects 1066-195·471A
Racial Variations in Treatment and Outcomes of African 
American and White Patients With Non ST-Elevation 
Acute Coronary Syndromes: Insights From 
CRUSADE 1135-76·414A
Rebirth of Bedside Cardiovascular Examination Using 
Hand-Carried Ultrasound 1016-152·309A
Risk of Cardiovascular Disease in US Persons With 
Metabolic Risk Factors, Diabetes, and Elevated 
C-Reactive Protein  820-2·486A
Screening for Asymptomatic Coronary Artery Disease 
in the Potential Renal Transplant Recipient 
1115-74·411A
Sex Disparities in the Treatment of Non–ST-Segment 
Elevation Acute Coronary Syndromes  869-4·304A
Systolic Blood Pressure Measured Serially From 
Childhood to Adulthood Predicts Arterial Stiffness in 
Young Adults: The Bogalusa Heart Study  
847-5·515A
The Impact of Contemporary Guideline Compliance on 
Risk Stratification Models for Acute Coronary 
Syndromes in The Registry of Acute Coronary 
Syndrome (TRACS) 1060-84·262A
The Incidence and Prognostic Value of Exertional 
Hypotension in Medically Managed Older Patients 
With Stable Coronary Artery Disease 1128-129·214A
The Pivotal Link Between Hepatitis C Virus Infection 
and Increased Arterial Stiffness in Patients With End 
Stage Renal Failure 1046-174·461A
The Severity of Mitral Annular Calcification Is 
Associated With Prevalent Cardiovascular Disease in 
the Elderly: The Cardiovascular Health Study  
885-4·240A
Cardiovascular disease prevention
Amlodipine/Atorvastatin Single Pill Dual Therapy 
Improves Goal Attainment in the Treatment of 
Concomitant Hypertension and Dyslipidemia: The 
Gemini Study 1008-190·447A
Association of Prehypertension by Joint National 
Committee 7 Criteria With Left Ventricular Structure 
and Function: The Strong Heart Study 
1142-183·513A
B-Type Natriuretic Peptide Levels in Asymptomatic 
Patients With B-Thalassaemia Major 1013-119·162A
Can Electrical Muscle Stimulation of the Legs Produce 
Cardiovascular Exercise? 1165-134·233A
Cardiovascular Disease in the Elderly: The Association 
of Self-Reported Health Behavior With Clinical 
Outcomes 1128-128·213A
Case Method Learning Is a Cost Effective 
Implementation Method of Evidence Based 
Secondary Prevention in Primary Care 1096-69·408A
Clustering of Novel Risk Factors Correlates With the 
Metabolic Syndrome 1137-96·297A
Combination Aspirin and Statin Therapy Markedly 
Reduces C-Reactive Protein Levels in a High-Risk 
Population Without Coronary Disease  847-2·514A
Degree of Physical Activity Is Associated With 
Subclinical Atherosclerosis in Patients Prone to 
Metabolic Syndrome 1124-189·503A
Effective Reduction of Novel Atherogenic Low-Density 
Lipoprotein Subfraction by Atorvastatin in Patients 
With Hypercholesterolemia  820-4·486A
Efficacy of Lipid Lowering Therapy in Inducing Arrest or 
Reversal of Coronary Disease as Assessed With 
Positron Emission Tomography  804-2·332A
Importance of an Oral Glucose Tolerance Test in 
Identifying High Prevalence of Dysglycemia in 
Individuals at High Cardiovascular Risk 
1128-120·211A
Long-Term Clopidogrel Therapy Following 
Percutaneous Coronary Intervention Improves 
Clinical Outcome but Is Not Associated With 
Increased Bleeding: New Insights From the CREDO 
Trial 1116-6·21A
Metabolic Syndrome and Prevention of Premature 
Coronary Artery Disease 1124-194·504A
Racial Differences in Utilization of Primary Prevention 
Strategies and Cardiac Catheterization Following 
First Myocardial Infarction 1097-99·277A
Rosuvastatin Is Efficacious as Monotherapy in Patients 
With Combined Dyslipidemia 1084-172·480A
Systolic Reflective Index: A New Parameter to Study 
Arterial Elasticity  873-5·528A
Carotid arteries
Carotid Angioplasty and Stenting: Early and Late 
Follow-Up Results 1156-64·91A
Carotid Artery Intima-Media Thickness Progression 
Rates in Young Adults: The Bogalusa Heart Study 
1082-188·478A
Effect of Contrast Enhancement on Measurement of 
Carotid Arterial Lumen and Wall Volume Using 
Magnetic Resonance Imaging 1055-153·322A
Elevated Preprocedural C-Reactive Protein Levels 
Predict Death and Stroke in Patients After Carotid 
Artery Stenting 1116-5·21A
Gender Differences in the Risk Factors Contributing to 
Carotid Intima-Medial Thickness: The Johns Hopkins 
Sibling Study 1082-184·477A
Increased Subclinical Atherosclerosis in Young Adults 
With Metabolic Syndrome: The Bogalusa Heart Study 
1028-174·455A
Nitric Oxide Synthase Gene Polymorphism (G894T) 
Influences Arterial Stiffness in Adults: The Bogalusa 
Heart Study  865-6·526A
Noninvasive Characterization of Carotid Plaque 
Inflammation in Humans With FDG-Positron 
Emission Tomography  848-4·516A
Noninvasive Detection of Carotid Artery Endothelial 
Dysfunction Due to Hypertriglyceridemia With High- 
Frequency Real-Time Low Mechanical Index Imaging 
of Retained Microbubbles 1001-34·9A
Quantitative Detection of Inflammation in Carotid 
Atherosclerosis by Dynamic Contrast Enhanced 
Magnetic Resonance Imaging  408-3·534A
Real-Time Contrast Enhanced Ultrasound Imaging of 
Neovascularization Within the Human Carotid Plaque  
881-3·374A
Stromelysin-1 (MMP-3) Gene 5A/6A Promoter 
Polymorphism Is Associated With Blood Pressure in 
a Community Population 1161-173·522A
Sustained Upregulation of Chemokine and Its Receptor 
Genes Associated With Matrix Metalloproteinase 
Overexpression in Human Carotid Plaque Rupture: 
Results From a Quantitative Study With Real-Time 
Reverse Transcriptase-Polymerase Chain Reaction- 
Method  831-4·497A
Symptomatic Patients Have Similar Outcomes 
Compared to Asymptomatic Patients After Carotid 
Artery Stenting With Emboli Protection  877-6·101A
Troponin T Elevation Is Associated With Functional and 
Anatomical Impairment of the Heart in Chronic Renal 
Failure on Maintenance Dialysis 1132-153·350A
Carotid Stenting
Carotid Angioplasty and Stenting: Early and Late 
Follow-Up Results 1156-64·91A
Carotid Artery Stenting in African Americans 
1156-66·92A
Consequences of Hemodynamic Instability After 
Carotid Artery Stenting 1116-4·20A
Economic Outcomes of Carotid Stenting Versus 
Endarterectomy for High Risk Patients: Preliminary 
Results From the SAPPHIRE Trial 1156-62·91A
Elevated Preprocedural C-Reactive Protein Levels 
Predict Death and Stroke in Patients After Carotid 
Artery Stenting 1116-5·21A
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Inaccuracy of Doppler Ultrasonography for Assessing 
Restenosis After Internal Carotid Artery Stenting 
1156-63·91A
Late Quantitative Angiographic Results Following 
Treatment With a Polymer-Based Paclitaxel-Eluting 
Stent Compared With a Bare Metal Stent in Patients 
With De Novo Coronary Disease: The TAXUS-IV 
Angiographic Results  843-3·87A
Post-Carotid Artery Stent Hypotension and Optimal 
Pressor Use 1156-65·91A
Predilatation Before Distal Protection Device Placement 
in Stenting Carotid Arteries Is Successful and Not 
Associated With Adverse Outcome 1156-60·90A
Short-Term Outcomes of Carotid Stenting in Low and 
High Surgical Risk Patients  877-5·101A
Symptomatic Patients Have Similar Outcomes 
Compared to Asymptomatic Patients After Carotid 
Artery Stenting With Emboli Protection  877-6·101A
Cell physiology
A Carboxyl-Tailless Mutant of Connexin43 
Overexpressed in Transgenic Mice Reduces the pH 
Gating Sensitivity Between Atrial Myocytes 
1034-213·111A
Expression of Tob by Human Coronary Arteries and 
BMP-Mediated Stimulation of Coronary Artery 
Endothelial Cell Proliferation 1122-170·499A
Gap Junction Channels: Coexpression of Cardiac 
Connexins Restricts Communication Pathways That 
Modulate Cell Growth but Not Membrane Potential 
1110-215·129A
Human Fat Tissue-Derived Stem Cells Show 
Cardiomyocytic Differentiation After Coculture 
1068-122·177A
In Vivo Magnetic Resonance Evaluation of the Effects 
of Mouse Embryonic Stem Cells on Cardiac Function  
404-1·532A
Stem Cell Factor Plays a Critical Role in Neointimal 
Formation by Bone Marrow Derived Progenitor Cells  
406-2·533A
The HNO/Nitric Oxide Donor Angeli’s Salt Enhances 
Myocyte Contractility in a PKA-Dependent Manner 
1011-110·156A
Cells
Acute and Early Changes in Plasma Vascular Growth 
Factors and Circulating Endothelial Progenitor Cells 
in Patients With Acute ST Elevation Myocardial 
Infarction 1025-63·38A
Autologous Fibroblast Transplantation Into Myocardial 
Infarcts in Pigs: Effects on Arrhythmogenesis and 
Arrhythmic Threshold 1110-217·129A
Autotransplantation of Bone Marrow Into Scarred 
Myocardium for the Improvement of Cardiac Function 
in Humans: Is It Durable and Safe?  814-3·187A
Cardiac Responses to Intracoronary-Delivered Stem 
Cells in Apolipoprotein-Null Mice: Assessment by 
Langendorff Perfusion 1011-108·155A
Cardiomyogenic Stem Cells in Human Bone Marrow 
1059-22·15A
Catheter-Based Transplantation of Autologous Bone 
Marrow Mononuclear Cells Safely Improves 
Collateral and Capillary Network in Adult Swine With 
Myocardial Ischemia 1100-57·64A
Cell Location May Be a Primary Determinant of Safety 
After Myoblast Transplantation Into the Infarcted 
Heart 1059-23·15A
Chronic Beta3-Adrenergic Receptor Blockade Causes 
Regression of Cardiac Dysfunction in a Rat Model of 
Progressive Heart Failure  870-1·235A
Circulating Endothelial Progenitor Cells in Patients With 
Unstable Angina: Association With Systemic 
Inflammation 1103-196·489A
Comparison Between Intracoronary Infusion and Direct 
Transendocardial Injection of Mesenchymal Stem 
Cells in a Dog Acute Ischemia Model 1100-56·63A
Cultured Adipose Tissue-Derived Stromal Cells 
Express the Stem Cell Marker CD34 and Show 
Evidence of Differentiation Into a Cardiomyocyte 
Phenotype 1068-126·177A
Cyclic Stretch of Adult Human Mesenchymal Stem 
Cells Induces Expression of Early Cardiac and 
Neuronal Genes 1068-125·177A
Development of a Transgenic Mouse Model for Imaging 
of Cellular Differentiation Into Cardiomyocyte 
1116-22·24A
Direct Comparison of Bone Marrow Stromal Versus 
Mononuclear Cells in Murine Cardiac Function After 
Cellular Cardiomyoplasty 1144-134·220A
Enhanced Angiogenesis With Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused 
Myocardial Infarction Model 1078-93·270A
Enhanced Cardiac Beta3-Adrenergic Functional 
Response in Alcoholic Monkeys 1029-181·456A
Epidermal-Derived Progenitor Cells Engraft the 
Infarcted Myocardium and Express Cardiomyocyte 
Markers 1078-90·269A
Fibrates Inhibit Plasminogen Activator Inhibitor Type-1 
Expression in Human Adipose Tissue: An 
Antiatherogenic Phenomenon? 1140-173·508A
Ghrelin Is Synthesized and Secreted by Human 
Cardiomyocytes Protecting These Cells From 
Apoptosis 1106-188·494A
Intramyocardial Injection of Autologous Bone Marrow 
Cells Improves Myocardial Perfusion in Severe 
Ischemic Heart Disease: A 30-Day Assessment 
1079-82·272A
Intravenous Mesenchymal Stem Cell Therapy Early 
After Reperfused Acute Myocardial Infarction 
Improves Left Ventricular Function and Alters 
Ventricular Electrophysiologic Properties 
1100-55·63A
Ischemic Precondition Improves Performance of the 
Hearts With Coronary Delivery of Embryonic Stem 
Cells: Assessment by a Langendorff Perfusion Model 
1068-127·178A
Kinetics of Circulating Endothelial Progenitor Cells in 
Congestive Heart Failure 1108-131·202A
Knock-Out of P21 Escapes Radiation-Induced Cell 
Cycle Arrest and Apoptosis in Vascular Smooth 
Muscle Cell 1158-54·95A
Long-Term Follow-Up of Safety and Feasibility of 
Autologous Skeletal Myoblast Transplantation in 
Patients Undergoing Coronary Artery Bypass Graft 
Surgery 1001-24·6A
Nonviral FasL Protects Allogeneic Myoblasts Against 
Cell Death in Cardiomyogenesis 1068-124·177A
Percutaneous Intracoronary Transplantation of 
Autologous Stem Cells After Acute Myocardial 
Infarction 1108-132·202A
Pitavastatin, a Potent Hydroxymethylglutaryl Coenzyme 
A Reductase Inhibitor, Increases Cholesterol 
7a-hydroxylase Gene Expression in HepG2 Cells 
1083-190·478A
Rosiglitazone Modulates Angiogenic Progenitor Cell 
Differentiation and Attenuates Intimal Hyperplasia 
After Vascular Intervention  867-5·527A
Skeletal Myoblast Transplantation Through a 
Catheter-Based Coronary Sinus Approach: An 
Effective Means of Improving Function of Infarcted 
Myocardium 1059-21·15A
Stem Cell Mobilization With Granulocyte 
Macrophage-Colony Stimulating Factor Has No Effect 
on Infarct Size and Left Ventricular Function in an 
Experimental Model of Acute Myocardial Infarction 
1078-89·269A
Survival, Differentiation, and Contractility of Immature 
Cardiac Cells Implanted Into the Outer Wall of Aorta 
in Rats as a Step in the Development of an Auxiliary 
Circulatory Pump  870-4·236A
The Number and Adhesive Properties of Circulating 
Endothelial Progenitor Cells in Patients With In-Stent 
Restenosis  803-1·53A
Time Course of Improvement Following Stem Cell 
Injections in Humans With Heart Failure  814-2·187A
Transdifferentiation of Mesenchymal Stem Cells Into 
Cardiomyocytes by Direct Cell-to-Cell Contact With 
Nenatal Cardiomyocytes but Not Adult 
Cardiomyocytes 1078-91·269A
Transendocardial Autologous Bone Marrow Cell 
Transplantation in Patients With Advanced Ischemic 
Heart Disease: Final Results From a Multi-center 
Feasibility Study  864-3·99A
Uncovering Human Cardiac Myocyte Progenitor Cells 
for Myocardial Regeneration  870-5·236A
Cellular mechanisms
Alterations in Cell Signaling Pathways During 
Pregnancy and Postpartum Cardiac Remodeling  
849-5·226A
Angiotensin II Induces TRAF-2 in Human Vascular 
Smooth Muscle Cells and Sensitizes CD40 Without 
Upregulation of CD40 Expression 1122-167·498A
Blood-Borne Hematopoetic Cells of Monocyte Origin: 
Precursors to Neointimal Myofibroblasts After 
Coronary Artery Injury 1001-5·2A
Calmodulin Kinase Activity Links Green Fluorescent 
Protein Overexpression to a Cardiomyopathic 
Phenotype 1144-128·219A
Calpain Activation and Inhibition in Acute Right Heart 
Failure 1144-130·219A
Expression of Tob by Human Coronary Arteries and 
BMP-Mediated Stimulation of Coronary Artery 
Endothelial Cell Proliferation 1122-170·499A
First Human Heart Myoblast Allograft 1025-65·39A
Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients 
With Coronary Artery Disease 1045-193·458A
Homocysteine Induced Endothelial Cell Damage 
Through NF-κB Activation and Monocyte 
Chemoattractant Protein-1 and Vascular Cell 
Adhesion Molecule-1 Expression 1122-172·499A
Human Fat Tissue-Derived Stem Cells Show 
Cardiomyocytic Differentiation After Coculture 
1068-122·177A
Impact of Protein Kinase C-Epsilon for Myocardial 
Hypertrophy After Chronic Pressure Overload: 
In-Vivo Study in Protein Kinase C-Epsilon Knockout 
Mice 1029-180·456A
Neoangiogenesis via Vascular Endothelial Growth 
Factor Expression Is Associated With an 
Osteoblast-like Bone Formation in Calcified 
Rheumatic Heart Valves 1107-135·433A
Platelet-Derived Growth Factor Signaling Has a Crucial 
Role in Vascular Maturation Following Myocardial 
Infarction 1002-98·245A
Proteomic Profiling of Restenotic Lesions Unveils 
Increased Expression of Structural Proteins That Are 
Inhibited by Intramural Delivery of Rapamycin  
1158-52·94A
Role of the Lipoxygenase-1 Receptor in Transducing 
the Apoptotic Signals of Circulating Atherogenic 
Low-Density Lipoprotein 1116-29·26A
The HNO/Nitric Oxide Donor Angeli’s Salt Enhances 
Myocyte Contractility in a PKA-Dependent Manner 
1011-110·156A
Transdifferentiation of Mesenchymal Stem Cells Into 
Cardiomyocytes by Direct Cell-to-Cell Contact With 
Nenatal Cardiomyocytes but Not Adult 
Cardiomyocytes 1078-91·269A
Versican Promoter Is a Target for the β-Catenin/Tcf-4 
Signaling Pathway in Vascular Smooth Muscle Cells  
867-6·527A
Cerebrovascular circulation
Catheter Sequence Rather Than Catheter Shape 
Determines the Frequency of Cerebral Microemboli 
During Cardiac Catheterization 1066-197·471A
Diastolic Heart Failure in Patients Hospitalized With 
Symptomatic Cerebral and Peripheral Vascular 
Disease  887-5·242A
Effects of Incomplete Chest Wall Decompression 
During Cardiopulmonary Resuscitation on Coronary 
and Cerebral Perfusion Pressures in a Porcine Model 
of Cardiac Arrest 1154-94·301A
Quantification of Absolute Myocardial Perfusion by 
Contrast Echocardiography: Algorithm, In Vitro and In 
Vivo Validation 1036-157·315A
Survival Differences Between Hispanic and 
Non-Hispanic Patients With Cardiovascular Disease 
Initiating Renal Replacement Therapy in the United 
States 1135-74·414A
The Safety of Carotid and Cerebral Angiography 
Performed by Cardiologists in the Cardiac 
Catheterization Laboratory 1156-61·91A
Cholesterol
Effect of a Single High-Fat Meal on Endothelial 
Microparticles as a Marker of Endothelial Injury 
1159-191·518A
Effect of Lipid Subfractions on Progression of Coronary 
Artery Disease Among Middle-Aged Women 
1116-33A·27A
Effects of Ezetimibe, Simvastatin, and 
Ezetimibe-Simvastatin on Noncholesterol Sterol 
1008-183·445A
Enteral Nutrition Affects Body Composition, Plasma 
Lipids and Cytokines in Cardiac Cachexia: Interim 
Analysis of a Double-Blind, Placebo-Controlled 
Intervention Trial 1088-132·193A
Ezetimibe/SimvastatinTherapy Is More Effective Than 
Simvastatin Alone at Reducing Remnant-Like Particle 
Cholesterol 1084-179·481A
Low High-Density Lipoprotein Cholesterol, 
Hypertension, Diabetes, but Not High Low-Density 
Lipoprotein Cholesterol as Predictors of Acute 
Coronary Syndrome in Northern Area of Japan: A 
Case-Control Study 1047-180·463A
Low-Density Lipoprotein Subfractions in a Random 
Sample of Children and Adolescents 1047-178·462A
Modulating Effects of Cholesterol Elevation by 
Diet-Feeding and Cholesterol Lowering by 
Simvastatin on Platelet-Activating Factor 
Acetylhydrolase Activity, Paraoxonase Activity, and 
Lysophosphatidylcholine Concentration 
1083-189·478A
Pitavastatin, a Potent Hydroxymethylglutaryl Coenzyme 
A Reductase Inhibitor, Increases Cholesterol 
7a-hydroxylase Gene Expression in HepG2 Cells 
1083-190·478A
Significant Lipid Changes in a Large-Scale Trial of 
Fenofibrate to Prevent Cardiovascular Disease in 
Type 2 Diabetes 1047-177·462A
Underachievement of Low-Density Lipoprotein 
Cholesterol Goal in Patients on Statins in Clinical 
Practice: Are We Using Low Doses of Statins Too 
Often? 1021-102·250A
Vascular Endothelin-1 Activity Correlates With 
Low-Density Lipoprotein Cholesterol Levels, but Not 
With Insulin Sensitivity in Hypercholesterolemic 
Patients 1105-169·490A
Cholesterol screening
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Nonhigh-Density Lipoprotein Cholesterol per National 
Cholesterol Education Panel and Advanced 
Lipoprotein Analysis: Correlation and Relationship to 
Premature Coronary Artery Disease  820-3·486A
Cholesterol-lowering drugs
A Pharmaco-Epidemiological Study of the Interaction 
Between Atorvastatin and Clopidogrel Following 
Percutaneous Coronary Interventions 1063-55·50A
Additive Gene-Gene Interaction Between CYP7A1 and 
Apolipoprotein E as Genetic Determinants of 
Low-Density Lipoprotein Cholesterol-Lowering 
Response to Atorvastatin 1124-197·505A
Amlodipine/Atorvastatin Single Pill Dual Therapy 
Improves Goal Attainment in the Treatment of 
Concomitant Hypertension and Dyslipidemia: The 
Gemini Study 1008-190·447A
Analysis of the Renal Safety of Atorvastatin in a Broad 
Spectrum of Patients With Dyslipidemia 
1084-173·480A
Benefit of Statins in Secondary Prevention After Acute 
Myocardial Infarction – Evidence of a Class Effect 
1008-185·446A
Cardiopulmonary Function Is Abnormal After 
Statin-Induced Rhabdomyolysis and Myositis 
1059-26·16A
Cholesterol Goal Attainment Is Associated With Lower 
Incidence of Cardiovascular Events and Cost of Care 
1047-187·464A
Circulating T Cell Perturbation and Macrophage 
Activation in Stable Coronary Artery Disease 
Patients: Effect of Atorvastatin Therapy 
1159-183·517A
Combination Aspirin and Statin Therapy Markedly 
Reduces C-Reactive Protein Levels in a High-Risk 
Population Without Coronary Disease  847-2·514A
Comparative Effects of Statins on Atherogenic 
Dyslipidemia in Patients With the Metabolic 
Syndrome  820-1·485A
Coronary Plaque Regression by Simvastatin Is 
Associated With Reduction in Vessel Volume: A 
Three-Dimensional Intravascular Ultrasound Study 
1059-8·12A
Delay in Dose Titration of Lipid-Lowering Therapy 
Leads to Adverse Cardiovascular Outcomes  
882-6·530A
Effect of Atorvastatin and Sildenafil on Endothelial 
Function in Patients With Erectile Dysfunction and 
Increased Cardiovascular Risk 1141-196·510A
Effect of Cerivastatin-Eluting Stent on Inflammatory 
Response, Platelet Deposition and Intimal 
Hyperplasia in a Porcine Coronary Model 
1139-50·83A
Effect of Fosinopril and Pravastatin on Carotid 
Intima-Media-Thickness in Microalbuminuric Subjects 
Without Hypertension or Hypercholesterolemia  
825-4·495A
Effective Reduction of Novel Atherogenic Low-Density 
Lipoprotein Subfraction by Atorvastatin in Patients 
With Hypercholesterolemia  820-4·486A
Effects of Ezetimibe, Simvastatin, and 
Ezetimibe-Simvastatin on Noncholesterol Sterol 
1008-183·445A
Effects of Prolonged Oral Simvastatin Treatment After 
Coronary Stenting on Neointimal Growth and Plaque 
Progression as Assessed by Intravascular 
Ultrasound: A Randomized Study  864-5·99A
Efficacy and Safety of Ezetimibe Coadministered With 
Simvastatin Versus Simvastatin Alone in 
Thiazolidinedione-Treated Patients With Type 2 
Diabetes Mellitus 1084-169·479A
Efficacy of Ezetimibe Coadminstered With Simvastatin 
Versus Atorvastatin in Patients With 
Hypercholesterolemia 1084-176·480A
Efficacy of Ezetimibe-10 mg/Day Coadministered With 
Multiple Doses of Simvastatin in Patients With 
Primary Hypercholesterolemia 1084-174·480A
Encapsulation of Pravastatin Tablets Produces Greater 
Low-Density Lipoprotein Cholesterol Lowering in 
Patients With Human Immunodeficiency Virus 
Infection Dyslipidemia Taking Protease Inhibitors 
1008-186·446A
Ezetimibe/SimvastatinTherapy Is More Effective Than 
Simvastatin Alone at Reducing Remnant-Like Particle 
Cholesterol 1084-179·481A
Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme a 
Reductase Attenuates Expression of Inducible Nitric 
Oxide Synthase in Cardiac Myocytes: A Possible Link 
With Direct Myocardial Protection During 
Ischemia-Reperfusion 1116-34·27A
Long-Term Effects of Statin Therapy in Patients With 
Acute ST-Elevation Myocardial Infarction and 
Moderate or Severe Left Ventricular Dysfunction: 
Reduction of Mortality but Not of Nonfatal Major 
Adverse Coronary and Cerebrovascular Events  
833-2·286A
Long-Term Statin Treatment Protects Against 
Nitrate-Induced Oxidative Stress 1140-165·507A
Marked Underutilization and Geographic Variation in 
Secondary Prevention Pharmacologic Therapy in 
Patients With Chronic Angina Undergoing Treatment 
With Enhanced External Counterpulsation 
1077-74·407A
Multidrug Resistance-1 Gene Polymorphisms Influence 
the Response to Atorvastatin Treatment in a Gender 
Specific Manner 1084-168·479A
Physician Beliefs About the Treatment of 
Hyperlipidemia and Treatment to National Cholesterol 
Education Program Low-Density-Lipoprotein 
Cholesterol Goal in High-Risk Patients 1153-75·418A
Pitavastatin, a Potent Hydroxymethylglutaryl Coenzyme 
A Reductase Inhibitor, Increases Cholesterol 
7a-hydroxylase Gene Expression in HepG2 Cells 
1083-190·478A
Preoperative Statins Are Associated With Shorter 
Length of Stay and Improved Long Term Survival in 
Patients Undergoing Vascular Surgery 
1046-171·460A
Preprocedural Statin Administration and Incidence of 
Creatine-Kinase and Troponin I Elevation After 
Elective Percutaneous Coronary Stent Implantation 
1043-45·42A
Preprocedural Statin Medication Reduces Small and 
Large Periprocedural Myocardial Injury in Patients 
With Stent Implantation 1025-45·38A
Preprocedural Statin Medication Reduces the Risk for 
PeriProcedural Myocardial Infarctions in Patients With 
Stent Implantation Independent of the Cholesterol 
Level 1063-59·51A
Renal Transplant Function as a Risk Factor for 
Cardiovascular Events and for All Cause Mortality in 
a Renal Transplant Population: Experience From the 
ALERT Trial 1116-33·27A
Rosuvastatin Is Efficacious as Monotherapy in Patients 
With Combined Dyslipidemia 1084-172·480A
Simvastatin Augments Rac Activation of Akt Signaling 
and Inhibits Endothelial Apoptosis by Modifying 
Subcellular Localization  867-2·526A
Statins Block Endotoxin-Induced Proinflammatory 
Responses in Human Coronary Artery Cells by 
Inhibition of Rho Protein-Mediated Signaling 
1122-169·498A
Statins Decrease Mortality in Patients Undergoing 
Percutaneous Coronary Intervention With Left 
Ventricular Dysfunction 1012-131·160A
The Effects of Pravastatin and Atorvastatin on Markers 
of Oxidant Stress In Vivo 1008-184·446A
Underachievement of Low-Density Lipoprotein 
Cholesterol Goal in Patients on Statins in Clinical 
Practice: Are We Using Low Doses of Statins Too 
Often? 1021-102·250A
Undertreatment of Low Serum High-Density Lipoprotein 
Cholesterol in Patients With Acute Myocardial 
Infarction  833-4·287A
Circadian rhythm
The Effects of Aspirin on Blood Pressure in Untreated 
Hypertensive Patients Are Dependent on the Time of 
Drug Administration 1085-196·483A
The Estrogen-Induced Alterations in Arterial Stiffness 
are Independent of the Non-Dipping Status but 
Attenuated by Progesterone in Hypertensive 
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Early Stent Thrombosis in Unselected Sirolimus- and 
Paclitaxel-Eluting Stent Populations  862-4·98A
Comparative Long-Term Prognostic Value of 
Dobutamine Stress Echocardiography Versus 
Dobutamine Stress Myocardial Perfusion SPECT  
802-3·331A
Comparison of Individually Adapted Breath-Hold and 
Free-Breathing Coronary Magnetic Resonance 
Angioplasty Using Steady State Free Precession 
1133-159·353A
Comparison of Retrospectively 
Electrocardiogram-Gated, Multislice Spiral Computed 
Tomography and Selective Coronary Angiography in 
the Analysis of Stent Permeability After Left Main or 
Ostial Coronary Artery Angioplasty 1018-147·313A
Coronary Artery Aneurysms Are an Independent 
Predictor of High Five-Year Mortality 1099-92·282A
Coronary Artery Magnetic Resonance Angiography 
Comparison of High Field Magnetic Resonance 
Imaging at 1.5 and 3 Tesla 1133-154·352A
Coronary Flow Velocity Reserve <2.0 by Transthoracic 
Doppler Echocardiography Can Detect Myocardial 
Ischemia Assessed by 201-Thallium Schintigraphy in 
a Large Population With Coronary Risk Factors  
866-5·373A
Coronary Lumen Change Is Determined Primarily by 
Adventitial Remodeling Rather Than Plaque Change 
During Therapy  831-2·496A
Coronary Plaque Regression by Simvastatin Is 
Associated With Reduction in Vessel Volume: A 
Three-Dimensional Intravascular Ultrasound Study 
1059-8·12A
Cost-Effectiveness of Screening Coronary Artery 
Disease Patients With B-Type Natriuretic Peptide 
1172-75·422A
Creatine Kinase-MB Elevation After Coronary Stenting 
in Lesions With Ruptured Plaque  808-2·54A
Demographics, Treatment, and Outcome of Acute 
Coronary Syndromes: 17 Years of Experience in a 
Tertiary Care Center 1137-95·297A
Depression in Smokers Hospitalized With Acute 
Cardiovascular Disease Increases Nicotine 
Withdrawal Symptoms and Early Relapse to Smoking 
1153-72·417A
Detection of Coronary Restenosis by Serial Doppler 
Echocardiographic Assessment of Coronary Flow 
Velocity Reserve After Percutaneous Coronary 
Intervention 1073-147·327A
Detection of Increased Blood Temperature in the 
Coronary Sinus of Patients With Coronary Artery 
Disease: The Impact of Temperature Measurements 
on Prognosis 1042-83·258A
Detection of Plaque Instability Predictors by Multislice 
Computed Tomography: Comparison With 
Intravascular Ultrasound 1018-146·313A
Diabetes Mellitus Might Be Associated With Multiple 
Vulnerable Plaque in 113 Patients With Stable 
Angina: A Prospective Study of Three-Vessel 
Intravascular Ultrasound  832-6·74A
Diagnostic Value of Adenosine Stress Magnetic 
Resonance (MR) Perfusion Imaging and Delayed MR 
Hyperenhancement Compared to Tl-201 SPECT and 
Coronary Angiography for Detection of Coronary 
Artery Disease and Myocardial Scar Tissue  
836-4·354A
Differences in the Rate of Invasively Confirmed 
Coronary Artery Disease Between Women and Men 
Presenting With an Acute Coronary Syndrome 
Without ST Elevation 1097-95·276A
Does Left Ventricular Hypertrophy Predict Sudden 
Cardiac Death Independent of Ischemia? The LIFE 
Study  888-2·530A
Drug-Eluting Stent Use May Negatively Impact the 
Economic Health of a Hospital: A Single-Center Case 
Study 1040-74·402A
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Drug-Eluting Stent Utilization and Outcomes From the 
Strategic Evaluation of New Transvascular Therapies 
(STENT) Group: A Large Prospective Multicenter 
“Real-World” Registry of Percutaneous Coronary 
Intervention 1044-58·46A
Early Use of Small Molecule Platelet Glycoprotein IIb/
IIIa Inhibitors for All Acute Coronary Syndrome 
Patients Is Superior to Selective Use of Abciximab for 
Only Those Requiring Percutaneous Coronary 
Interventions 1172-69·420A
Echocardiographic Manifestations of Obstructive Sleep 
Apnea Syndrome at Rest and With Dobutamine: A 
Guide to Effective Medical Management 
1112-147·341A
Echocardiograpic Characteristics of Unrecognized 
Myocardial Infarctions in a Population Based Study 
1059-35·18A
Effect of Lipid Subfractions on Progression of Coronary 
Artery Disease Among Middle-Aged Women 
1116-33A·27A
Effect of Obesity on Long-Term Survival Following 
Percutaneous Coronary Intervention 1115-70·410A
Effect of Slice Thickness on Image Quality and the 
Accuracy of Gated Computed Tomography Scanning 
for Coronary Calcium 1093-150·336A
Effects of Ezetimibe, Simvastatin, and 
Ezetimibe-Simvastatin on Noncholesterol Sterol 
1008-183·445A
Elevated Parathyroid Hormone Is an Important 
Predictor of Coronary Events in Patients With Chronic 
Hemodialysis 1137-101·298A
Elevated Plasma Level of Placental Growth Factor Is 
Correlated With Peripheral Monocyte Fraction in 
Patients With Acute Myocardial Infarction 
1042-84·259A
Enhanced Coronary Artery Disease Risk by Combining 
Pathogen Burden, C-Reactive Protein and Heat 
Shock Protein 60 Antibodies in the Absence of Heat 
Shock Protein 70 1103-170·488A
Enhanced Expression of Pro-Oxidant Enzyme 
Myeloperoxidase Is Associated With Plaque 
Destabilization in Human Coronary Atherosclerotic 
Lesions 1140-174·508A
Everolimus-Eluting Stents for the Prevention of 
Restenosis: Results of the FUTURE II Trial  
843-2·86A
External Counterpulsation Therapy: Significant Clinical 
Improvement Without Electrophysiologic Remodeling  
891-2·307A
Factors Impacting Five-Year Survival After 
Percutaneous Coronary Intervention for Chronic Total 
Occlusion 1080-65·57A
Fourier Phase Analysis Can Be Used to Objectively 
Analyze Real-Time Myocardial Contrast 
Echocardiograms 1017-164·312A
Fractional Flow Reserve Versus Intravascular 
Ultrasound for Decision-Making in Equivocal Left 
Main Coronary Stenosis 1157-42·92A
Functional Evaluation of Coronary Collateral Flow in 
Patients With Severe Coronary Artery Disease by 
Intracoronary Pressure Wire 1082-185·477A
Gender Differences in Initial Diagnosis of Coronary 
Heart Disease 1135-70·413A
Gender Differences in the Identification of Patients With 
Coronary Artery Disease by Brachial Artery 
Ultrasound 1105-168·490A
Gender- and Age-Related Differences in the Prognostic 
Value of C-Reactive Protein in Patients With 
Angiographic Coronary Artery Disease 
1098-83·279A
Genetic Variation in Cyclooxygenase-1 Associates With 
the Antiplatelet Effect of Aspirin in Stable Coronary 
Artery Disease 1141-192·510A
Geometric Deformity of the Saddle-Shaped Mitral 
Annulus in Patients With Ischemic Mitral 
Regurgitation: Real-Time Three-Dimensional 
Echocardiographic Study 1113-162·345A
Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients 
With Coronary Artery Disease 1045-193·458A
Health Related Quality of Life Is Not Improved in 
Parallel to Chest Pain Symptoms in a Nonselected 
Population of Patients With Coronary Artery Disease 
1099-90·281A
Heavy Coronary Plaque Calcification Is Associated 
With Only Minor Degrees of Plaque Macrophage and 
Neovessel Density Than Plaques With Less 
Calcification: Solving the Calcium Paradox? 
1140-169·507A
High Left Ventricular Mass Does Not Limit the Utility of 
Fractional Flow Reserve for the Physiologic 
Assessment of Lesion Severity 1120-64·76A
High-Dose Clopidogrel Loading Rapidly Reduces Both 
Platelet Inflammatory Marker Expression and 
Aggregation 1100-59·64A
Homocysteine Levels Predict Risk for Congestive Heart 
Failure in Patients With and Without Coronary Artery 
Disease 1163-112·227A
Identification and Characterization During Sinus 
Rhythm of a Mitral Isthmus in Patients With Inferior 
Myocardial Infarction and Monomorphic Ventricular 
Tachycardia  890-4·154A
Impact of Altered Expression Balance of Matrix 
Metalloproteinases and Tissue Inhibitor of 
Metalloproteinases Genes on Coronary Plaque 
Rupture: Results From Quantitative Tissue Analysis 
Using Real-Time Reverse Transcriptase-Polymerase 
Chain Reaction Method 1042-79·257A
Impact of Cerebrovascular and Peripheral Arterial 
Disease on Outcomes After Percutaneous Coronary 
Interventions 1043-48·43A
Impact of Gender on Outcome Following Percutaneous 
Coronary Intervention 1135-69·413A
Impact of Late Loss on Clinical, Angiographic and 
Intravascular Ultrasound Outcomes in the TAXUS IV 
Trial 1059-7·12A
Impact of Obesity on Cardiovascular Outcomes in 
Patients Undergoing Percutaneous Coronary 
Intervention: Is There Really a Paradox? 
1138-41·80A
Impact of Periprocedural Plaque/Thrombus Reduction 
on Myocardial Injury After Stent Deployment  
808-3·55A
Impact of Preinterventional Lesion Calcification on 
Neointimal Hyperplasia Following Sirolimus-Eluting 
Stent Implantation: An Intravascular Ultrasound 
Analysis 1101-63·67A
Impact of Stent Implantation Techniques on Stent Edge 
Neointimal Hyperplasia Following Sirolimus-Eluting 
Stenting 1139-56·84A
Impact of Troponin Status and Coronary Artery Disease 
by Angiography on Outcome in Acute Coronary 
Syndrome: A TACTICS TIMI-18 Substudy  
884-5·307A
Impact of Vessel Size on Outcomes of Different Distal 
Protection Devices During Saphenous Vein Graft 
Intervention: A FIRE Trial Substudy  830-3·72A
Increased Thermal Heterogeneity of the Culprit Lesion 
Is Prolonged in Patients With Recent Myocardial 
Infarction: The Role of Inflammation  831-5·497A
Incremental Prognostic Value of Stress 
Echocardiography Over Historical, Clinical, and 
Stress Electrocardiographic Variables Across a Wide 
Spectrum of Bayesian Pretest Probability for 
Coronary Artery Disease 1001-31·8A
Infantile Kawasaki Disease: High Incidence of Coronary 
Artery Aneurysms in Spite of Appropriate Intravenous 
Immunoglobulin Treatment 1171-205·394A
Intramyocardial Injection of Autologous Bone Marrow 
Cells Improves Myocardial Perfusion in Severe 
Ischemic Heart Disease: A 30-Day Assessment 
1079-82·272A
Intravascular Ultrasound Analysis of the New ABT-578 
Eluting Phosphorylcholine-Coated Stent Implantation 
to De Novo Human Coronary Lesions: The 
ENDEAVOR I Trial 1139-59·85A
Intravascular Ultrasound Assessment of Lesions With 
Sirolimus-Eluting Stent Failure 1101-41·65A
Invasive Therapy Along With Glycoprotein IIb/IIIa 
Inhibitors and Intracoronary Stents Improves Survival 
in Non-ST-Segment Elevation Acute Coronary 
Syndromes 1117-91·289A
Invasive Versus Conservative Treatment of Patients 
With Stable Angina and First Angiographic Diagnosis 
of Coronary Artery Disease in Germany: Results of 
the STAR Registry 1099-85·280A
Is Asymmetric Dimethylarginine a Marker for Diabetes, 
Coronary Artery Disease, and Death/Myocardial 
Infarction? Results of the Intermountain Heart 
Collaborative Angiographic Registry Study 
1028-168·454A
Is Computed Tomography-Based Coronary 
Angiography Ready for Prime Time? A Meta-Analysis 
1018-142·312A
Is Metabolic Dysfunction Equivalent to Diabetes as a 
Prognostic Marker in Acute Coronary Syndrome? 
1021-98·249A
Is the Sirolimus Drug Eluting Stent Better Than 
Paclitaxel Coated Stent in "Real Life" Environment? 
1139-61·86A
Is There an Association of High-Sensitive C-Reactive 
Protein With Coronary Calcium? The Heinz Nixdorf 
Recall Study 1093-143·334A
Ischemic Preconditioning Increases Heat Shock 
Protein-72 Protein Expression and Reduces 
Elevation of Creatine Kinase-MB Following Coronary 
Artery Bypass Graft in Humans 1136-85·295A
Late Total Occlusion Versus Treatment Failure Without 
Late Thrombotic Occlusion in Patients After 
Intracoronary Radiation: Angiographic and Clinical 
Outcomes 1080-64·57A
Limitation of Stroke Volume During Dobutamine Stress 
by Left Ventricular Filling Time in Patients With 
Coronary Artery Disease 1151-141·359A
Long-Term (Seven-Year) Outcomes After Bare Metal 
Coronary Stenting for Unprotected Left Main 
Coronary Stenosis 1081-58·60A
Long-Term Clopidogrel Therapy Following 
Percutaneous Coronary Intervention Improves 
Clinical Outcome but Is Not Associated With 
Increased Bleeding: New Insights From the CREDO 
Trial 1116-6·21A
Long-Term Prediction of Coronary Events According to 
the Results of High Dose Dipyridamole Contrast 
Echocardiography Myocardial Perfusion Studies 
1036-158·315A
Long-Term Prognostic Value of Pacing Stress 
Echocardiography Compared With Dipyridamole 
Tl201 Tomography in Patients With Permanent 
Pacemaker and Known or Suspected Coronary 
Artery Disease  802-5·331A
Longitudinal Vessel Remodeling Pattern Following 
Sirolimus-Eluting Stent Implantation: Analysis of 
Vessel Integrity Throughout Target Segment 
1101-43·66A
Low High-Density Lipoprotein Cholesterol, 
Hypertension, Diabetes, but Not High Low-Density 
Lipoprotein Cholesterol as Predictors of Acute 
Coronary Syndrome in Northern Area of Japan: A 
Case-Control Study 1047-180·463A
Low Power Myocardial Contrast Echocardiography 
Accurately Discriminates Between Grades of 
Coronary Artery Stenosis 1036-161·316A
Low Repeat Revascularization Rates Following 
Drug-Eluting Stent Implantation in De Novo 
Bifurcation Lesions 1024-54·36A
Manganese Superoxide Dismutase Alanine/Valine 
Polymorphism Is Associated With Coronary Artery 
Disease 1128-121·212A
Marked Underutilization and Geographic Variation in 
Secondary Prevention Pharmacologic Therapy in 
Patients With Chronic Angina Undergoing Treatment 
With Enhanced External Counterpulsation 
1077-74·407A
Multiexpert Blinded Interpretation of 
Electrocardiogram-Gated SPECT Imaging in Women: 
Relative Performance of Thallium-201 and 
Technetium-99m Sestamibi 1056-144·323A
Multislice Spiral Computed Tomography Coronary 
Angiography of the Entire Coronary Tree 
1075-161·329A
Myocardial Contrast Echocardiography Accurately 
Predicted Coronary Artery Disease in Patients 
Presenting With Acute Heart Failure 1001-36·9A
Noninvasive Assessment of In-Stent Restenosis by 
16-Slice Multislice Computed Tomography  
845-4·364A
Noninvasive Detection of Severe Stenosis and Total 
Occlusion in Left Anterior Descending Artery With 
Transthoracic Doppler Echocardiography in the 
Emergency Room  866-4·373A
Noninvasive Evaluation of Coronary Artery Flow Using 
Transthoracic Color Doppler Echocardiograpy in 
Patients With Acute Myocardial Infarction in the 
Emergency Room 1041-94·255A
Objective Evaluation of Tissue Level Perfusion Using 
Parametric Analysis of Myocardial Blush Kinetics 
1120-44·75A
Optimal Geometry Is Still Important With 
Sirolimus-Eluting Stents: Incomplete Stent Expansion 
as a Risk for Target Lesion Revascularization 
1139-55·84A
Optimal Reconstruction Protocol for Noninvasive 
Coronary Angiography With 16-Slice 
Multidetector-Row Computed Tomography 
1075-158·329A
Periadventitial Fat Inflammation Correlates With Plaque 
Inflammation in Patients With Coronary Plaque 
Ruptures: New Marker of Plaque Vulnerability?  
841-2·505A
Pexelizumab, a C5 Complement Inhibitor, Reduces 
30-Day Mortality in Patients Undergoing Coronary 
Artery Bypass Surgery or Receiving Reperfusion 
Therapy for Acute Myocardial Infarction  810-4·474A
Physiological Assessment of Coronary Artery Stenosis 
Using Transthoracic Doppler Echocardiography at 
Rest: Comparison of Flow Velocity Pattern Analysis 
With Exercise Thallium SPECT 1073-143·326A
Plasma Leptin Level Is an Important and Independent 
Predictor of Prognosis in Patients With Established 
Coronary Atherosclerosis  408-5·535A
Population Rates of Invasive Cardiac Procedures in 
British Columbia, 1995-2001 1040-75·403A
Porcine Model of Atherothrombotic Chronic Total 
Occlusion 1080-41·56A
Predicting Significant Coronary Artery Disease in Heart 
Failure Patients 1126-110·207A
Predictive Risk Factors for Coronary Events in Renal 
Transplant Patients 1124-191·503A
Predictors of 10-Year Patency of Saphenous Vein and 
Left Internal Mammary Artery Grafts After Coronary 
Artery Bypass Surgery: Results From a Department 
of Veterans Affairs Cooperative Study 1079-87·273A
Predictors of Reinfarction After ST Elevation Myocardial 
Infarction and Glycoprotein Receptor Blockade: 
Analysis From the CADILLAC Trial 1061-100·266A
Prevalence of Silent Ischemia in Diabetic Patients With 
Subclinical Atherosclerosis: Detection by Stress 
Myocardial Perfusion Imaging  816-6·340A
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Preventive Effects of Rosiglitazone on Restenosis After 
Coronary Stent Implantation in Patients With Type 2 
Diabetes Mellitus 1062-46·48A
Production of Reactive Oxygen Species by 
Mononuclear Cells Correlates With the Severity of 
Coronary Heart Disease and NADPH Oxidase 
Expression 1082-181·476A
Prognostic Significance of Dipyridamole-Induced 
ST-Segment Depression in Patients With Normal 
Rubidium-82 Positron Emission Tomography 
Perfusion Images 1094-160·338A
Prognostic Value of Rubidium-82 Perfusion Positron 
Emission Tomography: Preliminary Results From the 
Consecutive 153 Patients 1094-159·338A
Protective Role of Low C-Reactive Protein Levels 
Against Classical Risk Factors for Coronary 
Atherosclerotic Disease 1119-98·293A
Real-Time Three-Dimensional Echocardiographic 
Assessment of Endocardial Surface Can Quantitate 
the Size of Myocardial Infarction  837-3·355A
Reduced Shear Stress and Large Shear Stress 
Gradient Cause Coronary Aneurysm and Thrombus 
Formation in Children With Kawasaki Disease 
1157-48·94A
Reduction in Functional Mitral Regurgitation Using the 
Coapsys Annuloplasty Device in Patients Undergoing 
Off-Pump Coronary Artery Bypass Grafting: A 
Quantitative Echo Analysis  851-2·438A
Regression of Left Ventricular Remodelling but Not an 
Improvement in Resting Left Ventricular Ejection 
Fraction Following Revascularization Is Determined 
by the Quantity of Myocardial Viability 
1151-164·361A
Relationship Between Patterns of Calcification and 
Arterial Remodeling of Culprit Lesions: Comparing 
Patients With Acute Coronary Syndromes With 
Those With Stable Angina  832-4·74A
Restenosis After Sirolimus-Eluting Stent Implantation: 
Long-Term Evaluation Following Repeat 
Percutaneous Intervention  822-6·71A
Restenosis Is Better Associated With Change of 
Coronary Flow Reserve Rather Than With Absolute 
Value of Coronary Flow Reserve 1132-160·350A
Revascularization Alone for Functional Mitral 
Regurgitation: A Propensity Case-Match Analysis of 
the Off Pump Coronary Artery Bypass Approach 
1079-88·274A
Screening Stress Myocardial Perfusion Imaging for Risk 
Stratification in Asymptomatic Diabetic Men  
816-1·339A
Selection of Optimal Phase for 3-D Computed 
Tomography Reconstruction of Coronary Arteries 
Using an Automatic Vessel Tracking System 
1075-157·329A
Serum Levels of Angiogenic Growth Factors Predict 
Long-Term Clinical Outcome After Percutaneous 
Coronary Revascularization 1103-165·487A
Should Patients With Severe Aortic Stenosis and 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention Prior to Aortic Valve 
Replacement? 1162-138·440A
Should Statin Therapy Be Used Routinely in Pediatric 
Heart Transplant Recipients?  813-5·186A
Simple Risk Score Predicts Myocardial Infarction and 
Cardiovascular Death at 30 Days After Percutaneous 
Coronary Intervention: An Analysis of the 
REPLACE-2 and TARGET Data 1043-65·44A
Sirolimus-Eluting Stent Implantation in Routine Clinical 
Practice: A 12-Month Follow-Up Report From the 
International eCYPHER Registry  862-2·97A
Soluble CD40 Ligand in Predicting Coronary Artery 
Disease and Long-Term Outcomes in Stable Patients 
With Angiographically Defined Disease States 
1137-97·297A
ST-Segment Resolution, Time From Symptom Onset to 
Reperfusion, Thrombolysis in Myocardial Infarction 
Flow Grades, and Creatine Kinanse-Release: 
Association With Infarct Size as Assessed by Delayed 
Enhancement Magnetic Resonance Imaging  
836-6·354A
Steady State Free Precession Perfusion Allows Visual 
Assessment for the Clinical Diagnosis of Ischemia 
1169-154·366A
Stenting Under Intravascular Ultrasound Guidance of 
Coronary Bifurcation Lesions With a New Device 
Allowing Provisional Side Branch Treatment  
878-6·103A
Stents Without Restenosis: Enough to Replace Bypass 
Surgery?  862-6·98A
Suppression of Physiological Myocardial 
Fluorodeoxyglucose Uptake 1094-152·337A
Survival Differences Between Hispanic and 
Non-Hispanic Patients With Cardiovascular Disease 
Initiating Renal Replacement Therapy in the United 
States 1135-74·414A
Systemic Infections Lead to Infiltration of Macrophages 
in Adventitia of Human Atherosclerotic Coronary 
Arteries: Clue to Triggering Effect of Acute Infections 
on Acute Coronary Syndromes 1064-185·466A
Target Vessel Revascularization During the First Month 
After Bare Metal Coronary Stenting: Clinical 
Indications and Angiographic Findings 1081-59·61A
TAXUS IV Diabetic Subset Analysis: Improvements in 
Nine-Month Outcomes in Diabetics on Oral 
Medication as Well as Insulin 1059-5·11A
The Crushing Technique for Bifurcation Lesions: 
Immediate and Mid-Term Clinical Outcome 
1024-52·36A
The Impact of Deep Sternal Wound Infection on 
Long-Term Survival After Coronary Artery Bypass 
Grafting  809-2·268A
The Impact of Renal Insufficiency on Long-Term 
Survival of Patients With Diabetes Undergoing 
Percutaneous Coronary Intervention 1062-41·47A
The Incidence and Prognostic Value of Exertional 
Hypotension in Medically Managed Older Patients 
With Stable Coronary Artery Disease 1128-129·214A
The Introduction of Drug-Eluting Stents Causes a Shift 
From Coronary Artery Bypass Graft Towards 
Percutaneous Coronary Intervention: One-Year 
Outcome of a Single-Center Experience of 2,200 
Consecutive Procedures 1079-86·273A
The Limits of Quantifiable Differences in Dipyridamole 
Stress Magnetic Resonance Imaging Perfusion 
Defects in Human Subjects With Coronary Artery 
Disease  836-3·353A
The Medicine, Angioplasty, or Surgery Study (MASS II): 
Quality of Life of Patients With Symptomatic 
Multivessel Coronary Disease-24 Months of 
Follow-Up 1115-67·409A
The Polymorphisms C (-260) T in the Promoter Region 
of CD14 Receptor Gene and G (-174) C of 
Interleukin-6 Gene Are Not Related to the Immune 
Response to Chlamydia Pneumoniae Infection and 
Heat Shock Protein-60 in Ischaemic Heart Disease 
1136-88·295A
The Ratio of Oxidized Low-Density to High-Density 
Lipoproteins Is an Independent Predictor of Acute 
Myocardial Infarction in Unstable Coronary Artery 
Disease 1047-188·464A
The REAL Registry of Drug-Eluting Stents: An Italian 
Survey in Emilia Romagna Region 1044-59·46A
The Real-World Clinical Practice of Intracoronary 
Radiation Therapy as Compared to Investigational 
Trials 1080-63·57A
The Relation Between the Statin’s Effects on Coronary 
Plaque Composition and Plasma Low-Density 
Lipoprotein Cholesterol Level Evaluated by 
Intravascular Ultrasound Radiofrequency Signal 
Analysis 1006-58·34A
The Role of Tomographic Myocardial Perfusion Imaging 
in Risk Stratifying Patients With Coronary Artery 
Disease 1056-164·325A
The Role of Triglycerides, Very Low Density 
Lipoproteins, and Triglyceride Rich Atherogenic 
Lipoprotein in Predicting Premature Heart Disease 
1047-182·463A
Thoracic Aorta Atherosclerosis Burden Index Predicts 
Coronary Artery Disease in Patients Undergoing 
Transesophageal Echocardiography 1131-147·349A
Time-Course of Healing Responses After Intracoronary 
Photodynamic Therapy in Porcine Coronary Arteries 
1138-46·81A
Transendocardial Injection of Autologous Bone Marrow 
Mononuclear Cells May Enhance Myocardial Viability 
Around Cell Injection Site  814-1·186A
Transthoracic Doppler Echocardiography as a 
Noninvasive Tool to Assess Coronary Artery 
Stenoses: A Comparison With Quantitative Coronary 
Angiography 1073-142·326A
Transthoracic Echocardiographic Assessment of 
Thickness of Intima-Media Complex and Calcified 
Lesions of the Left Anterior Descending Coronary 
Artery 1073-141·325A
Treatment Bias Against Women With Acute Coronary 
Syndrome: Fact or Fantasy? 1097-96·276A
Urine and Plasma Matrix Metalloproteinase 9 and 2 
Levels in Patients With Coronary Artery Disease 
1001-22·6A
Use of Abciximab Prior to Primary Angioplasty in 
ST-Segment Elevation Myocardial Infarction Results 
in Early Recanalization of the Infarct-Related Artery: 
Results of the Multicenter Randomized 
ReoPro-BRIDGING Study 1011-112·156A
Usefulness of Primary Percutaneous Coronary 
Intervention With Thrombectomy Plus Distal 
Protection System for Acute Myocardial Infarction: 
Assessment of Salvaged Myocardium With a Rest 
Thallium-201 and Iodine-123 BMIPP SPECT 
1094-156·337A
Utility of Routine Functional Testing After Coronary 
Artery Bypass Graft Surgery: Results From the 
ROSETTA-CABG Study 1079-84·273A
Coronary circulation
Altered Myocardial Perfusion With Fatty Meal Ingestion 
in Normal Volunteers 1094-158·338A
Are High Doses of Intracoronary Adenosine an 
Alternative to Standard Intravenous Adenosine for the 
Assessment of Fractional Flow Reserve? 
1157-44·93A
Coronary Vasodilator Responses Are Impaired 
Independent of Nitric Oxide and Endothelial Function 
in Conscious Dogs With Dilated Cardiomyopathy  
834-4·204A
Detection of Coronary Restenosis by Serial Doppler 
Echocardiographic Assessment of Coronary Flow 
Velocity Reserve After Percutaneous Coronary 
Intervention 1073-147·327A
Differential Vasodilatory Effects of CVT-3146, an A2A 
Adenosine Receptor Agonist in Various Vascular 
Beds in Anesthetized Dogs 1170-142·367A
Distal Left Anterior Descending Flow Reserve by 
Dobutamine Versus Adenosine Transthoracic Doppler 
Echo During Conventional Dobutamine 
Echocardiography: Feasibility and Accuracy for Left 
Anterior Descending Patency 1151-144·360A
Does Sleep Loss Attenuate Coronary Circulation? 
1073-150·327A
Drug-Eluting Stents for Coronary Bifurcations: 
Bench-Top Insights Into the "Crush" Technique 
1024-53·36A
Effect of Caffeine on Fractional Flow Reserve 
1170-146·368A
Effect of Serum Cholesterol Levels on Coronary 
Vasoreactivity in Patients With Type II Diabetes 
Mellitus 1133-157·352A
Effect of Tadalafil, a Phosphodiesterase 5 Inhibitor, on 
Myocardial Blood Flow in Patients With Coronary 
Artery Disease 1170-147·369A
Epicardial Stenosis Severity Does Not Affect Minimal 
Microcirculatory Resistance 1120-45·75A
Eplerenone Improves Coronary Hemodynamics and 
Reduces Cardiac Fibrosis in Aging Spontaneously 
Hypertensive Rats 1085-194·482A
Interleukin-6 but Not C-Reactive Protein Is Elevated at 
the Site of Ruptured Plaques in Acute Coronary 
Syndromes  826-2·282A
Lesion Severity Index, a New Nonhyperemic 
Physiologic Parameter for the Assessment of 
Coronary Artery Stenosis: A Comparison to 
Fractional Flow Reserve 1157-41·92A
Measurement of Compartment Blood Volume in the 
Myocardium: Myocardial Contrast Echocardiographic 
Study 1017-162·311A
Myocardial Contrast Echocardiography Provides a 
Noninvasive Estimation of Fractional Flow Reserve 
1017-158·310A
Noninvasive Assessment of Coronary Artery Flow and 
Reserve in Top Athletes: Relationship With Oxygen 
Uptake 1033-118·169A
Noninvasive Vessel-Selective Perfusion Imaging With 
Intravenous Myocardial Contrast Echocardiography 
1017-160·311A
Obesity Predicts Coronary Endothelial Dysfunction 
Independently of Inflammation, Atherosclerosis, and 
Conventional Risk Factors  819-4·485A
Patients Maintain Coronary Perfusion and Exercise 
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Trial 1138-43·81A
Significant Increase in the Thrombolysis in Myocardial 
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for Inferior/Posterior Myocardial Infarction 
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612A SUBJECT INDEX JACC March 3, 2004
KEY: Abstract Title, Session-abstract number•page number
The Effectiveness of Distal-Protect Devices in Patients 
With Acute Coronary Syndromes: The Relationship 
Between Coronary Thrombus and Thrombolysis in 
Myocardial Infarction Frame Counts After 
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Determined by Atomic Absorption Spectroscopy in 
187 Patients With Aortic Valve Replacement 
1107-140·434A
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1119-95·292A
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845-3·363A
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Autologous Bone Marrow Mononuclear Cells for 
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Poor Outcome in Subsets of Renal Failure Patients 
Undergoing Coronary Artery Bypass Surgery: 
Mortality Results From a Cohort of 4,069 Patients  
809-5·269A
Predictors of Life-Threatening Ventricular Arrhythmias 
in High-Risk Patients With ST Elevation Acute 
Myocardial Infarction 1060-79·261A
Preliminary Experience With the Front Runner 
Coronary Catheter, Novel Device Dedicated to 
Mechanical Revascularization of Chronic Total 
Occlusions 1080-44·56A
Racial Variations in Treatment and Outcomes of African 
American and White Patients With Non ST-Elevation 
Acute Coronary Syndromes: Insights From 
CRUSADE 1135-76·414A
Relation of Diastolic Strain Measurements by Doppler 
Echocardiography to Myocardial Structure and 
Function in Healing Canine Infarcts: Implications for 
the Assessment of Myocardial Viability 
1168-164·365A
Relationship of Polymorphisms in the Oxidative 
Stress-Related Genes - Paraoxonase and p22phox - 
to Variant Angina and Coronary Artery Stenosis 
1027-188·451A
Selection of Optimal Electrocardiographic Criteria for 
Detection of Unrecognized Myocardial Infarction: A 
Population Based Study 1116-38·28A
Serum Triglycerides and the Risk of Cardiovascular 
Disease in the Asia Pacific Region: An Individual 
Participant Data Meta-Analysis of Cohort Studies 
Including 96,130 Individuals 1047-179·462A
Staged Initial Percutaneous Coronary Intervention 
Followed by Valve Surgery (“Hybrid” Approach) for 
Patients With Complex Coronary and Valve Disease  
851-3·438A
Temporal Trends in the Treatment of Total Coronary 
Occlusions 1080-45·56A
The Association of Plasma Homocysteine With 
Coronary Artery Atherosclerosis Is Modified by 
Conventional Risk Factors 1093-146·335A
The Changing Profile of First Reoperative Coronary 
Artery Bypass Surgery: Trends Over 17 Years in 
2,770 Patients  809-1·267A
The Impact of Prior Myocardial Infarction, Metabolic 
Syndrome, and High White Blood Cell Count on 
Coronary Heart Disease Mortality: The Multiple Risk 
Factor Intervention Trial (MRFIT) 18-Year Follow-Up 
Experience  838-6·416A
The Predictive Value of Parental History of Coronary 
Disease 1028-169·454A
The Presence of Side Branches Impacts Periprocedural 
Enzyme Elevation and Clinical Outcome in Patients 
Undergoing Brachytherapy for In-Stent Restenosis 
1121-55·78A
Time Course of Improvement Following Stem Cell 
Injections in Humans With Heart Failure  814-2·187A
Transendocardial Autologous Bone Marrow Cell 
Transplantation in Patients With Advanced Ischemic 
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Feasibility Study  864-3·99A
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Tomography for Predicting Left Ventricular Functional 
Recovery in Patients With Acute Myocardial Infarction 
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Technetium-99m Tetrofosmin SPECT 1094-154·337A
Velocity Data of Doppler Myocardial Imaging as a 
Predictor of Functional Recovery After Successful 
Revascularization 1037-146·318A
Coronary microcirculation
Angiographically Apparent Thrombus After Fibrinolytic 
Administration Is Associated With Impaired Epicardial 
Flow and Myocardial Perfusion in ST Elevation 
Myocardial Infarction Patients With Open Arteries 
1060-101·262A
Assessment of Microvascular Function After Acute 
Myocardial Infarction by 16-Slice Computed 
Tomography  845-5·364A
Atrial Fibrillation Reduces Endothelium-Independent 
Myocardial Perfusion Reserve: A Quantitative Study 
Using Positron Emission Tomography 1094-155·337A
Brugada-Type Electrocardiographic Pattern and 
ST-Segment Alternans in Right Precordial Leads 
During Percutaneous Coronary Intervention of the 
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Chronotropic Stress Enhances the Effects of 
Asynchronous Left Ventricular Activation on 
Myocardial Perfusion in Patients With Idiopathic 
Dilated Cardiomyopathy and Left Bundle Branch 
Block 1164-130·231A
Coronary Flow Velocity Pattern Immediately After 
Percutaneous Coronary Intervention as a Predictor of 
Complications After Acute Myocardial Infarction in 
Patients Achieving Thromblysis in Myocardial 
Infarction Grade 3 Flow 1157-43·92A
Coronary Flow Velocity Reserve and Asymmetric 
Dimethylarginine in Patients With Type 2 Diabetes 
Mellitus 1128-119·211A
Coronary Vascular Dysfunction Is Only Partially 
Predicted by Traditional Cardiovascular Risk Factors 
in Women Undergoing Evaluation for Suspected 
Ischemia: Results From the National Heart, Lung, 
and Blood Institue WISE Study  819-3·484A
Decreased Coronary Flow Reserve After Myocardial 
Infarction Is Associated With an Elevated Coronary 
Zero Flow Pressure 1120-46·75A
Drag Reduction by Polymer Infusion: A New 
Mechanism to Enhance Microcirculatory Perfusion for 
the Treatment of Ischemia 1118-79·290A
Early Results From the Japanese Asparagus Trial  
829-3·285A
Effect of Acute Administration of L-Propionylcarnitine 
on Coronary Flow Velocity Reserve in Patients With 
Systemic Sclerosis 1164-132·231A
Effect of Glucose Lowering on Coronary Circulatory 
Dysfunction in Type 2 Diabetes Mellitus  816-4·339A
Effect of Serum Cholesterol Levels on Coronary 
Vasoreactivity in Patients With Type II Diabetes 
Mellitus 1133-157·352A
Emboli Protection Improves Thrombolysis in Myocardial 
Infarction Perfusion Score in Saphenous Vein Graft 
Intervention 1120-65·76A
Epicardial Stenosis Severity Does Not Affect Minimal 
Microcirculatory Resistance 1120-45·75A
Impaired Coronary Circulation in Patients With Apical 
Hypertrophic Cardiomyopathy: Noninvasive Analysis 
by Transthoracic Doppler Echocardiography 
1032-131·167A
Impaired Coronary Microcirculation Evidenced by 
Abnormal Thrombolysis in Myocardial Infarction 
Frame Counts in Patients With Transient Left 
Ventricular Apical Ballooning Syndrome 
1013-118·162A
Impaired Myocardial Perfusion Is a Major Explanation of 
the Poor Outcome Observed in Patients Undergoing 
Primary Angioplasty for ST-Segment Elevation 
Myocardial Infarction and Signs of Heart Failure 
1061-98·265A
In Vitro Detection and Quantification of High Intensity 
Transient Signals by Using Intracoronary Doppler 
Ultrasound: A New Approach to Detect Coronary 
Microembolization 1026-55·39A
Intravenous Glucose Loading Attenuates Coronary 
Flow Velocity Reserve Due to Increased Baseline 
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Coronary Flow Velocity in Healthy Volunteers 
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Occlusion 1080-41·56A
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Radiation  864-6·100A
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1075-157·329A
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1116-7·21A
Steady State Free Precession Perfusion Allows Visual 
Assessment for the Clinical Diagnosis of Ischemia 
1169-154·366A
Temporal Trends in the Treatment of Total Coronary 
Occlusions 1080-45·56A
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Case Method Learning Is a Cost Effective 
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1108-130·201A
Heterologous Transplantation of CD34+ Cells From 
Patients With Coronary Ischemia Leads to Myocardial 
Salvage and Enhanced Functional Recovery in 
Murine Model of Myocardial Infarction 
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Homocysteine Promotes Ventricular Remodeling by 
Induction of Apoptosis of Rabbit Cardiomyocytes and 
Priming the Mast Cells to Induce Interleukin-6, With 
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Inherent Sex Differences in the Ischemia-Induced 
Myocardial Inflammatory Response of Proestrus 
Females and Normal Males  801-5·267A
Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme a 
Reductase Attenuates Expression of Inducible Nitric 
Oxide Synthase in Cardiac Myocytes: A Possible Link 
With Direct Myocardial Protection During 
Ischemia-Reperfusion 1116-34·27A
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Interleukin-18 and Interleukin-18 Binding Protein in 
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841-6·506A
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Syndrome 1001-1·1A
Intracellular Calcium Regulates Tumor Necrosis 
Factor-Alpha-Induced Embryonic Stem Cell Migration 
1078-95·270A
Localized Combinatorial Interleukin-4 and 
Interleukin-10 Gene Therapy Readjusts the Balance 
of Endogenous Th1/Th2 Cytokines and Induces the 
Tolerance of Cardiac Allografs 1051-133·176A
Markers of Inflammation Predict Mortality and Are 
Reduced by Pexelizumab in Patients With Acute 
Myocardial Infarction: Insights From the Complement 
Inhibition in Myocardial Infarction Treated With 
Angioplasty (COMMA) Trial  833-5·287A
Monocyte Chemoattractant Protein-1 Activates 
Vascular Endothelial Growth Factor- and Tumor 
Necrosis Factor-Alpha-Mediated Angiogenesis in 
Ischemic Hindlimbs of Mice 1045-195·458A
Monocytes, but Not Neutrophils or Lymphocytes Are 
Essential Mediators of Arteriogenesis 
1045-192·458A
Pentoxifylline Protects Allogenic Transplanted Hearts 
1089-119·195A
Platelet P-Selectin and Plasma Levels of Circulating 
Cytokines in Young Patients With Mild Arterial 
Hypertension 1059-9·12A
Platelet-Derived Growth Factor Signaling Has a Crucial 
Role in Vascular Maturation Following Myocardial 
Infarction 1002-98·245A
Relation of the –174 G/C and –572 G/C Promoter 
Polymorphisms of the Interleukin-6 Gene to 
Interleukin-6 and Highly Sensitive C-Reactive Protein 
Serum Levels and to the Extent of Infarction in Acute 
Myocardial Infarction 1136-90·296A
Relationship Between Plasma C-Reactive Protein 
Concentration on Admission and Long-Term 
Outcome in Unselected Hospitalized Heart Failure 
Patients 1163-123·229A
Serum Inflammatory Markers Correlate With 
Hemoglobin Levels in Women Undergoing Evaluation 
for Suspected Ischemia: Results From the National 
Heart, Lung, and Blood Institute WISE Study  
847-6·515A
Smoking-Related Endothelial Dysfunction and 
Increased Serum Levels of Proinflammatory 
Cytokines and Adhesion Molecules Are Reversible by 
Antioxidant Treatment 1159-185·517A
Soluble Tumor Necrosis Factor Receptor (Etanercept) 
Treatment Enhances Left Ventricular Dysfunction in 
an Experimental Model of Chronic Chagas Disease 
Cardiomyopathy  849-4·225A
Survival Benefit With Spironolactone Therapy Is Not 
Related to Reduced hsCRP Levels in Severe 
Congestive Heart Failure: Results From a RALES 
Substudy 1108-121·199A
Sustained Upregulation of Chemokine and Its Receptor 
Genes Associated With Matrix Metalloproteinase 
Overexpression in Human Carotid Plaque Rupture: 
Results From a Quantitative Study With Real-Time 
Reverse Transcriptase-Polymerase Chain Reaction- 
Method  831-4·497A
Sustained Upregulation of Inflammatory Cytokine and 
Its Receptor Genes Associated With Proteinase 
Activation in Abdominal Aortic Aneurysm: Results 
From Combined Study With cDNA Array and 
Real-Time Reverse Transcriptase Polymerase Chain 
Reaction Methods 1059-12·13A
The Critical Role of Thrombospondin (TSP)-1 in 
Limiting Expansion of Fibrosis in Healing Myocardial 
Infarcts: Studies in Dogs and TSP-1 -/- Mice 
1002-78·243A
Tumor Necrosis Factor-_ Blockade: A Key Inhibition to 
Modulate the Inflammatory Response in Patients 
With Unstable Angina? 1042-85·259A
Use of Quantitative Reverse Transcriptase-Polymerase 
Chain Reaction for Validation of Macrophage 
Inflammatory Protein-1β and Vascular 
Endothelium-Cadherin as Important Markers of Acute 
Rejection After Heart Transplantation 1051-129·175A
Vulnerable Plaque Can Be the Predominant Source of 
Serum Interleukin-6 but Not of Serum C-Reactive 
Protein in Patients With Acute Myocardial Infarction 
1043-46·42A
Death, sudden
A Simple Model Using the MUSTT Database Can 
Stratify Total Mortality and Sudden Death Risk of 
Coronary Disease Patients  889-6·425A
Cause of Death Across Full Spectrum of Ventricular 
Function in Patients With Heart Failure: The CHARM 
Study 1069-113·180A
Causes of Death in Patients With ST Elevation 
Myocardial Infarction Treated With Fibrinolysis 
1061-88·263A
Diagnostic Value of the Ajmaline Test Based on the 
Gene Analysis in Concealed Brugada Syndrome 
1130-208·136A
Incidence of Malignant Ventricular Tachycardia in 
Patients With Prophylactic Defibrillator Implantation 
Does Not Differ From Event Rates in Patients Treated 
for Survived Cardiac Arrest 1105-175·491A
L-Type Calcium Channel Inhibitor Diltiazem Prevents 
Diastolic Dysfunction and Stress-Induced Cardiac 
Decompensation and Death in a Mouse Model of 
Familial Hypertrophic Cardiomyopathy 
1144-132·220A
Nontraumatic Sudden Death During Military Basic 
Training, 1977-2001 1059-2·11A
Prospective Evaluation of Integrating the Existing 
Emergency Medical System With Automated External 
Defibrillators Operated by Volunteers and Lay 
Persons for Out-of-Hospital Cardiac Arrest: The 
Brescia Early Defibrillation Study (BEDS) 1059-3·11A
Sirolimus Coated Stent Implantation Versus 
Intracoronary Beta-Irradiation for the Treatment of De 
Novo Lesions 1139-62·86A
Spectrum and Frequency of Channelopathies in 
Near-Drownings 1116-40A·29A
Underutilization of Implantable 
Cardioverter-Defibrillators in Survivors of Sudden 
Cardiac Death: Discrepancies by Sex, Race, and 
Hospital Size 1147-213·139A
Ventricular Fibrillation Triggered by Thoracic 
Compression During Out-of-Hospital Cardiac Arrest 
Resuscitation in the Piacenza Vita Project 
1154-98·302A
Decision making, computer-assisted
Durability of Bioprosthetic Aortic Valves: What Is the 
Re-Operation Risk for My Patients? 1058-67·403A
Individualized Prediction of Heart Failure Survival: An 
Analysis From PRAISE1 1069-109·179A
Microsimulation to Support Prosthetic Aortic Valve 
Selection 1058-73·405A
Visualization of the Effect of Atrial-Ventricular and 
Right-Left Delay on Cardiac Output During 
Biventricular Pacing 1058-71·404A
Defibrillation, atrial
Cardioversion for Chronic Atrial Fibrillation Is 
Associated With an Immediate Drop in Brain 
Natriuretic Peptide 1129-211·134A
Cardioversion in Patients With Dense Spontaneous 
Echo Contrast  875-1·150A
Determinants of Muscular Damage With External 
Cardioversion of Atrial Fibrillation: Results of a 
Randomized Trial Comparing Biphasic With 
Monophasic Shock 1147-211·139A
Histopathological Study of Left Atrial Appendage 
Obtained at the Operation for Atrial Fibrillation 
1116-35·28A
Mapping of Successful and Failed Atrial Defibrillation 
1034-210·110A
Predictors of Left Atrial Appendage Thrombogenesis in 
Patients Undergoing Transesophageal 
Echocardiography-Guided Cardioversion for Atrial 
Fibrillation and Flutter 1131-142·348A
Quantification of Atrial Fibrillation Organization From 
the Surface Electrocardiogram 1148-207·140A
The Influence of Duration of Atrial Fibrillation on 
Maintenance of Sinus Rhythm by Angiotensin II 
Modulators After Electrical Cardioversion 
1014-214·106A
Defibrillation, ventricular
Compliance and Effectiveness of the Wearable 
Cardioverter Defibrillator Vest 1154-92·300A
Implant Defibrillator Threshold Characteristics in an 
Implantable Cardioverter Defibrillator Population 
Receiving Cardiac Resynchronization Therapy  
817-5·128A
Multicenter Study of Safety and Efficacy of a Biphasic 
Impedance-Compensating Waveform for 
Transthoracic Defibrillation 1154-89·299A
Ventricular Fibrillation Triggered by Thoracic 
Compression During Out-of-Hospital Cardiac Arrest 
Resuscitation in the Piacenza Vita Project 
1154-98·302A
Defibrillators, implantable
A Multicenter Study of Depression as a Predictor for 
Appropriate Shocks Among Patients With Implantable 
Cardioverter Defibrillators 1053-211·116A
A Simple Model Using the MUSTT Database Can 
Stratify Total Mortality and Sudden Death Risk of 
Coronary Disease Patients  889-6·425A
Accuracy of Arrhythmia Discrimination Algorithms: First 
Results From a Prospective, Randomized Trial of 
Single Versus Dual Chamber Implantable 
Cardioverter Defibrillators (PINAPP) 1147-212·139A
Angiotensin-Converting Enzyme Inhibitors Reduce the 
Incidence of Implantable Cardioverter Defibrillator 
Therapy in Idiopathic Dilated Cardiomyopathy With 
Congestive Heart Failure  817-4·127A
Cardiac Resynchronization Therapy Results in a Lower 
Arrhythmia Burden 1091-209·125A
Comparative Change in the Left Ventricular Ejection 
Fraction in Patients Undergoing Biventricular 
Defibrillator Implantation Using Transvenous 
Coronary Sinus Versus Epicardial Left Ventricular 
Leads  817-1·127A
Deaths From Heart Failure in the Era of the Implantable 
Defibrillator 1069-106·178A
Delineation of the Pericardiophrenic Vein for Optimal 
Left Ventricular Lead Placement  817-6·128A
Do Abandoned Leads Pose Risk to Implantable 
Defibrillator Patients? 1147-217·140A
Does Elevating Catecholamine Concentrations Impact 
the Defibrillation Threshold? 1059-20·15A
Effect of Cardiac Resynchronization Therapy in Patients 
With Right Bundle Branch Block 1059-19·14A
Electrosurgical Dissection for Extraction of Chronically 
Implanted Pacemaker and Defibrillator Leads 
1147-216·140A
Frequency and Mechanisms of Inappropriate 
Implantable Cardioverter Defibrillator Therapy in 
MADIT II 1111-226·132A
Heart Rate Dynamics Before the Onset of Ventricular 
Tachyarrhythmias: Results of the Cardioverter 
Defibrillator Registry MARITA 1091-211·125A
Heart Rate Variability and Heart Rate Changes Induced 
by Biventricular Pacing in Advanced Heart Failure  
817-3·127A
Holter-Based Risk Stratifiers May Increase 
Cost-Effectiveness of Defibrillator Therapy in MADIT 
II-Like Patients 1015-217·107A
Implant Defibrillator Threshold Characteristics in an 
Implantable Cardioverter Defibrillator Population 
Receiving Cardiac Resynchronization Therapy  
817-5·128A
Implantable Cardiac Defibrillator Interactions With 
Magnetic Resonance Imaging at 1.5 Tesla 
1147-210·138A
Implantable Cardioverter Defibrillator Follow-Up: Will 
Office Visits Be Replaced by Transtelephonic 
Monitoring? 1091-226·126A
Incidence of Malignant Ventricular Tachycardia in 
Patients With Prophylactic Defibrillator Implantation 
Does Not Differ From Event Rates in Patients Treated 
for Survived Cardiac Arrest 1105-175·491A
Initial Results From the Substrate Mapping and Ablation 
in Sinus Rhythm to Halt Ventricular Tachycardia Trial 
(SMASH VT)  890-2·153A
Long-Term Outcome of Patients With Cardiac 
Sarcoidosis Receiving Implantable Cardioverter 
Defibrillators 1091-224·126A
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Pocket Cleaning With Povidone-Iodine Does Not 
Reduce the Infection Rate of Implantable 
Pacemakers and Defibrillators 1147-218·140A
Potential Impact of MADIT II and the Centers for 
Medicaid Services Criteria on Care of Patients 
Diagnosed With Myocardial Infarction  846-3·419A
Primary and Secondary Prevention Implantable 
Cardioverter Defibrillator Patients Have Similar 
Proportions of Ventricular Tachyarrhythmia 
Detections and Equivalent Risk for Spurious 
Therapies: Results From PainFREE Rx II 
1091-207·125A
QRS Duration Does Not Predict Occurrence of 
Ventricular Tachyarrhythmias in Primary Prevention 
Patients With Implantable Cardioverter-Defibrillators 
1116-39·29A
Soft Indications for Pacing in the DAVID Trial Do Not 
Increase Mortality and Heart Failure Admission 
1147-215·139A
Spontaneous Implantable Defibrillator Shocks Do Not 
Increase Troponin T 1147-209·138A
The Implantable Defibrillator and the Long QT 
Syndrome: An Overview of Current Use and 
Outcome 1091-223·126A
The Predictive Value of Electrophysiologic Testing: 
Subgroup Analysis in the Dual Chamber and VVI 
Implantable Defibrillator (DAVID) Trial 1053-213·117A
The World Trade Center Attack: Increased Frequency of 
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Patients Living Remotely From New York City 
1091-210·125A
Underutilization of Implantable 
Cardioverter-Defibrillators in Survivors of Sudden 
Cardiac Death: Discrepancies by Sex, Race, and 
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Value of Signal-Averaged ECG and 
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Pacing 1147-214·139A
Diabetes mellitus
A Randomized Placebo-Controlled Trial of Abciximab 
for Prevention of In-Stent Restenosis in Diabetic 
Patients After Coronary Stenting 1063-58·51A
Acute Administration of Asymmetric Dimethylarginine 
Reduces Insulin Sensitivity in Mice  867-4·527A
Added Ramipril to Simvastatin Shows Additive Effects 
on Flow-Mediated Dilation and Inflammation Markers 
in Diabetic and Hypercholesterolemic Patients: A 
Randomized, Double-Blind, Placebo-Controlled, 
Crossover Study 1065-166·467A
Age and the Lack of an Adverse Effect of Diabetes 
Explain the “Obesity Paradox” in Patients With 
Myocardial Infarction 1137-94·297A
Anglo-Scandinavian Cardiac Outcomes Trial – 
Lipid-Lowering Arm (ASCOT-LLA): Results in the 
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Assessment of Glycemic Control in Patients With 
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Syndrome 1077-72·406A
Assessment of Myocardial Perfusion and Metabolism in 
Normal and Diabetic Rats by MicroPET Imaging 
1116-24·25A
Blood Glucose Level Predicts Severity of Renal and 
Myocardial Injury in Diabetic Patients Undergoing 
Coronary Interventions 1062-48·49A
Chromium Supplementation Shortens QTc Interval 
Duration in Patients With Type 2 Diabetes 
1141-195·510A
Clopidogrel Regulates Platelet, Leukocyte, and 
Endothelial Interactions in Type 2 Diabetes Mellitus 
1007-174·444A
Coronary Flow Velocity Reserve and Asymmetric 
Dimethylarginine in Patients With Type 2 Diabetes 
Mellitus 1128-119·211A
Diabetes Mellitus Might Be Associated With Multiple 
Vulnerable Plaque in 113 Patients With Stable 
Angina: A Prospective Study of Three-Vessel 
Intravascular Ultrasound  832-6·74A
Diabetic Patients With Acute Coronary Syndromes 
Were Undertreated and Had Worse One-Year 
Outcome 1021-77·248A
Diabetic Patients With Acute Myocardial Infarction Have 
Larger Infarct Size, Lower Ejection Fraction, and 
Higher Mortality  827-5·284A
Effect of Diabetes on Five-Year Outcomes After 
Coronary Stent Implantation 1081-54·59A
Effect of Free Fatty Acid Inhibition on Left Ventricular 
Function in Diabetic Patients With Coronary Artery 
Disease 1001-9·3A
Effect of Glucose Lowering on Coronary Circulatory 
Dysfunction in Type 2 Diabetes Mellitus  816-4·339A
Effect of Serum Cholesterol Levels on Coronary 
Vasoreactivity in Patients With Type II Diabetes 
Mellitus 1133-157·352A
Effects of Allopurinol on Endothelial Function and 
Nitrate Tolerance in Type 2 Diabetics With Stable 
Angina 1065-175·469A
Effects of Pioglitazone on Endothelial Function and 
Aortic Stiffness in Patients With Type 2 Diabetes 
Mellitus 1065-173·469A
Efficacy and Safety of Ezetimibe Coadministered With 
Simvastatin Versus Simvastatin Alone in 
Thiazolidinedione-Treated Patients With Type 2 
Diabetes Mellitus 1084-169·479A
Elevated Fibrinogen Level and Risk of Future Incidence 
of Diabetes Mellitus: Bezafibrate Infarction Prevention 
(BIP) Study 1082-187·478A
Endothelial-Dependent Vasodilation Does Not Improve 
With the Atkins' Diet in Diabetic Subjects 
1027-197·452A
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Type II Diabetic Mice 1011-107·155A
Genetic Predictive Factors for Restenosis in Diabetic 
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Angioplasty 1103-195·488A
Global Renal Revasculatization Preserves Renal 
Function in Diabetic and Nondiabetic Patients With 
Renal Insufficiency 1046-168·460A
Haptoglobin Polymorphism Is Associated With 
Short-Term Mortality and Heart Failure in Patients 
With Diabetes and Acute Myocardial Infarction 
1042-77·257A
Impact of Diabetes Mellitus on Abnormal Heart Rate 
Recovery After Exercise 1033-115·169A
Impact of Diabetes Mellitus on Thrombolysis in 
Myocardial Infarction Risk Score, Procedural 
Utilization, and Clinical Outcomes in Minorities and 
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Non-ST-Segment Elevation Acute Coronary 
Syndrome 1021-97·249A
Impact of Diabetes on 12-Month Outcomes Following 
Coronary Artery Bypass Graft Surgery: Results From 
the Routine Versus Selective Exercise Treadmill 
Testing After Coronary Artery Bypass Grafting 
(ROSETTA-CABG) Registry  809-4·268A
Impact of Radiation Dose on Outcomes in Diabetic 
Patients: Results From the SCRIPPS IV Trial  
822-5·71A
Impact of the Angiotensin-Receptor Blocker 
Candesartan in Preventing Diabetes in Patients With 
Heart Failure  810-1·473A
Importance of an Oral Glucose Tolerance Test in 
Identifying High Prevalence of Dysglycemia in 
Individuals at High Cardiovascular Risk 
1128-120·211A
Increased Urinary 8-Iso-Prostaglandin F2alpha 
Excretion Predict Cardiac Events in Patients With 
Type 2 Diabetes 1028-172·454A
Influence of Diabetes Mellitus on Coronary Collateral 
Flow: A Definite Answer to a Rather Elderly 
Controversy 1045-198·459A
Insulin Enhances Vascular Cell Adhesion Molecule -1 
Expression in Human Cultured Endothelial Cells: A 
Link to the Pathogenesis of Accelerated 
Atherosclerosis in Diabetes 1106-182·493A
Insulin Sensitizers Are Associated With Improved 
Outcomes in Diabetic Patients Undergoing 
Brachytherapy 1025-41·37A
Interaction of Age and Gender on Risk Stratification of 
Diabetic Patients With Rest/Stress ECG-Gated 
Tc-99m Sestamibi SPECT Imaging  816-3·339A
Is Metabolic Dysfunction Equivalent to Diabetes as a 
Prognostic Marker in Acute Coronary Syndrome? 
1021-98·249A
Latin America Small Vessel Randomized Study in 
Diabetic Patients (LASMAL II): Clinical and 
Angiographic Follow-Up Data 1081-48·58A
Left Ventricular Mass Reduction in Type 1 Diabetes 
Mellitus 1145-120·221A
Long-Term Use of Pioglitazone Slows Arteriosclerotic 
Progression in Type 2 Diabetics 1159-187·518A
Marked Improvements in In-Hospital Outcomes 
Following Contemporary Percutaneous Coronary 
Intervention in Patients With Diabetes 1062-47·48A
Metabolic Syndrome: A Major Risk Factor for Acute 
Myocardial Infarction in Patients < 45 Years of Age 
1021-99·249A
N Terminal Pro Brain Natriuretic Peptide Is the Most 
Powerful Predictor of Long-Term Mortality in Diabetic 
Patients With Acute Coronary Syndromes  
827-4·284A
Obesity Is the Major Determinant of Elevated 
C-Reactive Protein in Subjects With the Metabolic 
Syndrome 1028-165·453A
Outcomes in Diabetic Patients With Heart Failure: 
Impact of ACE D/I Polymorphism 1031-133·164A
Peroxisome Proliferator Activated Receptor Gamma 
Agonist Protects Against Arterial Thrombosis in a 
Mouse Model of Insulin Resistance 1007-176·444A
Peroxisome Proliferator-Activated Receptor Gamma 
Gene Polymorphisms and Risk of Restenosis After 
Coronary Artery Stenting in Patients With Diabetes 
1121-50·77A
Platelet Dysfunction Following a 300 mg Clopidogrel 
Loading Dose in Type 2 Diabetes Undergoing 
Coronary Stenting 1100-60·65A
Postprandial Lipoproteinemia Exhibits a Bimodal 
Response in Metabolic Syndrome Patients 
1047-185·464A
Preconditioning of the Diabetic Myocardium With Acute 
Metformin Treatment 1116-1·20A
Preprocedure Hyperglycemia Is Stongly Assoicated 
With Restenosis After Coronary Intervention in 
Diabetics 1062-43·48A
Prevalence of Silent Ischemia in Diabetic Patients With 
Subclinical Atherosclerosis: Detection by Stress 
Myocardial Perfusion Imaging  816-6·340A
Preventive Effects of Rosiglitazone on Restenosis After 
Coronary Stent Implantation in Patients With Type 2 
Diabetes Mellitus 1062-46·48A
Progression of Coronary Artery Disesase in Diabetics 
Demonstrated by Single Isotope Rest/Stress Tc-99m 
Sestamibi Myocardial Perfusion Imaging: More Rapid 
Than Nondiabetics?  816-5·340A
Randomized Comparison Between Stent and Balloon in 
Diabetic With ST-Segment Elevation Myocardial 
Infarction Undergoing Primary Angioplasty: A 
Substudy of the Zwolle-6 Randomized Trial 
1081-57·60A
Recovery of Impaired Microvascular Function in 
Collateral-Dependent Myocardium After 
Recanalization of a Chronic Total Coronary Occlusion 
1065-168·467A
Risk of Cardiovascular Disease in US Persons With 
Metabolic Risk Factors, Diabetes, and Elevated 
C-Reactive Protein  820-2·486A
Risk Stratification of Diabetic Patients With Rest/Stress 
ECG-Gated Tc-99m Sestamibi SPECT Imaging: 
Significance of Mild Perfusion Abnormalities  
816-2·339A
Rosiglitazone Reduces Novel Biomarkers of 
Cardiovascular Disease in Subjects With Type 2 
Diabetes Mellitus Already on Statin Therapy 
1124-192·504A
Ruptured Diabetic Atherosclerotic Plaques Have More 
Inflammation and Neovascularization Than Ruptured 
Plaques From Patients Without Diabetes  831-1·496A
Screening Stress Myocardial Perfusion Imaging for Risk 
Stratification in Asymptomatic Diabetic Men  
816-1·339A
Successful Percutaneous Revascularization of Chronic 
Total Occlusions Is Associated With a Significant 
Survival Benefit in Nondiabetics 1080-43·56A
Survival Differences Between Hispanic and 
Non-Hispanic Patients With Cardiovascular Disease 
Initiating Renal Replacement Therapy in the United 
States 1135-74·414A
Sympathetic Nerve Hyperactivity in Type 2 Diabetes: A 
Potential Cause for Increased Cardiovascular Risk 
1009-168·448A
TAXUS IV Diabetic Subset Analysis: Improvements in 
Nine-Month Outcomes in Diabetics on Oral 
Medication as Well as Insulin 1059-5·11A
The Impact of Insulin-Requiring Diabetes Mellitus on 
Effectiveness of Reperfusion and Outcome of 
Patients Undergoing Primary Percutaneous Coronary 
Intervention for Acute Myocardial Infarction 
1022-83·251A
The Impact of Prior Myocardial Infarction, Metabolic 
Syndrome, and High White Blood Cell Count on 
Coronary Heart Disease Mortality: The Multiple Risk 
Factor Intervention Trial (MRFIT) 18-Year Follow-Up 
Experience  838-6·416A
The Impact of Renal Insufficiency on Long-Term 
Survival of Patients With Diabetes Undergoing 
Percutaneous Coronary Intervention 1062-41·47A
The Incidence of Clinically Unrecognized Myocardial 
Infarction in Patients With Type 2 Diabetes, 
Hypertension, and Nephropathy 1099-89·281A
The Role of a Family History of Diabetes on Endothelial 
Function 1065-172·468A
Tissue Inhibitor of Matrix Metalloproteinase-1 Is a 
Marker of Left Ventricular Diastolic Dysfunction in 
Diabetic Heart Disease 1145-119·221A
Underutilization of Effective Treatement in Diabetic 
Patients Admitted With Acute Myocardial Infarction 
1077-69·405A
Use of Either Metformin or Thiazolidinedione Is 
Associated With Improved Survival Among Patients 
With Type 2 Diabetes From a Registry of 16,203 
Diabetic Patients  810-5·474A
Vascular Endothelial Growth Factor (VEGF) Plays a 
Central Role in the Development of Diabetic 
Cardiomyopathy and Gene Transfer of VEGF 
Improves Heart Failure in Long-Standing 
Streptozotocin-Induced Diabetic Rat  404-5·533A
Women With Diabetes Mellitus Have the Greatest 
Reduction in Myocardial Infarction Mortality Over the 
Past Decade: Evaluation of 1,428,596 Patients 
Enrolled in the National Registry of Myocardial 
Infarction 2, 3, and 4 From 1994-2002  827-3·284A
616A SUBJECT INDEX JACC March 3, 2004
KEY: Abstract Title, Session-abstract number•page number
Diagnosis, computer-assisted
A Bayesian Network to Evaluate Risk Factors Profiles in 
Patients With Coronary Artery Disease 
1020-74·400A
Clinical Application of Eigenvalue Analysis and the 
Derived Electrocardiogram as a Real-Time Marker for 
Infarction  854-4·424A
Comparison of the Diagnostic Performance of Totally 
Automatic Software for the Quantification of 
Myocardial Perfusion SPECT 1170-148·369A
It Is More Than Calcium? Characterization of Coronary 
Segments via Computer-Assisted Electron Beam 
Computed Tomography Image Analysis 
1075-164·330A
Noninvasive Evaluation of Coronary Artery Plaque With 
ECG-Gated Multislice Computed Tomography  
845-3·363A
Objective Detection of Stress-Induced Myocardial 
Ischemia Using Quantitative Analysis of Contrast 
Echocardiographic Parametric Perfusion Images  
866-2·372A
Role of Body Surface Mapping in Evaluation of Patients 
With Arrhythmogenic Right Ventricular Dysplasia and 
Right Bundle Branch Block  850-4·143A
Standards for Evaluation of Myocardial Viability With 
FDG-Positron Emission Tomography: A Comparison 
of Quantitative Methods  854-1·423A
Diagnostic techniques
Abnormalities in Magnetocardiographic Atrial Signals in 
Patients With Focally Triggered Lone Atrial Fibrillation 
1148-224·142A
Anatomical Observations of the Left Atrium and 
Pulmonary Veins by Multislice Computed 
Tomography in Patients With Atrial Fibrillation  
845-6·364A
Are High Doses of Intracoronary Adenosine an 
Alternative to Standard Intravenous Adenosine for the 
Assessment of Fractional Flow Reserve? 
1157-44·93A
Assessment of Aortic Wall Mechanics in Marfan 
Syndrome by Transesophageal Echocardiography 
and Tissue Doppler Imaging  844-5·362A
Changing Indications for Fetal Echocardiography in a 
University Center Population 1057-202·380A
Clinical Characteristics and Prevalence of Pericardial 
Effusion Using Cardiac Magnetic Resonance Imaging 
1109-103·202A
Comparison Between Myocardial Contrast 
Echocardiography and Contrast Enhanced Magnetic 
Resonance Imaging in Prediction of the Myocardial 
Viability After Direct Percutaneous Transluminal 
Coronary Angioplasty in Acute Myocardial infarction 
1116-21·24A
Comparison of 16-Slice Submillimeter Multidetector 
Spiral Computed Tomography With Conventional 
Angiography for Diagnosis of Coronary Artery 
Disease 1018-143·312A
Coronary Flow Velocity Reserve <2.0 by Transthoracic 
Doppler Echocardiography Can Detect Myocardial 
Ischemia Assessed by 201-Thallium Schintigraphy in 
a Large Population With Coronary Risk Factors  
866-5·373A
Coronary Lesion Temperature Measurement During 
Transient Blood Flow Occlusion Using a Novel 
Thermal Sensing System 1006-61·34A
Correlation Between Hyperenhancement on Delayed 
Contrast Enhanced Magnetic Resonance Imaging 
(MRI) and Diastolic Function Assessed by Steady 
State Cine MRI in Hypertrophic Cardiomyopathy  
855-3·370A
Current Diagnostic Accuracy of Fetal 
Echocardiography: A Cardiac Segment-Specific 
Analysis 1057-205·381A
Diagnostic Tests Have Incremental Value in Predicting 
Clinical Outcomes in Constrictive Pericarditis 
1109-108·203A
Diltiazem Attenuates the Coronary Vasodilatory 
Response to Adenosine and Reduces the Regional 
Myocardial Blood Flow Disparity and Sestamibi 
Defect Magnitude in Dogs With Critical Coronary 
Stenoses 1170-143·368A
Do Onset Mechanisms of Paroxysmal Atrial Fibrillation 
Influence the Arrhythmia Episode Duration in Patients 
With Dual Chamber Pacing? Relevance for 
Preventive Pacing Algorithms 1035-224·113A
Echocardiographic Phase Analysis: Timing of the 
Cardiac Cycle Using Left Atrial Motion 
1132-164·351A
Frequency and Evolution of Microvascular Obstruction 
Early After Interventional Therapy of Acute 
Myocardial Infarction  829-2·285A
Heart Rate Dynamics Before the Onset of Ventricular 
Tachyarrhythmias: Results of the Cardioverter 
Defibrillator Registry MARITA 1091-211·125A
Hemodynamic Impairment of Intermediate Stenoses in 
Saphenous Vein Coronary Artery Bypass Grafts and 
Recipient Vessels: Evaluation by Doppler Flow 
Velocity 1157-46·93A
High False Positive Rates for Serum B-Type Natriuretic 
Peptide Testing in the Routine Clinical Setting  
859-1·234A
Identification of Cardiac Sarcoidosis From the Patients 
Presenting as Unexplained Heart Failure and 
Cardiomyopathies  834-6·205A
In Vitro Detection and Quantification of High Intensity 
Transient Signals by Using Intracoronary Doppler 
Ultrasound: A New Approach to Detect Coronary 
Microembolization 1026-55·39A
In-Stent Restenosis Evaluation With 16-Slice 
Computed Tomography Coronary Scanner 
1018-149·314A
Independent Predictive Accuracy of Classical 
Electrocardiographic Criteria in the Diagnosis of 
Paroxysmal Junctional Tachycardias in Patients 
Without Preexcitation 1072-211·120A
Infantile Kawasaki Disease: High Incidence of Coronary 
Artery Aneurysms in Spite of Appropriate Intravenous 
Immunoglobulin Treatment 1171-205·394A
Initial Results Regarding the Safety, Tolerability, and 
Hemodynamic Effects of CVT-3146, a Selective 
Adenosine A2A Agonist, in Patients Undergoing 
Pharmacologic Stress SPECT Myocardial Perfusion 
Imaging 1170-141·367A
Is Computed Tomography-Based Coronary 
Angiography Ready for Prime Time? A Meta-Analysis 
1018-142·312A
Left Atrial Enlargement as a Marker for Cardiac 
Disease: Teaching One Simple Measure for 
Point-of-Care Ultrasound Screening 1059-33·18A
Left Atrial Volume and the Risk of Paroxysmal Atrial 
Fibrillation in Patients With Hypertrophic 
Cardiomyopathy 1037-144·317A
Long-Term Sensitivity and Positive Predictive Value of 
Symptoms as an Index of Atrial Tachyarrhythmia 
Recurrence in Paced Patients: A Report of 
Device-Based Monitoring in the Natural History of 
Atrial Fibrillation Trial 1166-209·144A
Low Frequency Audible Doppler Reveals That a 
Substantial Fraction of Patients With Suspected 
Pulseless Electrical Activity Have Occult Blood Flow 
1154-93·300A
Molecular Pathways of Cardiac Allograft Dysfunction 
Independent of Acute Cellular Rejection 
1051-127·175A
Myocardial Infarct Age Determined by 
Contrast-Enhanced Cine Magnetic Resonance 
Imaging 1169-159·367A
Noninvasive Assessment of In-Stent Restenosis by 
16-Slice Multislice Computed Tomography  
845-4·364A
Noninvasive Detection of Severe Stenosis and Total 
Occlusion in Left Anterior Descending Artery With 
Transthoracic Doppler Echocardiography in the 
Emergency Room  866-4·373A
Noninvasive Determination of Central Venous Pressure 
With a Bedside Ultrasound Device 1127-134·211A
Patients With the Metabolic Syndrome Have a High 
Prevalence of Left Ventricular Diastolic Dysfunction  
887-4·242A
Plaque Targeting in Atherosclerotic Mice Using a Small 
ImmunoProtein Against an Angiogenesis-Associated 
Fibronectin Isoform 1045-189·457A
Predicting Significant Coronary Artery Disease in Heart 
Failure Patients 1126-110·207A
Predictive Validity of Criteria for the Epidemiological 
Diagnosis of Heart Failure in the Elderly: The Icare 
Dicomano Study 1128-124·212A
Preserved Radial Strain Explains Normal Ejection 
Fraction in Cardiac Amyloidosis Patients With 
Abnormal Longitudinal Strain  844-3·362A
Pro B-Natriuretic Peptide (BNP) Measurement for the 
Emergency Diagnosis of Congestive Heart Failure: 
The ProBNP Investigation of Dyspnea in the 
Emergency Department Study (PRIDE)  859-3·235A
Real-Time Contrast Enhanced Ultrasound Imaging of 
Neovascularization Within the Human Carotid Plaque  
881-3·374A
Real-Time Three-Dimensional Echocardiographic 
Assessment of Endocardial Surface Can Quantitate 
the Size of Myocardial Infarction  837-3·355A
Rebirth of Bedside Cardiovascular Examination Using 
Hand-Carried Ultrasound 1016-152·309A
Selection of Optimal Phase for 3-D Computed 
Tomography Reconstruction of Coronary Arteries 
Using an Automatic Vessel Tracking System 
1075-157·329A
ST-Segment Elevation in Lead AVR in Acute Myocardial 
Infarction-Clue to Circumflex Coronary Artery Origin 
for Inferior/Posterior Myocardial Infarction 
1015-224·109A
Strain Echocardiography Predicts Reduced Ventricular 
Function in the Systemic Right Ventricle 
1134-201·388A
Subendocardial Radial Strain Activation Imaging: A 
New Method to Quantify Regional Dyssynchrony in a 
Model of Left Bundle Branch Block and Biventricular 
Pacing  844-2·362A
The Assessment of Arterial Compliance Using 
Noninvasive Techniques: A Comparison of Radial 
and Ocular Measures of Arterial Pressure and Flow 
1027-192·452A
The Duke Treadmill Score and Cardiac Mortality in 
Asymptomatic Women: The St James Women Take 
Heart Project  876-1·238A
The Limits of Quantifiable Differences in Dipyridamole 
Stress Magnetic Resonance Imaging Perfusion 
Defects in Human Subjects With Coronary Artery 
Disease  836-3·353A
The Relationship of Age, Hemodynamics, and Severity 
of Illness With Brain Natriuretic Peptide Levels in 
Pediatric Heart Disease 1152-203·392A
Tissue Doppler Strain Echocardiography Accurately 
Predicts Right Ventricular Systolic Function  
844-4·362A
Unique Diagnostics Identify Patients at Risk for Heart 
Failure Decompensation  817-2·127A
Use of Color M-Mode Tissue Doppler Imaging to 
Calculate Dynamic Compliance of the Pulmonary 
Arteries in Pulmonary Hypertension: Validation in an 
Animal Model 1054-147·320A
Usefulness of Tissue Doppler Imaging for Evaluating 
Systolic and Diastolic Left Ventricular Function in 
Patients With Primary Cardiac Amyloidosis 
1127-106·210A
Utility of B-Type Natriuretic Peptide and ProBNP in 
Evaluation of Patients Receiving Natrecor Therapy 
(UBET Study) 1049-112·171A
Validation of Criteria for Noncompacted Myocardium in 
Dilated Cardiomyopathy, Valvular, and Hypertensive 
Heart Disease 1013-120·162A
Value of Electrocardiographic Parameters in Identifying 
Patients With a Mild Form of Arrhythmogenic Right 
Ventricle Dysplasia 1015-218·108A
Ventricular Synchrony as Determined by Phase 
Analysis Correlates With Ejection Fraction 
1132-163·351A
Diastole
Anemia in Diastolic Heart Failure Is Frequent and 
Associated With Worse Outcome  842-1·216A
Assessment of Ventricular Untwisting Recoil Velocity by 
Doppler Tissue Echocardiography: An Index of 
Relaxation Time Constant 1087-133·189A
Brain Natriuretic Peptide Levels Correspond With 
Diastolic Function Following Orthotopic Heart 
Transplantation 1089-117·194A
Cardiac Parvovirus Type B19 Infection Is Associated 
With Isolated Diastolic Dysfunction  806-4·185A
Combined Effects of Diastolic Dysfunction and Left 
Ventricular (LV) Remodeling on Mortality in 7,267 
Patients With Preserved LV Systolic Function  
887-1·241A
Diastolic Heart Failure in Patients Hospitalized With 
Symptomatic Cerebral and Peripheral Vascular 
Disease  887-5·242A
Early Changes of Left Atrial Reservoir Function After 
Cardioversion of Paroxysmal Atrial Fibrillation Predict 
Relapse of Arrhythmia 1149-160·357A
Echocardiographic Diastolic Function Grade Accurately 
Reflects Changes in Ventricular Wall Stress and 
Stiffness 1149-153·356A
Elevated Levels of Circulating Tissue Inhibitor of 
Metalloproteinase-1 Correlate With Impaired Diastolic 
Relaxation in Hypertension: Implications for Diastolic 
Heart Failure 1142-186·513A
Enhanced Pressure Wave Reflection Contributes to 
Left Ventricular Diastolic Dysfunction in Hypertension  
873-2·527A
In Vivo Evidence of Isolated Impaired Myocardial 
Relaxation in Mice Overexpressing the Transcription 
Factor RTEF-1  870-2·235A
Incidence of Diastolic Dyssynchrony in Dilated 
Cardiomyopathy and Effects of Biventricular Pacing  
872-6·238A
Intensive Aerobic Physical Training Decreases 
Age-Related Decline of Left Ventricular Diastolic 
Function 1059-28·17A
Is Atherosclerotic Vascular Disease Associated With 
Left Ventricular Diastolic Function in Subjects With 
Normal Systolic Function? A Population-Based 
Transesophageal Echocardiographic Study 
1131-148·349A
Left Atrial Enlargement in Hypertrophic 
Cardiomyopathy: The Importance of Left Ventricular 
Hypertrophy and Diastolic Dysfunction 
1108-129·201A
Metalloproteinase Inhibition Prevents Diastolic 
Stiffening, AMP-Breakdown, and Oxypurine 
Accumulation in Accelerated Heart Failure  
870-3·236A
Mitral Deceleration Time in Acute Myocardial Infarction: 
Relation to Myocardial Perfusion After Successful 
Primary Percutaneous Coronary Intervention 
1149-156·357A
Multimedia Bedside Cardiac Examination: Controlled 
Intervention Study  853-2·423A
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Endothelial-Dependent Vasodilation Does Not Improve 
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Impact of Renal Insufficiency and Chronic Diuretic 
Therapy on Outcome and Resource Utilization in 
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1069-114·180A
Spironolactone Improves Coronary Endothelial 
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1159-195·519A
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Amyloidosis 1105-172·491A
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1054-150·321A
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1156-63·91A
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Substantial Fraction of Patients With Suspected 
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Noninvasive Detection of Severe Stenosis and Total 
Occlusion in Left Anterior Descending Artery With 
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Physiological Assessment of Coronary Artery Stenosis 
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1132-162·351A
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Flow: Analysis Using Transthoracic Color Doppler 
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Hypertensive Patients: The HyperGen Study 
1030-139·429A
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1112-150·342A
Regional Versus Global Left Ventricular Function in 
Patients After Heart Transplantation: A Doppler 
Myocardial Imaging Study 1089-116·194A
Relation of Diastolic Function as Measured by 
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Pressure to Rejection in Young Heart Transplant 
Patients 1134-206·389A
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Diastolic Function in Hibernating Myocardium  
802-1·330A
Subendocardial Radial Strain Activation Imaging: A 
New Method to Quantify Regional Dyssynchrony in a 
Model of Left Bundle Branch Block and Biventricular 
Pacing  844-2·362A
The Doppler Tei Index During Dobutamine Stress 
Echocardiography: A Powerful Predictor of Mortality 
After Acute Myocardial Infarction  802-4·331A
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Velocity of the Mitral Annulus Is Associated With 
B-Type Natriuretic Peptide Levels 1149-154·356A
Tissue Doppler Versus Strain Rate Imaging for 
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Vitro Model of the Myocardium 1016-155·309A
Tissue Doppler-Derived Indices Correlate With 
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Hypertrophic Cardiomyopathy  844-6·363A
Utility of Intracardiac Echocardiography to Guide 
Radiofrequency Catheter Ablation of Ventricular 
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Velocity Data of Doppler Myocardial Imaging as a 
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Dose-response relationship, drug
Current Enoxaparin Dosing Strategies Yield 
Supratherapeutic Anti-Xa Activity in Many Elderly 
Patients 1141-190·509A
Dose Response of Sirolimus-Eluting SMARTTM Stents 
in Porcine Iliac Arteries and Relationship to Arterial 
Tissue Sirolimus Levels 1005-45·32A
Dose-Response Study of the Efficacy and Safety of 
Fosinopril in Children With Hypertension: A 
Randomized, Double-Blind, Placebo-Controlled, 
Multicenter Clinical Trial 1085-167·482A
Optimization of Pharmacokinetic Vectors With a 
Programmable Paclitaxel Eluting Stent 1139-51·83A
Oral Rapamune to Inhibit Restenosis in Patients With 
Multi De Novo Coronary Lesions Requiring Stenting 
1063-60·51A
REDOX Trial - Reduced Sirolimus Doses on the Bx 
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Subcutaneous Treprostinil Therapy Evokes Both 
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Underachievement of Low-Density Lipoprotein 
Cholesterol Goal in Patients on Statins in Clinical 
Practice: Are We Using Low Doses of Statins Too 
Often? 1021-102·250A
Drug administration
An Antiulcer Drug, Geranylgeranylacetone, Suppresses 
Nitric Oxide Synthesis in Cytokine-Stimulated 
Cultured Vascular Smooth Muscle Cells 
1106-184·493A
Biodegradable Scaffolds Incorporating Vascular 
Endothelial Growth Factor as a Novel Sustained 
Delivery Platform to Induce Angiogenesis  
805-4·473A
Biolimus A9: A New Generation Rapamycin Analogue 
Inhibits Intimal Hyperplasia in a Porcine Model 
1139-52·84A
Combined Treatment With Epsilon Protein Kinase C 
Activator and Delta Protein Kinase C Inhibitor 
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Current Enoxaparin Dosing Strategies Yield 
Supratherapeutic Anti-Xa Activity in Many Elderly 
Patients 1141-190·509A
Delivery of Luciferase Enzyme to the Heart Using 
Ultrasound Targeted Microbubble Destruction  
881-4·374A
Encapsulation of Pravastatin Tablets Produces Greater 
Low-Density Lipoprotein Cholesterol Lowering in 
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Infection Dyslipidemia Taking Protease Inhibitors 
1008-186·446A
Evaluation of Beta-Blocker Dose in Community-Based 
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High Prevalence in Pharmacological Responses Mimic 
Brugada Syndrome in Japanese-A Pure Na Channel 
Blocker, Pilsicainide Challenge Test in the Normal 
Heart 1072-218·121A
Hypotension Associated With Nesiritide Infusion in 
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Monitoring and Dose Adjustments 1088-127·192A
Important Species Differences of Sirolimus, Paclitaxel, 
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Smooth Muscle and Endothelial Cells 1102-47·68A
Monocyte Chemoattractant Protein-1 Induced 
Monocyte Infiltration and Angiogenesis Does Not 
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Oral Rapamune to Inhibit Restenosis in Patients With 
Multi De Novo Coronary Lesions Requiring Stenting 
1063-60·51A
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Beneficial Effect of Oral Acetylcysteine for Prevention of 
Contrast-Induced Nephropathy in Patients With Renal 
Insufficiency: A Meta-Analysis 1141-191·509A
Clopidogrel in Unstable Angina Patients Who Would 
Have Been Excluded From Randomized Pivotal Trials 
1137-99·298A
Congestive Heart Failure and Cardiogenic Shock 
Complicating Acute Myocardial Infarction Have High 
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Ventriculography for Evaluation of Left Ventricular 
Ejection Fraction  881-5·374A
Contrast-Enhanced Echocardiography Improves 
Agreement on the Assessment of Ejection Fraction 
and Left Ventricular Volumes: A Multicenter Study 
1074-154·328A
Cost-Effectiveness of Screening Coronary Artery 
Disease Patients With B-Type Natriuretic Peptide 
1172-75·422A
Determinants of Severe Pulmonary Hypertension in 
Patients With Severe Aortic Stenosis 1112-145·341A
Determination of Left and Right Cardiac Function With 
Multislice Computed Tomography 1038-152·319A
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Cardiac Parvovirus Type B19 Infection Is Associated 
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841-1·505A
Chronic Endothelin Receptor Antagonism Preserves 
Endothelial Function in a Transgenic Mouse Model of 
Alzheimer’s Disease 1027-189·451A
Chronic Therapy With Phospodiesterase 5 Inhibitor 
Tadalafil Has a Sustained Effect on Endothelial 
Function 1141-194·510A
Circulating Endothelial Progenitor Cells Predict 
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Coronary Vasodilator Responses Are Impaired 
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834-4·204A
Cytomegalovirus Impairs Endothelial Nitric Oxide 
Synthase Pathway: Role of Oxidative Stress and Viral 
Entry 1140-167·507A
Differential Effects of Selective COX-2 Inhibitors on 
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Dimerization of Mitogen-Activated Protein Kinase and 
Auto-Phosphorylation of Akt Occur in the Newly 
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Effect of Atorvastatin and Sildenafil on Endothelial 
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Increased Cardiovascular Risk 1141-196·510A
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Disease 1066-192·470A
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Elevated Gene Expression of Asymmetric 
Dimethylarginine-Generating Enzymes in 
Atherosclerosis 1140-171·508A
Endothelial Dysfunction Accelerates Future 
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Cardiovascular Events 1027-191·451A
Endothelial Dysfunction in Children With Human 
Immunodeficiency Virus: Impact of Disease and 
Protease Inhibitor Therapy  819-1·484A
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Inhibition of p38 Mitogen Activated Protein Kinase 
Mediates Endothelial Cell Survival During Cardiac 
Transplantation 1051-130·175A
Kinetics of Circulating Endothelial Progenitor Cells in 
Congestive Heart Failure 1108-131·202A
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1122-169·498A
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1027-196·452A
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1159-192·519A
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Function 1065-172·468A
Thrombin and Histamine Stimulate Phosphorylation of 
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Pathway 1122-174·499A
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1138-46·81A
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Urotensin II Modulates Collagen Synthesis and the 
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834-1·204A
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1065-171·468A
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Low-Density Lipoprotein Cholesterol Levels, but Not 
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Hypertensive Patients 1059-11·13A
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Insulin Resistance in a Murine Model of Diet-Induced 
Obesity 1027-190·451A
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Augmentation of Glucose Metabolism With Perhexiline 
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Cardiomyopathy 1088-122·190A
Effects of Surgical Myectomy on Myocardial Energetics 
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Lipoprotein: Downregulation of 
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of Self-Reported Health Behavior With Clinical 
Outcomes 1128-128·213A
Cardiovascular Risk Factors as Correlates of Erectile 
Dysfunction: Results of a Survey in 71,503 Men in 
Brazil 1096-74·409A
Carotid Intima-Media Thickening as Surrogate 
Atherosclerosis Marker: Is It Relevant to the Asians? 
1082-182·476A
Clinical Characteristics and Prevalence of Pericardial 
Effusion Using Cardiac Magnetic Resonance Imaging 
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Does Elevating Catecholamine Concentrations Impact 
the Defibrillation Threshold? 1059-20·15A
Estrogen
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All-Cause Death in a Preventive Medicine Program  
876-2·238A
Impact of Diabetes Mellitus on Abnormal Heart Rate 
Recovery After Exercise 1033-115·169A
Impact of Gender on Long-Term Mortality in 4,234 
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Failure of Different Etiologies 1088-115·189A
Patients Maintain Coronary Perfusion and Exercise 
Capacity After Arterial Switch Surgery for 
Transposition of the Great Arteries  886-6·398A
Potential Beneficial Effects of Transdermal Capsaicine 
Patches on the Ischemic Threshold in Patients With 
Stable Coronary Disease 1023-92·253A
Prediction of Death or Myocardial Infarction by Exercise 
SPECT Scintigraphy Among Patients Who Have Had 
Recent Coronary Stenting 1081-52·59A
Prediction of Functional Capacity in Chronic Heart 
Failure Patients Using Myocardial Tissue Doppler 
1132-162·351A
Safety of Stress Testing Following an Acute Coronary 
Syndrome 1097-97·277A
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Serial Testing With Rest/Stress Tc-99m Sestamibi 
Myocardial Perfusion Imaging: Normal Results 
Provide an Extended Warranty 1056-157·324A
Severe Frequent Ventricular Ectopy After Exercise as a 
Predictor of Death in Patients With Advanced Systolic 
Heart Failure 1146-107·223A
Systolic Blood Pressure During Recovery Is Related to 
the Risk of Acute Myocardial Infarction in 
Middle-Aged Men 1146-112·224A
T-Wave Alternans Is Associated With Spatial 
Heterogeneity of T-Wave Morphology in Coronary 
Artery Disease Patients During Treadmill Exercise 
1033-114·168A
The Duke Treadmill Score and Cardiac Mortality in 
Asymptomatic Women: The St James Women Take 
Heart Project  876-1·238A
The Incidence and Prognostic Value of Exertional 
Hypotension in Medically Managed Older Patients 
With Stable Coronary Artery Disease 1128-129·214A
The Prognostic Significance of Exercise-Induced Atrial 
Arrhythmias 1146-105·223A
The Prognostic Value of Percent Heart Rate Reserve, 
Heart Rate Recovery, and Exercise Capacity Over 
Myocardial Perfusion SPECT in the Prediction of 
Cardiac, Noncardiac, and All-Cause Mortality  
876-3·238A
The Relationship Between Minute Ventilation and the 
Rate of CO2 Elimination Reflects the Right Ventricular 
Oxidative Metabolism in Heart Failure  804-4·332A
Utility of Routine Functional Testing After Coronary 
Artery Bypass Graft Surgery: Results From the 
ROSETTA-CABG Study 1079-84·273A
Extracellular matrix
Development of Murine Fibrotic Cardiomyopathy Is 
Dependent on Monocyte Chemoattractant Protein 1 
1164-125·230A
Early Serum Levels of Tissue Inhibitor of 
Metalloproteinases-1 but Not Matrix 
Metalloproteinase-1 Are Associated With 
Cardiovascular Death After Complicated Myocardial 
Infarction 1087-106·188A
Enhanced Instability of Membranous Type 1 Matrix 
Metalloproteinase in Response to Mechanical 
Loading in Left Ventricular Myocardium 
1087-108·189A
Evidence for Immediate Induced Percutaneous 
Coronary Intervention Matrix Metalloproteinase 2 
Variations in Peripheral Samples to Predict Target 
Vessel Revascularization After Nondrug-Eluting Stent 
Implantation 1043-47·42A
Extracellular Matrix Remodeling During Left Ventricular 
Assist Device Support: Relation Between Collagen 
and Passive Pressure-Volume Relations  849-3·225A
Over-Expression of Fibronectin Involves Activation of 
Mitogen-Activated Protein-Kinase-Kinase of the 
Stress Activated Protein Kinase/C-Jun N-Terminal 
Kinase in Aortic Regurgitation 1067-135·430A
Pathological Features Found Postmortem in 53 Patients 
With Cardiac Rupture Complicating Acute Myocardial 
Infarction 1118-83·291A
Plasma Metalloproteinase Levels Are Correlated With 
Natriuretic Peptide and Endothelin-1 Levels in 
Patients With Heart Failure 1087-103·188A
Proteomic Profiling of Restenotic Lesions Unveils 
Increased Expression of Structural Proteins That Are 
Inhibited by Intramural Delivery of Rapamycin  
1158-52·94A
Subnormal Tissue Inhibitor of Metalloproteinase 
Expression Modulates Matrix Metalloproteinase-2 
Activity and Fibrosis in Aortic Regurgitation 
1067-140·431A
The Critical Role of Thrombospondin (TSP)-1 in 
Limiting Expansion of Fibrosis in Healing Myocardial 
Infarcts: Studies in Dogs and TSP-1 -/- Mice 
1002-78·243A
Time-Dependent Upregulation of Extracellular Matrix 
Proteins in Chronic Hibernating Myocardium: Lack of 
Progressive Degeneration 1136-84·294A
Tissue Inhibitor of Matrix Metalloproteinase-1 Is a 
Marker of Left Ventricular Diastolic Dysfunction in 
Diabetic Heart Disease 1145-119·221A
Versican Promoter Is a Target for the β-Catenin/Tcf-4 
Signaling Pathway in Vascular Smooth Muscle Cells  
867-6·527A
Extracorporeal circulation
First Postoperative Day Prognosis Score in Patients 
Undergoing Cardiac Surgery Based on Pre-, Peri-, 
and Postoperative Variables 1172-73·421A
Randomized Comparison of Intra-Aortic Balloon 
Support Versus a Percutaneous Left Ventricular 
Assist Device in Patients With Acute Myocardial 
Infarction Complicated by Cardiogenic Shock  
856-4·234A
Fatty acids
Basal Respiratory Exchange Ratio Is Altered With 
Statin Use in Normals 1165-133·233A
Dose of Fish Oil Needed to Achieve Cardioprotective 
Blood Levels of Omega-3 Fatty Acids 1124-193·504A
High-Dose Dobutamine Stress Tl-201/I123-BMIPP Dual 
SPECT Reliably Identifies Myocardial Contractile 
Dysfunction Caused by Inducible Demand Ischemia 
1094-157·338A
Impact of Increased Fatty Acid Delivery on Myocardial 
Fatty Acid Metabolism in Obese Young Women  
804-5·332A
Partial Fatty Acid Inhibition by Trimetazidine Improves 
Left Ventricular Function in Patients With Heart 
Failure of Different Etiologies 1088-115·189A
Whole Body, Myocardial, and Coronary Vascular Insulin 
Resistance in Conscious Dogs With Pacing Induced 
Dilated Cardiomyopathy 1164-127·230A
Fetal cardiology
Assessment of Fetal Diastolic Function by Tissue 
Doppler Imaging 1149-157·357A
Changing Indications for Fetal Echocardiography in a 
University Center Population 1057-202·380A
Characteristics and Outcomes of Fetuses With 
Pericardial Effusions 1057-199·379A
Current Diagnostic Accuracy of Fetal 
Echocardiography: A Cardiac Segment-Specific 
Analysis 1057-205·381A
Diagnosis and Management of Foramen Ovale 
Restriction or Closure in Fetuses With Congenital 
Heart Disease  871-3·396A
Early Intervention for Pulmonary Outflow Tract 
Obstruction in Neonates Is Associated With Reverse 
Orientation of the Ductus Arteriosus 1134-204·389A
Fetal Aortic Stenosis With Apex-Forming Left Ventricle 
at Time of Diagnosis: Determinants of Biventricular 
Repair 1057-201·380A
Fetal Pulmonary Venous Doppler Patterns in 
Hypoplastic Left Heart Syndrome: Relationship to 
Atrial Septal Restriction 1057-206·???
Maternal Hyperglycemia Acutely Improves Fetal 
Cardiac Function During Tachycardia-Induced Heart 
Failure 1057-200·380A
Neurological Outcome of Fetal Arrhythmias 
Complicated by Hydrops 1171-199·393A
Opening of the Mitochondrial Potassium Adenosine 
Triphosphate Channel Improves Postanoxic Recovery 
of Conduction and Excitation-Contraction Coupling in 
the Developing Heart 1041-90·254A
Outcome Following Prenatal Identification of Structural 
Heart Disease: A Seven-Year Experience 
1057-204·381A
The L-Type Calcium and Sarcolemmal KATP Channels 
May Contribute to Pacing-Induced Cardioprotection 
1035-219·112A
The Monolithic Fetal Pacemaker III: Device Dimensions 
by Fetal Ultrasonography 1035-218·112A
Utility of Real Time Three-Dimensional 
Echocardiography for Fetal Heart Examination 
1113-158·344A
Ventricular Function in Fetal Congestive Heart Failure 
and Predictors of Perinatal Outcome 1057-203·380A
Fibrinolytic agents
Calcification of the Culprit Lesion Is Associated With 
Adverse Clinical Outcomes in ST Elevation 
Myocardial Infarction Patients Treated With 
Fibrinolytic Therapy 1060-83·261A
Distinct Modes of Cardiovascular Death Associated 
With Impaired Epicardial and Myocardial Perfusion 
Following Fibrinolysis for ST Elevation Myocardial 
Infarction 1118-82·290A
The Acuteness Score: New Insights in Predicting Infarct 
Size 1117-89·288A
The Association of Race With Angiographic and Clinical 
Outcomes Following Fibrinolytic Administration  
883-2·305A
Financial incentives/disincentives
Excessive Inducement Into Clinical Trials Using 
Monetary Incentives: Truth or Fallacy? 1040-68·401A
Fish oils
Dose of Fish Oil Needed to Achieve Cardioprotective 
Blood Levels of Omega-3 Fatty Acids 1124-193·504A
Effects of Fish Oil Supplements on Human Myocardial 
Omega-3 Fatty Acid Levels and Correlations With 
Erythrocytes  883-3·305A
Follow-up studies
Brachial Artery Intima-Media Thickness Is Closely 
Related to Long-Term Cardiovascular Events 
1103-166·487A
Combination Evidence-Based Therapy Improves 
Survival After Percutaneous Coronary Intervention 
1172-72·421A
Constellation of Risk Variables of Metabolic Syndrome 
at Low Levels in Childhood Is Beneficially Associated 
With Adulthood Cardiovascular Risk: The Bogalusa 
Heart Study  847-1·514A
Coronary Artery Aneurysms Are an Independent 
Predictor of High Five-Year Mortality 1099-92·282A
Does Use of Harmonic Imaging Increase the Yield of 
Echocardiographic Left Ventricular Mass 
Measurements on a Population Basis? The Strong 
Heart Study 1112-149·342A
Effect of Rim Deficiency and Occluder Size on Acute 
and Mid-Term Results of Transcatheter Atrial Septal 
Defect Closure in Adults 1019-202·376A
Elevated Parathyroid Hormone Is an Important 
Predictor of Coronary Events in Patients With Chronic 
Hemodialysis 1137-101·298A
Endothelial Dysfunction Accelerates Future 
Hypertensive Evolution and Causes Excess of Fatal 
Cardiovascular Events 1027-191·451A
Five-Year Survival Data From the APRICOT Trials: 
Does Female Gender Really Portend Unfavorable 
Outcome? 1137-100·298A
Higher Coronary Calcification Scores Improve 
Adherence to Cardiac Risk Factor-Modifying 
Behaviors  845-1·363A
Impact of Sirolimus-Eluting Stents on the Outcome of 
Patients With Chronic Total Occlusions: Multicenter 
Registry in Asia 1024-49·35A
Lone Atrial Fibrillation in Adolescent Patients 
1171-201·393A
Long-Term Clinical Follow-Up After Diffuse In-Stent 
Restenosis 1121-53·78A
Long-Term Efficacy of Intracoronary Beta-Radiation for 
the Treatment of In-Stent Restenosis: An 
Angiographic and Intravascular Ultrasound Analysis 
of the Late Catch-Up Phenomenon 1102-51·69A
Long-Term Noninvasive Electrophysiologic Assessment 
After Repair of Total Anomalous Pulmonary Venous 
Connection  857-2·394A
Long-Term Results With the St. Jude Medical Aortic 
Valve: A 25-Year Experience 1048-136·429A
Patent Foramen Ovale: A New Factor Associated With 
Progression of Carcinoid Heart Disease 
1030-140·429A
Plasma Leptin Level Is an Important and Independent 
Predictor of Prognosis in Patients With Established 
Coronary Atherosclerosis  408-5·535A
Populations Benefiting From the Ross Procedure: A 
Long-Term Follow-Up 1125-139·436A
Predictors of Mortality in 1,346 Patients With Heart 
Failure Scheduled for Guideline-Based Treatment 
1069-110·179A
Reasons for Nonadherence to Cardiac Medications in 
Patients Discharged With Acute Coronary 
Syndromes 1153-70·417A
Reduced Bone Mass in Men With Advanced Chronic 
Heart Failure Is Accompanied by 
Hyperparathyroidism, Andropenia, and Inflammation, 
and Predicts Poor Outcome 1108-117·198A
Reoperative Valve Replacement With the St. Jude 
Medical Valve Prosthesis: Long-Term Follow-Up 
1143-140·438A
Resting 12-Lead Electrocardiogram as a Reliable 
Predictor of Functional Recovery After Recanalization 
of Chronic Total Coronary Occlusions 1080-42·56A
Statin Therapy and Mortality in Patients With Acute 
Myocardial Infarction Treated With Primary 
Angioplasty  833-3·286A
The Impact of Deep Sternal Wound Infection on 
Long-Term Survival After Coronary Artery Bypass 
Grafting  809-2·268A
The Impact of the National Privacy Act on the 
Effectiveness and Costs of a Six-Month Follow-Up 
Study of Acute Coronary Syndromes 1040-67·401A
The Long-Term Impact of Initiating Treatment With the 
Angiotensin-Converting Enzyme Inhibitor Trandolapril 
After a Myocardial Infarction in Patients With Left 
Ventricular Dysfunction: A 10- to 12-Year Follow-Up 
Study 1012-128·159A
Utility of B-Natriuretic Peptide Levels in Predicting 
Outcome of Hospitalized Patients With Congestive 
Heart Failure: Results of the Breathing Not Properly 
(BNP) Multinational Study  859-2·234A
Utilizing of the Fibrin Meshwork to Induce 
Neovascularization in Patients With Chronic Limb 
Ischemia: Long-Term Follow-Up  848-2·516A
Valvular Regurgitation Predicts Cardiovascular 
Mortality and Morbidity Among American Indians: 
The Strong Heart Study 1030-138·429A
Free radicals/scavengers
Active Hydroxy Metabolite of Atorvastatin Increases 
Resistance of Human Low-Density Lipoproteins to 
Oxidative Modification  882-4·529A
Age-Related Changes in Adaptation of the Heart to 
Ischemia-Reperfusion: A Possible Role for NADPH 
Oxidase-Induced Superoxide Production 
1002-81·243A
Cytomegalovirus Impairs Endothelial Nitric Oxide 
Synthase Pathway: Role of Oxidative Stress and Viral 
Entry 1140-167·507A
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Impact of In Vivo Generation of 8-Isoprostaglandin F2_ 
After a 30-Minute Passive Smoking Exposure on 
Flow-Mediated Enothelium-Dependent Dilation of the 
Brachial Artery 1105-173·491A
Impact of NAD(P)H Oxidase-Derived Reactive Oxygen 
Species on Plaque Formation and Vascular 
Remodeling: Comparison of Histochemical 
Characteristics and Intravascular Ultrasound Finding 
of Atherosclerotic Lesions 1082-177·476A
Incremental Value of Redox Pattern in Predicting 
Cardiac Allograft Vasculopathy After Heart 
Transplantation  813-2·185A
Metalloproteinase Inhibition Prevents Diastolic 
Stiffening, AMP-Breakdown, and Oxypurine 
Accumulation in Accelerated Heart Failure  
870-3·236A
Opening of the Mitochondrial Potassium Adenosine 
Triphosphate Channel Improves Postanoxic Recovery 
of Conduction and Excitation-Contraction Coupling in 
the Developing Heart 1041-90·254A
Peroxynitrite Inactivates Akt Pathway and Enhances 
Tissue Factor Expression in Thrombin Stimulated 
Endothelial Cells  867-3·526A
Simulated Ischemia/Reperfusion Promotes Akt 
Phosphorylation via Both Redox-Sensitive and 
Insensitive Mechanisms in H9c2 Cells 1136-83·294A
Tetrahydrobiopterin Prevents Vascular Injury After 
Ischemia-Reperfusion in Humans  865-4·525A
The Influence of Simvastatin on the Angiotensin AT1 
Receptor Density, Oxidative Stress and Endothelial 
Function in Patients With Coronary Disease 
1159-192·519A
The Protective Effect of Edaravone on Myocardial 
Damage During Ischemia-Reperfusion in Rabbit 
Heart 1078-97·270A
G proteins
C825T Polymorphism of the G-Protein Beta(3) Subunit 
Gene and Atrial Fibrillation: Association of the TT 
Genotype With a Reduced Risk for Atrial Fibrillation 
1059-14·13A
Distinct Signaling Pathways Mediate Protease 
Activated Receptor-Dependent Endothelial 
Exocytosis 1064-181·465A
Regional Desensitization of β-Adrenergic Receptor 
Signaling in Swine With Chronic Hibernating 
Myocardium 1002-77·243A
Simvastatin Augments Rac Activation of Akt Signaling 
and Inhibits Endothelial Apoptosis by Modifying 
Subcellular Localization  867-2·526A
The Use of Abciximab During Percutaneous Coronary 
Angioplasty in Patients With Acute Coronary 
Syndrome Improves the Microcirculatory Function: 
Results of a Prospective Randomized Study 
1001-7·2A
Gap junctions
A Carboxyl-Tailless Mutant of Connexin43 
Overexpressed in Transgenic Mice Reduces the pH 
Gating Sensitivity Between Atrial Myocytes 
1034-213·111A
Enalapril Can Prevent Perpetuation of Atrial Fibrillation 
Through Suppression of Interstitial Fibrosis and 
Connexin43 Expression Associated With Shortening 
of Excitable Gap in a Canine Rapid Atrial Pacing 
Model With Tachycardia-Mediated Cardiomyopathy 
1034-208·110A
Gender
Adverse Outcomes in Women Undergoing 
Percutaneous Coronary Intervention 1043-64·44A
Any Measurable Coronary Artery Disease Identified in 
Women Presenting With Ischemic Chest Pain Is 
Associated With an Adverse Outcome: Findings From 
the National Institutes of Health-National Heart, Lung, 
and Blood Institute-Sponsored Womens Ischemia 
Syndrome Evaluation (WISE) Study Angiographic 
Core Laboratory 1119-93·292A
Brachial Artery Flow-Mediated Vasodilation Correlates 
With Exercise Capacity in Women 1065-165·467A
C-Reactive Protein, the Metabolic Syndrome, and 
Prediction of Cardiovascular Events in the 
Framingham Offspring Study  812-1·474A
Chronic Therapy With Phospodiesterase 5 Inhibitor 
Tadalafil Has a Sustained Effect on Endothelial 
Function 1141-194·510A
Contribution of Apolipoprotein A5 Gene Variants to Left 
Ventricle Hypertrophy in Hypertensive 
African-American Men 1142-184·513A
Differences in the Rate of Invasively Confirmed 
Coronary Artery Disease Between Women and Men 
Presenting With an Acute Coronary Syndrome 
Without ST Elevation 1097-95·276A
Does Indexation to Fat-Free Mass Eliminate or Reverse 
Gender Differences in Left Ventricular Mass? 
1142-181·512A
Enhanced External Counterpulsation Improves 
Functional Capacity and Quality of Life in Women 
With Chronic Angina  891-3·308A
Female Sex: A More Important Prognostic Marker Than 
Treatment Assignment or Comorbid Conditions 
Among Patients With Acute Myocardial Infarction in 
the GUSTO V Trial 1060-80·261A
Gender Bias Against Women: Men Receive Prophylaxis 
More Often to Prevent Deep Venous Thrombosis 
1001-13·3A
Gender Differences in Initial Diagnosis of Coronary 
Heart Disease 1135-70·413A
Gender Differences in the Identification of Patients With 
Coronary Artery Disease by Brachial Artery 
Ultrasound 1105-168·490A
Gender Differences in the Incidence of Coronary Artery 
Disease in Patients With Stable Angina and Positive 
or Negative Stress Test in Daily Clinical Practice in 
the Year 2002: Results of the ALKK Quality Control 
Registry 1119-96·293A
Healthcare Costs for Cardiovascular Disease in Women 
With and Without Obstructive Coronary Disease: 
Results From the National Institutes of 
Health-National Heart, Lung, and Blood 
Institutes-Sponsored Women's Ischemia Syndrome 
Evaluation (WISE) 1172-76·422A
High Levels of Leisure Time Physical Activity Reduce 
Subclinical Atherosclerosis in Asymptomatic Women 
1059-25·16A
Impact of Gender on Long-Term Mortality in 4,234 
Women and 6,898 Men Evaluated With Exercise and 
Dobutamine Stress Echocardiography 1001-29·7A
Impact of Gender on Outcome Following Percutaneous 
Coronary Intervention 1135-69·413A
Impaired Reverse Cholesterol Transport in Asian Indian 
Males Compared With Females Assessed by Nuclear 
Magnetic Resonance Spectroscopy 1047-183·463A
Improved Electrocardiographic Detection of Left 
Ventricular Hypertrophy in Women: Validation by 
Cardiovascular Magnetic Resonance 1015-215·107A
Influence of Gender on In-Hospital and Long-Term 
Clinical Outcomes Following Percutaneous or 
Surgical Revascularization: A Report From the 
Arterial Revascularization Therapies Study (ARTS) 
1081-55·60A
Inherent Sex Differences in the Ischemia-Induced 
Myocardial Inflammatory Response of Proestrus 
Females and Normal Males  801-5·267A
Looking Proximally to Understand Distal Outcomes: 
Gender Differences in Mortality After Acute 
Myocardial Infarction  889-5·425A
Management and Outcome of Elderly Women and Men 
With Acute Coronary Syndromes: A Prospective 
Observational Community-Based Study in 2000 and 
2002 1070-132·183A
Multiexpert Blinded Interpretation of 
Electrocardiogram-Gated SPECT Imaging in Women: 
Relative Performance of Thallium-201 and 
Technetium-99m Sestamibi 1056-144·323A
Predictors of Survival After Primary Percutaneous 
Coronary Intervention: The Impact of Myocardial 
Perfusion Grade in Female Patients  801-2 ·266A
Reduced Functional Capacity in Women Is Associated 
With Impaired Vascular Function 1119-94·292A
Sex Differences in Invasive Cardiac Procedures in the 
Elderly: 1993-1999 1135-68·412A
Sex Disparities in the Treatment of Non–ST-Segment 
Elevation Acute Coronary Syndromes  869-4·304A
The Duke Treadmill Score and Cardiac Mortality in 
Asymptomatic Women: The St James Women Take 
Heart Project  876-1·238A
Time Trends in the Treatment of Women and Men With 
Acute Myocardial Infarction in the United States 
1135-67·412A
Treatment Bias Against Women With Acute Coronary 
Syndrome: Fact or Fantasy? 1097-96·276A
Women Remain at Higher Risk for Retroperitoneal 
Hematoma After Percutaneous Coronary Intervention 
in the Era of Glycoprotein IIb/IIIa Inhibitors and 
Vascular Closure Devices  818-6·63A
Gene expression
Angiogenic Profiling of the Ischemic Human Heart In 
Vivo 1104-190·489A
Beta-Adrenergic Receptor Kinase Is Overexpressed in 
Patients With Chronic Mitral Regurgitation 
1067-136·431A
Calmodulin Kinase Inhibition Improves Cardiac 
Function After Myocardial Infarction 1041-92·255A
Chronic Beta3-Adrenergic Receptor Blockade Causes 
Regression of Cardiac Dysfunction in a Rat Model of 
Progressive Heart Failure  870-1·235A
Chronic Therapy With Eplerenone Reduces 
Tubulin-Alpha and -Beta mRNA Expression and 
Increases Titin mRNA Expression in Dogs With Heart 
Failure 1116-13·22A
CUG Expansions in a Myotonic Dystrophy Mouse 
Model Cause Cardiac Conduction Abnormalities and 
Pathologic Electrophysiology Findings  807-4·122A
Cyclic Stretch of Adult Human Mesenchymal Stem 
Cells Induces Expression of Early Cardiac and 
Neuronal Genes 1068-125·177A
Downregulation of Connexin 43 Expression in Chronic 
Cardiac Allograft Rejection 1051-134·176A
Elevated Gene Expression of Asymmetric 
Dimethylarginine-Generating Enzymes in 
Atherosclerosis 1140-171·508A
Enhanced Cardiac Beta3-Adrenergic Functional 
Response in Alcoholic Monkeys 1029-181·456A
Genetic Heterogeneity of the Nitric Oxide Synthase 3 
Locus and Heart Failure Outcomes: Comparison of 
the T786C Promoter, Intron 4b/a and the Asp298Glu 
Polymorphisms 1031-103·162A
Genomic Profiles of Left Ventricular and Right 
Ventricular Hypertrophy in Congenital Heart Disease 
1114-198·386A
How Does Myocardial Inducible Nitric Oxide Synthase 
Gene Expression Relate to Heart Failure Severity 
and to Subsequent Left Ventricular Reverse 
Remodeling in Patients With Chronic Heart Failure? 
1011-105·155A
Molecular Pathways of Cardiac Allograft Dysfunction 
Independent of Acute Cellular Rejection 
1051-127·175A
Profiling Inflammation in the Ischemic Human Heart In 
Vivo  826-5·283A
Regulation of Intercellular Adhesion Molecule-1 
Transcription in Ischemic-Reperfused Myocardium 
Through STAT3 Activation 1116-3·20A
Time-Dependent Upregulation of Extracellular Matrix 
Proteins in Chronic Hibernating Myocardium: Lack of 
Progressive Degeneration 1136-84·294A
Urotensin II Modulates Collagen Synthesis and the 
Expression of Matrix Metallproteinase-1 and Nitric 
Oxide Synthase in Endothelial Cells 1122-168·498A
Use of Quantitative Reverse Transcriptase-Polymerase 
Chain Reaction for Validation of Macrophage 
Inflammatory Protein-1β and Vascular 
Endothelium-Cadherin as Important Markers of Acute 
Rejection After Heart Transplantation 1051-129·175A
Versican Promoter Is a Target for the β-Catenin/Tcf-4 
Signaling Pathway in Vascular Smooth Muscle Cells  
867-6·527A
Gene-based therapy
A Phase I Study of Intramuscular Administration of 
Plasmid, Developmentally Regulated Endothelial Cell 
Locus-1 Gene, in Humans With Peripheral Arterial 
Disease 1066-191·470A
A Therapeutic Adenoviral-Eluting Stent Suppresses 
Neointimal Formation via Induction of Apoptosis 
1102-52·69A
Additional Gene Modifiers Reduce Effectiveness of 
β-Blockers in the Long QT Type 1 Syndrome  
807-3·122A
Effect of Enzyme Replacement Therapy on Intima 
Media Thickness and Endothelial Function in Fabry 
Disease 1066-192·470A
Gene Transfer of an ApoA-I Mimetic Peptide Reduces 
Atherosclerosis in Mice 1064-182·465A
Hypoxia Regulatable Aav-2 Vector Protects Against 
Cardiac Ischemia/Reperfusion Injury  406-1·533A
Indirect Imaging of Vasculat Endothelial Growth Factor 
Gene Expression Using a Positron Emission 
Tomography Reporter Gene  805-1·472A
Influence of Microsomal Triglyceride Transfer Protein - 
493G/T Polymorphism on Cardiovascular Events 
After Myocardial Infarction in Diabetic Patients 
1137-102·299A
Localized Combinatorial Interleukin-4 and 
Interleukin-10 Gene Therapy Readjusts the Balance 
of Endogenous Th1/Th2 Cytokines and Induces the 
Tolerance of Cardiac Allografs 1051-133·176A
Protecting Ischemic Hearts With a Hypoxia-Sensitive 
Heme Oxygenase-1 Plasmid System  406-3·533A
Short Interfering RNA Specifically Directed Against 
Protease 2A Lead to Significant Reduction of 
Coxsackievirus B3 Titers and Attenuation of Viral 
Cytopathogenicity  806-5·185A
The G1675A Gene Polymorphism of the Angiotensin II 
Type 2-Receptor Gene Influences Cardiac Structural 
Response to Antihypertensive Therapy 
1142-178·511A
Vascular Endothelial Growth Factor (VEGF) Plays a 
Central Role in the Development of Diabetic 
Cardiomyopathy and Gene Transfer of VEGF 
Improves Heart Failure in Long-Standing 
Streptozotocin-Induced Diabetic Rat  404-5·533A
Genetic techniques
Asymmetric Dimethylarginine Impairs Angiogenesis 
and Limb Perfusion in a Murine Model of Hindlimb 
Ischemia  805-5·473A
Manganese Superoxide Dismutase Alanine/Valine 
Polymorphism Is Associated With Coronary Artery 
Disease 1128-121·212A
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Genetics
1166 A/C Polymorphism of the Angiotensin AT1 
Receptor Gene Alters Simvastatin-Induced Change 
in the Endothelial Function  865-2·525A
Additive Gene-Gene Interaction Between CYP7A1 and 
Apolipoprotein E as Genetic Determinants of 
Low-Density Lipoprotein Cholesterol-Lowering 
Response to Atorvastatin 1124-197·505A
AMP Kinase Disease in Hypertrophic Cardiomyopathy: 
Evidence for a Multisystem Storage Disorder 
1032-128·166A
Aspirin Resistance Is Associated With a Single 
Nucleotide Polymorphism in the P2Y1 ADP Receptor 
Gene  847-3·515A
Association of Coronary Heart Disease With 
Interleukin-1 Gene Variants in the Atherosclerosis 
Risk in Communities Study 1028-166·453A
Blood Pressure Response to Strength Training Is 
Influenced by AGT (-20) Genotype in the Elderly 
1161-171·521A
C825T Polymorphism of the G-Protein Beta(3) Subunit 
Gene and Atrial Fibrillation: Association of the TT 
Genotype With a Reduced Risk for Atrial Fibrillation 
1059-14·13A
Clinical Significance of Lamin A/C Mutations in Dilated 
Cardiomyopathy 1164-131·231A
Clopidogrel Is an Inducer and a Potent Reversible 
Inhibitor of Cytochrome P450 3A4 In Vitro 
1106-181·493A
Comprehensive Mutational Analysis of Myosin Binding 
Protein C in 389 Unrelated Patients With 
Hypertrophic Cardiomyopathy 1032-122·165A
Contribution of Apolipoprotein A5 Gene Variants to Left 
Ventricle Hypertrophy in Hypertensive 
African-American Men 1142-184·513A
Contribution of Genetic Characteristics of Vascular 
Adrenergic Receptor to Variant Angina 1136-91·296A
ECG Characteristics in Andersen Syndrome Patients 
With KCNJ2 Mutations  850-3·143A
Effect of Apolipoprotein E, Gender, and Exercise on 
Lipase Activities 1116-30·26A
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Cardiology-National Cardiovascular Data Registry 
1004-51·30A
Effects of Wine, Beer, and Whisky on Vascular 
Endothelium and Thrombosis Fibrinolysis System 
1158-56·95A
Lower Doses of Hormone Replacement Therapy Did 
Not Increase hsC-Reactive Protein or F1+2 Levels 
but Improved Flow-Mediated Dilation in 
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Cardiomyocytes Protecting These Cells From 
Apoptosis 1106-188·494A
Hormone Replacement Therapy and Cardiac Disease: 
A Challenge to Change Practice Patterns 
1135-71·413A
Lower Doses of Hormone Replacement Therapy Did 
Not Increase hsC-Reactive Protein or F1+2 Levels 
but Improved Flow-Mediated Dilation in 
Postmenopausal Women: A Randomized, 
Double-Blind, Crossover Study 1001-11·3A
N-Terminal Pro-Brain Natriuretic Peptide Can Identify 
High and Low Risk Patients With Hypertension and 
Preserved Left Ventricular Systolic Function in the 
General Population 1161-178·523A
Prognostic Significance of B-Type Natriuretic Peptide in 
the Hemodialysis Patient  810-3·474A
Reduced Bone Mass in Men With Advanced Chronic 
Heart Failure Is Accompanied by 
Hyperparathyroidism, Andropenia, and Inflammation, 
and Predicts Poor Outcome 1108-117·198A
Testosterone Inhibits the _1C Subunit of L-Type Ca2+ 
Channels (Cav1.2) and _1H T-type Ca2+ Channels 
(Cav3.2) Stably Expressed in Human Embryonic 
Kidney 293 Cells 1106-186·494A
Testosterone Replacement Confers a Favourable 
Cytokine Profile in Men With Low Serum 
Testosterone and Coronary Disease 1001-10·3A
The Effect of Physical Exercise on Circulating 
Chromogranin A Levels in Patients With Congestive 
Heart Failure 1108-126·201A
The Estrogen-Induced Alterations in Arterial Stiffness 
are Independent of the Non-Dipping Status but 
Attenuated by Progesterone in Hypertensive 
Postmenopausal Women 1160-168·520A
Hyperlipoproteinemia
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Lipoxygenase-1 1122-175·500A
Pexelizumab, a C5 Complement Inhibitor, Reduces 
30-Day Mortality in Patients Undergoing Coronary 
Artery Bypass Surgery or Receiving Reperfusion 
Therapy for Acute Myocardial Infarction  810-4·474A
Presence of Mature Dendritic Cells to Early 
Postangioplasty Neointima: Markers of Antigen 
Presentation and Anti-Apoptosis 1158-55·95A
Splenectomy and Adoptive Transfer of Splenocytes 
Reveal a Critical Role for Spleen in Mediating 
Athero-Protective Effects of Immunization With 
Apolipoprotein B-100-Related Peptide Sequence in 
Apo E (-/-) Mice 1064-180·465A
Tissue Engineered Heart Valve Conduits of Porcine or 
Human Origin Differ Importantly in Chemotactic 
Activity for Monocytic Cells 1086-136·432A
Immunologic factors
Cardiac Dysfunction in Non-ST Elevation ACS Is Partly 
Reversible: Analysis of Serial Measurements of 
NT-Pro B-Type Natriutetic Peptide  884-2·306A
Chlamydia Pneumoniae-Heat Shock Protein 60 
Induces a Highly Specific Persistent Immune 
Response in Patients With Unstable Angina 
Independently From IgG and IgA Seropositivity 
1103-197·489A
Circulating T Cell Perturbation and Macrophage 
Activation in Stable Coronary Artery Disease 
Patients: Effect of Atorvastatin Therapy 
1159-183·517A
Clinical and Prognostic Role of IgG3 Autoantibodies in 
Patients With Heart Failure: A Substudy of the 
Vasogen's Immunmodalatory Therapy 
1163-110·226A
Clonal T-Cell-Receptor Composition Is Not Associated 
With Enteroviral or Adenoviral Infection in Dilated 
Cardiomyopathy: Implications for the Pathogenesis of 
Dilated Cardiomyopathy  834-2·204A
Detection and Propagation of Calcified Nanostructures 
From Human Aneurysms 1059-13·13A
Development of Murine Fibrotic Cardiomyopathy Is 
Dependent on Monocyte Chemoattractant Protein 1 
1164-125·230A
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Effects of Growth Hormone on Circulating Cytokine 
Dysbalance and Left Ventricular Geometry in Patients 
With Idiopathic Dilated Cardiomyopathy  810-2·473A
Elevated Fibrinogen Level and Risk of Future Incidence 
of Diabetes Mellitus: Bezafibrate Infarction Prevention 
(BIP) Study 1082-187·478A
Multiple Complex Plaques in Unstable Saphenous Vein 
Grafts 1060-81·261A
Pathological Features Found Postmortem in 53 Patients 
With Cardiac Rupture Complicating Acute Myocardial 
Infarction 1118-83·291A
Platelet P-Selectin and Plasma Levels of Circulating 
Cytokines in Young Patients With Mild Arterial 
Hypertension 1059-9·12A
Preprocedural Plasma Levels of C-Reactive Protein 
and Interleukin-6 Do Not Predict Late Coronary 
Angiographic Restenosis After Elective Stenting 
1121-48·77A
Soluble CD40 Ligand in Pulmonary Arterial 
Hypertension: Possible Pathogenic Role of 
Interaction Between Platelets and Endothelial Cells 
1123-187·503A
Testosterone Replacement Confers a Favourable 
Cytokine Profile in Men With Low Serum 
Testosterone and Coronary Disease 1001-10·3A
Urinary Tract Infection in Patients With Acute Coronary 
Syndrome: A Potential Systemic Inflammatory 
Connection 1001-3·1A
Immunologic techniques
Transforming Growth Factor Beta and Factor XIIIa Are 
Constituents of the Carcinoid Heart Endocardial 
Layer: A Study by Confocal Laser Microscopy 
1087-107·188A
Implants, artificial
Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO™) to Prevent Stroke in Patients 
With Atrial Fibrillation: Interim Results of the 
Multicenter Feasibility Trial 1005-65·33A
Relative Incidence of Thrombus Formation on the 
CardioSEAL and Amplatzer Interatrial Closure 
Devices 1076-201·382A
Safe Scanning, but Frequent Artifacts Mimicking 
Tachycardia During Magnetic Resonance Imaging in 
Patients With Insertable Loop Recorders 
1148-225·142A
The Incidence of Cerebral Embolism After 
Percutaneous Occlusion of the Left Atrial Appendage: 
A Serial and Prospective Study Using Cerebral 
Magnetic Resonance Imaging Scanning  875-4·151A
Infarct size
Acute Myocardial Infarction Size Determines 
N-Terminal Pro-Brain Natriuretic Peptide Release as 
Measured by Contrast Enhanced Magnetic 
Resonance Imaging 1041-96·256A
Carbon Monoxide Protects Against Cardiac 
Ischemia-Reperfusion Injury In Vivo Through 
Mitogen-Activated Protein Kinanse Pathway and 
Akt-Endothelial Nitric Oxide Synthase Pathway  
883-6·306A
Diabetic Patients With Acute Myocardial Infarction Have 
Larger Infarct Size, Lower Ejection Fraction, and 
Higher Mortality  827-5·284A
Distal Protection Device (PercuSurge) Can Reduce 
Infarct Size in Patients With Acute Myocardial 
Infarction Who Have Ruptured Culprit Plaque 
1026-62·41A
Echocardiograpic Characteristics of Unrecognized 
Myocardial Infarctions in a Population Based Study 
1059-35·18A
Glucose-Insulin-Potassium Infusion Improves 
Myocardial Salvage in Diabetic Patients With Acute 
Myocardial Infarction Treated With Reperfusion 
Therapy 1022-85·252A
Human Umbilical Cord Mononuclear Cells Limit Acute 
Myocardial Infarction Size 1078-92·269A
Hyperglycaemia Reduces Myocardial Reperfusion 
During Primary Percutaneous Coronary Intervention 
for ST-Elevation Myocardial Infarction 1154-86·299A
Myocardial Ischemia-Reperfusion Injury Is Dependent 
on Lectin Complement Activation  883-4·305A
Postconditioning by Repetitive I/R Cycles Subsequent 
to Myocardial Ischemia Protects the Rat Heart From 
Infarction and Is Dependent on the Activation of PI 
3-Kinase and mTOR 1136-80·294A
Preprocedural Statin Medication Reduces Small and 
Large Periprocedural Myocardial Injury in Patients 
With Stent Implantation 1025-45·38A
Preprocedural Statin Medication Reduces the Risk for 
PeriProcedural Myocardial Infarctions in Patients With 
Stent Implantation Independent of the Cholesterol 
Level 1063-59·51A
Pyrroloquinoline Quinone Decreases Myocardial Infarct 
Size and Improves Cardiac Function in Rat Models of 
Ischemia and Ischemia-Reperfusion 1002-101·245A
Randomized Comparison of Prehospital Combination 
Fibrinolysis Versus Prehospital-Initiated Facilitated 
Percutaneous Coronary Intervention in Acute 
Myocardial Infarction 1061-91·264A
Real-Time Three-Dimensional Echocardiographic 
Assessment of Endocardial Surface Can Quantitate 
the Size of Myocardial Infarction  837-3·355A
Remote Preconditioning by Infrarenal Occlusion of the 
Aorta Protects the Rat Heart From Infarction by a 
Molecular Mechanism Involving Free Radicals and a 
p38 Mitogen Activated Protein Kinase Activation 
1136-87·295A
Reperfusion Time-Dependent Myocardial Salvage in 
Patients With Acute Myocardial Infarction Who 
Undergo Emergent Percutaneous Coronary 
Intervention With Distal Protection Device 
PercuSurge 1003-87·246A
Sildenafil Citrate (Viagra) Induces Powerful 
Cardioprotective Effects Following 
Ischemia-Reperfusion Injury in Infant Rabbits 
1041-95·256A
ST-Segment Resolution, Time From Symptom Onset to 
Reperfusion, Thrombolysis in Myocardial Infarction 
Flow Grades, and Creatine Kinanse-Release: 
Association With Infarct Size as Assessed by Delayed 
Enhancement Magnetic Resonance Imaging  
836-6·354A
Successful Embolization Protection Using GuardWire 
System for Acute Myocardial Infarction: Multicenter 
Registry in Japan 1003-90·247A
The Protective Effect of Edaravone on Myocardial 
Damage During Ischemia-Reperfusion in Rabbit 
Heart 1078-97·270A
The Role of Collateral Circulation in the Acute Phase of 
ST-Segment Elevation Myocardial Infarction Treated 
With Primary Coronary Intervention 1078-96·270A
Inotropic agents
Dobutamine Versus Levosimendan Stress 
Echocardiography for the Prediction of Recovery of 
Left Ventricular Dyssynergies After Revascularization  
802-2·331A
Effects of Inotropic Stimulation on Left Ventricular 
Torsional Deformation in Tachycardia-Induced Dilated 
Cardiomyopathy 1144-127·218A
Pletal in Lieu of Home Parenteral Inotropes 
1088-124·191A
Insulin
Acute Administration of Asymmetric Dimethylarginine 
Reduces Insulin Sensitivity in Mice  867-4·527A
Anthropomorphic Predictors of Insulin Sensitivity in a 
Healthy Population 1124-195·504A
Association of Triglyceride to High-Density Lipoprotein 
Cholesterol Ratio With Heart Rate Recovery in 
Healthy Adults 1146-108·223A
Carvedilol Improves Myocardial Perfusion in Conscious 
Dogs With Pacing Induced Dilated Cardiomyopathy 
1012-124·158A
Decreased Serum Ghrelin and Insulin-Like Growth 
Factor-I Levels Associated With Insulin Resistance in 
Patients With Acute Heart Failure: Analysis by 
Steady-State Plasma Glucose Method 
1160-197·521A
Hyperinsulinemia Is Associated With Coronary 
Endothelial Dysfunction in Obese and Nondiabetic 
Patients 1157-50·94A
Impact of Diabetes on 12-Month Outcomes Following 
Coronary Artery Bypass Graft Surgery: Results From 
the Routine Versus Selective Exercise Treadmill 
Testing After Coronary Artery Bypass Grafting 
(ROSETTA-CABG) Registry  809-4·268A
Independent Relationship Between C-Reactive Protein 
and Markers of Insulin Resistance in Overweight and 
Obese Children 1103-193·488A
Insulin Enhances Vascular Cell Adhesion Molecule -1 
Expression in Human Cultured Endothelial Cells: A 
Link to the Pathogenesis of Accelerated 
Atherosclerosis in Diabetes 1106-182·493A
Insulin Sensitizers Are Associated With Improved 
Outcomes in Diabetic Patients Undergoing 
Brachytherapy 1025-41·37A
Long-Term Use of Pioglitazone Slows Arteriosclerotic 
Progression in Type 2 Diabetics 1159-187·518A
Six Months of Weight Loss Improves Metabolic and 
Vascular Indices in Overweight Adults  865-5·525A
The Effect of Losartan Versus Atenolol on Circulating 
Adhesion Molecules in Essential Hypertension: A 
LIFE Substudy 1007-180·445A
Vascular Endothelin-1 Activity Correlates With 
Low-Density Lipoprotein Cholesterol Levels, but Not 
With Insulin Sensitivity in Hypercholesterolemic 
Patients 1105-169·490A
Whole Body, Myocardial, and Coronary Vascular Insulin 
Resistance in Conscious Dogs With Pacing Induced 
Dilated Cardiomyopathy 1164-127·230A
Intravascular ultrasound/Doppler
An Intravascular Ultrasound Analysis From FUTURE I, 
the First Human Experience Using 
Everolimus-Eluting Stents: Six- and 12-Month 
Results 1139-60·85A
Can Intravascular Ultrasound Guided Cutting Balloon 
Angioplasty Before Stenting Be a Substitute for Drug 
Eluting Stent? Final Results of the Prospective 
Randomized Multicenter Trial Comparing Cutting 
Balloon With Balloon Angioplasty Before Stenting 
(Reduce III) 1138-66·82A
Characterization of Neointimal Hyperplasia After 
Sirolimus-Eluting Stent Implantation in Patients With 
Previous Brachytherapy Failure: Insights From the 
SECURE Study 1121-61·80A
Clinical, Angiographic, and Intravascular Ultrasound 
Comparisons Between Patients With Early Versus 
Late Saphenous Vein Graft Failure 1155-77·88A
Compensatory Enlargement Delay Vascular Healing of 
the Culprit Lesion Following Acute Myocardial 
Infarction 1082-180·476A
Contribution of Stent Underexpansion to Target Lesion 
Revascularization After Sirolimus-Eluting Stenting for 
In-Stent Restenosis 1101-45·66A
Coronary Flow Velocity Pattern Immediately After 
Percutaneous Coronary Intervention as a Predictor of 
Complications After Acute Myocardial Infarction in 
Patients Achieving Thromblysis in Myocardial 
Infarction Grade 3 Flow 1157-43·92A
Coronary Flow Velocity Pattern Immediately After 
Percutaneous Coronary Intervention in Patients With 
Acute Myocardial Infarction Can Predict Myocardial 
Viability Assessed by Thallium Scintigraphy at Six 
Months 1157-47·93A
Coronary Lumen Change Is Determined Primarily by 
Adventitial Remodeling Rather Than Plaque Change 
During Therapy  831-2·496A
Coronary Plaque Regression by Simvastatin Is 
Associated With Reduction in Vessel Volume: A 
Three-Dimensional Intravascular Ultrasound Study 
1059-8·12A
Correlation Between Angiotensin II Receptor Subtype 1 
and Vitronectin Receptor in Cardiac Transplantation 
1089-109·193A
Creatine Kinase-MB Elevation After Coronary Stenting 
in Lesions With Ruptured Plaque  808-2·54A
Cytomegalovirus Infectious Burden Is Proportional to 
Cardiac Allograft Vasculopathy in Heart Transplant 
Recipients  813-1·185A
Diabetes Mellitus Might Be Associated With Multiple 
Vulnerable Plaque in 113 Patients With Stable 
Angina: A Prospective Study of Three-Vessel 
Intravascular Ultrasound  832-6·74A
Dose Threshold for Clinical Success in Coronary 
Brachytherapy: A Nested Case-Control Study  
808-1·54A
Effect of Everolimus-Eluting Stents in Preventing 
Neointimal Hyperplasia: An Intravascular Ultrasound 
Analysis From the FUTURE II Trial 1101-44·66A
Effects of Avasimibe on Coronary Atherosclerosis 
Assessed by Intravascular Ultrasound  882-2·529A
Effects of Functional Coronary Collateral Flow on the 
Incidence of Right Ventricular Infarction After Primary 
Angioplasty in Patients With Acute Inferior Myocardial 
Infarction 1026-60·40A
Effects of Prolonged Oral Simvastatin Treatment After 
Coronary Stenting on Neointimal Growth and Plaque 
Progression as Assessed by Intravascular 
Ultrasound: A Randomized Study  864-5·99A
Elevated High-Sensitivity C-Reactive Protein Was 
Associated With Coronary Artery Remodeling in 
Patients With Unstable Angina 1026-59·40A
Evaluation of Left Anterior Descending Coronary Artery 
by High-Frequency Transthoracic Echocardiography: 
Comparison With Simultaneous Intravascular 
Ultrasound Measurements  866-1·372A
Exaggeration of Neointimal Hyperplasia Following Stent 
Deployment in Type B Bifurcation Lesions  808-4·55A
Findings of Intravascular Ultrasound During Acute Stent 
Thrombosis  808-5·55A
First Human Experience With the ABT-578 Eluting 
Phosphorylcholine Polymer Stent: A Serial Volumetric 
Intravascular Ultrasound Analysis From the PREFER 
Trial 1101-46·67A
Fractional Flow Reserve Versus Intravascular 
Ultrasound for Decision-Making in Equivocal Left 
Main Coronary Stenosis 1157-42·92A
Hyperinsulinemia Is Associated With Coronary 
Endothelial Dysfunction in Obese and Nondiabetic 
Patients 1157-50·94A
Impact of Coronary Artery Bending at Stent Edges on 
Subsequent Plaque Proliferation: A Serial Volumetric 
Itravascular Ultrasound Analysis 1139-57·85A
Impact of NAD(P)H Oxidase-Derived Reactive Oxygen 
Species on Plaque Formation and Vascular 
Remodeling: Comparison of Histochemical 
Characteristics and Intravascular Ultrasound Finding 
of Atherosclerotic Lesions 1082-177·476A
Impact of Periprocedural Plaque/Thrombus Reduction 
on Myocardial Injury After Stent Deployment  
808-3·55A
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Impact of Stent Implantation Techniques on Stent Edge 
Neointimal Hyperplasia Following Sirolimus-Eluting 
Stenting 1139-56·84A
In Vitro Detection and Quantification of High Intensity 
Transient Signals by Using Intracoronary Doppler 
Ultrasound: A New Approach to Detect Coronary 
Microembolization 1026-55·39A
In Vivo Macrophage Imaging of Acute Coronary 
Syndromes With Intracoronary Optical Coherence 
Tomography 1006-55·33A
Incidence and Characteristics of Ruptured Plaque in 
Human Femoro-Popliteal Arteries 1066-198·472A
Incidence of Vulnerable Plaques in Humans: 
Assessment With 3-D Intravascular Palpography  
884-6·307A
Independent Predictors of Multiple Vulnerable Plaque in 
143 Patients With Acute Coronary Syndrome: A 
Prospective Study of Three-Vessel Intravascular 
Ultrasound  832-3·73A
Influence of Vessel Wall Calcium on Neointimal Growth 
Following Bare Metal and Sirolimus-Eluting Stent 
Implantation: A 3-D Intravascular Ultrasound 
Substudy of the SIRIUS Trial 1044-54·45A
Intimal Hyperplasia Thickness Is Independent of Stent 
Size in Paclitaxel-Coated Stents: A Serial 
Intravascular Ultrasound Analysis From the Asian 
Paclitaxel-Eluting Stent Clinical Trial 1101-66·68A
Intracardiac Echocardiography Aids Decision-Making 
During Percutaneous Device Closure of Patent 
Foramen Ovales and Atrial Septal Defects in Adults: 
Lessons From 223 Procedures in the Cardiac 
Interventional Laboratory 1150-149·358A
Intravascular Ultrasound Analysis of the New ABT-578 
Eluting Phosphorylcholine-Coated Stent Implantation 
to De Novo Human Coronary Lesions: The 
ENDEAVOR I Trial 1139-59·85A
Intravascular Ultrasound Assessment of Lesions With 
Sirolimus-Eluting Stent Failure 1101-41·65A
Intravascular Ultrasound Follow-Up of the SECURE 
Trial: The Compassionate Use of Sirolimus-Elutings 
Stents Study  822-4·70A
Is Sirolimus-Eluting Stent Better Than Brachytherapy to 
Treat In-Stent Restenosis at Longer (12-Month) 
Follow-Up? Angiographic and Intravascular 
Ultrasound Analysis  822-2·70A
Is There a Relationship Between Stent/Lesion Length 
Ratio and Edge Effect in the Drug-Eluting Stent Era? 
An Intravascular Ultrasound Analysis 1044-52·45A
Late Four-Year Follow-Up From the First-in-Man 
Experience After Implantation of Sirolimus-Eluting 
Stents  862-5·98A
Lesion Severity Index, a New Nonhyperemic 
Physiologic Parameter for the Assessment of 
Coronary Artery Stenosis: A Comparison to 
Fractional Flow Reserve 1157-41·92A
Long-Term Efficacy of Intracoronary Beta-Radiation for 
the Treatment of In-Stent Restenosis: An 
Angiographic and Intravascular Ultrasound Analysis 
of the Late Catch-Up Phenomenon 1102-51·69A
Morphological Characteristics of De Novo Coronary 
Lesions Presenting With Plaque Rupture: An 
Intravascular Ultrasound Study  832-1·73A
Morphological Features of Marshall Ligament Tissue 
and Interatrial Septum in Patients With Repeated 
Pulmonary Vein Isolation: An Intracardiac 
Echocardiographic Imaging Study 1052-225·115A
Multiple Plaque Ruptures Are Not Frequent in Acute 
Coronary Syndrome: A Three-Vessel Intravascular 
Ultrasound Study  832-5·74A
Optimal Geometry Is Still Important With 
Sirolimus-Eluting Stents: Incomplete Stent Expansion 
as a Risk for Target Lesion Revascularization 
1139-55·84A
Patterns of Lesion Calcification in Infarct-Related 
Arteries: An Intravascular Ultrasound Analysis of 250 
Patients With Acute Myocardial Infarction 
1026-56·40A
Physiologic and Anatomical Evaluation Prior to and 
After Stent Implantation in Small Coronary Vessels: 
Final Results of PHANTOM Trial 1157-49·94A
Predictors of Edge Stenosis Following Sirolimus-Eluting 
Stent Deployment: A Quantitative Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
1101-65·67A
Relationship of Ultrasound Plaque Characteristics to 
Thrombolysis in Myocardial Infarction Myocardial 
Perfusion Grade Following Intracoronary Stenting 
1120-41·74A
Similar Outcomes Between Patients With Native 
Coronary and Bypass Graft Disease Treated With 
Sirolimus-Eluting Stents in the SECURE Trial 
1116-7·21A
Stenting Under Intravascular Ultrasound Guidance of 
Coronary Bifurcation Lesions With a New Device 
Allowing Provisional Side Branch Treatment  
878-6·103A
TAXUS IV: Results From the Intravascular Ultrasound 
Substudy 1101-42·66A
The Presence of Chlamydia Pneumoniae Contributes 
to Atherosclerotic Plaque Vulnerability 
1082-183·477A
The Relation Between the Statin’s Effects on Coronary 
Plaque Composition and Plasma Low-Density 
Lipoprotein Cholesterol Level Evaluated by 
Intravascular Ultrasound Radiofrequency Signal 
Analysis 1006-58·34A
The Reliability of Plaque Map Established by 
Multidetector Row Computed Tomography in Patients 
of Acute Coronary Syndrome 1018-145·313A
Transthoracic Echocardiographic Assessment of 
Thickness of Intima-Media Complex and Calcified 
Lesions of the Left Anterior Descending Coronary 
Artery 1073-141·325A
Virtual Histology of Intravascular Ultrasound Images: 
Feasibility and Clinical Correlations in Humans 
1006-56·33A
Investigational devices
Aqueous Oxygen Therapy for ST Segment Elevation 
Myocardial Infarction: AMIHOT Trial Safety Report 
and Enrollment Completion  869-3·304A
Comparative Efficacy of Everolimus and Sirolimus 
Delivered via Polymeric Drug-Eluting Stents in the 
Porcine Coronary Model 1139-48·83A
Effect of High Intensity Focused Ultrasound on Cardiac 
Valves 1168-161·364A
Feasibility of Focal Septal Myocardial Ablation Through 
the Right Ventricle Using High-Intensity Focused 
Ultrasound 1054-146·320A
Forward Looking Optical Coherence Tomography: A 
Potential Tool to Visualize the Total Chronic Occlusion 
1006-62·35A
High Frequency Ultrasound Thrombolysis: In Vitro 
Effects of Ultrasound Mode, Duration, Temperature, 
and Frequency 1168-163·365A
Impact of Percutaneous Left Atrial Appendage 
Transcatheter Occlusion Device on Left Atrial 
Structure and Function: Six-Month 
Echocardiographic Follow-Up 1131-145·348A
Incidence of Vulnerable Plaques in Humans: 
Assessment With 3-D Intravascular Palpography  
884-6·307A
Late Quantitative Angiographic Results Following 
Treatment With a Polymer-Based Paclitaxel-Eluting 
Stent Compared With a Bare Metal Stent in Patients 
With De Novo Coronary Disease: The TAXUS-IV 
Angiographic Results  843-3·87A
Lesion Severity Index, a New Nonhyperemic 
Physiologic Parameter for the Assessment of 
Coronary Artery Stenosis: A Comparison to 
Fractional Flow Reserve 1157-41·92A
Murine Cardiac Failure Model Produced by 
High-Intensity Focused Ultrasound 1054-145·320A
Porcine Model of Atherothrombotic Chronic Total 
Occlusion 1080-41·56A
Remote Catheter Ablation Using the New Magnetic 
Navigation System Niobe  860-4·149A
Targeted Ablation of Myocardium Using High Intensity 
Focused Ultrasound in Beating Dog Hearts 
1168-162·364A
The First Use of Medical Simulation for the Training of a 
New Device Roll-Out  853-4·423A
Time-Course of Healing Responses After Intracoronary 
Photodynamic Therapy in Porcine Coronary Arteries 
1138-46·81A
Use of Amplatzer Duct Occluder for Complex 
Congenital Cardiac Lesions: Results From the US 
Registry Group 1076-205·383A
Investigational drugs
A Phase I Study of Intramuscular Administration of 
Plasmid, Developmentally Regulated Endothelial Cell 
Locus-1 Gene, in Humans With Peripheral Arterial 
Disease 1066-191·470A
A Randomized Double-Blind Placebo-Controlled Phase 
2 Study on the Efficacy and Safety of Fasudil in 
Patients With Stable Angina 1023-96·254A
Comparative Efficacy of Everolimus and Sirolimus 
Delivered via Polymeric Drug-Eluting Stents in the 
Porcine Coronary Model 1139-48·83A
Direct, Selective, Factor Xa Inhibition in Patients With 
Non-ST Elevation Acute Coronary Syndromes From 
the United States, Canada, and Japan: Results of the 
XaNADU-ACS Trial  861-1·302A
Is the ICHOR Platelet Works Test as Valid as Flow 
Cytometry to Assess the Efficacy of Platelet 
Glycoprotein IIb/IIIa-Receptor Inhibitors in Patients 
Undergoing Percutaneous Coronary Intervention? 
1025-44·38A
Monocyte Chemoattractant Protein-1 Induced 
Monocyte Infiltration and Angiogenesis Does Not 
Result in Arteriogenesis or Improved Cardiac 
Function in Chronically Infarcted Myocardium 
1078-99·271A
Tissue Factor Pathway Inhibition, a New Antithrombotic 
Strategy: Phase-II Study of a Novel, Oral Factor Xa 
Inhibitor 1007-173·443A
Ion channels
Additional Gene Modifiers Reduce Effectiveness of 
β-Blockers in the Long QT Type 1 Syndrome  
807-3·122A
ECG Characteristics in Andersen Syndrome Patients 
With KCNJ2 Mutations  850-3·143A
Extracellular pH Modifies Drug Blockade on the Human 
Ether-A-Go-Go Related Gene (HERG) Channels  
807-5·122A
Frequency, Spectrum, and Phenotype of KCNJ2 
Mutations Among Patients Referred for Long QT 
(LQT)Syndrome Genetic Testing: Is KCNJ2 LQT7?  
811-1·383A
Opening of the Mitochondrial Potassium Adenosine 
Triphosphate Channel Improves Postanoxic Recovery 
of Conduction and Excitation-Contraction Coupling in 
the Developing Heart 1041-90·254A
Prevalence and Spectrum of Mutations in the Cardiac 
Ryanodine Receptor in Patients Referred for Long QT 
Syndrome Genetic Testing 1130-207·136A
Protein Kinase C Epsilon Is Upstream and Protein 
Kinase C Alpha Is Downstream of MitoKATP 
Channels in the Signaling of Ischemic 
Preconditioning in the Human Myocardium 
1136-86·295A
Ranolazine Inhibits Late Sodium Current in Isolated 
Left Ventricular Myocytes of Dogs With Heart Failure 
1068-128·178A
Selective Inhibition of Human Cardiac Kir2.2 Inward 
Rectifier Channels by Adrenergic Alpha-1a Receptors  
807-2·122A
Spectrum and Frequency of Channelopathies in 
Near-Drownings 1116-40A·29A
Testosterone Inhibits the _1C Subunit of L-Type Ca2+ 
Channels (Cav1.2) and _1H T-type Ca2+ Channels 
(Cav3.2) Stably Expressed in Human Embryonic 
Kidney 293 Cells 1106-186·494A
The L-Type Calcium and Sarcolemmal KATP Channels 
May Contribute to Pacing-Induced Cardioprotection 
1035-219·112A
Ion currents
Extracellular pH Modifies Drug Blockade on the Human 
Ether-A-Go-Go Related Gene (HERG) Channels  
807-5·122A
The Role of Slow Delayed Rectifier Potassium Current 
(IKs) in Cardiac Electrophysiology and Atrial 
Fibrillation 1059-18·14A
Ischemia
18F-Fluoro-2-Deoxyglucose as a Memory Marker of 
Transient Myocardial Ischemia  804-1·332A
Adjunctive Treatment With a Stent-Based Ventricle to 
Coronary Artery Bypass (VSTENT™) in Patients 
With Multivessel Disease Undergoing Coronary 
Artery Bypass Surgery (ADVANTAGE) 1079-85·273A
Arterial Retroperfusion by a Percutaneous Stent-Based 
Ventricle to Coronary Vein Bypass (VVPASSTM) 
1081-61·61A
Assessment of Transmyocardial Velocity Distribution 
During High Dose Dobutamine Stress 
Echocardiography Using Myocardial Velocity Profile 
1041-97·256A
Autologous Fibroblast Transplantation Into Myocardial 
Infarcts in Pigs: Effects on Arrhythmogenesis and 
Arrhythmic Threshold 1110-217·129A
Blood Pressure Control, Angina Episodes, and 
Cardiovascular Outcomes in Patients With Ischemia: 
The International Verapamil/Trandolapril Study 
1085-197·483A
Carvedilol Preserves Cellular Integrity and Improves 
Outcome in Patients With Chronic Hibernating 
Myocardium After Revascularization 1137-93·296A
Catheter-Based Transplantation of Autologous Bone 
Marrow Mononuclear Cells Safely Improves 
Collateral and Capillary Network in Adult Swine With 
Myocardial Ischemia 1100-57·64A
Comparative Effect of Trimetazidine Plus Sildenafil 
Versus Nitrates in the Control of Myocardial Ischemia 
During Sexual Activity 1023-94·253A
Comparison Between Successful and Unsuccessful 
Mitral Valve Repair of Ischemic Mitral Regurgitation: 
An Echocardiographic Follow-Up Study 
1086-139·433A
Comparison of Left Ventricular Sphericity and Papillary 
Muscle Tethering in the Mechanism of Ischemic Mitral 
Regurgitation in Patients With Inferior Myocardial 
Infarction  868-3·441A
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Electrocardiography, Exercise Tolerance Testing, 
Echocardiography and Magnetic Resonance Imaging 
in Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia 1127-104·209A
Evaluation of Myocardial Ischemia by Magnetic 
Resonance Myocardial Stress Perfusion in Renal 
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Compensated Severe Mitral Regurgitation 
1067-137·431A
Mechanism of Systolic Anterior Motion and 
Regurgitation Post Septal Ablation in Hypertrophic 
Cardiomyopathy  839-2·215A
Mitral Valve Dynamics With Different Pacing Sites 
1035-216·112A
Natural History of Insignificant Mitral Regurgitation 
Following Aortic Valve Replacement for Degenerative 
Aortic Valve Disease  868-4·441A
Percutaneous Edge-to-Edge Repair for Mitral 
Regurgitation Guided by Transesophageal and 
Transthoracic Echocardiography 1116-25·25A
Prevalence and Correlates of Mitral Regurgitation in 
Hypertensive Patients: The HyperGen Study 
1030-139·429A
Prevalence and Mechanism of Functional Mitral 
Regurgitation in Dilated Cardiomyopathy: Baseline 
Data From the Acorn Trials 1145-116·220A
Prognostic Significance of Mitral Regurgitation 
Identified Using Color Doppler Echocardiography 
Early After Acute Myocardial Infarction  823-5·347A
Proximal Flow Convergence Region as Assessed by 
Real-Time 3-D Echocardiography: Challenging the 
Hemispheric Assumption  837-5·355A
Real-Time Three-Dimensional Color Doppler Flow: 
Feasibility and Initial Quantitative Comparison With 
Two-Dimensional Methods  837-6·356A
Reduction in Functional Mitral Regurgitation Using the 
Coapsys Annuloplasty Device in Patients Undergoing 
Off-Pump Coronary Artery Bypass Grafting: A 
Quantitative Echo Analysis  851-2·438A
Revascularization Alone for Functional Mitral 
Regurgitation: A Propensity Case-Match Analysis of 
the Off Pump Coronary Artery Bypass Approach 
1079-88·274A
Significant Mitral Regurgitation Is Protective Against 
Left Atrial Spontaneous Echo Contrast and 
Thrombogenesis in Atrial Fibrillation: An ACUTE Trial 
Ancillary Study 1131-144·348A
Tissue Doppler Imaging for Estimation of Filling 
Pressures: Validation in Patients With Primary or 
Secondary Mitral Regurgitation  863-3·371A
Valvular Regurgitation Predicts Cardiovascular 
Mortality and Morbidity Among American Indians: 
The Strong Heart Study 1030-138·429A
Mitral valve
Accuracy of Presurgical Assessment of Myxomatous 
Mitral Valve Pathology Using Real-Time 
Three-Dimensional Echocardiography 
1048-140·430A
Calcification of the Fibrous Skeleton of the Base of the 
Heart, Aortic Valve Sclerosis and Prevalent 
Cardiovascular Disease in the Elderly: The 
Cardiovascular Health Study 1128-125·212A
Durability and Outcomes of Mitral Valve Repair for 
Infective Endocarditis 1162-136·439A
Echocardiographic Presence of Mitral Annular 
Calcification Predicts Increased Mortality in Patients 
With Normal Left Ventricular Ejection Fraction 
1030-136·428A
Edge-to-Edge Mitral Repair Seems to Induce 
Functional Restriction 1048-138·430A
Effect of High Intensity Focused Ultrasound on Cardiac 
Valves 1168-161·364A
Impact of Percutaneous Left Atrial Appendage 
Transcatheter Occlusion Device on Left Atrial 
Structure and Function: Six-Month 
Echocardiographic Follow-Up 1131-145·348A
Influence of Surgical Treatment of Atrial Fibrilation on 
Late Morbi-Mortality After Correction of Mitral Valve 
Lesions Associated With Chronic Atrial Fibrillation 
1010-140·428A
Mechanism of Systolic Anterior Motion and 
Regurgitation Post Septal Ablation in Hypertrophic 
Cardiomyopathy  839-2·215A
Reoperative Valve Replacement With the St. Jude 
Medical Valve Prosthesis: Long-Term Follow-Up 
1143-140·438A
The Severity of Mitral Annular Calcification Is 
Associated With Prevalent Cardiovascular Disease in 
the Elderly: The Cardiovascular Health Study  
885-4·240A
Mitral valve stenosis
Balloon Mitral Valvuloplasty Performed in Mobile 
Catheterization Laboratory as Part of Community 
Outreach Program at Primary Care Hospitals 
1096-67·407A
The Role of Real-Time and Freehand 
Three-Dimensional Echocardiography in the 
Evaluation of Rheumatic Mitral Stenosis 
1113-163·345A
Molecular biology
AKT Signaling in Pacing-Induced Heart Failure 
1144-131·219A
An Antiulcer Drug, Geranylgeranylacetone, Suppresses 
Nitric Oxide Synthesis in Cytokine-Stimulated 
Cultured Vascular Smooth Muscle Cells 
1106-184·493A
Anti-ErbB2 Modulation of Bcl-xL/Bcl-xS Causes 
Mitochondrial Dysfunction and Apoptosis 
1029-175·455A
Calmodulin Kinase Activity Links Green Fluorescent 
Protein Overexpression to a Cardiomyopathic 
Phenotype 1144-128·219A
Calmodulin Kinase Inhibition Improves Survival in 
Calcineurin Transgenic Mice 1001-23·6A
Expression of Tob by Human Coronary Arteries and 
BMP-Mediated Stimulation of Coronary Artery 
Endothelial Cell Proliferation 1122-170·499A
Ghrelin Is Synthesized and Secreted by Human 
Cardiomyocytes Protecting These Cells From 
Apoptosis 1106-188·494A
Homocysteine Promotes Ventricular Remodeling by 
Induction of Apoptosis of Rabbit Cardiomyocytes and 
Priming the Mast Cells to Induce Interleukin-6, With 
Significant Inhibition by Troglitazone 1011-111·156A
Inhibition of ERK/p38 MAP-kinase and 
Calcineurin-NFAT Hypertrophy Signaling by Inducible 
Hemoxygenase-1 in Cardiac Myocytes 1001-21·5A
Rescue of Internalization-Impaired Angiotensin II AT1 
Mutants by β-Arrestin Overexpression 
1029-176·455A
The Clinical Significance of a Common, Functional, 
X-Linked Angiotensin II Type 2-Receptor Gene 
Polymorphism (-1332 G/A) in a Cohort of 509 
Families With Premature Coronary Artery Disease 
1029-184·457A
The Role of Angiopoietin-1 in Physiologic and 
Pathologic Cardiac Remodeling and in Promoting 
Cardiac Myocyte Survival  870-6·236A
Monitoring, physiologic
Unique Diagnostics Identify Patients at Risk for Heart 
Failure Decompensation  817-2·127A
Monoclonal antibodies
Markers of Inflammation Predict Mortality and Are 
Reduced by Pexelizumab in Patients With Acute 
Myocardial Infarction: Insights From the Complement 
Inhibition in Myocardial Infarction Treated With 
Angioplasty (COMMA) Trial  833-5·287A
Morphogenesis
Cardiac Conduction System-L acZ Expression in the 
Atrioventricular Ring and Moderator Band of 
Transgenic Murine Embryos: A Developmental 
Substrate for Wolff-Parkinson-White Syndrome and 
Mahaim Tachycardia? 1001-17·4A
Muscle, skeletal
Arrhythmias and Cardiac Involvement in 
Non-Duchenne, Non-Myotonic Muscular Dystrophy  
850-5·143A
Basal Respiratory Exchange Ratio Is Altered With 
Statin Use in Normals 1165-133·233A
Can Autologous Myoblast Transplantation Decrease 
Chronic Ischemic Mitral Regurgitation? 1059-16·14A
Cardiopulmonary Function Is Abnormal After 
Statin-Induced Rhabdomyolysis and Myositis 
1059-26·16A
CUG Expansions in a Myotonic Dystrophy Mouse 
Model Cause Cardiac Conduction Abnormalities and 
Pathologic Electrophysiology Findings  807-4·122A
Fiber Type-Specific Angiogenic Dysregulation in a 
Genetic Mouse Model of Heart Failure 
1045-196·458A
Skeletal Myoblast Transplantation Through a 
Catheter-Based Coronary Sinus Approach: An 
Effective Means of Improving Function of Infarcted 
Myocardium 1059-21·15A
Utilizing of the Fibrin Meshwork to Induce 
Neovascularization in Patients With Chronic Limb 
Ischemia: Long-Term Follow-Up  848-2·516A
Muscle, smooth
An Antiulcer Drug, Geranylgeranylacetone, Suppresses 
Nitric Oxide Synthesis in Cytokine-Stimulated 
Cultured Vascular Smooth Muscle Cells 
1106-184·493A
Expression of HMG-1, a Novel Mediator of 
Inflammation, by Human Smooth Muscle Cells of 
Atherosclerosis and Ppercutaneous Transluminal 
Coronary Angioplasty-Restenosis Lesions 
1140-176·509A
Oxidized Low-Density Lipoprotein-Stimulated Smooth 
Muscle Cell Growth Is Mediated by the Helix Loop 
Helix Factor Id3: A Novel Mechanism Contributing to 
Atherosclerotic Lesion Formation  406-5·534A
Potential Involvement of Novel Scavenger Receptor in 
Oxidized Low-Density Lipoproteins Promoted 
Atherogenic Effects in Human Aortic Smooth Muscle 
Cells 1029-178·456A
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Time-Course of Healing Responses After Intracoronary 
Photodynamic Therapy in Porcine Coronary Arteries 
1138-46·81A
Upregulation of Akt and Endothelial Nitric Oxide 
Synthase Induces Vascular Smooth Muscle Cell 
Differentiation in Hypertension In Vivo 
1161-172·521A
Myocardial contraction
Age-Related Left Ventricular Function Alterations in 
Mice: A Tissue Doppler Imaging Study  866-6·373A
Area of Left Ventricular Regional Conduction Delay and 
Preserved Contractility Predict Responses to Cardiac 
Resynchronization Therapy 1111-207·130A
Beta-Adrenergic Receptor Kinase Is Overexpressed in 
Patients With Chronic Mitral Regurgitation 
1067-136·431A
Biventricular Pacing Resynchronizes Septal Perfusion/
Wall Motion Match by a Primary Increase of 
Myocardial Blood Flow 1167-222·147A
By Relieving Obstruction, Disopyramide Increases 
Extent and Duration of Systolic Shortening in 
Obstructive Hypertrophic Cardiomyopathy: A Doppler 
Tissue Imaging Study 1032-129·166A
Calpain Activation and Inhibition in Acute Right Heart 
Failure 1144-130·219A
Chronotropic Stress Enhances the Effects of 
Asynchronous Left Ventricular Activation on 
Myocardial Perfusion in Patients With Idiopathic 
Dilated Cardiomyopathy and Left Bundle Branch 
Block 1164-130·231A
Determinants of Visual 2-D Echo Assessment of Left 
Ventricular Wall Motion: Comparison With Myocardial 
Thickening on Cardiac Magnetic Resonance Imaging 
1112-141·340A
Differential Response of Radial Versus Longitudinal 
Myocardial Velocities to Dobutamine Stress: 
Noninvasive Measurement by Tissue Doppler 
Imaging 1001-30·8A
Enhanced Left Ventricular Systolic Function Early in 
Type II Diabetic Mice 1011-107·155A
Mechanical Asynchrony Is an Important Component of 
Left Ventricular Dysfunction in Patients With Narrow 
QRS Complex: An Assessment by Real-Time 
Transthoracic 3-D Echo 1113-160·344A
Myocardial Performance Index Independently Predicts 
Cardiovascular Morbidity and Mortality in 
Hypertensive Patients With Electrocardiographic Left 
Ventricular Hypertrophy: The LIFE Study 
1163-111·227A
Negative Inotropic Effect of Selective AT2 Receptor 
Stimulation and Its Modulation by Endocardial 
Endothelium, Nitric Oxide, and Prostaglandins 
1106-180·492A
Postsystolic Shortening Is Consistently Prevalent in 
Nonviable Myocardium in Patients With Acute 
Myocardial Infarction: Comparison With 
Contrast-Enhanced Magnetic Resonance Imaging 
1037-142·317A
Quantitative Myocardial Contrast Echocardiography Is 
Useful to Evaluate Transmural Extent of 
Microvascular Damage in Patients With Myocardial 
Infarction 1017-163·311A
Time Course of Improvement Following Stem Cell 
Injections in Humans With Heart Failure  814-2·187A
Tissue Doppler Analysis of Nonuniform Transmural 
Recovery of Myocardial Contractility in Cardiac 
Raynaud's Phenomenon in Sclerodermic 
Cardiomyopathy 1092-163·333A
Myocardial hibernation
Accuracy of Strain Rate Techniques for Identification of 
Viability at Dobutamine Stress Echo: A Follow-Up 
Study After Revascularization 1151-145·360A
Akinetic Segments of Myocardial Infarction Contain 
Contracting Myocytes: A Finite Element Model Study 
1068-123·177A
Can Resting Myocardial Contrast Echocardiography 
Replace 99mTechnetium Sestamibi SPECT for the 
Diagnosis of Myocardial Viability Following 
Myocardial Infarction 1036-156·314A
Comparison Between Myocardial Contrast 
Echocardiography and Contrast Enhanced Magnetic 
Resonance Imaging in Prediction of the Myocardial 
Viability After Direct Percutaneous Transluminal 
Coronary Angioplasty in Acute Myocardial infarction 
1116-21·24A
Dobutamine Versus Levosimendan Stress 
Echocardiography for the Prediction of Recovery of 
Left Ventricular Dyssynergies After Revascularization  
802-2·331A
Does Improvement of Left Ventricular Ejection Fraction 
in Patients With Viable Myocardium Persist Over the 
Long-Term After Coronary Revascularization? 
1088-129·192A
Duke Viability Index Predicts Long-Term Mortality in 
Patients With Ischemic Cardiomyopathy Independent 
of Treatment Allocation 1056-163·325A
Prediction of Reversible Left Ventricular Dysfunction: 
Comparison of Contrast-Enhanced Magnetic 
Resonance Imaging and Thallium-201 SPECT 
1169-151·365A
Regional Desensitization of β-Adrenergic Receptor 
Signaling in Swine With Chronic Hibernating 
Myocardium 1002-77·243A
Regionally Altered Action Potential Duration Restitution 
in Swine With Hibernating Myocardium and Sudden 
Cardiac Death 1110-219·129A
Relationship Between Contractile Reserve and 
Diastolic Function in Hibernating Myocardium  
802-1·330A
Standards for Evaluation of Myocardial Viability With 
FDG-Positron Emission Tomography: A Comparison 
of Quantitative Methods  854-1·423A
Time-Dependent Upregulation of Extracellular Matrix 
Proteins in Chronic Hibernating Myocardium: Lack of 
Progressive Degeneration 1136-84·294A
Transendocardial Injection of Autologous Bone Marrow 
Mononuclear Cells May Enhance Myocardial Viability 
Around Cell Injection Site  814-1·186A
Myocardial infarction, pathophysiology
A Novel Approach in Risk Stratification: Combined 
Assessment of Regional Perfusion and Function 
From Rest/Stress Tc-99m Sestamibi Gated SPECT 
1170-149·369A
Abnormal Calcium Handling and Focal Source 
Ventricular Fibrillation During Subacute Myocardial 
Infarction in Rabbits 1001-15·4A
Acute Myocardial Infarction Is a Stimulus for Stem Cell 
Mobilisation and Elevated Erythropoietin Serum 
Levels 1078-94·270A
Age and the Lack of an Adverse Effect of Diabetes 
Explain the “Obesity Paradox” in Patients With 
Myocardial Infarction 1137-94·297A
Angiographically Apparent Thrombus After Fibrinolytic 
Administration Is Associated With Impaired Epicardial 
Flow and Myocardial Perfusion in ST Elevation 
Myocardial Infarction Patients With Open Arteries 
1060-101·262A
Antecedent Hypertension and the Risk of Subsequent 
Left Ventricular Remodeling After Acute Myocardial 
Infarction: Insights From the Survival and Ventricular 
Enlargement Trial 1142-177·511A
Aortic Gadolinium Enhancement Is Associated With 
Myocardial Infarction, Aging, and Decreased Aortic 
Distensibility 1055-151·321A
Assessment of Myocardial Viability in Patients With 
Myocardial Infarction: Comparison of 
Contrast-Enhanced Magnetic Resonance Imaging 
With Dobutamine Stress Echocardiography 
1151-146·360A
B-Type Natriuretic Peptide Levels on Admission Predict 
Short-Term Mortality and Angiographic Success of 
Procedure in Patients With Acute ST Elevation 
Myocardial Infarction Treated With Primary 
Angioplasty  826-4·283A
Baseline White Blood Cell Count and Interleukin-6 
Levels Provide Complementary Prognostic 
Information in Acute Myocardial Infarction: Results 
From the CARDINAL Trial 1118-102·291A
Breast Arterial Calcification Predicts Lower 
Cardiovascular Event Rate in a Higher Risk 
Population of Postmenopausal Women 
1128-127·213A
C-Reactive Protein on Admission Is an Independent 
Predictor of One-Year Mortality in Patients With Acute 
Myocardial Infarction: A Prospective Study 
1098-102·280A
Calcification of the Culprit Lesion Is Associated With 
Adverse Clinical Outcomes in ST Elevation 
Myocardial Infarction Patients Treated With 
Fibrinolytic Therapy 1060-83·261A
Calmodulin Kinase Inhibition Improves Cardiac 
Function After Myocardial Infarction 1041-92·255A
Cardiogenic Shock in Patients With Preserved Left 
Ventricular Systolic Function: Characteristics and 
Insight Into Mechanisms  887-2·241A
Clinical Application of Eigenvalue Analysis and the 
Derived Electrocardiogram as a Real-Time Marker for 
Infarction  854-4·424A
Compensatory Enlargement Delay Vascular Healing of 
the Culprit Lesion Following Acute Myocardial 
Infarction 1082-180·476A
Coronary Arterial Wall Temperature Heterogenity in 
Patients With Acute Coronary Syndrome: An 
Intracoronary Thermography Study 1006-60·34A
Coronary Flow Velocity Pattern Immediately After 
Percutaneous Coronary Intervention in Patients With 
Acute Myocardial Infarction Can Predict Myocardial 
Viability Assessed by Thallium Scintigraphy at Six 
Months 1157-47·93A
Correlation Between the Extent of Diseased Vessels 
and the Incidence of In-Hospital Cardiac Mortality in 
Acute Myocardial Infarction  885-3·240A
Early Elevation of C-Terminal Telopeptide of Type I 
Collagen Is Highly Correlated With 30-Day Mortality 
in Patients With Myocardial Infarction Regardless of 
Infarct Localization  826-3·282A
Early Serum Levels of Tissue Inhibitor of 
Metalloproteinases-1 but Not Matrix 
Metalloproteinase-1 Are Associated With 
Cardiovascular Death After Complicated Myocardial 
Infarction 1087-106·188A
Echocardiographic and Angiographic Correlations in 
Cardiogenic Shock 1050-120·173A
Effects of Functional Coronary Collateral Flow on the 
Incidence of Right Ventricular Infarction After Primary 
Angioplasty in Patients With Acute Inferior Myocardial 
Infarction 1026-60·40A
Effects of Preinfarction Angina Pectoris on Left 
Ventricular Function in Diabetic Patients With a First 
ST-Elevation Myocardial Infarction Treated With 
Primary Percutaneous Coronary Intervention 
1002-97·244A
Elevated Plasma Level of Placental Growth Factor Is 
Correlated With Peripheral Monocyte Fraction in 
Patients With Acute Myocardial Infarction 
1042-84·259A
Fasting Glucose Is an Independent Predictor of 30-Day 
Mortality in Nondiabetic Patients With Acute 
Myocardial Infarction: A Prospective Study  
827-2·283A
Genetic Polymorphism G894T on Endothelial Nitric 
Oxide Synthase Gene as a Risk Factor for 
Premature, Nonfatal Myocardial Infarction in Young 
Male Smokers  408-1·534A
Haptoglobin Polymorphism Is Associated With 
Short-Term Mortality and Heart Failure in Patients 
With Diabetes and Acute Myocardial Infarction 
1042-77·257A
High Risk Genotypes for Myocardial Infarction Are More 
Common in African Americans Than European 
Americans  801-4 ·267A
Hyponatremia: A Useful Marker for Early Risk 
Assessment in Acute ST Elevation Myocardial 
Infarction  826-6·283A
Identification of Novel Genetic Markers Associated With 
Risk of Myocardial Infarction From a Genomic Scale 
Scan of Putative Functional Polmorphisms 
1103-194·488A
Impact of Altered Expression Balance of Matrix 
Metalloproteinases and Tissue Inhibitor of 
Metalloproteinases Genes on Coronary Plaque 
Rupture: Results From Quantitative Tissue Analysis 
Using Real-Time Reverse Transcriptase-Polymerase 
Chain Reaction Method 1042-79·257A
Impact of Body Mass Index on Outcomes After Primary 
Angioplasty in Acute Myocardial Infarction: The 
Obesity Paradox 1002-82·244A
Impact of Periprocedural Plaque/Thrombus Reduction 
on Myocardial Injury After Stent Deployment  
808-3·55A
In Vivo Macrophage Imaging of Acute Coronary 
Syndromes With Intracoronary Optical Coherence 
Tomography 1006-55·33A
In Women With Symptoms of Ischemic Heart Disease, 
Global and Regional Myocardial Perfusion Status by 
Magnetic Resonance Imaging Better Assigns Risk: 
Results From the National Heart, Lung, and Blood 
Institute-Sponsored Women's Ischemia Syndrome 
Evaluation (WISE)  801-1 ·266A
Incidence and Characteristics of Ruptured Plaque in 
Human Femoro-Popliteal Arteries 1066-198·472A
Increased Cardiovascular Mortality With the Turn of the 
Millennium 1060-77·260A
Independent Predictors of Multiple Vulnerable Plaque in 
143 Patients With Acute Coronary Syndrome: A 
Prospective Study of Three-Vessel Intravascular 
Ultrasound  832-3·73A
Infarct Age and Electrogram Characteristics in Patients 
With Postinfarction Ventricular Tachycardia  
890-5·154A
Influence of Microsomal Triglyceride Transfer Protein - 
493G/T Polymorphism on Cardiovascular Events 
After Myocardial Infarction in Diabetic Patients 
1137-102·299A
Interleukin-6 but Not C-Reactive Protein Is Elevated at 
the Site of Ruptured Plaques in Acute Coronary 
Syndromes  826-2·282A
Intra-Aortic Balloon Counterpulsation Improves 
Regional Systolic Function After Acute Myocardial 
Infarction: Randomized Experimental Magnetic 
Resonance Imaging Study 1169-153·366A
Ischemia Modified Albumin Improves the Sensitivity and 
Negative Predictive Value of Standard Cardiac 
Biomarkers for the Diagnosis of Myocardial Ischemia 
1042-80·258A
Markers of Inflammation Predict Mortality and Are 
Reduced by Pexelizumab in Patients With Acute 
Myocardial Infarction: Insights From the Complement 
Inhibition in Myocardial Infarction Treated With 
Angioplasty (COMMA) Trial  833-5·287A
Metabolic Syndrome: An Underecognized Risk Factor 
for Myocardial Infarction in the Young 1021-100·249A
Multiple Complex Plaques in Unstable Saphenous Vein 
Grafts 1060-81·261A
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Multiple Plaque Ruptures Are Not Frequent in Acute 
Coronary Syndrome: A Three-Vessel Intravascular 
Ultrasound Study  832-5·74A
Myocardial Ischemia-Reperfusion Injury Is Dependent 
on Lectin Complement Activation  883-4·305A
Noise Exposure and the Risk of Myocardial Infarction 
1096-72·408A
Noninvasive Evaluation of Coronary Artery Flow Using 
Transthoracic Color Doppler Echocardiograpy in 
Patients With Acute Myocardial Infarction in the 
Emergency Room 1041-94·255A
Pathological Features Found Postmortem in 53 Patients 
With Cardiac Rupture Complicating Acute Myocardial 
Infarction 1118-83·291A
Patterns of Lesion Calcification in Infarct-Related 
Arteries: An Intravascular Ultrasound Analysis of 250 
Patients With Acute Myocardial Infarction 
1026-56·40A
Platelet-Derived Growth Factor Signaling Has a Crucial 
Role in Vascular Maturation Following Myocardial 
Infarction 1002-98·245A
Prediction of Left Ventricular Functional Recovery in 
Patients With Thrombolysis in Myocardial Infarction 3 
Flow: Analysis Using Transthoracic Color Doppler 
Echocardiography 1073-146·326A
Procedural Predictors of Creatine Kinase-MB 
Elevations in the REPLACE-2 Study 1043-66·44A
Prognostic Significance of Mitral Regurgitation 
Identified Using Color Doppler Echocardiography 
Early After Acute Myocardial Infarction  823-5·347A
Protecting Ischemic Hearts With a Hypoxia-Sensitive 
Heme Oxygenase-1 Plasmid System  406-3·533A
QT Prolongation Is the Most Consistent 
Electrocardiographic Change Seen in Patients During 
Balloon Occlusion of the Coronary Artery With 
Percutaneous Coronary Intervention 1110-220·130A
Quantitative Evaluation of Coronary Reperfusion by 
Transthoracic Doppler Echocardiography in Patients 
With Anterior Acute Myocardial Infarction 
1026-61·41A
Relation of the –174 G/C and –572 G/C Promoter 
Polymorphisms of the Interleukin-6 Gene to 
Interleukin-6 and Highly Sensitive C-Reactive Protein 
Serum Levels and to the Extent of Infarction in Acute 
Myocardial Infarction 1136-90·296A
Relationship Between Day of Week/Time of Day and 
Presentation and Outcome in Patients With Acute 
Coronary Syndromes 1060-78·260A
Right Ventricular Function Recovery After Acute 
Myocardial Infarction: The Relation With Left 
Ventricular Function and Interventricular Septum 
Motion-The GISSI-3 Echo Substudy 1108-115·198A
Risk Stratification in ST-Segment Elevation Myocardial 
Infarction With Multiple Biomarkers 1042-86·259A
ßeta-2 Receptors Are Upregulated in Canine Ventricles 
With a Chronic Myocardial Infarction 1136-89·296A
Stem Cell Mobilization With Granulocyte 
Macrophage-Colony Stimulating Factor Has No Effect 
on Infarct Size and Left Ventricular Function in an 
Experimental Model of Acute Myocardial Infarction 
1078-89·269A
Systolic and Diastolic Strain Rates by Tagged Magnetic 
Resonance Imaging Distinguishes Regions With 
Different Degrees of Myocardial Injury After Acute 
Myocardial Infarction 1169-160·367A
Systolic Blood Pressure During Recovery Is Related to 
the Risk of Acute Myocardial Infarction in 
Middle-Aged Men 1146-112·224A
The CenterSurface Method for Quantatative Evaluation 
of Cardiac Magnetic Resonance Regional Wall 
Thickening 1126-112·207A
The Doppler Tei Index During Dobutamine Stress 
Echocardiography: A Powerful Predictor of Mortality 
After Acute Myocardial Infarction  802-4·331A
The Incidence of Clinically Unrecognized Myocardial 
Infarction in Patients With Type 2 Diabetes, 
Hypertension, and Nephropathy 1099-89·281A
The Ratio of Oxidized Low-Density to High-Density 
Lipoproteins Is an Independent Predictor of Acute 
Myocardial Infarction in Unstable Coronary Artery 
Disease 1047-188·464A
Urinary Tract Infection in Patients With Acute Coronary 
Syndrome: A Potential Systemic Inflammatory 
Connection 1001-3·1A
Use of Administrative Databases May Lead to Incorrect 
Estimates of the Effects of Nonaspirin Nonsteroidal 
Anti-Inflammatory Drugs on MIyocardial Infarction 
Risk 1172-67·420A
Vulnerable Plaque Can Be the Predominant Source of 
Serum Interleukin-6 but Not of Serum C-Reactive 
Protein in Patients With Acute Myocardial Infarction 
1043-46·42A
White Blood Cell Count Predicts Higher Risk of 
Intermediate-Term Outcomes in Patients Stabilized 
After Acute Coronary Syndromes: Observations From 
the SYMPHONY and 2nd SYMPHONY Trials 
1042-82·258A
Myocardial infarction, treatment
30-Day Mortality Trends Following Acute Myocardial 
Infarction in the Elderly 1040-76·403A
A Prospective, Randomized Trial of Mild Hypothermia 
During Primary Percutaneous Intervention for Acute 
Myocardial Infarction (COOL-MI): One-Year Clinical 
Outcome 1022-82·251A
A Randomized Trial Comparing Rheolytic 
Thrombectomy Before Infarct Artery Stenting With 
Stenting Alone in Patients Undergoing Percutaneous 
Coronary Intervention for Acute Myocardial Infarction  
829-6·286A
Acute and Early Changes in Plasma Vascular Growth 
Factors and Circulating Endothelial Progenitor Cells 
in Patients With Acute ST Elevation Myocardial 
Infarction 1025-63·38A
Adrenomedullin Enhances Therapeutic Potency of 
Bone Marrow Transplantation for Acute Myocardial 
Infarction in Rats 1061-96·265A
Age-Related Complications and Outcomes After 
Primary Percutaneous Coronary Interventions 
1070-104·182A
An Updated Meta-Analysis of the Effect of 
Glucose-Insulin-Potassium on Survival in Acute 
Myocardial Infarction: Impact of Reperfusion Therapy  
833-6·287A
Anemia Worsens Prognosis After Primary Angioplasty 
in Acute Myocardial Infarction: Analysis From the 
CADILLAC Trial  801-3·267A
Angiographic No-Reflow Phenomenon in the Patients 
With Acute Myocardial Infarction After Percutaneous 
Transluminal Coronary Intervention 1003-89·246A
Aqueous Oxygen Therapy for ST Segment Elevation 
Myocardial Infarction: AMIHOT Trial Safety Report 
and Enrollment Completion  869-3·304A
Aspirin Resistance in Cardiovascular Disease: 
Underdosing of Overweight Patients  404-2·532A
Association of Inflammation and Benefit of Statins in 
Patients With Acute Myocardial Infarction 
1022-86·252A
Beneficial Effects of Combined Thrombolytic Therapy 
and Percutaneous Coronary Angioplasty in Transfer 
Patients With ST Segment Elevation Myocardial 
Infarction: A Report From the American College of 
Cardiology-National Cardiovascular Data Registry  
869-6·304A
Benefit of Statins in Secondary Prevention After Acute 
Myocardial Infarction – Evidence of a Class Effect 
1008-185·446A
Carbon Monoxide Protects Against Cardiac 
Ischemia-Reperfusion Injury In Vivo Through 
Mitogen-Activated Protein Kinanse Pathway and 
Akt-Endothelial Nitric Oxide Synthase Pathway  
883-6·306A
Carvedilol Better Protects Against Vascular Events 
Than Metoprolol in Heart Failure: Results From 
COMET   835-2·205A
Causes of Death in Patients With ST Elevation 
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Vascular Endothelial Growth Factor- and Tumor 
Necrosis Factor-Alpha-Mediated Angiogenesis in 
Ischemic Hindlimbs of Mice 1045-195·458A
Percutaneous Peripheral Intervention Is Associated 
With Sustained Improvement in Health-Related 
Quality of Life 1005-46·32A
Percutaneous Transfemoral Coronary and Peripheral 
Procedures via Aortofemoral Synthetic Vascular 
Grafts: A Review of 123 Diagnostic and Interventional 
Cases  818-5·63A
Preoperative Statins Are Associated With Shorter 
Length of Stay and Improved Long Term Survival in 
Patients Undergoing Vascular Surgery 
1046-171·460A
Prevalence and Clinical Correlates of Symptomatic 
Peripheral Arterial Disease in Italy 1046-173·461A
Prevention of Flight-Related Thrombosis With 
Low-Molecular Weight Heparin 1001-12·3A
Recanalization of Long Superficial Femoral Artery 
Occlusions by a Transpopliteal Approach: Acute and 
12- Month Results 1005-42·32A
Results of Four Multicenter, Phase III, Magnetic 
Resonance Angiography (MRA) Trials With MS-325, 
a Blood Pool Contrast Agent, for the Detection of 
Vascular Disease in the Aortoiliac, Renal, and Pedal 
Regions 1133-156·352A
Survival Differences Between Hispanic and 
Non-Hispanic Patients With Cardiovascular Disease 
Initiating Renal Replacement Therapy in the United 
States 1135-74·414A
The Effect of Body Weight Change on Arterial Wall 
Properties 1027-198·453A
The Modulating Role of CD44 During Arteriogenesis: 
An Experimental and a Clinical Approach  
805-3·472A
The Severity of Peripheral Vascular Disease Can Be 
Assessed by Skeletal Muscle Contrast-Enhanced 
Ultrasound 1074-155·328A
Vascular Brachytherapy With 192Iridium After 
Femoropopliteal Stenting in High-Risk Patients: 
Results From the Vienna-5 Trial 1005-44·32A
Pharmacokinetics
Adrenomedullin Is a Pulmonary Peptide 
1106-183·493A
Carbon Monoxide Protects Against Cardiac 
Ischemia-Reperfusion Injury In Vivo Through 
Mitogen-Activated Protein Kinanse Pathway and 
Akt-Endothelial Nitric Oxide Synthase Pathway  
883-6·306A
Clopidogrel Resistance Is Associated With Cytochrome 
3A Polymorphism 1063-51·49A
Dose Response of Sirolimus-Eluting SMARTTM Stents 
in Porcine Iliac Arteries and Relationship to Arterial 
Tissue Sirolimus Levels 1005-45·32A
Drug-Eluting Stent With Multidimensional 
Programmable Pharmacokinetics 1139-47·83A
Encapsulation of Pravastatin Tablets Produces Greater 
Low-Density Lipoprotein Cholesterol Lowering in 
Patients With Human Immunodeficiency Virus 
Infection Dyslipidemia Taking Protease Inhibitors 
1008-186·446A
Indirect Imaging of Vasculat Endothelial Growth Factor 
Gene Expression Using a Positron Emission 
Tomography Reporter Gene  805-1·472A
Initial Response to Statin Therapy Predicts Response 
to Dose Titration 1084-171·479A
Optimization of Pharmacokinetic Vectors With a 
Programmable Paclitaxel Eluting Stent 1139-51·83A
Pharmacokinetics of Clopidogrel and Its Active 
Metabolite in Human Plasma 1106-177·492A
Sirolimus-Eluting Stents: Pharmacokinetics in Blood, 
Vessel, and Myocardium in a Porcine Coronary Model 
1139-49·83A
Pharmacology
Additive Gene-Gene Interaction Between CYP7A1 and 
Apolipoprotein E as Genetic Determinants of 
Low-Density Lipoprotein Cholesterol-Lowering 
Response to Atorvastatin 1124-197·505A
Chromium Supplementation Shortens QTc Interval 
Duration in Patients With Type 2 Diabetes 
1141-195·510A
Clopidogrel Is an Inducer and a Potent Reversible 
Inhibitor of Cytochrome P450 3A4 In Vitro 
1106-181·493A
Direct, Dose-Dependent Antifibrotic Effects of 
Atorvastatin in Human Cardiac Fibroblast Cell Culture 
1012-134·160A
Distinct Signaling Pathways Mediate Protease 
Activated Receptor-Dependent Endothelial 
Exocytosis 1064-181·465A
Dual Angiotensin-II Suppression With 
Angiotensin-Converting Enzyme Inhibitor and 
Irbesartan Improves Submaximal Exercise Time 
Without Changes in Exercise-Induced Neurohumoral 
Response in Patients With Congestive Heart Failure 
1012-129·159A
Etoricoxib Has No Adverse Effects on Biomarkers of 
Cardiovascular Risk in Patients With Osteoarthritis 
1141-198·511A
Genetic Variation in Cyclooxygenase-1 Associates With 
the Antiplatelet Effect of Aspirin in Stable Coronary 
Artery Disease 1141-192·510A
Impact of the Angiotensin-Receptor Blocker 
Candesartan in Preventing Diabetes in Patients With 
Heart Failure  810-1·473A
Limited Antiplatelet Effect of Aspirin and Clopidogrel in 
Patients With Stable Coronary Artery Disease: The 
Platelet Glycoprotein Ia/IIa and Glycoprotein IIb/IIIa 
Genetics and Female Sex 1141-189·509A
Multidrug Resistance-1 Gene Polymorphisms Influence 
the Response to Atorvastatin Treatment in a Gender 
Specific Manner 1084-168·479A
Neurohormones but Not Adrenomedullin Correlate With 
Left Ventricular Structure in Patients With Heart 
Failure: Results From an EARTH Substudy 
1163-116·228A
Peroxisome Proliferator Activated Receptor Gamma 
Agonist Protects Against Arterial Thrombosis in a 
Mouse Model of Insulin Resistance 1007-176·444A
Pharmacokinetics of Clopidogrel and Its Active 
Metabolite in Human Plasma 1106-177·492A
Protective Effect of Diazoxide Is Maintained in Aged 
Heart 1070-131·183A
Short Burst Oral Amiodarone Improves Cardioversion 
Success Rates for Patients in Persistent Atrial 
Fibrillation 1141-193·510A
Superior Early Platelet Inhibition by 600mg Clopidogrel 
Loading in Elective Stenting 1100-62·65A
Phonocardiography
Multimedia Bedside Cardiac Examination: Controlled 
Intervention Study  853-2·423A
Phosphodiesterase inhibitors
Effect of Tadalafil, a Phosphodiesterase 5 Inhibitor, on 
Myocardial Blood Flow in Patients With Coronary 
Artery Disease 1170-147·369A
Improved Calcium Homeostasis and Antiarrhythmic 
Effects of a Novel Chimeric Molecule That Inhibits 
Both Type III Phosphodiesterase and L-Type Calcium 
Channel in Failing Hearts 1087-134·189A
Sildenafil Citrate (Viagra) Induces Powerful 
Cardioprotective Effects Following 
Ischemia-Reperfusion Injury in Infant Rabbits 
1041-95·256A
Physiology
A Synergistic Interaction Between Premature Family 
History of Coronary Heart Disease and Metabolic 
Risk Factors Enhances Risk of Subclinical 
Atherosclerosis 1028-167·453A
Calmodulin Kinase Inhibition Improves Cardiac 
Function After Myocardial Infarction 1041-92·255A
Calmodulin Kinase Inhibition Improves Survival in 
Calcineurin Transgenic Mice 1001-23·6A
Comparison of Intracoronary Bolus Injection and 
Intracoronary Continuous Infusion Methods for 
Inducing Hyperemia 1120-63·76A
Effect of Caffeine on Fractional Flow Reserve 
1170-146·368A
Enhanced Instability of Membranous Type 1 Matrix 
Metalloproteinase in Response to Mechanical 
Loading in Left Ventricular Myocardium 
1087-108·189A
Functional Capacity Assessment by Cardiopulmonary 
Exercise Testing in Organic Mitral Regurgitation: A 
Prospective Quantitative Study  868-6·442A
Increased Capillary Fluid Filtration Rate in Elderly 
Subjects With Symptomatic Hypotension During 
Head-Up Tilt Table Testing 1070-133·184A
Lowered Resting Heart Rate in High Fit Healthy 
Subjects Is Caused by a Lowered Intrinsic Heart 
Rate, Not by Elevated Parasympathetic Tone 
1033-110·167A
Optimal Preload Adjustment of Right Ventricular Power 
Allows for Single Beat Estimation of Contractility 
1144-129·219A
Protein Kinase C Epsilon Is Upstream and Protein 
Kinase C Alpha Is Downstream of MitoKATP 
Channels in the Signaling of Ischemic 
Preconditioning in the Human Myocardium 
1136-86·295A
Plaque
Assessment of Coronary Atherosclerotic Plaque 
Composition by Multidetector Computed 
Tomography: Comparison to Intravascular Ultrasound 
1018-144·312A
Atherosclerotic Plaque Can Be Quantified Using 
Multifractal and Wavelet Decomposition Techniques 
1006-57·34A
Attenuation of Human Atherosclerotic Plaque 
Inflammation by PPAR-γ Agonist and NF-κB Inhibitor  
841-5·506A
Coronary Lumen Change Is Determined Primarily by 
Adventitial Remodeling Rather Than Plaque Change 
During Therapy  831-2·496A
Diabetes Mellitus Might Be Associated With Multiple 
Vulnerable Plaque in 113 Patients With Stable 
Angina: A Prospective Study of Three-Vessel 
Intravascular Ultrasound  832-6·74A
Distal Protection Device (PercuSurge) Can Reduce 
Infarct Size in Patients With Acute Myocardial 
Infarction Who Have Ruptured Culprit Plaque 
1026-62·41A
Elevated High-Sensitivity C-Reactive Protein Was 
Associated With Coronary Artery Remodeling in 
Patients With Unstable Angina 1026-59·40A
Impact of Altered Expression Balance of Matrix 
Metalloproteinases and Tissue Inhibitor of 
Metalloproteinases Genes on Coronary Plaque 
Rupture: Results From Quantitative Tissue Analysis 
Using Real-Time Reverse Transcriptase-Polymerase 
Chain Reaction Method 1042-79·257A
Incidence and Characteristics of Ruptured Plaque in 
Human Femoro-Popliteal Arteries 1066-198·472A
Incidence of Vulnerable Plaques in Humans: 
Assessment With 3-D Intravascular Palpography  
884-6·307A
Independent Predictors of Multiple Vulnerable Plaque in 
143 Patients With Acute Coronary Syndrome: A 
Prospective Study of Three-Vessel Intravascular 
Ultrasound  832-3·73A
Molecular Imaging of Human Thrombus With 
Computed Tomography 1001-38·10A
Morphological Characteristics of De Novo Coronary 
Lesions Presenting With Plaque Rupture: An 
Intravascular Ultrasound Study  832-1·73A
Multiple Complex Plaques in Unstable Saphenous Vein 
Grafts 1060-81·261A
Noninvasive Characterization of Carotid Plaque 
Inflammation in Humans With FDG-Positron 
Emission Tomography  848-4·516A
Photodynamic Therapy Reduces Atherosclerotic 
Plaque Inflammation, Induces Plaque Stabilization 
and Promotes Plaque Reduction 1064-184·466A
Plaque Targeting in Atherosclerotic Mice Using a Small 
ImmunoProtein Against an Angiogenesis-Associated 
Fibronectin Isoform 1045-189·457A
Qualitative and Quantitative Analysis of Saphenous 
Vein Graft Plaque Debris Within the MedNova 
CardioShield™ Embolic Capture Device  878-4·102A
Relationship of Ultrasound Plaque Characteristics to 
Thrombolysis in Myocardial Infarction Myocardial 
Perfusion Grade Following Intracoronary Stenting 
1120-41·74A
Sustained Upregulation of Chemokine and Its Receptor 
Genes Associated With Matrix Metalloproteinase 
Overexpression in Human Carotid Plaque Rupture: 
Results From a Quantitative Study With Real-Time 
Reverse Transcriptase-Polymerase Chain Reaction- 
Method  831-4·497A
Systemic Infections Lead to Infiltration of Macrophages 
in Adventitia of Human Atherosclerotic Coronary 
Arteries: Clue to Triggering Effect of Acute Infections 
on Acute Coronary Syndromes 1064-185·466A
The Reliability of Plaque Map Established by 
Multidetector Row Computed Tomography in Patients 
of Acute Coronary Syndrome 1018-145·313A
Vulnerable Plaque Can Be the Predominant Source of 
Serum Interleukin-6 but Not of Serum C-Reactive 
Protein in Patients With Acute Myocardial Infarction 
1043-46·42A
Plasminogen activators
Aldosterone and Plasma Renin Activity Influence 
Plasma Plasminogen Activato Inhibitor-1 Levels in 
Overweight Subjects 1007-182·445A
Platelet inhibitors
A Comparison of the Effect of Eptifibatide Plus Heparin 
Versus Bivalirudin on Thrombin Generation and Clot 
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Coronary Intervention 1043-42·41A
A Randomized Comparison of Cilostazol Versus 
Clopidogrel After Coronay Stenting: The Preliminary 
Results 1063-56·50A
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Noncardiac Surgery 1063-53·49A
Abciximab Administration for the Prevention of 
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1025-42·37A
Adjunctive Pharmacotherapy During Higher Risk 
Percutaneous Coronary Intervention: 
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1004-53·31A
Baseline Platelet Count Correlates With Ischemic 
Events and Mortality at Follow-Up After Percutaneous 
Coronary Intervention 1063-57·50A
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1137-99·298A
Clopidogrel Increases Post Cardiac Surgery Bleeding 
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1010-135·427A
Clopidogrel Is an Inducer and a Potent Reversible 
Inhibitor of Cytochrome P450 3A4 In Vitro 
1106-181·493A
Clopidogrel Regulates Platelet, Leukocyte, and 
Endothelial Interactions in Type 2 Diabetes Mellitus 
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Clopidogrel Resistance Is Associated With Cytochrome 
3A Polymorphism 1063-51·49A
Early Administration of Clopidogrel Is Safe After Off- 
Pump Coronary Artery Bypass Surgery 1059-15·13A
Early Use of Small Molecule Platelet Glycoprotein IIb/
IIIa Inhibitors for All Acute Coronary Syndrome 
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Interventions 1172-69·420A
Effect of a 600 mg Clopidogrel Loading Dose on 
Platelet Function in Patients Undergoing Coronary 
Stenting 1100-61·65A
Enoxaparin Versus Unfractionated Heparin in Patients 
Treated With Tirofiban, Aspirin, and an Early 
Conservation Initial Management Strategy: Results 
From the A Phase of the A to Z Trial  861-2·302A
Excessive Bleeding With Aspirin, Clopidogrel, and 
Warfarin "Triple Therapy" 1023-95·254A
Genetic Variation in Cyclooxygenase-1 Associates With 
the Antiplatelet Effect of Aspirin in Stable Coronary 
Artery Disease 1141-192·510A
High-Dose Clopidogrel Loading Rapidly Reduces Both 
Platelet Inflammatory Marker Expression and 
Aggregation 1100-59·64A
Impact of Abciximab on Distal Embolization Induced by 
Primary Angioplasty 1004-52·31A
Interpretation of the Actual Platelet Inhibition Induced 
by Clopidogrel: A New Look at How to Represent 
Drug Response 1100-58·64A
Investigating Platelet Activation With Abciximab and 
High-Dose Tirofiban in Patients With Acute 
Myocardial Infarction Undergoing Primary 
Percutaneous Coronary Intervention  864-4·99A
Is Early Prehospital Administration of Abciximab 
Superior to Periprocedural Therapy in Patients With 
ST-Segment Elevation Myocardial Infarction and 
Planned Percutaneous Coronary Intervention? Early 
and Late Results From the Randomized 
REOMOBILE Pilot Study 1022-79·250A
Is the ICHOR Platelet Works Test as Valid as Flow 
Cytometry to Assess the Efficacy of Platelet 
Glycoprotein IIb/IIIa-Receptor Inhibitors in Patients 
Undergoing Percutaneous Coronary Intervention? 
1025-44·38A
Large Oligomeric Grape Skin Polyphenolics Are Most 
Effective as Antioxidants and Antiplatelet Agents 
1083-192·479A
Limited Antiplatelet Effect of Aspirin and Clopidogrel in 
Patients With Stable Coronary Artery Disease: The 
Platelet Glycoprotein Ia/IIa and Glycoprotein IIb/IIIa 
Genetics and Female Sex 1141-189·509A
Long-Term Clopidogrel Therapy Following 
Percutaneous Coronary Intervention Improves 
Clinical Outcome but Is Not Associated With 
Increased Bleeding: New Insights From the CREDO 
Trial 1116-6·21A
Long-Term Clopidogrel Therapy Is Particularly 
Beneficial for Patients Requiring Repeat 
Revascularization After an Initial Percutaneous 
Coronary Intervention 1063-54·50A
Long-Term Cost-Effectiveness of Clopidogrel in 
Patients Having Percutaneous Coronary Intervention 
Early After Acute Coronary Syndrome: Results From 
PCI-CURE 1137-77·296A
Long-Term Results of ISAR-REACT: A Randomized 
Trial Evaluating Abciximab in Patients With Elective 
Percutaneous Coronary Intervention After 
Pretreatment With a High Loading Dose of 
Clopidogrel 1001-8·2A
Pharmacokinetics of Clopidogrel and Its Active 
Metabolite in Human Plasma 1106-177·492A
Platelet Dysfunction Following a 300 mg Clopidogrel 
Loading Dose in Type 2 Diabetes Undergoing 
Coronary Stenting 1100-60·65A
Platelet Glycoprotein IIb/IIIa Receptor Inhibition as 
Adjunctive Treatment During Saphenous Vein Graft 
Stenting: Differential Effects After Randomization to 
Occlusion or Filter-Based Embolic Protection  
830-2·71A
Prolonged Clopidogrel Treatment Reduces Lesion Cell 
Proliferation After Balloon Injury and Intracoronary 
Radiation  864-6·100A
Renal Function Predicts Outcomes in Acute Coronary 
Syndromes: Insights From the CURE Trial 
1098-79·278A
Role of the 807 C/T Polymorphism of Glycoprotein Ia/
IIa on Platelet Function Following Clopidogrel 
Loading Dose in Patients Undergoing Coronary 
Stenting 1159-190·518A
Safety and Efficacy of Glycoprotein IIb/IIIa Receptor 
Blockers in Patients With Chronic Renal Insufficiency 
Undergoing Contemporary Percutaneous Coronary 
Intervention  838-3·415A
Subgroup Analysis of the Impact of the Glycoprotein IIb/
IIIa Inhibitor Abciximab in Patients Undergoing 
Elective Stent Placement >2 Hours After Treatment 
With a 600 Milligram Loading Dose of Clopidogrel: 
Results From the ISAR REACT Trial  878-3·102A
Superior Early Platelet Inhibition by 600mg Clopidogrel 
Loading in Elective Stenting 1100-62·65A
The Impact of Abciximab on Final Infarct Size and Left 
Ventricular Function of Patients With Acute 
Myocardial Infarction Undergoing Primary Stenting: 
Insights From the Abciximab and Carbostent 
Evaluation (ACE) Trial 1118-81·290A
The Risk of Bleeding in Renal Failure Patients 
Undergoing Glycoprotein IIb/IIIa Receptor Inhibition: 
A Report From the American College of 
Cardiology-National Cardiovascular Data Registry 
1004-49·30A
Underuse of Glycoprotein IIb/IIIa Receptor Blockers in 
Diabetics Undergoing Percutaneous Coronary 
Intervention for Acute Coronary Syndromes in 
Current Clinical Practice in Europe: Results of the 
International Shakespeare Registry  827-6·284A
Platelets
Antithrombotic Effects of Angiotensin II Receptor 
Blockade 1007-175·444A
Aspirin Resistance Is Associated With a Single 
Nucleotide Polymorphism in the P2Y1 ADP Receptor 
Gene  847-3·515A
Baseline Platelet Count Correlates With Ischemic 
Events and Mortality at Follow-Up After Percutaneous 
Coronary Intervention 1063-57·50A
Bivalirudin Confers Antiplatelet Effects in Patients 
Undergoing Percutaneous Coronary Intervention 
1025-43·37A
Detection of Aspirin Resistance in Subjects With 
Multiple Risk Factors for Cardiovascular Disease 
1141-197·511A
Endothelial, Coagulation, and Platelet Function in Atrial 
Fibrillation: Effect of Direct Current Cardioversion 
1129-212·134A
Functional Interplay Between Endothelial Dysfunction 
and Platelet Activation in Patients With Stable 
Coronary Heart Disease 1027-183·450A
Grape Seed and Skin Extracts Alter Platelet Function 
and Release of Reactive Oxygen Species 
1159-188·518A
High-Dose Clopidogrel Loading Rapidly Reduces Both 
Platelet Inflammatory Marker Expression and 
Aggregation 1100-59·64A
Incidence and Evaluation of Heparin-Induced 
Thrombocytopenia (HIT) Among Patients Treated 
With Prolonged Heparin and Among 
Thrombocytopenic Patients in the Cardiac Care Unit: 
Preliminary Results of the CATCH Registry 
1123-180·501A
Interpretation of the Actual Platelet Inhibition Induced 
by Clopidogrel: A New Look at How to Represent 
Drug Response 1100-58·64A
Is the ICHOR Platelet Works Test as Valid as Flow 
Cytometry to Assess the Efficacy of Platelet 
Glycoprotein IIb/IIIa-Receptor Inhibitors in Patients 
Undergoing Percutaneous Coronary Intervention? 
1025-44·38A
NAD(P)H Dependent Superoxide Production in Human 
Platelets: The Role of Angiotensin II and Protein 
Kinase C 1122-176·500A
Persistently Increased Platelet Reactivity Prestages 
Subsequent Cardiac Events After an Acute Coronary 
Event 1098-84·279A
Platelet Dysfunction Following a 300 mg Clopidogrel 
Loading Dose in Type 2 Diabetes Undergoing 
Coronary Stenting 1100-60·65A
Platelet Glycoprotein IIIa Genotype Is Not a Risk Factor 
for Target Vessel Revascularization Following 
Percutaneous Coronary Intervention 1138-44·81A
Platelet P-Selectin and Plasma Levels of Circulating 
Cytokines in Young Patients With Mild Arterial 
Hypertension 1059-9·12A
Platelet-Derived Vascular Endothelial Growth Factor in 
Patients With Hypertension: Relationship to Platelet 
Activation and Plasma Indices of Angiogenesis 
1161-175·522A
Soluble CD40 Ligand in Pulmonary Arterial 
Hypertension: Possible Pathogenic Role of 
Interaction Between Platelets and Endothelial Cells 
1123-187·503A
Superior Early Platelet Inhibition by 600mg Clopidogrel 
Loading in Elective Stenting 1100-62·65A
The Long-Term Clinical Results of a Platelet 
Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: 
ReoPro®) Coated Stent in Patients With Coronary 
Artery Disease 1139-53·84A
Use of Administrative Databases May Lead to Incorrect 
Estimates of the Effects of Nonaspirin Nonsteroidal 
Anti-Inflammatory Drugs on MIyocardial Infarction 
Risk 1172-67·420A
Point-of-services
Detection of Aspirin Resistance in Subjects With 
Multiple Risk Factors for Cardiovascular Disease 
1141-197·511A
The Effect of Chart Review, Feedback, and a 
Hand-Held Management Program on Blood Pressure 
Control in Hypertensive Patients: The PROMPT 
Study 1085-198·484A
Preexcitation
AMP Kinase Disease in Hypertrophic Cardiomyopathy: 
Evidence for a Multisystem Storage Disorder 
1032-128·166A
Pregnancy
Alterations in Cell Signaling Pathways During 
Pregnancy and Postpartum Cardiac Remodeling  
849-5·226A
Outcomes of Peripartum Cardiomyopathy in the Current 
Era of Heart Failure Management  834-5·205A
Pregnancy in Women With Corrected Tetralogy of Fallot 
1095-206·???
Pressure-volume relation
Enhanced Left Ventricular Systolic Function Early in 
Type II Diabetic Mice 1011-107·155A
L-Type Calcium Channel Inhibitor Diltiazem Prevents 
Diastolic Dysfunction and Stress-Induced Cardiac 
Decompensation and Death in a Mouse Model of 
Familial Hypertrophic Cardiomyopathy 
1144-132·220A
Prevention
Aggressive Treatment of Atrial Fibrillation Reduces 
Stoke Following Cardiac Surgery 1115-72·411A
B-type Natriuretic Peptide Levels Predict Postoperative 
Atrial Fibrillation in Patients Undergoing Cardiac 
Surgery  408-4·535A
Bariatric Surgery Is Effective in Controlling Major Risk 
Factors for Atherosclerosis in Obese Patients With 
Coronary Artery Disease 1096-75·409A
Carotid Artery Intima-Media Thickness Progression 
Rates in Young Adults: The Bogalusa Heart Study 
1082-188·478A
Cholesterol Goal Attainment Is Associated With Lower 
Incidence of Cardiovascular Events and Cost of Care 
1047-187·464A
Coronary Artery Bypass Grafting: Are We Getting With 
the Program? 1077-75·407A
Correlates of Elevated C-Reactive Protein Among 
Adults in the United States: Findings From the 
1999-2000 National Health and Nutrition Examination 
Survey  812-3·475A
Depression in Smokers Hospitalized With Acute 
Cardiovascular Disease Increases Nicotine 
Withdrawal Symptoms and Early Relapse to Smoking 
1153-72·417A
Distal Protection Device Was Associated With Better 
Left Ventricular Function by Improving 
Microcirculation After Primary Coronary Intervention 
1120-43·75A
Effect of Apolipoprotein E, Gender, and Exercise on 
Lipase Activities 1116-30·26A
Effects of Fish Oil Supplements on Human Myocardial 
Omega-3 Fatty Acid Levels and Correlations With 
Erythrocytes  883-3·305A
Erectile Dysfunction of Vascular Origin Is Associated 
With Generalized Endothelial Dysfunction 
1066-196·471A
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Exercise Training Reduces Vascular Inflammation in 
Patients With Cardiovascular Risk or Disease 
1165-105·232A
Getting Risk Factors to Goal: Lifestyle Intervention Is 
Worth the Effort in Patients With Hypertension, 
Hyperlipidemia, and/or Hyperglycemia 1116-32·27A
High Levels of Leisure Time Physical Activity Reduce 
Subclinical Atherosclerosis in Asymptomatic Women 
1059-25·16A
Incidence of Malignant Ventricular Tachycardia in 
Patients With Prophylactic Defibrillator Implantation 
Does Not Differ From Event Rates in Patients Treated 
for Survived Cardiac Arrest 1105-175·491A
Increased Subclinical Atherosclerosis in Young Adults 
With Metabolic Syndrome: The Bogalusa Heart Study 
1028-174·455A
Independent Information Provided by Framingham Risk 
Algorithm and Coronary Calcium Scores in a Large 
German Population Sample: Heinz Nixdorf Recall 
Study 1093-142·334A
Inpatient Cardiac Risk Factor Management Program 
Can Promote Therapeutic Lifestyle Change 
1124-190·503A
Noise Exposure and the Risk of Myocardial Infarction 
1096-72·408A
Nonhigh-Density Lipoprotein Cholesterol per National 
Cholesterol Education Panel and Advanced 
Lipoprotein Analysis: Correlation and Relationship to 
Premature Coronary Artery Disease  820-3·486A
Obesity Does Not Attenuate the Effectiveness of 
Low-Dose Dalteparin in Preventing Venous 
Thromboembolism in Medically Ill Patients 
1123-182·501A
Patients at Risk for Recurrent Embolism After 
Percutaneous Closure of Patent Foramen Ovale for 
Presumed Paradoxical Embolism 1001-27·7A
Physical Inactivity and Increased Thrombotic Risk: The 
Framingham Heart Study  876-4·239A
Prediction of Mortality Risk in the Very Old: Incremental 
Value of Inflammatory Mediators and Surrogate 
Markers of Atherosclerosis 1128-122·212A
Pulse Pressure Is the Best Predictor of Cardiovascular 
Mortality in 12,763 Middle-Aged Men of the Seven 
Countries Study: 25-Year Follow-Up  873-3·528A
Reduced Adverse Event Rates After Transcatheter 
Closure of Patent Foramen Ovale When Using the 
Amplatzer-PFOTM Compared to the CardioSealTM 
Device 1019-206·???
Regular Exercise Improves Risk Profile and Motor 
Development in Early Childhood 1161-181·523A
Risk Factors for and Inadequate Prophylaxis Against 
Upper Extremity Deep Vein Thrombosis  858-1·524A
Risk of Cardiovascular Disease in US Persons With 
Metabolic Risk Factors, Diabetes, and Elevated 
C-Reactive Protein  820-2·486A
The American Heart Association Get With the 
Guidelines Coronary Artery Disease Program 
Improves Care for Patients of All Ages 1059-27·16A
The Duke Treadmill Score and Cardiac Mortality in 
Asymptomatic Women: The St James Women Take 
Heart Project  876-1·238A
Prognosis
50-Year Heart Failure Mortality for England and Wales 
1069-105·178A
A Pretest Score Used in Patients With Suspected 
Coronary Disease Referred for Pharmacologic Stress 
Testing Stratifies Well According to Cardiac Death but 
Not All-Cause Mortality 1146-113·224A
Abnormal Hemodynamic Response to Adenosine and 
Poststress Left Ventricular Ejection Fraction Provide 
Incremental Prognostic Information in Patients 
Undergoing Gated Myocardial Perfusion SPECT 
1170-144·368A
Admission Polymorphonuclear Cells Count Is a Better 
Risk Stratification Soluble Marker Than Troponin I 
and C-Reactive Protein in Patients With Unstable 
Angina 1042-88·260A
An Analysis of Patients With Hypertrophic Obstructive 
Cardiomyopathy and Persisting New York Heart 
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Effects of Intracoronary Low-Dose Enalaprilat on QT 
Dynamicity in Patients Undergoing Direct 
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Prognostic Significance of Dipyridamole-Induced 
ST-Segment Depression in Patients With Normal 
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Myocardial Infarction 1036-156·314A
Can Stress Myocardial Perfusion SPECT Risk Stratify 
Patients With High Duke Treadmill Scores 
Cost-Effectively? 1056-162·325A
Chronotropic Stress Enhances the Effects of 
Asynchronous Left Ventricular Activation on 
Myocardial Perfusion in Patients With Idiopathic 
Dilated Cardiomyopathy and Left Bundle Branch 
Block 1164-130·231A
Comparative Long-Term Prognostic Value of 
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Interaction of Age and Gender on Risk Stratification of 
Diabetic Patients With Rest/Stress ECG-Gated 
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Myocardial Sympathetic Denervation Precedes the 
Neurological Involvement in Patients With Familial 
Amyloidotic Polyneuropathy 1056-160·324A
Noninvasive Detection of Angiogenesis With a 
Technetium-99m Labeled Peptide Targeted at _vβ3 
Integrin Following Hindlimb Ischemia 1116-23·25A
Physiological Assessment of Coronary Artery Stenosis 
Using Transthoracic Doppler Echocardiography at 
Rest: Comparison of Flow Velocity Pattern Analysis 
With Exercise Thallium SPECT 1073-143·326A
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Assessing the Need for Repeat Baseline Exercise Tests 
in Heart Failure Patients: Early Experience From 
HF-ACTION 1033-109·167A
Can the Response to Exercise Training Be Predicted in 
Patients With Heart Failure? 1108-125·200A
Effect of Exercise Training on Sleep Disordered 
Breathing in Severe Heart Failure Patients 
1108-124·200A
Exercise Training Meta-Analysis of Trials in Chronic 
Heart Failure Patients (ExTraMATCH)  876-6·239A
Measurement Versus Calculation of Training Heart Rate 
in Patients With Coronary Artery Disease Treated by 
Beta-Blockers 1165-107·232A
Modulatory Effect of Inflammation on Blood Pressure 
Reduction Following Therapeutic Lifestyle Change 
via Cardiac Rehabilitation and Exercise Training 
1161-177·522A
Prevalence and Effects of Cardiac Rehabilitation on 
Hostility in Young Coronary Patients 1165-108·232A
Prognostic Impact of Depression Following Myocardial 
Infarction: A Meta-Analysis 1115-75·411A
Somatosensory Stimulation as an Alternative for 
Exercise to Enhance the Arterial Baroreflex 
1165-104·232A
Submaximal Effort Tolerance After Cardiac 
Rehabilitation Is a Strong and Age-Independent 
Predictor of All-Cause Mortality  876-5·239A
Reimbursement
Potential Impact of MADIT II and the Centers for 
Medicaid Services Criteria on Care of Patients 
Diagnosed With Myocardial Infarction  846-3·419A
Renal circulation
Assessment of Renal Artery Stenosis by 3-D 
Contrast-Enhanced and 3-D Phase-Contrast 
Magnetic Resonance Angiography: A Comparison 
With Conventional X-Ray Angiography 
1055-156·323A
Severe Renal Artery Stenosis Is Common in Patients 
With Severe Thoracic Aortic Plaque 1046-175·461A
The Impact of Percutaneous Renal Artery 
Revascularization on QT Dispersion in Patients With 
Hypertensive Heart Disease.  848-5·516A
Renal function
Adverse Events in Patients With Normal Renal Function 
Are Increased With Modest Increases in Creatinine 
Clearance After Percutaneous Coronary Intervention 
1062-42·47A
Association of Glomerular Filtration Rate on 
Presentation With Subsequent Mortality in Non- ST 
Elevation Acute Coronary Syndromes 
1021-101·250A
Beneficial Effect of Oral Acetylcysteine for Prevention of 
Contrast-Induced Nephropathy in Patients With Renal 
Insufficiency: A Meta-Analysis 1141-191·509A
Blood Glucose Level Predicts Severity of Renal and 
Myocardial Injury in Diabetic Patients Undergoing 
Coronary Interventions 1062-48·49A
Clinical and Pathologic Characteristics of Dilated 
Cardiomyopathy in Dialysis Patients 1127-133·211A
Clinical Outcome Following Percutaneous Coronary 
Intervention in Patients With End-Stage Renal 
Disease 1062-49·49A
Cystatin C, a Novel Risk Marker for Mortality in the 
General Population: Data Obtained From the 
PREVEND Study 1159-194·519A
Does Statin Therapy Reduce Contrast-Induced 
Nephropathy? An Analysis From a Large Regional 
Registry of Contemporary Percutaneous 
Interventions 1172-68·420A
Effect of Nesiritide on Renal Function After Implantation 
of the AbioCor Total Artificial Heart 1059-30·17A
Effect of Percutaneous Transluminal Renal Artery 
Angioplasty With Stenting on Renal Function in 
Patients With Atherosclerotic Renal Artery Stenosis  
877-3·100A
Global Renal Revasculatization Preserves Renal 
Function in Diabetic and Nondiabetic Patients With 
Renal Insufficiency 1046-168·460A
High-Normal Creatinine: An Underappreciated 
Predictor of Poor Outcomes in Chest Pain Patients 
1098-80·278A
Hypothermia, but Not N-Acetylcysteine or Fenoldopam, 
Prevents Experimental Contrast-Induced 
Nephropathy 1062-44·48A
Impact of Renal Insufficiency and Chronic Diuretic 
Therapy on Outcome and Resource Utilization in 
Patients With Acute Decompensated Heart Failure 
1069-114·180A
Left Ventricular Mass Reduction in Type 1 Diabetes 
Mellitus 1145-120·221A
Microalbuminuria Predicts Coronary Microvascular 
Dysfunction in Hypertensive African Americans With 
Left Ventricular Hypertrophy  873-4·528A
Nesiritide Does Not Improve Renal Function in Patients 
With Chronic Heart Failure and Worsening Creatinine 
1088-126·191A
Poor Outcome in Subsets of Renal Failure Patients 
Undergoing Coronary Artery Bypass Surgery: 
Mortality Results From a Cohort of 4,069 Patients  
809-5·269A
Prevention of Contrast-Agent-Induced Nephropathy in 
Patients Undergoing a Coronary Procedure by 
Ascorbic Acid 1062-45·48A
Prognostic Significance of B-Type Natriuretic Peptide in 
the Hemodialysis Patient  810-3·474A
Renal Function Predicts Outcomes in Acute Coronary 
Syndromes: Insights From the CURE Trial 
1098-79·278A
Renal Transplant Function as a Risk Factor for 
Cardiovascular Events and for All Cause Mortality in 
a Renal Transplant Population: Experience From the 
ALERT Trial 1116-33·27A
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Undergoing Coronary Artery Bypass Surgery: 
Mortality Results From a Cohort of 4,069 Patients  
809-5·269A
Predictors of Reinfarction After ST Elevation Myocardial 
Infarction and Glycoprotein Receptor Blockade: 
Analysis From the CADILLAC Trial 1061-100·266A
Preliminary Experience With the Front Runner 
Coronary Catheter, Novel Device Dedicated to 
Mechanical Revascularization of Chronic Total 
Occlusions 1080-44·56A
Racial Differences in Utilization of Primary Prevention 
Strategies and Cardiac Catheterization Following 
First Myocardial Infarction 1097-99·277A
Sex Differences in Invasive Cardiac Procedures in the 
Elderly: 1993-1999 1135-68·412A
Target Vessel Revascularization During the First Month 
After Bare Metal Coronary Stenting: Clinical 
Indications and Angiographic Findings 1081-59·61A
The Effect of State Mandated Continuing Medical 
Education on the Use of Proven Therapies in Patients 
With an Acute Myocardial Infarction 1040-69·401A
The Long-Term Clinical Results of a Platelet 
Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: 
ReoPro®) Coated Stent in Patients With Coronary 
Artery Disease 1139-53·84A
The Medicine, Angioplasty, or Surgery Study (MASS II): 
Analyses in Male and Female Populations of Medical 
Therapy, Coronary Angioplasty, and Bypass Surgery 
Study During the First Year of Follow-Up 
1099-86·280A
The Medicine, Angioplasty, or Surgery Study (MASS II): 
Quality of Life of Patients With Symptomatic 
Multivessel Coronary Disease-24 Months of 
Follow-Up 1115-67·409A
The Real-World Clinical Practice of Intracoronary 
Radiation Therapy as Compared to Investigational 
Trials 1080-63·57A
TIMI, PURSUIT and GRACE Risk Scores in Acute 
Coronary Syndromes: Comparison and Interaction 
With Myocardial Revascularization 1098-77·277A
Rheumatic heart disease
Neoangiogenesis via Vascular Endothelial Growth 
Factor Expression Is Associated With an 
Osteoblast-like Bone Formation in Calcified 
Rheumatic Heart Valves 1107-135·433A
Rhythm disorders
The Prognostic Significance of Right Bundle Branch 
Block Associated With Additional Conduction 
Abnormalities 1072-210·119A
The World Trade Center Attack: Increased Frequency of 
Defibrillator Shocks for Ventricular Arrhythmias in 
Patients Living Remotely From New York City 
1091-210·125A
Risk factors
A Bayesian Network to Evaluate Risk Factors Profiles in 
Patients With Coronary Artery Disease 
1020-74·400A
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A Modified Diamond-Forrester Score Accurately 
Identifies Asymptomatic Patients With a High 
Coronary Artery Calcium Score 1093-141·334A
A Synergistic Interaction Between Premature Family 
History of Coronary Heart Disease and Metabolic 
Risk Factors Enhances Risk of Subclinical 
Atherosclerosis 1028-167·453A
Amlodipine/Atorvastatin Single Pill Dual Therapy 
Improves Goal Attainment in the Treatment of 
Concomitant Hypertension and Dyslipidemia: The 
Gemini Study 1008-190·447A
Anthropomorphic Predictors of Insulin Sensitivity in a 
Healthy Population 1124-195·504A
Antibodies to Infectious Pathogen Are Associated With 
Hypertension 1059-10·12A
Aspirin Resistance Is Associated With a Single 
Nucleotide Polymorphism in the P2Y1 ADP Receptor 
Gene  847-3·515A
Association of Coronary Heart Disease With 
Interleukin-1 Gene Variants in the Atherosclerosis 
Risk in Communities Study 1028-166·453A
Asymmetric Dimethylarginine and the Risk of Coronary 
Heart Disease: Relationship With Traditional Risk 
Factors as Assessed in the Multicenter CARDIAC 
Study  847-4·515A
Blood Pressure Response to Strength Training Is 
Influenced by AGT (-20) Genotype in the Elderly 
1161-171·521A
C-Reactive Protein Levels and Race/Ethnicity  
858-4·524A
Can We Predict Sudden Death After Atrial Repair for 
Transposition of the Great Arteries? 1095-202·385A
Cardiac Troponin Elevations in Marathon Runners: 
Prevalence and Risk Factors  408-2·534A
Cardiovascular Disease in the Elderly: The Association 
of Self-Reported Health Behavior With Clinical 
Outcomes 1128-128·213A
Cardiovascular Risk Factors and Outcomes in Patients 
With Definite Endocarditis: The International 
Collaboration on Endocarditis – Prospective Cohort 
Study  868-2·441A
Cardiovascular Risk Factors as Correlates of Erectile 
Dysfunction: Results of a Survey in 71,503 Men in 
Brazil 1096-74·409A
Case Method Learning Is a Cost Effective 
Implementation Method of Evidence Based 
Secondary Prevention in Primary Care 1096-69·408A
Combination Aspirin and Statin Therapy Markedly 
Reduces C-Reactive Protein Levels in a High-Risk 
Population Without Coronary Disease  847-2·514A
Constellation of Risk Variables of Metabolic Syndrome 
at Low Levels in Childhood Is Beneficially Associated 
With Adulthood Cardiovascular Risk: The Bogalusa 
Heart Study  847-1·514A
Coronary Flow Velocity Reserve <2.0 by Transthoracic 
Doppler Echocardiography Can Detect Myocardial 
Ischemia Assessed by 201-Thallium Schintigraphy in 
a Large Population With Coronary Risk Factors  
866-5·373A
Coronary Vascular Dysfunction Is Only Partially 
Predicted by Traditional Cardiovascular Risk Factors 
in Women Undergoing Evaluation for Suspected 
Ischemia: Results From the National Heart, Lung, 
and Blood Institue WISE Study  819-3·484A
Correlates of Elevated C-Reactive Protein Among 
Adults in the United States: Findings From the 
1999-2000 National Health and Nutrition Examination 
Survey  812-3·475A
Current Percutaneous Transluminal Coronary 
Angioplasty Practice and Clinical Outcomes in the 
Netherlands: The Real World 1043-49·43A
Cystatin C, a Novel Risk Marker for Mortality in the 
General Population: Data Obtained From the 
PREVEND Study 1159-194·519A
Depression in Smokers Hospitalized With Acute 
Cardiovascular Disease Increases Nicotine 
Withdrawal Symptoms and Early Relapse to Smoking 
1153-72·417A
Depression Is Strongly Associated With Worse Health 
Status in Patients With Myocardial Infarction 
Complicated by Heart Failure: Data From the 
EPHESUS Trial 1115-71·410A
Depression Predicts Mortality and Hospitalization in 
Patients With Acute Myocardial Infarction 
Complicated by Heart Failure: Data From the 
EPHESUS Trial 1069-111·179A
Difference in Subclinical Atherosclerosis in Brazilian 
and Portuguese Populations 1093-148·336A
Do Differing C-Reactive Protein Assay Methods Impact 
Cardiovascular Risk Assessment? 1117-86·288A
Does Chronic Infection With Chlamydia Pneumoniae 
Influence the Prognosis of Acute Coronary 
Syndromes? Insights From a Nested Matched 
Case-Control Substudy of the GUSTO IV Acute 
Coronary Syndromes Trial 1042-78·257A
Dynamic Modeling of ST Elevation Acute Myocardial 
Infarction: Insights From COMMA 1098-82·279A
Early Morning Impairment of Endothelial Function in 
Healthy Humans 1065-174·469A
Echocardiographic Correlates of Pulmonary 
Hypertension in 2,337 Patients 1159-189·518A
Effect of Body Mass Index on Long-Term Mortality in 
Patients Undergoing Coronary Artery Bypass Graft 
1115-76·411A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Intima-Media-Thickness in 
Microalbuminuric Patients Without Hypertension 
1007-172·443A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Urinary Albumin Excretion  
825-3·495A
Elevated Parathyroid Hormone Is an Important 
Predictor of Coronary Events in Patients With Chronic 
Hemodialysis 1137-101·298A
Enhanced Coronary Artery Disease Risk by Combining 
Pathogen Burden, C-Reactive Protein and Heat 
Shock Protein 60 Antibodies in the Absence of Heat 
Shock Protein 70 1103-170·488A
Framingham Risk Estimate Is Weakly Correlated With 
Coronary Artery Calcification in Asymptomatic 
Population  845-2·363A
Functional Interplay Between Endothelial Dysfunction 
and Platelet Activation in Patients With Stable 
Coronary Heart Disease 1027-183·450A
Getting Risk Factors to Goal: Lifestyle Intervention Is 
Worth the Effort in Patients With Hypertension, 
Hyperlipidemia, and/or Hyperglycemia 1116-32·27A
Global Risk Score and Exercise Testing for Predicting 
All-Cause Death in a Preventive Medicine Program  
876-2·238A
Hemoglobin Level Is Associated With Mortality and 
Hospitalization in Patients With Severe Chronic Heart 
Failure: Results From the COPERNICUS Study  
842-2·216A
High Risk of Obstructive Sleep Apnea in Patients With 
Atrial Fibrillation 1014-209·105A
High- but Not Low-Dose Folic Acid Improves 
Endothelial Function in Coronary Artery Disease 
1159-186·517A
High-Density Lipoprotein-Mediated Cholesterol Efflux 
From Cells Is a Strong Independent Predictor of 
Cardiovascular Risk 1047-181·463A
Hip Ratio Cutoffs Associated With Metabolic Risk 
Factors and Subclinical Coronary Atherosclerosis in 
Nonobese Asymptomatic Men 1105-171·491A
Holter-Based Risk Stratifiers May Increase 
Cost-Effectiveness of Defibrillator Therapy in MADIT 
II-Like Patients 1015-217·107A
How Low Is Optimal Blood Pressure With Respect to 
Hypertension Risk? 1009-167·448A
Impact of In Vivo Generation of 8-Isoprostaglandin F2_ 
After a 30-Minute Passive Smoking Exposure on 
Flow-Mediated Enothelium-Dependent Dilation of the 
Brachial Artery 1105-173·491A
Importance of an Oral Glucose Tolerance Test in 
Identifying High Prevalence of Dysglycemia in 
Individuals at High Cardiovascular Risk 
1128-120·211A
Increased Coronary Atherosclerosis in Persons With 
Chronic Spinal Cord Injury 1093-149·336A
Influence of Microsomal Triglyceride Transfer Protein - 
493G/T Polymorphism on Cardiovascular Events 
After Myocardial Infarction in Diabetic Patients 
1137-102·299A
Inpatient Cardiac Risk Factor Management Program 
Can Promote Therapeutic Lifestyle Change 
1124-190·503A
Insulin Enhances Vascular Cell Adhesion Molecule -1 
Expression in Human Cultured Endothelial Cells: A 
Link to the Pathogenesis of Accelerated 
Atherosclerosis in Diabetes 1106-182·493A
Investigation of a Unique Approach to Patient 
Interactive Education: The Audience Response 
Method 1153-69·417A
Is Asymmetric Dimethylarginine a Marker for Diabetes, 
Coronary Artery Disease, and Death/Myocardial 
Infarction? Results of the Intermountain Heart 
Collaborative Angiographic Registry Study 
1028-168·454A
Lack of Predictive Risk Factors for Adverse Interstage 
Events After Norwood Palliation Necessitates Routine 
Surveillance Monitoring  857-3·395A
Long-Term Effectiveness of the Management of 
Dyslipidemia With a Planned Strategy of 
Management 1047-184·463A
Long-Term Secondary Prevention With Folic Acid: No 
Effects on Clinical Outcomes (the GOES Extension 
Study)  825-6·496A
Measurement of Endothelial Dysfunction With an 
Observer-Independent Magnetic Resonance 
Approach 1065-169·468A
Metabolic Syndrome and Cardiovascular Risk Profile in 
Patients With Myocardial Infarction  812-5·475A
Metabolic Syndrome and Prevention of Premature 
Coronary Artery Disease 1124-194·504A
Metabolic Syndrome: An Underecognized Risk Factor 
for Myocardial Infarction in the Young 1021-100·249A
Modulating Effects of Cholesterol Elevation by 
Diet-Feeding and Cholesterol Lowering by 
Simvastatin on Platelet-Activating Factor 
Acetylhydrolase Activity, Paraoxonase Activity, and 
Lysophosphatidylcholine Concentration 
1083-189·478A
N-Terminal Pro-Brain Natriuretic Peptide and Urinary 
Albumin Excretion Is Independent Predictors of All 
Cause Mortality in the General Population 
1049-118·173A
N-Terminal Pro-Brain Natriuretic Peptide Can Identify 
High and Low Risk Patients With Hypertension and 
Preserved Left Ventricular Systolic Function in the 
General Population 1161-178·523A
Nonhigh-Density Lipoprotein Cholesterol per National 
Cholesterol Education Panel and Advanced 
Lipoprotein Analysis: Correlation and Relationship to 
Premature Coronary Artery Disease  820-3·486A
Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO™) to Prevent Stroke in Patients 
With Atrial Fibrillation: Interim Results of the 
Multicenter Feasibility Trial 1005-65·33A
Plasma B-Type Natriuretic Peptide in Obstructive Sleep 
Apnea 1049-111·171A
Plasma Leptin Level Is an Important and Independent 
Predictor of Prognosis in Patients With Established 
Coronary Atherosclerosis  408-5·535A
Postprandial Lipoproteinemia Exhibits a Bimodal 
Response in Metabolic Syndrome Patients 
1047-185·464A
Predictive Risk Factors for Coronary Events in Renal 
Transplant Patients 1124-191·503A
Predictors of Major Hemorrhage Following Initiation of 
Warfarin Therapy 1007-177·444A
Preservation of Brachial Artery Endothelial Function in 
Otherwise Healthy Patients With Obstructive Sleep 
Apnea 1105-178·492A
Prevalence and Prognostic Implications of Transient 
ST-Segment Elevation Early After Primary 
Angioplasty for ST-Segment Elevation Myocardial 
Infarction 1015-220·108A
Prevention of Atrial Fibrillation in Symptomatic Chronic 
Heart Failure by Candesartan: Results From CHARM 
1145-122·222A
Production of Reactive Oxygen Species by 
Mononuclear Cells Correlates With the Severity of 
Coronary Heart Disease and NADPH Oxidase 
Expression 1082-181·476A
Prognostic Implications of Nonsustained Ventricular 
Tachycardia Early After ST Elevation Myocardial 
Infarction Treated With Fibrinolysis or Primary 
Angioplasty 1116-36·28A
Progression of Aortic Valve Calcification Measured by 
Electron Beam Computed Tomography: A 
Population-Based Study 1107-136·433A
Protective Role of Low C-Reactive Protein Levels 
Against Classical Risk Factors for Coronary 
Atherosclerotic Disease 1119-98·293A
Pulmonary Edema Prognostic Score: A Novel Simple 
Prognostic Tool for Short-Term Events in Acute 
Cardiogenic Pulmonary Edema 1108-110·197A
Pulse Wave Velocity Measured by Complior Method in 
a Brazilian Young Population Followed-Up for a 13 
Year-Period: The Rio de Janeiro Study 
1142-188·514A
Racial Differences in Utilization of Primary Prevention 
Strategies and Cardiac Catheterization Following 
First Myocardial Infarction 1097-99·277A
Regular Exercise Improves Risk Profile and Motor 
Development in Early Childhood 1161-181·523A
Risk Factors for and Inadequate Prophylaxis Against 
Upper Extremity Deep Vein Thrombosis  858-1·524A
Serum Inflammatory Markers Correlate With 
Hemoglobin Levels in Women Undergoing Evaluation 
for Suspected Ischemia: Results From the National 
Heart, Lung, and Blood Institute WISE Study  
847-6·515A
Serum Uric Acid and Ischemic Stroke Risk Among 
Hypertensive Patients With Left Ventricular 
Hypertrophy: The Losartan Intervention for Endpoint 
Reduction in Hypertension (LIFE) Study  812-4·475A
Serum Uric Acid and Risk for Development of 
Hypertension: The Normative Aging Study 
1161-179·523A
Shock in Patients With Acute Aortic Dissection: Clinical 
Characteristics, Risk Factors, and Outcomes 
1116-10·22A
Should Volume Influence Patient Choice of Hospital for 
Aortic Valve Replacement?  846-2·419A
Simple Risk Score Predicts Myocardial Infarction and 
Cardiovascular Death at 30 Days After Percutaneous 
Coronary Intervention: An Analysis of the 
REPLACE-2 and TARGET Data 1043-65·44A
Soluble CD40 Ligand in Predicting Coronary Artery 
Disease and Long-Term Outcomes in Stable Patients 
With Angiographically Defined Disease States 
1137-97·297A
Speed of QT Rate Adaptation Predicts Risk in 
Myocardial Infarction Survivors 1015-221·108A
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Submaximal Effort Tolerance After Cardiac 
Rehabilitation Is a Strong and Age-Independent 
Predictor of All-Cause Mortality  876-5·239A
Suboptimal Treatment of Patients With Non-ST 
Elevation Acute Coronary Syndromes Presenting 
With Positive Baseline Troponin Values 
1154-90·300A
Systolic Blood Pressure Measured Serially From 
Childhood to Adulthood Predicts Arterial Stiffness in 
Young Adults: The Bogalusa Heart Study  
847-5·515A
The Association of Plasma Homocysteine With 
Coronary Artery Atherosclerosis Is Modified by 
Conventional Risk Factors 1093-146·335A
The Combined Impact of Metabolic Syndrome and 
Physical Inactivity on Subclinical Atherosclerosis in 
the Asymptomatic Population 1116-17·23A
The Impact of Deep Sternal Wound Infection on 
Long-Term Survival After Coronary Artery Bypass 
Grafting  809-2·268A
The Impact of Prior Myocardial Infarction, Metabolic 
Syndrome, and High White Blood Cell Count on 
Coronary Heart Disease Mortality: The Multiple Risk 
Factor Intervention Trial (MRFIT) 18-Year Follow-Up 
Experience  838-6·416A
The Interleukin–174G/C Polymorphism Is a Powerful 
Predictor for Restenosis After Coronary Stent 
Implantation   803-3·54A
The Predictive Value of Parental History of Coronary 
Disease 1028-169·454A
TIMI, PURSUIT and GRACE Risk Scores in Acute 
Coronary Syndromes: Comparison and Interaction 
With Myocardial Revascularization 1098-77·277A
Traditional Risk Factors Are Associated With Regional 
Left Ventricular Dysfunction in Asymptomatic 
Individuals: The Multi-Ethnic Study of Atherosclerosis 
(MESA) 1163-115·228A
Treatment Patterns for Hypertension, Dyslipidaemia, 
and Both Conditions in the United Kingdom: 1997 to 
2001 1161-182·523A
Vascular Compliance Versus Endothelial Function: 
Which Correlates Better to Risk Factor Score? 
1065-171·468A
Virtual Histology of Intravascular Ultrasound Images: 
Feasibility and Clinical Correlations in Humans 
1006-56·33A
Which Is the Best Pharmacological Treatment for 
Obese Hypertensive Patients With Hyperuricemia? 
1161-180·523A
Risk factors, gender-related
Adverse Outcomes in Women Undergoing 
Percutaneous Coronary Intervention 1043-64·44A
Aldosterone and Plasma Renin Activity Influence 
Plasma Plasminogen Activato Inhibitor-1 Levels in 
Overweight Subjects 1007-182·445A
Does Indexation to Fat-Free Mass Eliminate or Reverse 
Gender Differences in Left Ventricular Mass? 
1142-181·512A
Effect of Lipid Subfractions on Progression of Coronary 
Artery Disease Among Middle-Aged Women 
1116-33A·27A
Evaluation of B-Type Natriuretic Peptide Levels in 
Normal and Pre-Eclamptic Women During Pregnancy 
1049-109·171A
Five-Year Survival Data From the APRICOT Trials: 
Does Female Gender Really Portend Unfavorable 
Outcome? 1137-100·298A
Gender Differences in the Risk Factors Contributing to 
Carotid Intima-Medial Thickness: The Johns Hopkins 
Sibling Study 1082-184·477A
Gender- and Age-Related Differences in the Prognostic 
Value of C-Reactive Protein in Patients With 
Angiographic Coronary Artery Disease 
1098-83·279A
Hypoxia Increased Matrix Metalloproteinase Activity 
and Superoxide Formation Before Atherosclerosis in 
Female Artery of Apolipoprotein E-Knockout Mice 
1140-175·508A
In Women With Symptoms of Ischemic Heart Disease, 
Global and Regional Myocardial Perfusion Status by 
Magnetic Resonance Imaging Better Assigns Risk: 
Results From the National Heart, Lung, and Blood 
Institute-Sponsored Women's Ischemia Syndrome 
Evaluation (WISE)  801-1 ·266A
Low High-Density Lipoprotein Cholesterol, 
Hypertension, Diabetes, but Not High Low-Density 
Lipoprotein Cholesterol as Predictors of Acute 
Coronary Syndrome in Northern Area of Japan: A 
Case-Control Study 1047-180·463A
The Medicine, Angioplasty, or Surgery Study (MASS II): 
Analyses in Male and Female Populations of Medical 
Therapy, Coronary Angioplasty, and Bypass Surgery 
Study During the First Year of Follow-Up 
1099-86·280A
Septal defects
Do Patients of Advanced Age Benefit From 
Transcatheter Atrial Septal Defect Closure? 
1019-205·377A
Migraine Relief Following Transcatheter Closure of 
Patent Foramen Ovale 1019-200·376A
Reduced Adverse Event Rates After Transcatheter 
Closure of Patent Foramen Ovale When Using the 
Amplatzer-PFOTM Compared to the CardioSealTM 
Device 1019-206·???
Transthoracic Echocardiography Is Superior to 
Transesophageal Imaging for Detection of Right to 
Left Atrial Shunting 1059-34·18A
Serotonin
5-Hydroxytryptamine 4 (5HT4) Receptor mRNA 
Processing in Favor of the 'b' Isoform Correlates With 
Left Atrial Dilatation and May Predispose to Atrial 
Fibrillation After Coronary Artery Bypass Grafting 
1034-212·111A
Shock
B-Tpe Natriuretic Peptide Strongly Predicts Mortality in 
Intensive Care Unit Shock 1049-103·169A
Cardiogenic Shock in Patients With Preserved Left 
Ventricular Systolic Function: Characteristics and 
Insight Into Mechanisms  887-2·241A
Causes of Death in Patients With ST Elevation 
Myocardial Infarction Treated With Fibrinolysis 
1061-88·263A
Congestive Heart Failure and Cardiogenic Shock 
Complicating Acute Myocardial Infarction Have High 
Mortality and Are Associated With Intense 
Inflammatory Response: Results From the 
CARDINAL Trials 1118-101·291A
Dynamic Modeling of ST Elevation Acute Myocardial 
Infarction: Insights From COMMA 1098-82·279A
Echocardiographic and Angiographic Correlations in 
Cardiogenic Shock 1050-120·173A
Impact of Obesity on Cardiovascular Outcomes in 
Patients Undergoing Percutaneous Coronary 
Intervention: Is There Really a Paradox? 
1138-41·80A
Increased In-Hospital Mortality After Acute Myocardial 
Infarction in Patients With Impaired Fasting Glucose 
1021-78·248A
Levosimendan Is Safe and Effective in Patients With 
Severe Low Cardiac Output Heart Failure and Critical 
Hypotension 1088-125·191A
Long-Term Outcome of Patients With Cardiogenic 
Shock Complicating Acute Myocardial Infarction  
815-2·274A
Long-Term Survivors of Cardiogenic Shock Enjoy Good 
Functional Capacity, and a Strategy of Early 
Revascularization Is Protective Against Functional 
Class Deterioration and Death  815-3·275A
Natriuretic Peptides as Predictors of Clinical Course in 
Patients With End-Stage Heart Failure 
1049-107·170A
Randomized Comparison of Intra-Aortic Balloon 
Support Versus a Percutaneous Left Ventricular 
Assist Device in Patients With Acute Myocardial 
Infarction Complicated by Cardiogenic Shock  
856-4·234A
Shock in Patients With Acute Aortic Dissection: Clinical 
Characteristics, Risk Factors, and Outcomes 
1116-10·22A
Trends in Fibrinolytic Therapy and Intra-Aortic Balloon 
Pump Counterpulsation Utilization in Patients With 
Cardiogenic Shock Complicating Acute Myocardial 
Infarction in Hospitals Without Percutaneous 
Transluminal Coronary Angioplasty/Coronary Artery 
Bypass Graft Capability: Observations From the 
National Registry of Myocardial Infarction 1116-9·21A
Signal averaging
Abnormalities in Magnetocardiographic Atrial Signals in 
Patients With Focally Triggered Lone Atrial Fibrillation 
1148-224·142A
Arrhythmias and Cardiac Involvement in 
Non-Duchenne, Non-Myotonic Muscular Dystrophy  
850-5·143A
Evaluation of Electrocardiography, Signal Averaged 
Electrocardiography, Exercise Tolerance Testing, 
Echocardiography and Magnetic Resonance Imaging 
in Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia 1127-104·209A
Reverse Left Ventricular Remodeling by Carvedilol 
Reduces the Spatial Dispersion of QRS Duration in 
Patients With Chronic Heart Failure: A Prospective 
Placebo-Controlled Study 1148-226·142A
Right Ventricular but Not Biventricular Pacing Increases 
Markers of Ventricular Electrical Vulnerability  
874-1·149A
The Influence of Atrial and Ventricular Pacing on T 
Wave Alternans 1015-219·108A
Value of Signal-Averaged ECG and 
Electrophysiological Testing in Identifying 
Arrhythmogenic Right Ventricle Dysplasia Patients 
Who Do Receive Implantable Cardioverter 
Defibrillator Therapy  850-2·142A
Signal transduction
AKT Signaling in Pacing-Induced Heart Failure 
1144-131·219A
Atherogenic Low-Density Lipoprotein Impairs Vascular 
Endothelial Cell Survival by Disrupting the 
FGF2-PI3K-Akt Autoregulatory Loop 1122-171·499A
Biphasic Regulation of STAT1alpha Expression in 
Vascular Smooth Muscle Cells by Oxidized 
Low-Density Lipoprotein 1083-191·479A
Calmodulin Kinase Inhibition Improves Cardiac 
Function After Myocardial Infarction 1041-92·255A
Cardioprotective Effects of Rosiglitazone Against 
Ischemia-Reperfusion Injury Are Associated With 
Modulation of Angiotensin Receptor Expression and 
Signaling  883-5·305A
Dimerization of Mitogen-Activated Protein Kinase and 
Auto-Phosphorylation of Akt Occur in the Newly 
Differentiated Endothelial-Like Cells From Adult Bone 
Marrow Stem Cells In Vitro 1122-165·498A
Dynamic Intracardiac Calcium Transition in Very 
Early-Stage Ebryonic Mouse Heart Tube Regulated 
by G Protein Coupled Signal Pathway 
1110-216·129A
Epigallocatechin-3-Gallate Inhibits Stat-1 Activation and 
Protects Cardiac Myocytes From Ischemia/
Reperfusion–Induced Apoptosis 1041-98·256A
Epsilon Protein Kinase C (PKC) Activation by Delta 
PKC in Ethanol-Induced Cardiac Protection From 
Ischemia 1136-81·294A
High-Density Lipoprotein-Induced Tube Formation 
Requires the Activation of Ras/Raf/Mitogen-Activated 
Protein Kinase in Human Coronary Artery Endothelial 
Cells 1045-191·458A
Impact of Protein Kinase C-Epsilon for Myocardial 
Hypertrophy After Chronic Pressure Overload: 
In-Vivo Study in Protein Kinase C-Epsilon Knockout 
Mice 1029-180·456A
Inherent Sex Differences in the Ischemia-Induced 
Myocardial Inflammatory Response of Proestrus 
Females and Normal Males  801-5·267A
Inhibition of p38 Mitogen Activated Protein Kinase 
Mediates Endothelial Cell Survival During Cardiac 
Transplantation 1051-130·175A
Nicotine Administration Significantly Alters Peripheral, 
Bone Marrow and Splenic Stem Cell Populations in 
C57/Bl6 Mice. 1104-191·490A
Over-Expression of Fibronectin Involves Activation of 
Mitogen-Activated Protein-Kinase-Kinase of the 
Stress Activated Protein Kinase/C-Jun N-Terminal 
Kinase in Aortic Regurgitation 1067-135·430A
Pioglitazone Modulates Collagen Synthesis in 
Fibroblasts in Response to Angiotensin II 
1087-104·188A
Postconditioning by Repetitive I/R Cycles Subsequent 
to Myocardial Ischemia Protects the Rat Heart From 
Infarction and Is Dependent on the Activation of PI 
3-Kinase and mTOR 1136-80·294A
Protein Kinase C Epsilon Is Upstream and Protein 
Kinase C Alpha Is Downstream of MitoKATP 
Channels in the Signaling of Ischemic 
Preconditioning in the Human Myocardium 
1136-86·295A
Remote Preconditioning by Infrarenal Occlusion of the 
Aorta Protects the Rat Heart From Infarction by a 
Molecular Mechanism Involving Free Radicals and a 
p38 Mitogen Activated Protein Kinase Activation 
1136-87·295A
Thrombin and Histamine Stimulate Phosphorylation of 
Endothelial Nitric Oxide-Synthase via an 
Akt-Independent, AMP-Activated Kinase-Dependent 
Pathway 1122-174·499A
Tyrosine Kinase-Dependent Mechanism Occurs 
Downstream of Protein Kinase C Activation in the 
Pharmacological Preconditioning by Alpha-1 
Adrenoceptor Stimulation 1002-100·245A
Upregulation of Akt and Endothelial Nitric Oxide 
Synthase Induces Vascular Smooth Muscle Cell 
Differentiation in Hypertension In Vivo 
1161-172·521A
Urotensin II Modulates Collagen Synthesis and the 
Expression of Matrix Metallproteinase-1 and Nitric 
Oxide Synthase in Endothelial Cells 1122-168·498A
Versican Promoter Is a Target for the β-Catenin/Tcf-4 
Signaling Pathway in Vascular Smooth Muscle Cells  
867-6·527A
Sinoatrial node
Pacing Mode and Quality of Life in the Mode Selection 
Trial 1167-220·147A
The Sinus Nodal Tissue Arrangement Into the 
Musculature of the Terminal Crest: Implications in 
Ablation of Inappropriate Sinus Node Tachycardia? 
1090-213·123A
Sleep apnea
662A SUBJECT INDEX JACC March 3, 2004
KEY: Abstract Title, Session-abstract number•page number
Characteristics of Hypertensive Patients Associated 
With Obstructive Sleep Apnea 1009-165·448A
Echocardiographic Manifestations of Obstructive Sleep 
Apnea Syndrome at Rest and With Dobutamine: A 
Guide to Effective Medical Management 
1112-147·341A
Effect of Exercise Training on Sleep Disordered 
Breathing in Severe Heart Failure Patients 
1108-124·200A
High Risk of Obstructive Sleep Apnea in Patients With 
Atrial Fibrillation 1014-209·105A
Plasma B-Type Natriuretic Peptide in Obstructive Sleep 
Apnea 1049-111·171A
Preservation of Brachial Artery Endothelial Function in 
Otherwise Healthy Patients With Obstructive Sleep 
Apnea 1105-178·492A
Sleep disorders
Cardiac Resynchronization Therapy Improves Sleep 
Related Breathing Disorders in Patients With Chronic 
Heart Failure  879-4·152A
Does Sleep Loss Attenuate Coronary Circulation? 
1073-150·327A
Smoking
Atorvastatin Restores Endothelial Function in 
Normocholesterolemic Smokers  819-5·485A
Depression in Smokers Hospitalized With Acute 
Cardiovascular Disease Increases Nicotine 
Withdrawal Symptoms and Early Relapse to Smoking 
1153-72·417A
Do Elderly Patients With Acute Myocardial Infarction 
Show the "Smoker´s Paradox"? Results From the 
PPRIMM75 Registry 1128-131·214A
Genetic Polymorphism G894T on Endothelial Nitric 
Oxide Synthase Gene as a Risk Factor for 
Premature, Nonfatal Myocardial Infarction in Young 
Male Smokers  408-1·534A
Impact of In Vivo Generation of 8-Isoprostaglandin F2_ 
After a 30-Minute Passive Smoking Exposure on 
Flow-Mediated Enothelium-Dependent Dilation of the 
Brachial Artery 1105-173·491A
Is Smoking as Important a Risk Factor for Coronary 
Heart Disease in Asia as It Is in Primarily Caucasian 
Populations? 1135-75·414A
Reduced Inflammation and Neovascularization and 
Increased Fibrous Cap Thickness in Advanced Aortic 
Atherosclerotic Plaques From Cigarette Smokers 
1082-186·477A
Smoking-Related Endothelial Dysfunction and 
Increased Serum Levels of Proinflammatory 
Cytokines and Adhesion Molecules Are Reversible by 
Antioxidant Treatment 1159-185·517A
Sodium
Cardiac Structural and Functional Responses to Salt 
Loading in Spontaneosly Hypertensive Rats 
1142-185·513A
Hyponatremia: A Useful Marker for Early Risk 
Assessment in Acute ST Elevation Myocardial 
Infarction  826-6·283A
Predictors of Mortality in Patients Hospitalized With 
Worsening Heart Failure: Insights From the ACTIV in 
CHF Trial 1069-119·181A
The Benefit of Coronary Stenting in Small Vessels Is 
Dependent on Reference Vessel Diameter: Results 
From a Meta-Analysis of 11 Randomized Trials 
1081-47·58A
Sotolol
Randomized Trial of Two Antiarrhythmic Agents 
(Amiodarone and Sotalol) in Patients With Atrial 
Fibrillation for Whom Direct Current Cardioversion Is 
Planned  875-5·151A
Spectrum analysis
Depressive Symptoms Are Associated With Reduced 
Heart Rate Variability in Individuals Without Coronary 
Artery Disease 1072-215·120A
What Proportion of Patients With Heart Failure and 
Preserved Left Ventricular Systolic Function Has an 
Elevated Plasma Concentration of B-Type Natriuretic 
Peptide?  887-3·241A
ST segments
Brugada-Type Electrocardiographic Pattern and 
ST-Segment Alternans in Right Precordial Leads 
During Percutaneous Coronary Intervention of the 
Proximal Right Coronary Artery 1130-220·137A
Does the Presence of Q Waves in the Infarct-Leads at 
the Presentation of an ST Elevation Myocardial 
Infarction Predict 30-Day Outcome After Fibrinolytic 
Therapy? Results From the HERO-2 Trial 
1117-87·288A
High Prevalence in Pharmacological Responses Mimic 
Brugada Syndrome in Japanese-A Pure Na Channel 
Blocker, Pilsicainide Challenge Test in the Normal 
Heart 1072-218·121A
Outcomes Prediction With Continuous 12-Lead 
ST-Segment Recovery in ST Elevation Myocardial 
Infarction: Similarities or Differences With 
Thrombolytic Versus Direct Stenting Populations? 
1003-93·247A
Racial Differences in the Prognostic Value of the 
Electrocardiographic Strain Pattern in Hypertensive 
Patients: The LIFE Study  888-3 ·530A
Reproducibility and Interpretation of 
Magneto-Cardio-Gram Maps in Detecting Ischemia  
874-2·149A
Rheolytic Thrombectomy for the Treatment of Acute 
Myocardial Infarction in Patients With Angiographic 
Large Thrombus Burden: One-Year Results of the 
VeGAS 2 Acute Myocardial Infarction Registry 
1003-94·248A
ST-Segment Resolution, Time From Symptom Onset to 
Reperfusion, Thrombolysis in Myocardial Infarction 
Flow Grades, and Creatine Kinanse-Release: 
Association With Infarct Size as Assessed by Delayed 
Enhancement Magnetic Resonance Imaging  
836-6·354A
Stent
A Double-Blind Randomized Dose Finding Study of 
Gamma Radiation for In-Stent Restenosis 
1121-58·79A
A Novel Antirestenosis Effect of Paclitaxel-Eluting 
Stents 1158-51·94A
A Pooled Analysis of Sirolimus and Paclitaxel-Eluting 
Stent Trials 1155-83·89A
A Randomized Comparison of Cilostazol Versus 
Clopidogrel After Coronay Stenting: The Preliminary 
Results 1063-56·50A
A Randomized Placebo-Controlled Trial of Abciximab 
for Prevention of In-Stent Restenosis in Diabetic 
Patients After Coronary Stenting 1063-58·51A
A Randomized Study Comparing a 
Titanium-Nitride-Oxide Coated With an Uncoated 
Stent for Coronary Revascularization 1139-58·85A
A Randomized Trial Comparing Rheolytic 
Thrombectomy Before Infarct Artery Stenting With 
Stenting Alone in Patients Undergoing Percutaneous 
Coronary Intervention for Acute Myocardial Infarction  
829-6·286A
A Rational Approach to Coronary Stenting Prior to 
Noncardiac Surgery 1063-53·49A
A Systemic Inflammatory Response Reflected by 
Increased Soluble CD40 Ligand Is Evident Within 10 
Minutes of Coronary Stenting  878-1·101A
Abciximab Administration for the Prevention of 
Angiographic Restenosis in Small Coronary Arteries: 
Results From the Randomized ISAR-SMART-2 Trial 
1025-42·37A
Adjunctive Pharmacotherapy During Higher Risk 
Percutaneous Coronary Intervention: 
Eptifibatide-Based Antiplatelet Therapy Accompanied 
by Only Limited, Specific Antithrombin Therapy 
1004-53·31A
Adjunctive Treatment With a Stent-Based Ventricle to 
Coronary Artery Bypass (VSTENT™) in Patients 
With Multivessel Disease Undergoing Coronary 
Artery Bypass Surgery (ADVANTAGE) 1079-85·273A
Adverse Outcomes in Women Undergoing 
Percutaneous Coronary Intervention 1043-64·44A
An Intravascular Ultrasound Analysis From FUTURE I, 
the First Human Experience Using 
Everolimus-Eluting Stents: Six- and 12-Month 
Results 1139-60·85A
Angiographic No-Reflow Phenomenon in the Patients 
With Acute Myocardial Infarction After Percutaneous 
Transluminal Coronary Intervention 1003-89·246A
Arterial Closure Device Decreases Vascular 
Complications After Percutaneous Coronary 
Interventions 1063-66·53A
Arterial Retroperfusion by a Percutaneous Stent-Based 
Ventricle to Coronary Vein Bypass (VVPASSTM) 
1081-61·61A
Assessment of Coronary Artery Stent Patency With 
In-Stent Contrast Enhancement in Multirow Detector 
Computed Tomography Angiography 1018-148·313A
AST SLK-View™: A Novel Approach for Treatment of 
Bifurcation Lesions 1081-51·59A
Atorvastatin Therapy Reduces Markers of Myocardial 
Damage After Percutaneous Coronary Interventions? 
Preliminary Data From a Randomized Study 
1008-189·447A
Baseline Platelet Count Correlates With Ischemic 
Events and Mortality at Follow-Up After Percutaneous 
Coronary Intervention 1063-57·50A
Biolimus A9: A New Generation Rapamycin Analogue 
Inhibits Intimal Hyperplasia in a Porcine Model 
1139-52·84A
Bone Marrow and Neural Crest Derived Cells 
Contribute to In-Stent Restenosis 1121-47·76A
Brain Natriuretic Peptide Is Increased in Patients With 
Renal Artery Stenosis and It Significantly Decreases 
After Endovascular Stenting  877-4·101A
Can Intravascular Ultrasound Guided Cutting Balloon 
Angioplasty Before Stenting Be a Substitute for Drug 
Eluting Stent? Final Results of the Prospective 
Randomized Multicenter Trial Comparing Cutting 
Balloon With Balloon Angioplasty Before Stenting 
(Reduce III) 1138-66·82A
Cardiac Catheterization Simulator 1001-40·10A
Characterization of Neointimal Hyperplasia After 
Sirolimus-Eluting Stent Implantation in Patients With 
Previous Brachytherapy Failure: Insights From the 
SECURE Study 1121-61·80A
Clinical Outcomes From Patients Treated With 
Endovascular Stent Graft for Thoracic Aortic 
Aneurysms 1066-194·471A
Clopidogrel Resistance Is Associated With Cytochrome 
3A Polymorphism 1063-51·49A
Comparative Efficacy of Everolimus and Sirolimus 
Delivered via Polymeric Drug-Eluting Stents in the 
Porcine Coronary Model 1139-48·83A
Comparative Incidence of Angiographically Proven 
Early Stent Thrombosis in Unselected Sirolimus- and 
Paclitaxel-Eluting Stent Populations  862-4·98A
Comparison of Retrospectively 
Electrocardiogram-Gated, Multislice Spiral Computed 
Tomography and Selective Coronary Angiography in 
the Analysis of Stent Permeability After Left Main or 
Ostial Coronary Artery Angioplasty 1018-147·313A
Contribution of Stent Underexpansion to Target Lesion 
Revascularization After Sirolimus-Eluting Stenting for 
In-Stent Restenosis 1101-45·66A
Coronary Blood Flow Velocity and Myocardial Perfusion 
With Balloon Occlusion and Filter-Based Distal 
Protection Devices in Saphenous Vein Graft Stenting: 
Early Experience of Two Centers 1063-65·52A
Creatine Kinase-MB Elevation After Coronary Stenting 
in Lesions With Ruptured Plaque  808-2·54A
Creatine Kinase-MB Enzyme Elevation After 
Percutaneous Coronary Interventions Using 
Sirolimus-Eluting Stents 1044-61·47A
Debulking of Chronic Total Occlusions With Rotational 
or Directional Atherectomy Before Stenting Trial: A 
Multicenter Randomized Study 1081-53·59A
Dendritic Cells Contribute to In-Stent Restenosis: 
Recruitment in Early Neointima Formation After 
Porcine Aortic Stent Implantation and in Human 
In-Stent Restenosis  803-5·54A
Dose Thrombus Aspiration With Distal Protection Using 
PercuSurgeTM Before Stenting for Acute Myocardial 
Infarction Reduce No-Reflow Phenomenon?  
829-4·285A
Drug-Eluting Stent Use May Negatively Impact the 
Economic Health of a Hospital: A Single-Center Case 
Study 1040-74·402A
Drug-Eluting Stent Utilization and Outcomes From the 
Strategic Evaluation of New Transvascular Therapies 
(STENT) Group: A Large Prospective Multicenter 
“Real-World” Registry of Percutaneous Coronary 
Intervention 1044-58·46A
Drug-Eluting Stent With Multidimensional 
Programmable Pharmacokinetics 1139-47·83A
Drug-Eluting Stents for Coronary Bifurcations: 
Bench-Top Insights Into the "Crush" Technique 
1024-53·36A
Drug-Eluting Stents for the Treatment of Bifurcated 
Coronary Lesions: A Randomized Comparison of 
Simple Versus Complex-Strategy Approach  
843-5·87A
Early and Mid-Term Results of Cypher Stents in 
Unprotected Left Main 1116-8·21A
Early Results From the Japanese Asparagus Trial  
829-3·285A
Effect of a 600 mg Clopidogrel Loading Dose on 
Platelet Function in Patients Undergoing Coronary 
Stenting 1100-61·65A
Effect of Cerivastatin-Eluting Stent on Inflammatory 
Response, Platelet Deposition and Intimal 
Hyperplasia in a Porcine Coronary Model 
1139-50·83A
Effect of Everolimus-Eluting Stents in Preventing 
Neointimal Hyperplasia: An Intravascular Ultrasound 
Analysis From the FUTURE II Trial 1101-44·66A
Effect of Percutaneous Transluminal Renal Artery 
Angioplasty With Stenting on Renal Function in 
Patients With Atherosclerotic Renal Artery Stenosis  
877-3·100A
Effect of Successful Percutaneous Coronary 
Intervention on 30-Day Mortality in Elderly Patients 
With Acute Myocardial Infarction 1070-134·184A
Effects of Prolonged Oral Simvastatin Treatment After 
Coronary Stenting on Neointimal Growth and Plaque 
Progression as Assessed by Intravascular 
Ultrasound: A Randomized Study  864-5·99A
Elective Percutaneous Coronary Intervention Without 
On-Site Surgery: Inability of Preprocedural 
Characteristics to Accurately Identify Low Risk 
Patients  852-2·96A
Endovascular Stent-Graft Placement for Nonsurgical 
Repair of Descending Aortic Perforations: Acute and 
Follow-Up Results 1066-193·470A
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Epicardial Stenosis Severity Does Not Affect Minimal 
Microcirculatory Resistance 1120-45·75A
Evaluation of Sirolimus-Eluting Stents for the Treatment 
of Bifurcation Lesions: A Real World Study 
1024-51·36A
Evidence for Immediate Induced Percutaneous 
Coronary Intervention Matrix Metalloproteinase 2 
Variations in Peripheral Samples to Predict Target 
Vessel Revascularization After Nondrug-Eluting Stent 
Implantation 1043-47·42A
Evolution of Percutaneous Coronary Intervention in 
Acute Myocardial Infarction: Insights From a Large 
Single Center Database 1081-56·60A
Exaggeration of Neointimal Hyperplasia Following Stent 
Deployment in Type B Bifurcation Lesions  808-4·55A
Financial Impact of Drug-Eluting Stents: The US 
Academic Experience 1040-73·402A
Findings of Intravascular Ultrasound During Acute Stent 
Thrombosis  808-5·55A
Fractional Flow Reserve Versus Intravascular 
Ultrasound for Decision-Making in Equivocal Left 
Main Coronary Stenosis 1157-42·92A
Full Metal Jacket in the Drug-Eluting Stent Era: 
In-Hospital and 30-Day Outcome 1044-53·45A
High Rate of In-Stent Thrombosis in Cocaine Users 
Undergoing Coronary Stent Placement 1081-60·61A
Homocysteine Levels and Methylenetetrahydrofolate 
Reductase Polymorphisms Are Not Associated With 
Restenosis After Coronary Artery Stenting 
1121-49·77A
How Efficacious Is Vascular Brachytherapy for the 
Treatment of Ostial In-stent Restenosis? 
1080-66·58A
Identification of Risk Factors for In-Hospital 
Complications in Patients With Severe Left 
Ventricular Dysfunction Undergoing Percutaneous 
Coronary Intervention 1138-65·82A
Immediate and Mid-Term Results of the Treatment of 
In-Stent Restenosis With Sirolimus-Eluting Stents 
1121-59·79A
Impact of Aortic Stenting on Blood Pressure in Adult 
Coarctation 1076-202·382A
Impact of Cerebrovascular and Peripheral Arterial 
Disease on Outcomes After Percutaneous Coronary 
Interventions 1043-48·43A
Impact of Coronary Artery Bending at Stent Edges on 
Subsequent Plaque Proliferation: A Serial Volumetric 
Itravascular Ultrasound Analysis 1139-57·85A
Impact of Late Loss on Clinical, Angiographic and 
Intravascular Ultrasound Outcomes in the TAXUS IV 
Trial 1059-7·12A
Impact of Periprocedural Plaque/Thrombus Reduction 
on Myocardial Injury After Stent Deployment  
808-3·55A
Impact of Preinterventional Lesion Calcification on 
Neointimal Hyperplasia Following Sirolimus-Eluting 
Stent Implantation: An Intravascular Ultrasound 
Analysis 1101-63·67A
Impact of Radiation Dose on Outcomes in Diabetic 
Patients: Results From the SCRIPPS IV Trial  
822-5·71A
Impact of Sirolimus-Eluting Stents on the Outcome of 
Patients With Chronic Total Occlusions: Multicenter 
Registry in Asia 1024-49·35A
Impact of Stent Implantation Techniques on Stent Edge 
Neointimal Hyperplasia Following Sirolimus-Eluting 
Stenting 1139-56·84A
Impact of Vessel Size on Outcomes of Different Distal 
Protection Devices During Saphenous Vein Graft 
Intervention: A FIRE Trial Substudy  830-3·72A
Implications of the “Watermelon Seeding” Phenomenon 
During Coronary Interventions for In-Stent 
Restenosis Insights From the Restenosis Intrastent 
Balloon Angioplasty Versus Elective Stenting (RIBS) 
Randomized Trial 1121-54·78A
Important Species Differences of Sirolimus, Paclitaxel, 
and Tacrolimus on Porcine and Human Coronary 
Smooth Muscle and Endothelial Cells 1102-47·68A
In-Stent Restenosis Evaluation With 16-Slice 
Computed Tomography Coronary Scanner 
1018-149·314A
Inadequate Margins Remain a Major Source of Failure 
After Brachytherapy for In-Stent Restenosis: Analysis 
of 255 Lesions With One-Year Follow-Up 
1080-46·57A
Increasing Brachytherapy Dose Dramatically Improves 
Outcome in Patients With Long Lesions 1121-57·79A
Influence of Gender on In-Hospital and Long-Term 
Clinical Outcomes Following Percutaneous or 
Surgical Revascularization: A Report From the 
Arterial Revascularization Therapies Study (ARTS) 
1081-55·60A
Influence of Vessel Wall Calcium on Neointimal Growth 
Following Bare Metal and Sirolimus-Eluting Stent 
Implantation: A 3-D Intravascular Ultrasound 
Substudy of the SIRIUS Trial 1044-54·45A
Inhibition of In-Stent Restenosis in Porcine Coronary 
Arteries by Copper Chelation 1121-52·78A
Initial Experience With Sirolimus-Eluting Stents in Left 
Main no Option Patients: Data From the SECURE 
Trial 1044-57·46A
Interpretation of the Actual Platelet Inhibition Induced 
by Clopidogrel: A New Look at How to Represent 
Drug Response 1100-58·64A
Intimal Hyperplasia Thickness Is Independent of Stent 
Size in Paclitaxel-Coated Stents: A Serial 
Intravascular Ultrasound Analysis From the Asian 
Paclitaxel-Eluting Stent Clinical Trial 1101-66·68A
Intraprocedural Stent Thrombosis: A Potentially New 
Emerging Complication With Usage of Long Stents in 
the Drug-Eluting Stent Era 1024-48·35A
Intravascular Ultrasound Analysis of the New ABT-578 
Eluting Phosphorylcholine-Coated Stent Implantation 
to De Novo Human Coronary Lesions: The 
ENDEAVOR I Trial 1139-59·85A
Intravascular Ultrasound and Valved Stent for Beating 
Heart Valve Implantation: Is There Really a Need for 
Angiography? 1010-137·427A
Intravascular Ultrasound Assessment of Lesions With 
Sirolimus-Eluting Stent Failure 1101-41·65A
Is Sirolimus-Eluting Stent Better Than Brachytherapy to 
Treat In-Stent Restenosis at Longer (12-Month) 
Follow-Up? Angiographic and Intravascular 
Ultrasound Analysis  822-2·70A
Is the Sirolimus Drug Eluting Stent Better Than 
Paclitaxel Coated Stent in "Real Life" Environment? 
1139-61·86A
Is There a Relationship Between Stent/Lesion Length 
Ratio and Edge Effect in the Drug-Eluting Stent Era? 
An Intravascular Ultrasound Analysis 1044-52·45A
Lack of Efficacy of Clopidogrel Pretreatment in the 
Prevention of Myocardial Damage After Elective Stent 
Implantation 1063-52·49A
Lack of Efficacy of Intracoronary Thrombus Aspiration 
Before Coronary Stenting in Patients With Acute 
Myocardial Infarction: A Multicenter Randomized Trial 
1003-85·245A
Late Four-Year Follow-Up From the First-in-Man 
Experience After Implantation of Sirolimus-Eluting 
Stents  862-5·98A
Late Quantitative Angiographic Results Following 
Treatment With a Polymer-Based Paclitaxel-Eluting 
Stent Compared With a Bare Metal Stent in Patients 
With De Novo Coronary Disease: The TAXUS-IV 
Angiographic Results  843-3·87A
Latin America Small Vessel Randomized Study in 
Diabetic Patients (LASMAL II): Clinical and 
Angiographic Follow-Up Data 1081-48·58A
Long-Term (Seven-Year) Outcomes After Bare Metal 
Coronary Stenting for Unprotected Left Main 
Coronary Stenosis 1081-58·60A
Long-Term Clinical Follow-Up After Diffuse In-Stent 
Restenosis 1121-53·78A
Long-Term Clopidogrel Therapy Following 
Percutaneous Coronary Intervention Improves 
Clinical Outcome but Is Not Associated With 
Increased Bleeding: New Insights From the CREDO 
Trial 1116-6·21A
Long-Term Cost-Effectiveness of Clopidogrel in 
Patients Having Percutaneous Coronary Intervention 
Early After Acute Coronary Syndrome: Results From 
PCI-CURE 1137-77·296A
Long-Term Results of ISAR-REACT: A Randomized 
Trial Evaluating Abciximab in Patients With Elective 
Percutaneous Coronary Intervention After 
Pretreatment With a High Loading Dose of 
Clopidogrel 1001-8·2A
Longitudinal Vessel Remodeling Pattern Following 
Sirolimus-Eluting Stent Implantation: Analysis of 
Vessel Integrity Throughout Target Segment 
1101-43·66A
Low Incidence of Coronary Microembolization During 
Recanalization of Chronic Total Coronary Occlusions 
1154-87·299A
Magnetic Resonance Angiography Detects In-Stent 
Thrombosis and Thrombolysis 1055-154·322A
Marked Improvements in In-Hospital Outcomes 
Following Contemporary Percutaneous Coronary 
Intervention in Patients With Diabetes 1062-47·48A
Matched Comparison of Direct Stenting to Predilation 
With the Sirolimus-Eluting Bx VelocityTM Stent  
862-1·97A
Nitric Oxide Through Biodegradable Layer Elective 
Study for Safety and Efficacy (NOBLESSE): Final 
Results From the South American Study Arm 
1139-54·84A
Noninvasive Assessment of In-Stent Restenosis by 
16-Slice Multislice Computed Tomography  
845-4·364A
Optimal Geometry Is Still Important With 
Sirolimus-Eluting Stents: Incomplete Stent Expansion 
as a Risk for Target Lesion Revascularization 
1139-55·84A
Oral Rapamune to Inhibit Restenosis in Patients With 
Multi De Novo Coronary Lesions Requiring Stenting 
1063-60·51A
Oral Rapamycin in Patients Undergoing Coronary Stent 
Therapy: Final Results of the ORAR Study (Oral 
Rapamycin in Argentina)  878-2·102A
Oral Sirolimus to Inhibit Recurrent In-Stent Stenosis: 
The Randomized, Double-Blind, Placebo-Controlled 
OSIRIS Trial  822-1·70A
Overdilation of Cypher 3.0 mm 6 Cells Stent: Clinical 
Consequences 1044-55·45A
Paclitaxel-Eluting Stent in Complicated Lesions or 
Patient Subsets: A Subanalysis From the TAXUS II 
Study 1044-56·46A
Pattern of Brachytherapy Failure in Unselected Patients 
Treated With Gamma and Beta Radiation for 
Saphenous Vein Graft In-Stent Restenosis 
1121-62·80A
Percutaneous Aortic Valve Replacement With a 
Self-Expandable Stent-Valve in the Beating Heart: In 
Vivo Stress Testing in an Animal Model  824-5·435A
Percutaneous Endovascular Reconstruction for Chronic 
Occlusions in Peripheral Vascular Disease: A Quality 
of Life Perspective 1005-41·31A
Percutaneous Implantation of a New Prosthetic Heart 
Valve in the Descending Aorta in Sheep: Results at 
Six Weeks in a Model of Severe Aortic Insufficiency  
824-3·434A
Percutaneous Peripheral Intervention Is Associated 
With Sustained Improvement in Health-Related 
Quality of Life 1005-46·32A
PeriStent Restenosis Following Drug-Eluting Stents: 
Influence of Contributing Factors 1044-51·44A
Peroxisome Proliferator-Activated Receptor Gamma 
Gene Polymorphisms and Risk of Restenosis After 
Coronary Artery Stenting in Patients With Diabetes 
1121-50·77A
Physiologic and Anatomical Evaluation Prior to and 
After Stent Implantation in Small Coronary Vessels: 
Final Results of PHANTOM Trial 1157-49·94A
Platelet Glycoprotein IIb/IIIa Receptor Inhibition as 
Adjunctive Treatment During Saphenous Vein Graft 
Stenting: Differential Effects After Randomization to 
Occlusion or Filter-Based Embolic Protection  
830-2·71A
Post-Market Surveillance of the CYPHER 
Sirolimus-Eluting Stent: One-Month Clinical Results 
From the United States 1044-62·47A
Potential Impact of Frame Bias Upon Quantitative 
Coronary Angiographic Outcomes in Coronary Stent 
Trials 1081-62·61A
Prediction of Death or Myocardial Infarction by Exercise 
SPECT Scintigraphy Among Patients Who Have Had 
Recent Coronary Stenting 1081-52·59A
Predictors of Target Vessel Revascularization After 
Stenting Coronary Bifurcation Lesions: Insights From 
a Large Prospective Single-Center Database 
1081-50·59A
Predilatation Before Distal Protection Device Placement 
Is Associated With Increased Procedure-Related 
Myocardial Infarction: Analysis From the FIRE Trial 
1063-64·52A
Preprocedural Plasma Levels of C-Reactive Protein 
and Interleukin-6 Do Not Predict Late Coronary 
Angiographic Restenosis After Elective Stenting 
1121-48·77A
Preprocedural Statin Administration and Incidence of 
Creatine-Kinase and Troponin I Elevation After 
Elective Percutaneous Coronary Stent Implantation 
1043-45·42A
Preprocedural Statin Medication Reduces Small and 
Large Periprocedural Myocardial Injury in Patients 
With Stent Implantation 1025-45·38A
Preprocedural Statin Medication Reduces the Risk for 
PeriProcedural Myocardial Infarctions in Patients With 
Stent Implantation Independent of the Cholesterol 
Level 1063-59·51A
Primary Angioplasty Versus Facilitated Intervention 
(Tenecteplase Plus Stenting) in Patients With ST 
Elevated Acute Myocardial Infarction: Final Results of 
the GRACIA-2 Trial 1118-78·289A
Procedural Predictors of Creatine Kinase-MB 
Elevations in the REPLACE-2 Study 1043-66·44A
Provisional Versus Systematic T Stenting: Insights 
From a Large Prospective Single-Center Database  
878-5·102A
Recanalization of Long Superficial Femoral Artery 
Occlusions by a Transpopliteal Approach: Acute and 
12- Month Results 1005-42·32A
Recanalized Chronic Total Occlusions Covered by 
Sirolimus-Eluting Stents 1024-50·36A
REDOX Trial - Reduced Sirolimus Doses on the Bx 
VELOCITYTM Stent Four-Month Results  843-1·86A
Reduction in Late Loss and Restenosis in Patients With 
Small Vessels Treated With the Slow Rate-Release, 
Polymer-Based Paclitaxel-Eluting Stent: Results 
From TAXUS-IV  843-4·87A
Relationship Between Embolic Material Retrieval and 
Adverse Events With Different Distal Protection 
Devices During Saphenous Vein Graft Stenting  
830-6·72A
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Relationship of Obesity to Target Vessel 
Revascularization and Other Outcomes Following 
Coronary Stenting: Observations From the TARGET 
Trial 1138-43·81A
Relationship of Troponin I Elevation After 
Uncomplicated Coronary Stenting With Thrombotic 
(D-Dimer), Inflammatory (C-Reactive Protein and 
Fibrinogen), Procedural, and Clinical Factors 
1063-63·52A
Renal Artery Stenting for Blood Pressure Control Is 
Equally Effective in Unilateral and Bilateral Renal 
Artery Stenosis. 1046-169·460A
Restenosis After Sirolimus-Eluting Stent Implantation: 
Long-Term Evaluation Following Repeat 
Percutaneous Intervention  822-6·71A
Role of the 807 C/T Polymorphism of Glycoprotein Ia/
IIa on Platelet Function Following Clopidogrel 
Loading Dose in Patients Undergoing Coronary 
Stenting 1159-190·518A
Safety and Feasibility of Paclitaxel-Eluting Stents in the 
Treatment of ST-Elevation Acute Myocardial Infarction 
1022-80·251A
Similar Clinical Outcomes for Sirolimus-Eluting Stent 
Implantation and Coronary Brachytherapy for the 
Treatment of In-Stent Restenosis 1155-99·90A
Simple Risk Score Predicts Myocardial Infarction and 
Cardiovascular Death at 30 Days After Percutaneous 
Coronary Intervention: An Analysis of the 
REPLACE-2 and TARGET Data 1043-65·44A
Sirolimus Coated Stent Implantation Versus 
Intracoronary Beta-Irradiation for the Treatment of De 
Novo Lesions 1139-62·86A
Sirolimus Drug-Eluting Stent for the Treatment of 
In-Stent Restenosis (I-SR) With a Clinical and 
Angiographical Follow-Up Over Six Months 
1121-60·80A
Sirolimus Versus Plain Old Balloon Angioplasty Small 
Vessels 1024-47·35A
Sirolimus-Eluting Stents for Failed Brachytherapy: 
Results From the SECURE Registry  822-3·70A
Sirolimus-Eluting Stents: Pharmacokinetics in Blood, 
Vessel, and Myocardium in a Porcine Coronary Model 
1139-49·83A
Six-Month Intracoronary Ultrasound Findings Following 
Sirolimus-Eluting Stents for the Treatment of 
Restenosis-Prone Coronary Lesions 1101-64·67A
Staged Initial Percutaneous Coronary Intervention 
Followed by Valve Surgery (“Hybrid” Approach) for 
Patients With Complex Coronary and Valve Disease  
851-3·438A
Stenting Under Intravascular Ultrasound Guidance of 
Coronary Bifurcation Lesions With a New Device 
Allowing Provisional Side Branch Treatment  
878-6·103A
Stents Without Restenosis: Enough to Replace Bypass 
Surgery?  862-6·98A
SU11218, a Platelet-Derived Growth Factor Receptor 
and Vascular Endothelial Growth Factor Receptor 2 
Inhibitor Blocks Adventitial Angiogenesis and 
Prevents Intimal Hyperplasia After Coronary Stenting 
in a Porcine Model 1121-51·77A
Subacute Stent Thrombosis After Successful 
Placement of Sirolimus-Eluting Coronary Stents: 
Real-World Experience  862-3·98A
Subgroup Analysis of the Impact of the Glycoprotein IIb/
IIIa Inhibitor Abciximab in Patients Undergoing 
Elective Stent Placement >2 Hours After Treatment 
With a 600 Milligram Loading Dose of Clopidogrel: 
Results From the ISAR REACT Trial  878-3·102A
Superior Early Platelet Inhibition by 600mg Clopidogrel 
Loading in Elective Stenting 1100-62·65A
Suppressive Effects of Eplerenone on Accumulation of 
Extra Cellular Matrix in Neointima After Coronary 
Stent Implantation Using Swine 1158-53·95A
T-Stenting of Bifurcation Lesions Is Associated With a 
High Incidence of Stent Thrombosis 1081-49·58A
Target Vessel Revascularization During the First Month 
After Bare Metal Coronary Stenting: Clinical 
Indications and Angiographic Findings 1081-59·61A
TAXUS IV Diabetic Subset Analysis: Improvements in 
Nine-Month Outcomes in Diabetics on Oral 
Medication as Well as Insulin 1059-5·11A
TAXUS IV: Results From the Intravascular Ultrasound 
Substudy 1101-42·66A
The Benefit of Coronary Stenting in Small Vessels Is 
Dependent on Reference Vessel Diameter: Results 
From a Meta-Analysis of 11 Randomized Trials 
1081-47·58A
The Crushing Technique for Bifurcation Lesions: 
Immediate and Mid-Term Clinical Outcome 
1024-52·36A
The Foundation for Advanced Medical Education Renal 
and Iliac Artery Stent Training Program 1005-43·32A
The Impact of Abciximab on Final Infarct Size and Left 
Ventricular Function of Patients With Acute 
Myocardial Infarction Undergoing Primary Stenting: 
Insights From the Abciximab and Carbostent 
Evaluation (ACE) Trial 1118-81·290A
The Impact of Renal Insufficiency on Long-Term 
Survival of Patients With Diabetes Undergoing 
Percutaneous Coronary Intervention 1062-41·47A
The Incremental Hospital Cost of Treating Major 
Complications Among Medicare Beneficiaries 
Undergoing Percutaneous Coronary Interventions 
1043-43·42A
The Interleukin–174G/C Polymorphism Is a Powerful 
Predictor for Restenosis After Coronary Stent 
Implantation   803-3·54A
The Introduction of Drug-Eluting Stents Causes a Shift 
From Coronary Artery Bypass Graft Towards 
Percutaneous Coronary Intervention: One-Year 
Outcome of a Single-Center Experience of 2,200 
Consecutive Procedures 1079-86·273A
The Long-Term Clinical Results of a Platelet 
Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: 
ReoPro®) Coated Stent in Patients With Coronary 
Artery Disease 1139-53·84A
The Multicenter Evaluation of the Everolimus-Eluting 
Stent for Inhibition of Neointimal Hyperplasia: Results 
of the Pooled FUTURE I and II Trials 1059-6·12A
The REAL Registry of Drug-Eluting Stents: An Italian 
Survey in Emilia Romagna Region 1044-59·46A
Three-Year Follow-Up of the RAVEL Study: A 
Randomized Study With the Sirolimus-Eluting Bx 
VELOCITY™ Stent in the Treatment of Patients With 
De Novo Native Coronary Artery Lesions  843-6·87A
Treatment of Multivessel Coronary Artery Disease With 
Sirolimus-Eluting Stent Implantation: Immediate and 
Mid-Term Results 1044-60·46A
Treatment of True Bifurcation Lesions With the 
Simultaneous Kissing Stent Technique 1158-58·96A
Utility of an Online Clinical Database for Tracking 
Innovative Technology: The Academic Drug-Eluting 
Stent Experience 1020-68·399A
Vascular Brachytherapy With 192Iridium After 
Femoropopliteal Stenting in High-Risk Patients: 
Results From the Vienna-5 Trial 1005-44·32A
Stress
Clinical Evaluation of Patients With Suspected 
Coronary Artery Disease Using a Multimodality 
Stress Magnetic Resonance Imaging Protocol 
1169-152·365A
Disparity Between Dobutamine Stress and Physical 
Exercise Magnetic Resonance Imaging in Patients 
With an Intra-Atrial Correction for Transposition of the 
Great Arteries 1095-199·384A
Effect of Caffeine on Fractional Flow Reserve 
1170-146·368A
Enhanced Instability of Membranous Type 1 Matrix 
Metalloproteinase in Response to Mechanical 
Loading in Left Ventricular Myocardium 
1087-108·189A
Evaluation of the Roll-off of Radiotracer Uptake Under 
Adenosine, Dobutamine and Nitroglycerin Stress: 
Demonstration of Flow Dependence 1170-150·369A
Mental Stress Provokes Ischemia In Some Coronary 
Artery Disease Patients Without Exercise / 
Adenosine- Induced Ischemia 1056-161·325A
Percutaneous Aortic Valve Replacement With a 
Self-Expandable Stent-Valve in the Beating Heart: In 
Vivo Stress Testing in an Animal Model  824-5·435A
Prognostic Impact of Depression Following Myocardial 
Infarction: A Meta-Analysis 1115-75·411A
Prognostic Value of Rubidium-82 Perfusion Positron 
Emission Tomography: Preliminary Results From the 
Consecutive 153 Patients 1094-159·338A
Psychological Stress Increases Heterogeneity of 
Repolarization in Patients With Structural Heart 
Disease and Ventricular Arrhythmias 1148-208·140A
The World Trade Center Attack: Increased Frequency of 
Defibrillator Shocks for Ventricular Arrhythmias in 
Patients Living Remotely From New York City 
1091-210·125A
Transient Left Ventricular Apical Ballooning Syndrome: 
A US Case-Series 1127-105·210A
Stress echocardiography
A Study of Left Ventricular Function in Children With 
Persistent Coronary Arterial Aneurysm Long After 
Acute Kawasaki Disease by Dobutamine Stress 
Echocardiography 1171-203·393A
Accuracy of Strain Rate Techniques for Identification of 
Viability at Dobutamine Stress Echo: A Follow-Up 
Study After Revascularization 1151-145·360A
Aerobic Capacity in the Metabolic Syndrome: An 
Exercise Echo Doppler Study 1151-148·361A
Are American College of Cardiology/American Heart 
Association Preoperative Practice Guidelines for 
Stress Testing Followed? 1040-72·402A
Assessment of Myocardial Viability in Patients With 
Myocardial Infarction: Comparison of 
Contrast-Enhanced Magnetic Resonance Imaging 
With Dobutamine Stress Echocardiography 
1151-146·360A
Assessment of Transmyocardial Velocity Distribution 
During High Dose Dobutamine Stress 
Echocardiography Using Myocardial Velocity Profile 
1041-97·256A
Autotransplantation of Bone Marrow Into Scarred 
Myocardium for the Improvement of Cardiac Function 
in Humans: Is It Durable and Safe?  814-3·187A
B-Type Natriuretic Peptide Is a Biochemical Predictor of 
Myocardial Contractile Reserve During Dobutamine 
Stress Echocardiogram 1049-117·173A
Can Symptomatic Sinus Deceleration During 
Dobutamine Stress Echocardiography Be Prevented? 
1151-142·359A
Comparative Long-Term Prognostic Value of 
Dobutamine Stress Echocardiography Versus 
Dobutamine Stress Myocardial Perfusion SPECT  
802-3·331A
Comprehensive Stress Magnetic Resonance Imaging 
Compared to Stress Echo in the Evaluation of 
Patients Presenting to the Emergency Department 
With Chest Pain  836-5·354A
Differential Response of Radial Versus Longitudinal 
Myocardial Velocities to Dobutamine Stress: 
Noninvasive Measurement by Tissue Doppler 
Imaging 1001-30·8A
Distal Left Anterior Descending Flow Reserve by 
Dobutamine Versus Adenosine Transthoracic Doppler 
Echo During Conventional Dobutamine 
Echocardiography: Feasibility and Accuracy for Left 
Anterior Descending Patency 1151-144·360A
Dobutamine Versus Levosimendan Stress 
Echocardiography for the Prediction of Recovery of 
Left Ventricular Dyssynergies After Revascularization  
802-2·331A
Dobutamine-Induced Obstruction May Not Predict 
Exercise-Induced Obstruction in Hypertrophic 
Cardiomyopathy 1032-130·167A
Does Real-Time Myocardial Contrast 
Echocardiography Cause Cardiac Arrhythmias in 
Humans? A Comparative Study at Rest and During 
Pharmacological Stress 1036-162·316A
Feasibility of Using New Real-Time Volume Rendering 
Three-Dimensional Dobutamine Stress 
Echocardiography 1151-163·361A
High-Dose Dobutamine Stress Tl-201/I123-BMIPP Dual 
SPECT Reliably Identifies Myocardial Contractile 
Dysfunction Caused by Inducible Demand Ischemia 
1094-157·338A
Incremental Prognostic Value of Stress 
Echocardiography Over Historical, Clinical, and 
Stress Electrocardiographic Variables Across a Wide 
Spectrum of Bayesian Pretest Probability for 
Coronary Artery Disease 1001-31·8A
Live 3-D Echo as an Adjunct During Conventional 2-D 
Dobutamine Stress Echocardiography  837-1·355A
Long-Term Prediction of Coronary Events According to 
the Results of High Dose Dipyridamole Contrast 
Echocardiography Myocardial Perfusion Studies 
1036-158·315A
Long-Term Prognostic Value of Pacing Stress 
Echocardiography Compared With Dipyridamole 
Tl201 Tomography in Patients With Permanent 
Pacemaker and Known or Suspected Coronary 
Artery Disease  802-5·331A
Noninvasive Assessment of Coronary Artery Flow and 
Reserve in Top Athletes: Relationship With Oxygen 
Uptake 1033-118·169A
Regional Wall Motion Abnormalities During Dobutamine 
Stress Echocardiography in Patients With Systemic 
Sclerosis 1151-143·360A
Relationship Between Contractile Reserve and 
Diastolic Function in Hibernating Myocardium  
802-1·330A
The Ability of a Dobutamine Stress Contrast Enhanced 
Echocardiogram to Improve the Detection of 
Coronary Artery Disease: Results From the CADET 
Pilot Study  881-2·373A
The Doppler Tei Index During Dobutamine Stress 
Echocardiography: A Powerful Predictor of Mortality 
After Acute Myocardial Infarction  802-4·331A
Tissue Doppler Analysis of Nonuniform Transmural 
Recovery of Myocardial Contractility in Cardiac 
Raynaud's Phenomenon in Sclerodermic 
Cardiomyopathy 1092-163·333A
Transthoracic Doppler Echocardiographic Recordings 
of Coronary Flow Velocity and Reserve: Feasibility in 
American Versus Japanese Patients 1073-144·326A
Stroke
Aggressive Treatment of Atrial Fibrillation Reduces 
Stoke Following Cardiac Surgery 1115-72·411A
Benefits of Losartan on Preventing Stroke in Patients 
With Isolated Systolic Hypertension: A LIFE 
Substudy 1085-170·482A
Carotid Artery Stenting in African Americans 
1156-66·92A
Carvedilol Better Protects Against Vascular Events 
Than Metoprolol in Heart Failure: Results From 
COMET   835-2·205A
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Catheter Sequence Rather Than Catheter Shape 
Determines the Frequency of Cerebral Microemboli 
During Cardiac Catheterization 1066-197·471A
Economic Outcomes of Carotid Stenting Versus 
Endarterectomy for High Risk Patients: Preliminary 
Results From the SAPPHIRE Trial 1156-62·91A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Elderly Patients With 
Nonvalvular Atrial Fibrillation: Observations From the 
SPORTIF Trials  825-1·494A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Women and Men With 
Nonvalvular Atrial Fibrillation in the SPORTIF Trials  
825-2·495A
Patients at Risk for Recurrent Embolism After 
Percutaneous Closure of Patent Foramen Ovale for 
Presumed Paradoxical Embolism 1001-27·7A
Patients Benefit From Intracardiac Echocardiography 
Used as a Novel Guiding Tool for Device Closure of 
Interatrial Communications 1150-151·359A
Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO™) to Prevent Stroke in Patients 
With Atrial Fibrillation: Interim Results of the 
Multicenter Feasibility Trial 1005-65·33A
Reduced Adverse Event Rates After Transcatheter 
Closure of Patent Foramen Ovale When Using the 
Amplatzer-PFOTM Compared to the CardioSealTM 
Device 1019-206·???
Serial Echocardiographic Follow-Up of Percutaneous 
Left Atrial Appendage Transcatheter Occlusion 
(PLAATOTM) in Patients With Atrial Fibrillation 
1131-146·348A
Serum Triglycerides and the Risk of Cardiovascular 
Disease in the Asia Pacific Region: An Individual 
Participant Data Meta-Analysis of Cohort Studies 
Including 96,130 Individuals 1047-179·462A
Serum Uric Acid and Ischemic Stroke Risk Among 
Hypertensive Patients With Left Ventricular 
Hypertrophy: The Losartan Intervention for Endpoint 
Reduction in Hypertension (LIFE) Study  812-4·475A
The Impact of Aortic Manipulation on Neurological 
Outcomes After Coronary Artery Bypass Surgery: A 
Risk-Adjusted Study 1079-79·272A
Stroke volume
Failure to Rise Stroke Volume in Patients With 
Transposition of the Great Arteries After Atrial Switch 
Operation Is Due to Fixed Venous Return 
1059-32·18A
Left Ventricular Ejecting Force of the Intra-Aortic 
Balloon Pump Assisted and Nonassisted Beats 
1050-124·174A
Sudden death
Amiodarone in Survivors of Life-Threatening Ventricular 
Arrhythmias: Does It Improve Outcome? Results of 
the Leiden Out of Hospital Cardiac Arrest Trial 
(LOHCAT) 1053-209·116A
Calmodulin Kinase Inhibition Improves Survival in 
Calcineurin Transgenic Mice 1001-23·6A
Can We Predict Sudden Death After Atrial Repair for 
Transposition of the Great Arteries? 1095-202·385A
Cardiac Histopathologic Changes in Young Military 
Recruits Experiencing Sudden Death Due to 
Anomalous Coronary Origin Compared With 
Obstructive Coronary Artery Disease 1152-206·392A
Cardiac Magnetic Resonance Imaging in the Diagnosis 
of Sarcoidosis 1169-157·366A
Diagnostic Utility of Contrast Enhanced Magnetic 
Resonance Imaging for Screening Patients at Risk for 
Sudden Cardiac Death  836-2·353A
Does a Narrow QRS Identify a Low-Risk Subgroup of 
Patients With Ischemic Heart Disease? Results of 
Electrophysiology Testing and T Wave Alternans 
Testing in a "MADIT-2" Population  890-1·153A
Does Left Ventricular Hypertrophy Predict Sudden 
Cardiac Death Independent of Ischemia? The LIFE 
Study  888-2·530A
Electrocardiographic Progression of Arrhythmogenic 
Right Ventricular Dysplasia/Cardiomyopathy 
1015-222·109A
Multicenter Study of Safety and Efficacy of a Biphasic 
Impedance-Compensating Waveform for 
Transthoracic Defibrillation 1154-89·299A
Nontraumatic Sudden Death During Military Basic 
Training, 1977-2001 1059-2·11A
Regionally Altered Action Potential Duration Restitution 
in Swine With Hibernating Myocardium and Sudden 
Cardiac Death 1110-219·129A
Syncope in Implantable Cardioverter Defibrillator 
Patients: Predictors and Outcomes 1091-208·125A
T-Wave Alternans Is Associated With Spatial 
Heterogeneity of T-Wave Morphology in Coronary 
Artery Disease Patients During Treadmill Exercise 
1033-114·168A
The Implantable Defibrillator and the Long QT 
Syndrome: An Overview of Current Use and 
Outcome 1091-223·126A
The Influence of Atrial and Ventricular Pacing on T 
Wave Alternans 1015-219·108A
The Value of B-Type Natriuretic Peptide and Cardiac 
Troponin I as Predictors of Sudden Death in Patients 
With Advanced Heart Failure 1049-115·172A
Superoxide dismutase
Hydrogen Peroxide-Induced Superoxide Production in 
Endothelial Cells: Role of Nitric Oxide Synthase 
1140-170·508A
Manganese Superoxide Dismutase Alanine/Valine 
Polymorphism Is Associated With Coronary Artery 
Disease 1128-121·212A
Supraventricular tachycardia
Accuracy of Arrhythmia Discrimination Algorithms: First 
Results From a Prospective, Randomized Trial of 
Single Versus Dual Chamber Implantable 
Cardioverter Defibrillators (PINAPP) 1147-212·139A
Independent Predictive Accuracy of Classical 
Electrocardiographic Criteria in the Diagnosis of 
Paroxysmal Junctional Tachycardias in Patients 
Without Preexcitation 1072-211·120A
Primary and Secondary Prevention Implantable 
Cardioverter Defibrillator Patients Have Similar 
Proportions of Ventricular Tachyarrhythmia 
Detections and Equivalent Risk for Spurious 
Therapies: Results From PainFREE Rx II 
1091-207·125A
Remote Catheter Ablation Using the New Magnetic 
Navigation System Niobe  860-4·149A
The Prognostic Significance of Exercise-Induced Atrial 
Arrhythmias 1146-105·223A
The Sinus Nodal Tissue Arrangement Into the 
Musculature of the Terminal Crest: Implications in 
Ablation of Inappropriate Sinus Node Tachycardia? 
1090-213·123A
Syncope
Increased Capillary Fluid Filtration Rate in Elderly 
Subjects With Symptomatic Hypotension During 
Head-Up Tilt Table Testing 1070-133·184A
Syncope After Myocardial Infarction: Clinical and 
Electrophysiological Prognostic Factors 
1099-88·281A
Syncope in Implantable Cardioverter Defibrillator 
Patients: Predictors and Outcomes 1091-208·125A
Use of the Implantable Loop Recorder in the Diagnosis 
and Management of Syncope: Long-Term Follow-Up 
1116-37·28A
Systole
Multimedia Bedside Cardiac Examination: Controlled 
Intervention Study  853-2·423A
Reduction in Regional Myocardial Function Is 
Associated With Concentric Left Ventricular 
Remodeling: Multi-Ethnic Study of Atherosclerosis 
1145-117·221A
Systolic Reflective Index: A New Parameter to Study 
Arterial Elasticity  873-5·528A
Traditional Risk Factors Are Associated With Regional 
Left Ventricular Dysfunction in Asymptomatic 
Individuals: The Multi-Ethnic Study of Atherosclerosis 
(MESA) 1163-115·228A
Tachycardia
Maternal Hyperglycemia Acutely Improves Fetal 
Cardiac Function During Tachycardia-Induced Heart 
Failure 1057-200·380A
Tech assessment
Identification of Electrocardiogram Characteristic 
Points: Wavelet Transform Versus Derivative-Based 
Method 1020-72·400A
Noninvasive Determination of Central Venous Pressure 
With a Bedside Ultrasound Device 1127-134·211A
Utility of an Online Clinical Database for Tracking 
Innovative Technology: The Academic Drug-Eluting 
Stent Experience 1020-68·399A
Tetralogy of Fallot
Myocardial Fibrosis Patterns Correlate With Adverse 
Right Ventricular Morphology and Function in 
Patients With Repaired Conotruncal Heart Defects  
840-1·390A
Optimal Timing for Pulmonary Valve Replacement in 
Adults After Tetralogy of Fallot Repair: A Magnetic 
Resonance Imaging Study  886-5·398A
Pregnancy in Women With Corrected Tetralogy of Fallot 
1095-206·???
QRS Duration and Depolarization Heterogeneity in 
Tetralogy of Fallot Patients Before and After Surgical 
Repair of the Pulmonary Valve 1095-201·385A
Right Ventricular Resynchronization Fails to Improve 
Hemodynamics Early After Tetralogy of Fallot Repair  
811-3·383A
Thrombin inhibitors
A Comparison of the Effect of Eptifibatide Plus Heparin 
Versus Bivalirudin on Thrombin Generation and Clot 
Lysis in Patients Undergoing a Percutaneous 
Coronary Intervention 1043-42·41A
A Phase I Open-Label Dose Escalation Trial of a 
Monoclonal Antibody Against Tissue Factor (Sunol 
cH36) in Stable Coronary Artery Disease: Results of 
the PROXIMATE-TIMI 27 Trial  861-3·303A
Adjunctive Pharmacotherapy During Higher Risk 
Percutaneous Coronary Intervention: 
Eptifibatide-Based Antiplatelet Therapy Accompanied 
by Only Limited, Specific Antithrombin Therapy 
1004-53·31A
Bivalirudin Confers Antiplatelet Effects in Patients 
Undergoing Percutaneous Coronary Intervention 
1025-43·37A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Elderly Patients With 
Nonvalvular Atrial Fibrillation: Observations From the 
SPORTIF Trials  825-1·494A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Women and Men With 
Nonvalvular Atrial Fibrillation in the SPORTIF Trials  
825-2·495A
Enhancement of Bone Marrow-Derived Endothelial 
Progenitor Cell Differentiation by Protease-Activated 
Receptor-1 Activation 1104-189·489A
Excessive Bleeding With Aspirin, Clopidogrel, and 
Warfarin "Triple Therapy" 1023-95·254A
Inhibitory Effect of E5555, an Orally Active Thrombin 
Receptor Antagonist, on Intimal Hyperplasia 
Following Balloon Injury 1102-48·68A
Tissue Factor Pathway Inhibition, a New Antithrombotic 
Strategy: Phase-II Study of a Novel, Oral Factor Xa 
Inhibitor 1007-173·443A
Thromboembolism
Cardioversion in Patients With Dense Spontaneous 
Echo Contrast  875-1·150A
Dose Thrombus Aspiration With Distal Protection Using 
PercuSurgeTM Before Stenting for Acute Myocardial 
Infarction Reduce No-Reflow Phenomenon?  
829-4·285A
Elevated Levels of Hemostatic Markers in Patients With 
Atrial Fibrillation and Aortic Atherosclerosis 
1007-178·444A
Hepatosplenic and Renal Embolisms in Infective 
Endocarditis 1143-139·437A
Implications and Prevention of Large Periprocedural 
Myocardial Infarction After Percutaneous Intervention 
of Diseased Saphenous Vein Grafts and Thrombotic 
Native Coronary Lesions 1155-78·88A
In Vitro Detection and Quantification of High Intensity 
Transient Signals by Using Intracoronary Doppler 
Ultrasound: A New Approach to Detect Coronary 
Microembolization 1026-55·39A
Incidence and Evaluation of Heparin-Induced 
Thrombocytopenia (HIT) Among Patients Treated 
With Prolonged Heparin and Among 
Thrombocytopenic Patients in the Cardiac Care Unit: 
Preliminary Results of the CATCH Registry 
1123-180·501A
Incidence of Cerebral Embolism After Cardioversion of 
Atrial Fibrillation: A Prospective and Serial Study 
Using Magnetic Resonance Imaging 1129-209·134A
Incidence of Cerebral Embolism in High-Risk Patients 
With Atrial Fibrillation 1129-210·134A
The Fate of Left Atrial Thrombi: A Prospective and 
Serial Follow-Up Over Three Years With 
Transesophageal Echocardiography and Cerebral 
Magnetic Resonance Imaging 1131-143·348A
Thromboembolic Events Among Children With 
Cardiomyopathy: Results From the National 
Australian Childhood Cardiomyopathy Study 
1152-199·391A
Thromboembolic Events in Patients Undergoing Atrial 
Fibrillation Ablation-Incidence, Timing, and Predictors 
1052-222·115A
Thrombus Aspiration for the Treatment of No-Reflow 
Phenomenon Complicating Primary Angioplasty for 
Acute Myocardial Infarction 1003-95·248A
Tissue Factor Pathway Inhibition, a New Antithrombotic 
Strategy: Phase-II Study of a Novel, Oral Factor Xa 
Inhibitor 1007-173·443A
Thrombolysis
Beneficial Effects of Combined Thrombolytic Therapy 
and Percutaneous Coronary Angioplasty in Transfer 
Patients With ST Segment Elevation Myocardial 
Infarction: A Report From the American College of 
Cardiology-National Cardiovascular Data Registry  
869-6·304A
Comparison Between Rescue Surgical Embolectomy 
and Repeat Thrombolysis After Unsuccessful 
Thrombolysis in Acute Pulmonary Embolism 
1123-179·501A
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Effect of Attenuation on Intravascular Thrombus 
Dissolution Using Transcutaneous Ultrasound and 
Intravenous Microbubbles  881-6·374A
Effect of Therapeutic Transcutaneous Ultrasound 
Following Thrombolysis: Results of the Perfusion by 
Thromobolytic and Ultrasound (PLUS) Trial 
1061-95·265A
Five-Year Survival Data From the APRICOT Trials: 
Does Female Gender Really Portend Unfavorable 
Outcome? 1137-100·298A
High Frequency Ultrasound Thrombolysis: In Vitro 
Effects of Ultrasound Mode, Duration, Temperature, 
and Frequency 1168-163·365A
Magnetic Resonance Angiography Detects In-Stent 
Thrombosis and Thrombolysis 1055-154·322A
Primary Angioplasty Is More Cost-Effective Than 
Prehospital Thrombolysis for Patients Within 90 
Minutes From a Percutaneous Coronary Intervention 
Center: One-Year Follow-Up of a CAPTIM Substudy  
869-5·304A
Primary Angioplasty Versus Facilitated Intervention 
(Tenecteplase Plus Stenting) in Patients With ST 
Elevated Acute Myocardial Infarction: Final Results of 
the GRACIA-2 Trial 1118-78·289A
Randomized Comparison of Prehospital Combination 
Fibrinolysis Versus Prehospital-Initiated Facilitated 
Percutaneous Coronary Intervention in Acute 
Myocardial Infarction 1061-91·264A
Randomized Trial of Radial Versus Femoral Access for 
Primary and Rescue Angioplasty 1004-48·30A
Relation Between Time of Pain and Long-Term 
Outcome in Patients With Acute Myocardial Infarction 
Transferred to Primary Angioplasty or Angioplasty 
Facilitated With Thrombolysis 1061-92·264A
Risk Stratification in ST-Segment Elevation Myocardial 
Infarction With Multiple Biomarkers 1042-86·259A
Survival Benefits of Primary Angioplasty Over 
Thrombolysis After Adjustment for Percutaneous 
Transluminal Coronary Angioplasty Related Time 
Delay 1022-84·251A
The Association of Race With Angiographic and Clinical 
Outcomes Following Fibrinolytic Administration  
883-2·305A
Trends in Fibrinolytic Therapy and Intra-Aortic Balloon 
Pump Counterpulsation Utilization in Patients With 
Cardiogenic Shock Complicating Acute Myocardial 
Infarction in Hospitals Without Percutaneous 
Transluminal Coronary Angioplasty/Coronary Artery 
Bypass Graft Capability: Observations From the 
National Registry of Myocardial Infarction 1116-9·21A
Use of Abciximab Prior to Primary Angioplasty in 
ST-Segment Elevation Myocardial Infarction Results 
in Early Recanalization of the Infarct-Related Artery: 
Results of the Multicenter Randomized 
ReoPro-BRIDGING Study 1011-112·156A
Thrombosis
A New Approach to Anticoagulation Therapy: The 
Fiscal and Quality Impact of Computerized Decision 
Support and Point of Care Testing 1001-14·4A
Antithrombotic Effects of Angiotensin II Receptor 
Blockade 1007-175·444A
Aspirin Resistance in Cardiovascular Disease: 
Underdosing of Overweight Patients  404-2·532A
Atorvastatin Affects the Expression of Both 
Endothelium- and Liver-Derived Components of 
Thrombosis/Fibrinolysis System and Endothelial 
Function in Patients With Congestive Heart Failure 
1012-132·160A
Atorvastatin Affects Thrombosis/Fibrinolysis System 
During the Acute Phase of Unstable Angina 
1008-192·447A
Bivalirudin Confers Antiplatelet Effects in Patients 
Undergoing Percutaneous Coronary Intervention 
1025-43·37A
Clinical and Magnetic Resonance Imaging 
Characteristics of Pathologically Confirmed Left 
Ventricular Thrombus in Patients With 
Cardiomyopathy 1126-114·208A
Comparative Incidence of Angiographically Proven 
Early Stent Thrombosis in Unselected Sirolimus- and 
Paclitaxel-Eluting Stent Populations  862-4·98A
Direct, Selective, Factor Xa Inhibition in Patients With 
Non-ST Elevation Acute Coronary Syndromes From 
the United States, Canada, and Japan: Results of the 
XaNADU-ACS Trial  861-1·302A
Distinct Signaling Pathways Mediate Protease 
Activated Receptor-Dependent Endothelial 
Exocytosis 1064-181·465A
Effect of a 600 mg Clopidogrel Loading Dose on 
Platelet Function in Patients Undergoing Coronary 
Stenting 1100-61·65A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Elderly Patients With 
Nonvalvular Atrial Fibrillation: Observations From the 
SPORTIF Trials  825-1·494A
Efficacy and Safety of Ximelagatran Compared With 
Well-Controlled Warfarin in Women and Men With 
Nonvalvular Atrial Fibrillation in the SPORTIF Trials  
825-2·495A
Elimination of Soluble Vasoactive Factors by the 
PercuSurge GuardWire Distal Protection Device 
During Percutaneous Coronary Intervention of 
Saphenous Vein Graft  830-1·71A
Endothelial, Coagulation, and Platelet Function in Atrial 
Fibrillation: Effect of Direct Current Cardioversion 
1129-212·134A
Fibrates Inhibit Plasminogen Activator Inhibitor Type-1 
Expression in Human Adipose Tissue: An 
Antiatherogenic Phenomenon? 1140-173·508A
Findings of Intravascular Ultrasound During Acute Stent 
Thrombosis  808-5·55A
Gender Bias Against Women: Men Receive Prophylaxis 
More Often to Prevent Deep Venous Thrombosis 
1001-13·3A
Grape Seed and Skin Extracts Alter Platelet Function 
and Release of Reactive Oxygen Species 
1159-188·518A
High Rate of In-Stent Thrombosis in Cocaine Users 
Undergoing Coronary Stent Placement 1081-60·61A
Higher Levels of Thrombus Precursor Protein Are 
Associated With Increased Death and Ischemic 
Complications in Patients With Acute Coronary 
Syndromes  884-4·306A
In Vivo Caspase-Inhibition Prevents Plaque 
Progression by Reducing Apoptosis and 
Tissue-Factor Expression in a Mouse Model of 
Chronic Atherosclerosis 1140-168·507A
Incidence and Evaluation of Heparin-Induced 
Thrombocytopenia (HIT) Among Patients Treated 
With Prolonged Heparin and Among 
Thrombocytopenic Patients in the Cardiac Care Unit: 
Preliminary Results of the CATCH Registry 
1123-180·501A
Intracoronary Radiation Therapy Using a Novel Beta 
Emitter for In-Stent Restenosis: Tungsten WRIST 
1155-100·90A
Magnetic Resonance Angiography Detects In-Stent 
Thrombosis and Thrombolysis 1055-154·322A
Molecular Imaging of Human Thrombus With 
Computed Tomography 1001-38·10A
Obesity Does Not Attenuate the Effectiveness of 
Low-Dose Dalteparin in Preventing Venous 
Thromboembolism in Medically Ill Patients 
1123-182·501A
Peroxynitrite Inactivates Akt Pathway and Enhances 
Tissue Factor Expression in Thrombin Stimulated 
Endothelial Cells  867-3·526A
Pharmacokinetics of Clopidogrel and Its Active 
Metabolite in Human Plasma 1106-177·492A
Platelet Dysfunction Following a 300 mg Clopidogrel 
Loading Dose in Type 2 Diabetes Undergoing 
Coronary Stenting 1100-60·65A
Predictors of Left Atrial Appendage Thrombogenesis in 
Patients Undergoing Transesophageal 
Echocardiography-Guided Cardioversion for Atrial 
Fibrillation and Flutter 1131-142·348A
Prevention of Flight-Related Thrombosis With Elastic 
Stockings: The JPA-Study, Final Analysis  
858-2·524A
Prevention of Flight-Related Thrombosis With 
Low-Molecular Weight Heparin 1001-12·3A
Relative Incidence of Thrombus Formation on the 
CardioSEAL and Amplatzer Interatrial Closure 
Devices 1076-201·382A
Rheolytic Thrombectomy for the Treatment of Acute 
Myocardial Infarction in Patients With Angiographic 
Large Thrombus Burden: One-Year Results of the 
VeGAS 2 Acute Myocardial Infarction Registry 
1003-94·248A
Risk Factors for and Inadequate Prophylaxis Against 
Upper Extremity Deep Vein Thrombosis  858-1·524A
Safety of Bivalirudin as a Single Antithrombotic Agent in 
Patients Undergoing Percutaneous Coronary 
Intervention and Vascular Brachytherapy With 
Gamma and Beta Emitters 1063-62·52A
Subacute Stent Thrombosis After Successful 
Placement of Sirolimus-Eluting Coronary Stents: 
Real-World Experience  862-3·98A
Sulfatides Are Targets for Antiphospholipid Antibodies 
1140-172·508A
Target Vessel Revascularization During the First Month 
After Bare Metal Coronary Stenting: Clinical 
Indications and Angiographic Findings 1081-59·61A
The Effectiveness of Distal-Protect Devices in Patients 
With Acute Coronary Syndromes: The Relationship 
Between Coronary Thrombus and Thrombolysis in 
Myocardial Infarction Frame Counts After 
Percutaneous Coronary Interventions 1026-58·40A
The Lonflit Study: Evaluation of Venous Thrombosis in 
5,000 Long-Haul Passengers 1123-178·500A
Thromboprophylaxis With Dalteparin Reduces Clinically 
Important Venous Thromboembolism in Patients With 
Congestive Heart Failure 1123-181·501A
Tissue Factor Pathway Inhibition, a New Antithrombotic 
Strategy: Phase-II Study of a Novel, Oral Factor Xa 
Inhibitor 1007-173·443A
Tomography
Assessment of Aortic Valve Calcification by 
Electrocardiogram-Gated Multislice Spiral Computed 
Tomography as a Marker for Severe Aortic Stenosis 
1093-145·335A
Assessment of Coronary Atherosclerotic Plaque 
Composition by Multidetector Computed 
Tomography: Comparison to Intravascular Ultrasound 
1018-144·312A
Association Between F-18 Fluorodeoxyglucose Uptake 
in Large Arteries and Atherogenic Risk Factors in 
Healthy Subjects 1094-151·336A
Atrial Fibrillation Reduces Endothelium-Independent 
Myocardial Perfusion Reserve: A Quantitative Study 
Using Positron Emission Tomography 1094-155·337A
Detection of Plaque Instability Predictors by Multislice 
Computed Tomography: Comparison With 
Intravascular Ultrasound 1018-146·313A
Determination of Left and Right Cardiac Function With 
Multislice Computed Tomography 1038-152·319A
Individualized Cardiac Phase Selection by Tissue 
Doppler Imaging Improves Image Quality in Multislice 
Computed Tomography of the Coronary Vessels 
1075-159·329A
Optimal Reconstruction Protocol for Noninvasive 
Coronary Angiography With 16-Slice 
Multidetector-Row Computed Tomography 
1075-158·329A
Prognostic Value of Rubidium-82 Perfusion Positron 
Emission Tomography: Preliminary Results From the 
Consecutive 153 Patients 1094-159·338A
Registration of Cardiac Computed Tomography Images 
With Three-Dimensional Electroanatomical Mapping 
to Guide Catheter Manipulation in the Left Atrium: 
Implications for Pulmonary Venous Isolation 
1052-226·115A
Stability of Right and Left Ventricular Ejection Fractions 
and End-Diastolic Volumes After Heart 
Transplantation 1056-158·324A
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White Blood Cell Count Predicts Higher Risk of 
Intermediate-Term Outcomes in Patients Stabilized 
After Acute Coronary Syndromes: Observations From 
the SYMPHONY and 2nd SYMPHONY Trials 
1042-82·258A
Valvular disease
Accuracy of Presurgical Assessment of Myxomatous 
Mitral Valve Pathology Using Real-Time 
Three-Dimensional Echocardiography 
1048-140·430A
Calcium-Phosphorus Product Is Associated With 
Severity of Aortic Stenosis in Patients With Normal 
Renal Function 1107-139·434A
Creases and Folds: Why Does the Bicuspid Aortic 
Valve Fail So Early? 1125-140·436A
Echocardiographic Characteristics Predictive of 
Successful Repair in Patients With Isolated Tricuspid 
Aortic Valve Regurgitation 1010-139·428A
Effect of High Intensity Focused Ultrasound on Cardiac 
Valves 1168-161·364A
Effects of Ramipril on Left Ventricular Size, Mitral 
Regurgitation Severity, Exercise Time, and Quality of 
Life in Asymptomatic Patients With Mitral 
Regurgitation  868-5·441A
Impact of Associated Coronary Disease on Hospital 
Survival of Patients With Valvular Heart Diseases in 
New York State (1983-2000) 1048-139·430A
Impact of Valve Prosthesis-Patient Mismatch on 
Pulmonary Arterial Pressure After Mitral Valve 
Replacement 1048-137·429A
Influence of C-Reactive Protein on Matrix Remodeling 
in Calcific Aortic Stenosis 1107-137·433A
Intravascular Ultrasound and Valved Stent for Beating 
Heart Valve Implantation: Is There Really a Need for 
Angiography? 1010-137·427A
Is Visual Assessment a Valid Tool to Assess the 
Severity of the Mitral Regurgitation in Clinical Trials?  
1067-139·431A
Mastering Cardiac Auscultation: The Power of 
Repetition 1059-39·19A
N-Terminal Pro-Braintype Natriuretic Peptide in Patients 
With Aortic Valve Disease: Correlation to Surgical 
Result 1125-138·436A
Natural History of Insignificant Mitral Regurgitation 
Following Aortic Valve Replacement for Degenerative 
Aortic Valve Disease  868-4·441A
Patent Foramen Ovale: A New Factor Associated With 
Progression of Carcinoid Heart Disease 
1030-140·429A
Percutaneous Aortic Valve Replacement With a 
Self-Expandable Stent-Valve in the Beating Heart: In 
Vivo Stress Testing in an Animal Model  824-5·435A
Percutaneous Implantation of a New Prosthetic Heart 
Valve in the Descending Aorta in Sheep: Results at 
Six Weeks in a Model of Severe Aortic Insufficiency  
824-3·434A
Predictive Factors of Peri and Post Operative Outcome 
After Valve Replacement in Patients With Critical 
Aortic Stenosis and Very Low Ejection Fraction 
1125-136·435A
Prognostic Implications of Vegetation Size at Hospital 
Admission in Infective Endocarditis 1143-138·437A
Prosthetic Endocarditis: Which Therapy for Which 
Patient? 1010-138·427A
Real-Time Three-Dimensional Color Doppler Flow: 
Feasibility and Initial Quantitative Comparison With 
Two-Dimensional Methods  837-6·356A
Should Mechanical Valves Be Used in the Pulmonary 
Position  840-5·390A
Staged Initial Percutaneous Coronary Intervention 
Followed by Valve Surgery (“Hybrid” Approach) for 
Patients With Complex Coronary and Valve Disease  
851-3·438A
Statin Therapy Does Not Affect Bioprosthetic Valve 
Degeneration 1107-138·433A
Valve Renovation in Calcific Aortic Stenosis: Safety and 
Feasibility of a Novel Endoaortic System for Native 
Valve Preservation 1125-135·435A
Valve Surgery in Octogenarians: In-Hospital and 
Long-Term Outcomes 1162-137·440A
Valvuloplasty
Balloon Mitral Valvuloplasty Performed in Mobile 
Catheterization Laboratory as Part of Community 
Outreach Program at Primary Care Hospitals 
1096-67·407A
Comparison Between Successful and Unsuccessful 
Mitral Valve Repair of Ischemic Mitral Regurgitation: 
An Echocardiographic Follow-Up Study 
1086-139·433A
Durability and Outcomes of Mitral Valve Repair for 
Infective Endocarditis 1162-136·439A
Echocardiographic Characteristics Predictive of 
Successful Repair in Patients With Isolated Tricuspid 
Aortic Valve Regurgitation 1010-139·428A
Edge-to-Edge Mitral Repair Seems to Induce 
Functional Restriction 1048-138·430A
Late Outcomes After Pulmonary Valve Balloon Dilation 
in Childhood 1076-206·???
Percutaneous Implantation of a New Prosthetic Heart 
Valve in the Descending Aorta in Sheep: Results at 
Six Weeks in a Model of Severe Aortic Insufficiency  
824-3·434A
Vascular biology
Angiotensin II Inhibition of Vascular Matrix 
Metalloproteinases in Heart Failure Is Nitric 
Oxide-Dependent 1002-80·243A
Apolipoprotein A1 Mimetic Peptide Reduces 
Accelerated Atherosclerosis in a Vein Graft Bypass 
Model in ApoE (-/-) Mice  841-3·506A
Asymmetric Dimethylarginine Impairs Angiogenesis 
and Limb Perfusion in a Murine Model of Hindlimb 
Ischemia  805-5·473A
Atherogenic Low-Density Lipoprotein Impairs Vascular 
Endothelial Cell Survival by Disrupting the 
FGF2-PI3K-Akt Autoregulatory Loop 1122-171·499A
Bach1 Is a Key-Repressor of Heme Oxygenase-1 and 
Regulates Cell Proliferation  841-4·506A
Baseline Brachial Artery Diameter Is a Predictor of 
Endothelial Function Assessed by Brachial Artery 
Vasoreactivity Testing 1027-187·451A
Bone Marrow Mononuclear Cell Therapy Reduces 
Post-Angioplasty Neointimal Formation in Rabbits 
1064-188·467A
Ceramide Triggers Weibel-Palade Body Exocytosis  
841-1·505A
Coffee Has a More Potent Effect on Arterial Stiffness 
Than Caffeine 1009-198·450A
Compensatory Enlargement Delay Vascular Healing of 
the Culprit Lesion Following Acute Myocardial 
Infarction 1082-180·476A
Effect of Black Tea on Aortic Stiffness 1105-176·492A
Effect of Fosinopril and Pravastatin on Albuminuria in a 
Nonhypertensive, Nonhypercholesterolemic 
Population 1007-171·443A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Intima-Media-Thickness in 
Microalbuminuric Patients Without Hypertension 
1007-172·443A
Effect of Fosinopril on Cardiovascular Events in 
Relation to the Urinary Albumin Excretion  
825-3·495A
Endothelium-Derived Hyperpolarizing Factor Is 
Involved in Flow-Dependent Dilation of Peripheral 
Conduit Arteries in Healthy Volunteers  865-1·525A
Enhancement of Bone Marrow-Derived Endothelial 
Progenitor Cell Differentiation by Protease-Activated 
Receptor-1 Activation 1104-189·489A
Exercise Training Increases the Number of Endothelial 
Progenitor Cells in Patients With Coronary Heart 
Disease and Cardiovascular Risk Factors 
1007-179·445A
Heterologous Transplantation of CD34+ Cells From 
Patients With Coronary Ischemia Leads to Myocardial 
Salvage and Enhanced Functional Recovery in 
Murine Model of Myocardial Infarction 
1104-192·490A
High-Dose Clopidogrel Loading Rapidly Reduces Both 
Platelet Inflammatory Marker Expression and 
Aggregation 1100-59·64A
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Hydrogen Peroxide-Induced Superoxide Production in 
Endothelial Cells: Role of Nitric Oxide Synthase 
1140-170·508A
Important Species Differences of Sirolimus, Paclitaxel, 
and Tacrolimus on Porcine and Human Coronary 
Smooth Muscle and Endothelial Cells 1102-47·68A
Incidence and Predictors of Left Ventricular Dysfunction 
in Patients With Takayasu or Giant Cell Aortitis 
1046-167·460A
Inhibitory Effect of E5555, an Orally Active Thrombin 
Receptor Antagonist, on Intimal Hyperplasia 
Following Balloon Injury 1102-48·68A
Intracoronary Radiation Therapy Using a Novel Beta 
Emitter for In-Stent Restenosis: Tungsten WRIST 
1155-100·90A
Mice Deficient in Leptin or the Leptin Receptor Exhibit 
Reduced Neointima Formation Following Vascular 
Injury 1064-179·465A
Mice Lacking the Transcription Factor CHF1/Hey2 
Show Decreased Arterial Neointimal Formation After 
Injury and Impaired Vascular Smooth Muscle Cell 
Responsiveness to Growth Factors  406-4·533A
Obesity Predicts Coronary Endothelial Dysfunction 
Independently of Inflammation, Atherosclerosis, and 
Conventional Risk Factors  819-4·485A
Physical Inactivity and Increased Thrombotic Risk: The 
Framingham Heart Study  876-4·239A
Presence of Mature Dendritic Cells to Early 
Postangioplasty Neointima: Markers of Antigen 
Presentation and Anti-Apoptosis 1158-55·95A
Production of Reactive Oxygen Species by 
Mononuclear Cells Correlates With the Severity of 
Coronary Heart Disease and NADPH Oxidase 
Expression 1082-181·476A
Prolonged Clopidogrel Treatment Reduces Lesion Cell 
Proliferation After Balloon Injury and Intracoronary 
Radiation  864-6·100A
Pulse Wave Velocity Measured by Complior Method in 
a Brazilian Young Population Followed-Up for a 13 
Year-Period: The Rio de Janeiro Study 
1142-188·514A
Repeated Non-invasive Measurement of pO2 by a 
Novel Electron Paramagnetic Resonance Method in a 
Rabbit Model of Hindlimb Ischemia  805-2·472A
Rosiglitazone Modulates Angiogenic Progenitor Cell 
Differentiation and Attenuates Intimal Hyperplasia 
After Vascular Intervention  867-5·527A
Six Months of Weight Loss Improves Metabolic and 
Vascular Indices in Overweight Adults  865-5·525A
Sustained Upregulation of Inflammatory Cytokine and 
Its Receptor Genes Associated With Proteinase 
Activation in Abdominal Aortic Aneurysm: Results 
From Combined Study With cDNA Array and 
Real-Time Reverse Transcriptase Polymerase Chain 
Reaction Methods 1059-12·13A
Tetrahydrobiopterin Corrects Escherichia Coli 
Endotoxin-Induced Endothelial Dysfunction 
1027-196·452A
The Role of Angiopoietin-1 in Physiologic and 
Pathologic Cardiac Remodeling and in Promoting 
Cardiac Myocyte Survival  870-6·236A
Tissue Engineered Endothelial Cells Inhibit Early 
Events in the Vascular Response to Injury to Prevent 
Restenosis 1001-6·2A
Vascular and Autonomic Dysfunction in the 
Asymptomatic Stage of Chagas’s Disease  
834-1·204A
Whole-Body Insulin Resistance Precedes Vascular 
Insulin Resistance in a Murine Model of Diet-Induced 
Obesity 1027-190·451A
Vascular surgery
A Gap in Care: Heart Failure Patients Undergoing Major 
Noncardiac Surgery 1108-120·199A
Percutaneous Transfemoral Coronary and Peripheral 
Procedures via Aortofemoral Synthetic Vascular 
Grafts: A Review of 123 Diagnostic and Interventional 
Cases  818-5·63A
Preoperative Statins Are Associated With Shorter 
Length of Stay and Improved Long Term Survival in 
Patients Undergoing Vascular Surgery 
1046-171·460A
Vasoconstriction




Contribution of Genetic Characteristics of Vascular 
Adrenergic Receptor to Variant Angina 1136-91·296A
Endothelial Dysfunction Predicts Cardiovascular Events 
in a Multi-Ethnic General Population (Northern 
Manhattan Study)  812-2·475A
Endothelial Function and Carotid Intima-Media 
Thickness in Young Healthy Subjects Among 
Endothelial Nitric Oxide Synthase Polymorphisms 
1064-183·466A
Impaired Endothelial Function Correlates With 
Coronary Calcification in Asymptomatic 
Perimenopausal Women 1065-167·467A
Improvement of Endothelium-Dependent Vasodilation 
by Simvastatin Is Potentiated by Combination With 
L-Arginine in Patients With Elevated Asymmetric 
Dimethylarginine Levels  865-3·525A
Increased Body Mass Index Is Associated With 
Impaired Endothelial Function in Women but Not 
Men: A NOMAS Substudy 1105-174·491A
Pharmacologic and Carbon Dioxide Reactivity of 
Coronary Circulation as Determined by Computed 
Tomography Perfusion 1038-154·320A
Testosterone Inhibits the _1C Subunit of L-Type Ca2+ 
Channels (Cav1.2) and _1H T-type Ca2+ Channels 
(Cav3.2) Stably Expressed in Human Embryonic 
Kidney 293 Cells 1106-186·494A
Vascular Compliance Versus Endothelial Function: 
Which Correlates Better to Risk Factor Score? 
1065-171·468A
Vasodilator agents
A Randomized Double-Blind Placebo-Controlled Phase 
2 Study on the Efficacy and Safety of Fasudil in 
Patients With Stable Angina 1023-96·254A
Adrenomedullin Is a Pulmonary Peptide 
1106-183·493A
Coronary Vasodilator Responses Are Impaired 
Independent of Nitric Oxide and Endothelial Function 
in Conscious Dogs With Dilated Cardiomyopathy  
834-4·204A
Evaluation of the Roll-off of Radiotracer Uptake Under 
Adenosine, Dobutamine and Nitroglycerin Stress: 
Demonstration of Flow Dependence 1170-150·369A
Long-Term Afterload Reduction Halts Progression of 
Left Ventricular Dysfunction in Patients With Chronic 
Compensated Severe Mitral Regurgitation 
1067-137·431A
Potential Beneficial Effects of Transdermal Capsaicine 
Patches on the Ischemic Threshold in Patients With 
Stable Coronary Disease 1023-92·253A
Venous Endothelium Dysfunction Is Also Presented in 
Hypertensive Patients 1059-11·13A
Vasopressin
Predictors of Mortality in Patients Hospitalized With 
Worsening Heart Failure: Insights From the ACTIV in 
CHF Trial 1069-119·181A
Ventilation
Effect of Beta-Blocker Therapy on Ventilatory 
Responses in Patients With Heart Failure 
1165-103·231A
Excessive Ventilation During Cardiopulmonary 
Resuscitation Decreases Survival Rates in a Porcine 
Model of Cardiac Arrest 1059-1·10A
First Postoperative Day Prognosis Score in Patients 
Undergoing Cardiac Surgery Based on Pre-, Peri-, 
and Postoperative Variables 1172-73·421A
Ventricular action potential
Ranolazine Inhibits Late Sodium Current in Isolated 
Left Ventricular Myocytes of Dogs With Heart Failure 
1068-128·178A
Ventricular arrhythmia
A Multicenter Study of Depression as a Predictor for 
Appropriate Shocks Among Patients With Implantable 
Cardioverter Defibrillators 1053-211·116A
Abnormal Calcium Handling and Focal Source 
Ventricular Fibrillation During Subacute Myocardial 
Infarction in Rabbits 1001-15·4A
Angiotensin-Converting Enzyme Inhibitors Reduce the 
Incidence of Implantable Cardioverter Defibrillator 
Therapy in Idiopathic Dilated Cardiomyopathy With 
Congestive Heart Failure  817-4·127A
Assessment of Microvolt T Wave Alternans on and off 
Beta-Blocker Therapy  874-3·150A
Autologous Fibroblast Transplantation Into Myocardial 
Infarcts in Pigs: Effects on Arrhythmogenesis and 
Arrhythmic Threshold 1110-217·129A
Brugada-Type Electrocardiographic Pattern and 
ST-Segment Alternans in Right Precordial Leads 
During Percutaneous Coronary Intervention of the 
Proximal Right Coronary Artery 1130-220·137A
Cardiac Resynchronization Therapy Results in a Lower 
Arrhythmia Burden 1091-209·125A
Different Criteria of Cardiac Resynchronization Therapy 
Have Different Prognostic Value for Worsening Heart 
Failure or Major Arrhythmic Events in Idiopathic 
Dilated Cardiomyopathy 1127-107·210A
Does Abatement of Ventricular Ectopy With Exercise 
Mean a Better Prognosis? 1146-106·223A
Does Elevating Catecholamine Concentrations Impact 
the Defibrillation Threshold? 1059-20·15A
ECG Characteristics in Andersen Syndrome Patients 
With KCNJ2 Mutations  850-3·143A
Effects of Fish Oil Supplements on Human Myocardial 
Omega-3 Fatty Acid Levels and Correlations With 
Erythrocytes  883-3·305A
Heart Rate Dynamics Before the Onset of Ventricular 
Tachyarrhythmias: Results of the Cardioverter 
Defibrillator Registry MARITA 1091-211·125A
Impact of Left Ventricular Remodeling Upon Ventricular 
Ectopic Activity in Patients With Preserved Systolic 
Function 1013-116·161A
Predictors of Life-Threatening Ventricular Arrhythmias 
in High-Risk Patients With ST Elevation Acute 
Myocardial Infarction 1060-79·261A
Prior Ischemia Enhances Arrhythmogenicity in Isolated 
Canine Ventricular Wedge Model of Long QT 3 
1130-221·137A
Prognostic Value of Ventricular Arrhythmias in Patients 
With Unstable Angina 1060-82·261A
QRS Duration Does Not Predict Occurrence of 
Ventricular Tachyarrhythmias in Primary Prevention 
Patients With Implantable Cardioverter-Defibrillators 
1116-39·29A
Ranolazine Inhibits Late Sodium Current in Isolated 
Left Ventricular Myocytes of Dogs With Heart Failure 
1068-128·178A
Reduction of QRS Duration After Pulmonary Valve 
Replacement in Adult Fallot Patients Is Related to 
Degree of Reduction of Right Ventricular Volume 
1039-199·378A
Robust Long-Term Cardiac Monitoring Using Dry, 
Nonadhesive Capacitive Electrodes 1148-223·141A
Severe Frequent Ventricular Ectopy After Exercise as a 
Predictor of Death in Patients With Advanced Systolic 
Heart Failure 1146-107·223A
Temporal Patterns of Ventricular Tachyarrhythmia 
Recurrences Follow a Weibull Distribution 
1053-212·116A
The Influence of Atrial and Ventricular Pacing on T 
Wave Alternans 1015-219·108A
The Predictive Value of Electrophysiologic Testing: 
Subgroup Analysis in the Dual Chamber and VVI 
Implantable Defibrillator (DAVID) Trial 1053-213·117A
The Role of Slow Delayed Rectifier Potassium Current 
(IKs) in Cardiac Electrophysiology and Atrial 
Fibrillation 1059-18·14A
The World Trade Center Attack: Increased Frequency of 
Defibrillator Shocks for Ventricular Arrhythmias in 
Patients Living Remotely From New York City 
1091-210·125A
Transplantation of Autologous Bone Marrow 
Mononuclear Cells Does Not Alter Arrhythmia 
Threshold in Adult Swine With Chronic Myocardial 
Ischemia 1078-98·271A
Underutilization of Implantable 
Cardioverter-Defibrillators in Survivors of Sudden 
Cardiac Death: Discrepancies by Sex, Race, and 
Hospital Size 1147-213·139A
Utility of Intracardiac Echocardiography to Guide 
Radiofrequency Catheter Ablation of Ventricular 
Tachycardia of Different Etiologies 1150-152·359A
Value of Electrocardiographic Parameters in Identifying 
Patients With a Mild Form of Arrhythmogenic Right 
Ventricle Dysplasia 1015-218·108A
Ventricular fibrillation
Cariporide but Not Epinephrine Prevents Ischemic 
Contracture During Closed-Chest Resuscitation 
1154-91·300A
Effects of Incomplete Chest Wall Decompression 
During Cardiopulmonary Resuscitation on Coronary 
and Cerebral Perfusion Pressures in a Porcine Model 
of Cardiac Arrest 1154-94·301A
Excessive Ventilation During Cardiopulmonary 
Resuscitation Decreases Survival Rates in a Porcine 
Model of Cardiac Arrest 1059-1·10A
Implant Defibrillator Threshold Characteristics in an 
Implantable Cardioverter Defibrillator Population 
Receiving Cardiac Resynchronization Therapy  
817-5·128A
Incidence and Prognosis of Ventricular Tachycardia and 
Ventricular Fibrillation After Non-ST Elevation Acute 
Coronary Syndromes: Insights From the Global 
Registry of Acute Coronary Events 1053-210·116A
Regional Distribution of Depolarization Alternans 
Preceding Ventricular Fibrillation Onset in a Canine 
Ischemic Model 1116-40·29A
Regionally Altered Action Potential Duration Restitution 
in Swine With Hibernating Myocardium and Sudden 
Cardiac Death 1110-219·129A
Ventricular Fibrillation Triggered by Thoracic 
Compression During Out-of-Hospital Cardiac Arrest 
Resuscitation in the Piacenza Vita Project 
1154-98·302A
Ventricular function
A Novel Approach in Risk Stratification: Combined 
Assessment of Regional Perfusion and Function 
From Rest/Stress Tc-99m Sestamibi Gated SPECT 
1170-149·369A
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Akinetic Segments of Myocardial Infarction Contain 
Contracting Myocytes: A Finite Element Model Study 
1068-123·177A
Alterations in Cell Signaling Pathways During 
Pregnancy and Postpartum Cardiac Remodeling  
849-5·226A
Assessment of Left Ventricular Torsional Deformation 
by Doppler Tissue Imaging: A Validation Study Using 
Tagged Magnetic Resonance Imaging  866-3·372A
Assessment of Left Ventricular Volumes and Ejection 
Fraction by Live 3-D–Contrast Enhanced 
Echocardiography Comparison With Cine Magnetic 
Resonance Imaging 1113-156·343A
Assessment of Ventricular Untwisting Recoil Velocity by 
Doppler Tissue Echocardiography: An Index of 
Relaxation Time Constant 1087-133·189A
Brain Natriuretic Peptide Correlates With Myocardial 
Performance Index in Congenital Heart Disease 
Patients 1152-201·391A
Cancion Cardiac Recovery System: Hemodynamic and 
Renal Effects 1088-123·190A
Cardiac Dysfunction in Non-ST Elevation ACS Is Partly 
Reversible: Analysis of Serial Measurements of 
NT-Pro B-Type Natriutetic Peptide  884-2·306A
Cardiac Structural and Functional Responses to Salt 
Loading in Spontaneosly Hypertensive Rats 
1142-185·513A
Cause of Death Across Full Spectrum of Ventricular 
Function in Patients With Heart Failure: The CHARM 
Study 1069-113·180A
Changing Outlook After Aortic Valve Surgery for 
Chronic Aortic Regurgitation With Severe Left 
Ventricular Dysfunction  851-4·439A
Chronic Infusion of Bradykinin Preserves Vascular 
Nitric Oxide-Mediated Endothelial Function and 
Limits the Alteration in Left Ventricular Function 
During Pacing-Induced Heart Failure in Conscious 
Dogs 1144-103·218A
Chronic Treatment With Carvedilol Improves Left 
Ventricular Pump Performance by Increasing Intrinsic 
Myocardial Contractility in Patients With Heart Failure 
1012-122·157A
Clinical and Magnetic Resonance Imaging 
Characteristics of Pathologically Confirmed Left 
Ventricular Thrombus in Patients With 
Cardiomyopathy 1126-114·208A
Comparison of Modified Acoustic Quantification With 
Echocardiographic Contrast and Radionuclide 
Ventriculography for Evaluation of Left Ventricular 
Ejection Fraction  881-5·374A
Determinants of Visual 2-D Echo Assessment of Left 
Ventricular Wall Motion: Comparison With Myocardial 
Thickening on Cardiac Magnetic Resonance Imaging 
1112-141·340A
Diastolic Dysfunction in Children and Young Adults With 
Marfan Syndrome 1127-103·209A
Diastolic Heart Failure in Patients Hospitalized With 
Symptomatic Cerebral and Peripheral Vascular 
Disease  887-5·242A
Differential Response of Radial Versus Longitudinal 
Myocardial Velocities to Dobutamine Stress: 
Noninvasive Measurement by Tissue Doppler 
Imaging 1001-30·8A
Does Improvement of Left Ventricular Ejection Fraction 
in Patients With Viable Myocardium Persist Over the 
Long-Term After Coronary Revascularization? 
1088-129·192A
Doppler Tissue Imaging Analysis of Ventricular 
Function After Surgical and Transcatheter Closure of 
Atrial Septal Defect 1019-204·377A
Dynamic Changes of the Tricuspid Annulus and 
Papillary Muscles During the Cardiac Cycle 
1067-138·431A
Effects of Inotropic Stimulation on Left Ventricular 
Torsional Deformation in Tachycardia-Induced Dilated 
Cardiomyopathy 1144-127·218A
Efficacy of Granulocyte-Colony Stimulating Factor After 
Coronary Ligation in Rats: Evaluation by 
Echocardiographic Acoustic Quantification and 
Myocardial Contrast 1061-97·265A
Enhanced Pressure Wave Reflection Contributes to 
Left Ventricular Diastolic Dysfunction in Hypertension  
873-2·527A
Frank Starling Mechanism Is an Independent 
Contributor to Ventricular Performance Variability in 
Atrial Fibrillation 1014-213·106A
Growth Hormone–Releasing Peptide Can Suppress 
Myocardial Oxidative Stress and Ameliorate 
Progressive Left Ventricular Remodeling in 
Cardiomyopathic Hamsters 1106-185·494A
Human Umbilical Cord Mononuclear Cells Limit Acute 
Myocardial Infarction Size 1078-92·269A
Impedance Cardiography in Heart Failure Patients in 
the Intensive Care Unit: Its Value in the Detection of 
Left Ventricular Systolic Dysfunction and Correlation 
With the Echocardiogram 1126-109·207A
Incidence and Predictors of Left Ventricular Dysfunction 
in Patients With Takayasu or Giant Cell Aortitis 
1046-167·460A
Incremental Value of Transient Poststress Left 
Ventricular Dysfunction After Dobutamine-Atropine 
Stress Echocardiography 1151-147·360A
Intensive Aerobic Physical Training Decreases 
Age-Related Decline of Left Ventricular Diastolic 
Function 1059-28·17A
Left Atrial Enlargement in Hypertrophic 
Cardiomyopathy: The Importance of Left Ventricular 
Hypertrophy and Diastolic Dysfunction 
1108-129·201A
Long-Term Afterload Reduction Halts Progression of 
Left Ventricular Dysfunction in Patients With Chronic 
Compensated Severe Mitral Regurgitation 
1067-137·431A
Mismatch of the Coronary Circulation: Impact on the 
Systemic Right Ventricle  840-2·390A
Myocardial Performance Index in Pediatric Patients 
With Primary Pulmonary Hypertension: Correlation 
With Pulmonary Artery Pressure and Response to 
Vasodilators 1134-200·388A
Noninvasive Diagnosis of Acute Coronary Syndrome 
Among Patients With Chest Pain by 
Echocardiographic Detection of Postischemic 
Regional Left Ventricular Delayed Relaxation Using 
Color Kinesis 1037-148·318A
Nonterminal Pro B-Type Natriuretic Peptide in Patients 
With Chronic Heart Failure: Correlation With B-Type 
Natriuretic Peptide and Left Ventricular Structure and 
Function  859-4·235A
Optimal Echocardiographic Method for Determination of 
Right Ventricular Volumes and Systolic Function 
1113-154·343A
Optimal Preload Adjustment of Right Ventricular Power 
Allows for Single Beat Estimation of Contractility 
1144-129·219A
Optimal Timing for Pulmonary Valve Replacement in 
Adults After Tetralogy of Fallot Repair: A Magnetic 
Resonance Imaging Study  886-5·398A
PG-530742, a Novel Matrix Metalloproteinase Inhibitor, 
Improves Left Ventricular Function and Attenuates 
Remodeling in Dogs With Chronic Heart Failure 
1116-12·22A
Pulse Pressure as Cardiovascular Risk Marker During 
Losartan or Atenolol Based Therapy in Hypertensive 
Patients With Electrocardiographic Left Ventricular 
Hypertrophy (the LIFE Trial) 1009-166·448A
Pyrroloquinoline Quinone Decreases Myocardial Infarct 
Size and Improves Cardiac Function in Rat Models of 
Ischemia and Ischemia-Reperfusion 1002-101·245A
Quantitative Regional and Global Right Ventricular 
Geometry in Health and Disease by Real-Time 3-D 
Echocardiography 1059-36·18A
Relation of Diastolic Strain Measurements by Doppler 
Echocardiography to Myocardial Structure and 
Function in Healing Canine Infarcts: Implications for 
the Assessment of Myocardial Viability 
1168-164·365A
Relative Importance of Errors in 2-D Echocardiographic 
Calculation of Left Ventricular Volumes: Insights From 
Live 3-D Echocardiography and Cardiac Magnetic 
Resonance Imaging 1113-153·343A
Right Ventricular Dysfunction on Preoperative 
Transesophageal Echocardiography Predicted Poor 
Outcomes of Cardiac Surgery 1131-150·349A
Right Ventricular Function Recovery After Acute 
Myocardial Infarction: The Relation With Left 
Ventricular Function and Interventricular Septum 
Motion-The GISSI-3 Echo Substudy 1108-115·198A
Simplified Three-Dimensional Measurement of Left 
Ventricular Volume and Ejection Fraction Using 
Automated Contour Tracking Method in Patients 
1037-141·317A
Soluble Tumor Necrosis Factor Receptor (Etanercept) 
Treatment Enhances Left Ventricular Dysfunction in 
an Experimental Model of Chronic Chagas Disease 
Cardiomyopathy  849-4·225A
Strain Echocardiography Predicts Reduced Ventricular 
Function in the Systemic Right Ventricle 
1134-201·388A
Strain Rate and Strain Rate-Derived Time to Onset of 
Relaxation Can Be Used for the Early Detection of 
Impaired Myocardial Function in Asymptomatic Boys 
With Duchenne Muscular Dystrophy 1013-113·160A
The CenterSurface Method for Quantatative Evaluation 
of Cardiac Magnetic Resonance Regional Wall 
Thickening 1126-112·207A
The Novel Organic Nitroxyl Donor, Isopropylamine/
Nitric Oxide Exerts Beta-Independent Positive 
Inotropy/Lusitropy in Failing Hearts 1144-104·218A
The Peroxisome Proliferator Activated Receptor-_ 
Activator, Fenofibrate, Improves Recovery of Left 
Ventricular Contractile Function After Ischemia and 
Reperfusion in Pigs 1002-79·243A
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